data_2ksp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ksp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 6.2 t90 . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 108.526 -0.916 . . . . 0.94 108.526 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.2 m -56.79 -26.06 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.911 -0.586 . . . . 1.86 112.28 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.633 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 40.8 t -62.77 -19.42 23.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.898 0.38 . . . . 2.02 110.829 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.34 -23.38 64.4 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.789 -0.72 . . . . 0.67 111.982 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -84.11 -28.13 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.794 0.807 . . . . 3.38 109.314 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.909 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.1 m-20 -84.29 -28.08 27.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.288 -1.324 . . . . 1.82 111.455 -175.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 4.2 mmmp? -47.06 -54.73 18.64 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 115.342 1.608 . . . . 1.61 115.342 -168.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.5 Cg_endo -50.21 -41.77 49.0 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.279 1.986 . . . . 0.66 112.792 -173.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.4 m -70.63 -43.98 68.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.759 -0.655 . . . . 1.21 111.026 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.909 ' CE2' ' HB3' ' A' ' 49' ' ' ASP . 16.6 m-85 -76.74 -19.79 57.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.074 -0.512 . . . . 1.49 110.229 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.96 -44.65 80.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.894 -0.78 . . . . 1.86 108.894 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -61.91 -45.51 93.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.382 -0.826 . . . . 2.0 110.536 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.11 -39.48 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.153 0.501 . . . . 1.28 110.58 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.59 -37.23 75.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.625 -0.716 . . . . 0.52 110.619 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -75.82 -24.69 55.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 3.37 112.11 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.1 p -81.63 -14.95 56.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.575 -0.45 . . . . 1.41 111.393 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.7 mt -90.88 3.92 53.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.444 -0.344 . . . . 1.96 110.75 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.1 t 68.76 84.86 0.14 Allowed Pre-proline 0 C--O 1.232 0.151 0 O-C-N 123.949 0.78 . . . . 1.74 111.246 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.67 110.84 3.17 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.368 2.045 . . . . 0.76 112.27 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.22 116.07 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.258 0.552 . . . . 2.08 110.195 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 60.31 23.18 12.64 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.608 -0.724 . . . . 2.3 111.257 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.26 18.53 60.53 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.959 -0.564 . . . . 0.7 113.645 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HG2' ' HB3' ' A' ' 100' ' ' LEU . 37.3 tttt -153.84 125.19 7.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.301 0.551 . . . . 2.76 109.765 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.4 pt -85.32 155.46 3.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.159 0.504 . . . . 1.05 110.874 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.466 ' HA ' HD22 ' A' ' 100' ' ' LEU . 73.5 p -87.37 176.19 7.63 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.375 -0.83 . . . . 1.09 110.995 -176.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.446 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -66.24 -26.91 72.65 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.847 -0.692 . . . . 0.4 112.468 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.481 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -69.84 -43.62 71.6 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.922 0.391 . . . . 1.09 111.145 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -60.92 -51.89 67.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.714 0.769 . . . . 1.73 109.996 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.434 ' HB3' ' HZ3' ' A' ' 90' ' ' TRP . . . -73.54 -24.29 60.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.481 -0.781 . . . . 1.17 110.985 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.654 ' HD3' ' HB2' ' B' ' 150' ' ' PRO . 34.0 ttpt -64.1 -46.84 82.47 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.586 -0.446 . . . . 1.25 110.278 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.692 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 5.4 ptpp? -71.09 -27.32 63.53 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 120.232 -0.587 . . . . 2.79 110.728 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.541 ' HA ' ' HZ1' ' A' ' 78' ' ' LYS . 17.7 tp10 -67.3 -44.12 80.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.228 0.537 . . . . 0.82 109.851 174.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.477 ' HE1' ' HB1' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -61.45 -39.57 91.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.427 -0.806 . . . . 1.38 111.674 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' A' ' 74' ' ' LYS . 19.2 m -73.72 -23.03 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.366 -0.534 . . . . 1.53 110.71 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.692 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 32.6 mtmm -73.17 -24.14 60.52 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.981 0.419 . . . . 3.56 110.147 174.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.2 m -68.84 -16.04 63.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 1.06 111.089 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? 67.59 31.08 6.31 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.441 0.534 . . . . 2.48 112.441 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' A' ' 81' ' ' LEU . 3.6 mm? -97.66 152.92 38.41 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.486 -0.325 . . . . 2.1 110.16 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.537 ' O ' HD12 ' A' ' 86' ' ' LEU . 35.5 Cg_exo -57.64 143.12 95.67 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.552 2.168 . . . . 0.9 111.616 174.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -57.38 -34.77 69.19 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.85 0.357 . . . . 1.09 111.436 -173.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.0 m -58.6 -38.86 78.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.872 -0.604 . . . . 1.14 110.948 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.593 ' O ' HG12 ' A' ' 89' ' ' ILE . 98.6 t -70.21 -39.24 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.81 -0.632 . . . . 1.19 109.426 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 82' ' ' PRO . 6.5 mp -57.67 -47.02 83.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.462 -0.79 . . . . 2.0 110.527 178.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.53 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -60.67 -39.92 97.28 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.033 -0.603 . . . . 0.37 112.401 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -69.96 -45.34 67.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.664 0.269 . . . . 1.64 110.604 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 85' ' ' VAL . 46.0 mm -56.64 -47.09 82.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 1.5 110.266 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.446 ' CH2' ' HA2' ' A' ' 69' ' ' GLY . 22.9 t-105 -64.46 -46.62 82.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.855 -0.611 . . . . 0.41 110.906 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -66.32 -24.1 66.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 2.0 111.38 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 126' ' ' LEU . 4.3 mm? -86.72 -47.44 9.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.349 -0.387 . . . . 2.23 110.841 173.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.48 -38.16 83.96 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.95 0.722 . . . . 1.1 112.95 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -76.59 86.28 3.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.274 0.559 . . . . 0.59 109.719 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.0 t -76.62 -25.01 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.648 -0.706 . . . . 2.11 110.786 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.546 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 67.1 m-20 -70.49 -24.82 62.92 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.606 -0.438 . . . . 1.45 110.871 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 97' ' ' LYS . 41.2 mmtm 56.27 35.78 26.36 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.776 0.798 . . . . 3.13 108.997 -170.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.546 ' OD1' ' HB2' ' A' ' 96' ' ' ASP . 9.0 p-10 -99.6 -18.72 17.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.486 -1.234 . . . . 1.22 110.692 -173.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.72 -6.85 77.34 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.613 -0.803 . . . . 0.51 112.777 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.503 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . 67.8 mt -117.67 160.15 21.79 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.458 -0.571 . . . . 1.2 109.458 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.41 HD23 ' HB3' ' A' ' 105' ' ' GLU . 65.0 mt -121.54 113.96 20.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.977 0.417 . . . . 1.38 110.321 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.727 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 3.4 p30 -84.29 -176.28 6.18 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.56 -0.904 . . . . 1.42 108.56 171.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -63.7 -28.16 69.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.623 0.601 . . . . 1.73 112.623 -170.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.727 ' HG2' ' OD1' ' A' ' 102' ' ' ASP . 13.3 pt-20 -85.42 -39.07 17.95 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 119.841 -0.744 . . . . 1.53 110.704 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.41 ' HB3' HD23 ' A' ' 101' ' ' LEU . 46.0 mt-10 -63.61 -45.84 88.52 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.361 0.601 . . . . 1.2 110.27 175.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -64.44 -39.33 93.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.197 -0.91 . . . . 0.49 110.657 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.79 79.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.143 -0.481 . . . . 1.1 110.734 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.2 mt -68.98 -41.42 77.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.623 -0.262 . . . . 1.96 110.462 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.477 ' HB1' ' HE1' ' A' ' 76' ' ' MET . . . -54.01 -52.07 61.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 1.08 110.509 174.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -65.6 -39.78 91.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.273 -0.421 . . . . 1.54 110.95 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.634 ' O ' HG23 ' A' ' 115' ' ' VAL . 79.1 t60 -57.87 -47.29 83.17 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.534 -0.303 . . . . 0.75 110.428 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.468 HD11 HD12 ' A' ' 122' ' ' LEU . 92.5 mt -65.18 -43.3 92.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.526 -0.306 . . . . 1.54 111.018 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.451 HD11 ' HE2' ' A' ' 76' ' ' MET . 73.9 mt -56.63 -44.24 80.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 120.989 0.423 . . . . 1.07 110.304 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.648 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 62.9 tttp -61.35 -42.87 99.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.898 -0.592 . . . . 2.6 110.833 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 111' ' ' HIS . 29.8 t -55.92 -42.02 69.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.889 0.376 . . . . 1.16 110.062 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 29.1 mmmt -62.61 -43.77 97.98 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.748 -0.66 . . . . 1.86 110.802 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.96 -29.59 70.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.36 -0.382 . . . . 1.46 111.494 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.648 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 53.9 mm-40 -72.18 -4.77 31.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.24 -0.436 . . . . 1.65 110.753 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.34 2.24 56.71 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.851 -0.69 . . . . 0.8 112.295 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.594 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 72.3 m-70 -112.33 -178.36 3.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.755 0.312 . . . . 1.31 110.177 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.43 156.45 46.96 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.967 0.413 . . . . 3.6 110.649 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.468 HD12 HD11 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -80.81 140.25 50.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.691 -0.686 . . . . 2.04 109.271 177.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.53 8.09 2.02 Favored 'Trans proline' 0 N--CA 1.476 0.483 0 C-N-CA 122.997 2.465 . . . . 1.16 113.655 -174.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.7 19.15 11.58 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.242 0.544 . . . . 1.47 111.027 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.474 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 39.6 m-20 -120.48 127.38 52.16 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.862 -0.608 . . . . 1.94 110.088 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.475 HD12 ' O ' ' A' ' 92' ' ' LEU . 86.6 mt -94.18 97.34 2.17 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.317 -0.401 . . . . 1.29 110.284 167.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.698 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 86.0 Cg_endo -83.02 173.03 10.41 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.666 2.244 . . . . 0.91 111.542 175.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.96 -31.32 52.47 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.811 2.34 . . . . 1.02 113.225 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -90.8 14.16 14.36 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.759 0.314 . . . . 1.1 111.627 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.698 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 31.2 mt -131.06 -28.91 1.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.413 -0.358 . . . . 1.44 110.504 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 85.8 t . . . . . 0 C--N 1.33 -0.274 0 N-CA-C 110.062 -0.347 . . . . 2.06 110.062 174.317 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 . . . . . 0 CA--C 1.518 -0.273 0 CA-C-O 121.253 0.549 . . . . 1.03 109.813 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.556 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 53.7 t-20 -114.97 117.76 41.35 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.202 -0.908 . . . . 0.55 109.772 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.654 ' HB2' ' HD3' ' A' ' 73' ' ' LYS . 59.1 Cg_endo -72.11 -2.76 12.09 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.955 2.437 . . . . 0.87 112.596 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 29.7 m-85 -107.87 5.96 26.93 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.287 -0.634 . . . . 0.55 109.287 175.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . 0.556 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 29.0 tt0 . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 114.851 -1.068 . . . . 1.42 108.508 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.9 t90 . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 121.534 0.683 . . . . 0.94 109.212 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.87 5.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.148 -0.933 . . . . 1.86 112.827 -173.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.488 HG13 ' HE2' ' A' ' 53' ' ' TYR . 24.6 t -93.95 -17.04 7.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.935 0.398 . . . . 2.02 110.091 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.18 -18.87 71.6 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.506 -0.854 . . . . 0.67 112.67 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -87.18 -26.83 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.917 0.389 . . . . 3.38 111.759 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 22.9 m-20 -101.1 -2.71 30.79 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.324 0.583 . . . . 1.82 109.878 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.566 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 2.8 tmtp? -55.17 -50.06 88.75 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 114.932 -1.031 . . . . 1.61 112.635 -175.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.9 Cg_endo -51.45 -38.63 64.15 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.546 2.164 . . . . 0.66 112.095 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 m -69.24 -40.08 78.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.829 -0.623 . . . . 1.21 110.716 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.488 ' HE2' HG13 ' A' ' 46' ' ' VAL . 14.5 m-85 -70.33 -24.29 62.97 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.127 0.489 . . . . 1.49 109.763 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.67 -44.74 61.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.478 -0.783 . . . . 1.86 109.989 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.09 -45.77 90.0 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.6 -0.727 . . . . 2.0 110.388 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.9 mt -64.33 -44.58 97.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 121.207 0.527 . . . . 1.28 110.73 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -52.06 -45.19 64.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.495 -0.775 . . . . 0.52 111.476 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -81.78 -23.71 36.41 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.36 0.504 . . . . 3.37 112.36 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.3 p -75.33 -16.79 60.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.136 0.493 . . . . 1.41 110.627 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 72.4 mt -84.46 -10.0 57.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.893 -0.594 . . . . 1.96 110.307 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.0 m 70.07 93.09 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.314 0 O-C-N 124.161 0.913 . . . . 1.74 111.311 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HA ' HG23 ' A' ' 67' ' ' ILE . 1.0 OUTLIER -84.23 140.67 8.79 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.654 2.903 . . . . 0.76 111.653 178.641 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.2 m -97.37 107.62 20.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.443 0.64 . . . . 2.08 110.326 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 m120 63.55 31.22 14.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.194 -0.912 . . . . 2.3 111.014 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.15 -0.01 66.09 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.726 -0.75 . . . . 0.7 114.37 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.522 ' HE2' ' HB2' ' A' ' 100' ' ' LEU . 71.8 tttt -137.47 138.21 39.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.755 0.778 . . . . 2.76 109.371 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.428 HG23 ' HA ' ' A' ' 62' ' ' PRO . 46.2 pt -93.14 156.71 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.632 -0.427 . . . . 1.05 111.102 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.402 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 50.0 p -88.24 -179.65 6.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.512 -0.767 . . . . 1.09 110.322 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.81 -14.46 81.48 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.554 -0.831 . . . . 0.4 111.808 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.03 -39.88 28.94 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.947 0.403 . . . . 1.09 110.745 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.7 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 5.4 m120 -63.44 -52.22 62.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.981 0.896 . . . . 1.73 109.653 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.436 ' HB2' ' HZ3' ' A' ' 90' ' ' TRP . . . -67.66 -26.45 66.21 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.267 -0.879 . . . . 1.17 110.732 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.436 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 35.7 ttmt -65.42 -47.79 75.02 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.743 -0.383 . . . . 1.25 110.739 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.7 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 19.8 ptmt -64.74 -31.0 72.02 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.928 0.394 . . . . 2.79 110.477 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HA ' ' HZ3' ' A' ' 78' ' ' LYS . 17.1 tp10 -71.11 -48.38 52.59 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.251 0.548 . . . . 0.82 110.21 175.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.421 ' HG3' HD21 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -58.13 -47.3 83.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.532 -0.758 . . . . 1.38 111.604 -178.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.8 m -67.47 -34.74 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.671 0.272 . . . . 1.53 110.804 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HZ3' ' HA ' ' A' ' 75' ' ' GLU . 3.2 mtpm? -64.38 -18.7 64.92 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 112.282 0.475 . . . . 3.56 112.282 174.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.4 m -84.18 2.32 40.26 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.744 0.307 . . . . 1.06 111.127 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? 54.92 50.36 15.74 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.76 0.652 . . . . 2.48 112.76 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.476 ' HB2' HD22 ' A' ' 86' ' ' LEU . 96.3 mt -120.49 141.44 32.1 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 110.092 -0.336 . . . . 2.1 110.092 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.514 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 37.1 Cg_exo -59.62 151.41 69.93 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.061 2.507 . . . . 0.9 112.82 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -51.41 -45.27 62.5 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.822 -0.627 . . . . 1.09 111.77 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.0 m -58.25 -41.39 84.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.01 0.434 . . . . 1.14 111.285 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 89' ' ' ILE . 46.2 t -68.88 -42.08 82.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.981 0.42 . . . . 1.19 109.881 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 82' ' ' PRO . 67.3 mt -62.31 -38.94 91.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.652 -0.704 . . . . 2.0 110.033 177.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.96 -37.22 94.04 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.792 -0.64 . . . . 0.37 112.251 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -66.6 -47.06 73.9 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.894 0.378 . . . . 1.64 110.034 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 85' ' ' VAL . 38.2 mm -55.08 -50.05 66.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.355 -0.839 . . . . 1.5 109.962 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.436 ' HZ3' ' HB2' ' A' ' 72' ' ' ALA . 34.9 t-105 -65.81 -44.5 85.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.919 -0.582 . . . . 0.41 111.545 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ttpt -67.46 -21.37 65.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.079 0.466 . . . . 2.0 110.738 -174.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.602 HD11 HD11 ' A' ' 122' ' ' LEU . 24.7 mt -91.92 -38.37 12.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.767 -0.651 . . . . 2.23 111.139 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.77 -35.36 67.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 1.1 111.781 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -85.09 82.28 8.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.744 0.783 . . . . 0.59 109.289 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.2 t -74.1 -27.68 22.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.072 -0.967 . . . . 2.11 110.951 -173.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 55.3 p30 -86.81 -10.14 54.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.565 -0.289 . . . . 1.45 111.191 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 53.51 51.52 15.1 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.493 0.495 . . . . 3.13 110.808 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -111.98 -8.68 14.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.061 -0.518 . . . . 1.22 111.089 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.1 4.84 86.42 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.97 -0.633 . . . . 0.51 112.529 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.522 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 52.3 mt -129.68 162.53 28.14 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.828 -0.434 . . . . 1.2 109.828 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.4 mt -122.66 117.52 25.97 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.801 -0.359 . . . . 1.38 110.946 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.05 -178.04 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.419 -0.956 . . . . 1.42 108.419 169.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -60.51 -29.23 68.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.892 0.331 . . . . 1.73 111.892 -173.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.78 -42.23 18.18 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.811 -0.356 . . . . 1.53 110.464 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -65.72 -40.44 92.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.22 0.534 . . . . 1.2 110.265 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -69.4 -34.48 74.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.678 -0.692 . . . . 0.49 109.998 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.33 -42.25 98.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.329 -0.396 . . . . 1.1 110.284 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 1.8 mm? -59.5 -44.16 93.17 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.713 -0.477 . . . . 1.96 109.713 173.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.443 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.58 -54.24 48.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.651 -0.704 . . . . 1.08 110.978 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -66.33 -34.88 78.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.736 0.303 . . . . 1.54 110.855 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 115' ' ' VAL . 85.4 t60 -63.7 -43.1 97.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.403 -0.362 . . . . 0.75 110.282 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 108' ' ' LEU . 96.1 mt -66.62 -39.83 88.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.305 -0.407 . . . . 1.54 110.624 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 109' ' ' ALA . 77.9 mt -61.39 -40.35 85.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.499 . . . . 1.07 109.951 174.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -59.6 -47.35 85.91 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.74 -0.664 . . . . 2.6 110.391 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 111' ' ' HIS . 21.1 t -56.54 -43.93 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.353 0.597 . . . . 1.16 110.263 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.68 -46.97 83.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.04 -0.982 . . . . 1.86 111.041 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.65 -17.24 51.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 1.46 111.384 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.501 ' HB3' ' HD2' ' A' ' 120' ' ' HIS . 11.7 mm-40 -70.01 -8.01 45.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.179 -0.464 . . . . 1.65 111.183 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.87 23.06 34.01 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.51 -0.853 . . . . 0.8 111.402 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.501 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 85.0 m-70 -129.67 -173.3 2.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.004 0.43 . . . . 1.31 110.123 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -134.18 160.08 38.92 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.618 -0.719 . . . . 3.6 110.441 -171.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.602 HD11 HD11 ' A' ' 92' ' ' LEU . 0.1 OUTLIER -106.8 115.32 60.6 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 115.039 -0.982 . . . . 2.04 108.806 173.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.07 24.3 0.3 Allowed 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.664 2.909 . . . . 1.16 114.445 -167.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 59.16 25.58 14.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.113 0.482 . . . . 1.47 111.036 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -131.28 138.78 49.43 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.03 -0.532 . . . . 1.94 110.047 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.457 ' HB3' ' CG1' ' A' ' 131' ' ' VAL . 96.7 mt -106.14 90.22 4.44 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.623 -0.262 . . . . 1.29 110.677 172.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -73.59 158.97 46.85 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.844 2.363 . . . . 0.91 112.33 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.55 -28.55 81.49 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.47 2.78 . . . . 1.02 114.177 -175.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -85.94 6.68 27.42 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.736 -0.385 . . . . 1.1 111.605 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 62.0 mt -122.92 -22.97 5.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.519 0.199 . . . . 1.44 111.397 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 126' ' ' LEU . 29.3 m . . . . . 0 C--N 1.324 -0.514 0 CA-C-O 120.741 0.305 . . . . 2.06 111.318 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.63 0.252 . . . . 1.03 110.352 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 53.2 t-20 -115.96 108.62 46.11 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.55 109.795 -175.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.23 -5.95 17.7 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.191 2.594 . . . . 0.87 112.65 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 29.6 m-85 -107.01 -4.43 19.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.918 0.39 . . . . 0.55 110.221 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 30.6 tt0 . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 121.879 0.847 . . . . 1.42 108.926 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.2 t90 . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 108.013 -1.106 . . . . 0.94 108.013 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.524 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 90.6 t -56.51 -29.56 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.843 -0.617 . . . . 1.86 112.229 -171.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 111' ' ' HIS . 18.9 m -77.69 -13.36 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 122.179 -0.326 . . . . 2.02 111.109 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.8 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -65.09 -24.46 70.34 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.063 -0.589 . . . . 0.67 112.255 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 18.5 ptpt -87.17 0.34 55.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.746 0.307 . . . . 3.38 111.234 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -138.71 21.24 2.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.694 0.759 . . . . 1.82 109.767 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.8 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 5.0 mmmp? -57.86 -40.15 81.56 Favored Pre-proline 0 C--O 1.22 -0.484 0 CA-C-N 115.353 -0.84 . . . . 1.61 112.491 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 8.9 Cg_endo -50.35 -42.26 48.52 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 122.308 2.005 . . . . 0.66 112.527 176.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.7 m -69.59 -44.05 71.55 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.12 -0.491 . . . . 1.21 110.295 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -71.18 -22.65 62.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.953 -0.567 . . . . 1.49 110.416 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.71 -45.53 29.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.893 -0.781 . . . . 1.86 108.893 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.69 -54.07 43.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.3 -0.864 . . . . 2.0 110.629 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.2 mt -64.88 -44.52 96.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.234 -0.439 . . . . 1.28 111.435 -176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.411 ' HE1' HG12 ' A' ' 67' ' ' ILE . 51.2 t80 -58.56 -44.18 89.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.52 110.79 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 13.1 m-85 -76.34 -24.33 54.25 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.122 0.416 . . . . 3.37 112.122 -177.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 p -76.3 -15.97 59.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.025 0.44 . . . . 1.41 111.035 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mp -88.29 -4.25 58.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.979 -0.555 . . . . 1.96 110.516 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m 69.29 89.32 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.314 0 CA-C-N 115.232 -0.895 . . . . 1.74 111.735 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 58.7 Cg_endo -86.65 117.01 1.4 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.705 2.27 . . . . 0.76 112.747 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.1 t -91.45 132.79 34.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.258 -0.645 . . . . 2.08 109.258 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.8 p30 49.48 23.71 0.96 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.726 0.81 . . . . 2.3 112.108 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.78 6.75 61.95 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.073 -0.584 . . . . 0.7 113.403 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -135.74 155.58 50.15 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.673 0.749 . . . . 2.76 112.316 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.411 HG12 ' HE1' ' A' ' 57' ' ' PHE . 41.3 pt -114.13 152.82 15.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.749 -1.114 . . . . 1.05 108.775 171.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -88.0 175.65 7.67 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 120.449 -0.501 . . . . 1.09 110.23 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.94 -27.25 71.0 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.641 -0.79 . . . . 0.4 112.528 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.63 -48.36 82.13 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.954 0.407 . . . . 1.09 111.915 -176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -71.8 -40.78 68.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.282 0.563 . . . . 1.73 110.571 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.537 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -72.07 -28.79 63.55 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.465 -0.494 . . . . 1.17 110.095 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.405 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 40.7 ttmt -64.79 -50.15 67.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.725 -0.216 . . . . 1.25 110.533 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -62.18 -38.22 88.27 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.508 -0.315 . . . . 2.79 110.58 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.93 -50.64 72.96 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.423 0.63 . . . . 0.82 110.22 174.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.793 ' HB3' HD23 ' A' ' 86' ' ' LEU . 22.8 mmt -58.52 -45.24 89.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.528 -0.76 . . . . 1.38 112.197 -177.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.87 -16.6 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.946 0.403 . . . . 1.53 110.796 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -91.19 -5.76 54.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.169 -0.469 . . . . 3.56 111.063 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 7.1 t -89.54 -1.18 57.95 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.271 0.558 . . . . 1.06 110.135 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 79' ' ' SER . 9.1 mptt 70.82 16.61 6.61 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.236 0.828 . . . . 2.48 113.236 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.486 ' HB2' HD21 ' A' ' 86' ' ' LEU . 2.6 mm? -91.29 142.85 27.49 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.574 -0.45 . . . . 2.1 111.124 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.577 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 21.3 Cg_exo -65.49 154.87 71.77 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.263 2.642 . . . . 0.9 112.474 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -56.12 -41.23 74.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.223 -0.444 . . . . 1.09 111.55 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.462 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 7.9 m -58.21 -48.25 80.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.218 0.532 . . . . 1.14 110.938 178.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 89' ' ' ILE . 96.4 t -63.57 -42.06 94.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.731 -0.668 . . . . 1.19 110.479 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.793 HD23 ' HB3' ' A' ' 76' ' ' MET . 79.0 mt -61.92 -44.06 97.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.062 -0.517 . . . . 2.0 110.762 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.7 -31.63 71.85 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 121.027 -0.606 . . . . 0.37 112.308 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 84' ' ' THR . 55.4 mtpt -72.66 -46.56 53.26 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.747 0.308 . . . . 1.64 110.479 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 85' ' ' VAL . 43.5 mm -55.53 -52.08 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.66 -0.7 . . . . 1.5 109.899 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -63.78 -39.49 94.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.983 -0.553 . . . . 0.41 110.841 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -59.72 -35.62 74.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.773 0.32 . . . . 2.0 111.194 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.422 ' O ' HD13 ' A' ' 126' ' ' LEU . 6.3 mp -88.75 -34.6 17.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.146 -0.479 . . . . 2.23 111.343 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.21 -42.71 65.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.967 0.413 . . . . 1.1 111.757 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.566 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 24.9 t70 -89.33 91.11 8.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.385 0.612 . . . . 0.59 109.545 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.0 m -82.48 -29.78 9.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.118 -0.946 . . . . 2.11 112.204 -171.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -86.99 -13.11 45.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.665 -0.243 . . . . 1.45 111.151 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.566 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 17.0 mmmt 57.84 45.07 19.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.847 -0.615 . . . . 3.13 110.718 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.538 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 11.4 p-10 -93.29 -13.22 28.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.612 -0.722 . . . . 1.22 110.965 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.63 5.47 74.76 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.797 -0.716 . . . . 0.51 111.993 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.538 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 30.9 mt -128.27 166.27 18.91 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.241 -0.281 . . . . 1.2 110.241 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.0 mt -122.35 119.85 32.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.322 -0.399 . . . . 1.38 110.157 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -95.79 -175.86 3.55 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.168 -0.678 . . . . 1.42 109.168 171.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.34 -33.64 67.95 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.835 0.35 . . . . 1.73 111.495 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.96 -56.56 4.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.278 -0.419 . . . . 1.53 110.28 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.427 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 25.6 mt-10 -59.27 -37.0 76.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.732 -0.667 . . . . 1.2 111.096 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -71.23 -35.28 71.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.417 -0.356 . . . . 0.49 110.865 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.63 -38.32 90.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.735 0.302 . . . . 1.1 110.436 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.39 -41.03 96.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 1.96 110.12 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.422 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.06 -52.48 64.1 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.765 -0.652 . . . . 1.08 110.941 177.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.07 -30.1 69.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.452 . . . . 1.54 111.355 -176.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.53 ' O ' HG21 ' A' ' 115' ' ' VAL . 83.9 t60 -62.02 -45.86 91.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.776 0.322 . . . . 0.75 110.377 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.6 mt -68.87 -41.55 78.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.872 -0.604 . . . . 1.54 110.856 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 109' ' ' ALA . 78.1 mt -61.17 -39.97 84.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.951 -0.568 . . . . 1.07 110.034 176.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.597 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 32.3 tttm -56.26 -50.4 71.45 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.93 -0.577 . . . . 2.6 110.606 175.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.53 HG21 ' O ' ' A' ' 111' ' ' HIS . 46.0 t -51.34 -39.11 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.101 -0.5 . . . . 1.16 111.145 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -68.58 -30.39 69.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.722 0.296 . . . . 1.86 111.469 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.4 -34.55 67.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.97 0.414 . . . . 1.46 110.07 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.597 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 41.7 mm-40 -68.4 -25.96 65.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.884 -0.598 . . . . 1.65 109.611 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.52 35.08 4.5 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.604 -0.726 . . . . 0.8 112.802 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -132.99 173.55 11.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.066 0.433 . . . . 1.31 110.638 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.88 156.14 20.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.862 -0.608 . . . . 3.6 109.985 -177.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.26 135.18 24.65 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.546 -0.538 . . . . 2.04 109.546 176.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.36 4.66 4.22 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.013 2.476 . . . . 1.16 113.726 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 65.33 19.65 11.69 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.488 0.492 . . . . 1.47 111.425 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -131.27 148.63 52.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.048 -0.524 . . . . 1.94 110.126 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 92' ' ' LEU . 79.1 mt -109.05 108.81 60.78 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.867 -0.606 . . . . 1.29 110.38 173.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.631 ' HD2' HD13 ' A' ' 130' ' ' LEU . 26.4 Cg_exo -61.03 154.06 59.67 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.592 2.195 . . . . 0.91 111.662 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.49 -4.93 9.04 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.811 2.341 . . . . 1.02 113.116 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -100.94 4.03 42.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.981 0.419 . . . . 1.1 110.38 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.631 HD13 ' HD2' ' A' ' 127' ' ' PRO . 35.5 mt -116.21 -8.3 11.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 1.44 111.095 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.0 m . . . . . 0 C--N 1.326 -0.423 0 CA-C-O 121.433 0.635 . . . . 2.06 110.267 177.677 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 . . . . . 0 CA--C 1.514 -0.429 0 CA-C-O 121.104 0.478 . . . . 1.03 110.27 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.687 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 55.9 t-20 -138.52 116.17 9.17 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.474 -0.785 . . . . 0.55 109.39 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 23.1 Cg_exo -66.1 -14.48 44.59 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 123.442 2.761 . . . . 0.87 113.362 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.665 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 17.9 m-85 -107.33 -1.62 21.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.498 0.666 . . . . 0.55 110.133 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . 0.687 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 42.4 tt0 . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 114.673 -1.149 . . . . 1.42 108.39 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.9 t90 . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 108.587 -0.894 . . . . 0.94 108.587 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.1 t -54.82 -32.25 25.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.951 -0.568 . . . . 1.86 111.164 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 45.2 t -79.04 -15.21 13.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.93 -0.577 . . . . 2.02 111.321 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.83 -23.88 71.11 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.798 -0.715 . . . . 0.67 111.813 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -87.09 -16.02 36.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 122.304 1.049 . . . . 3.38 109.881 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.424 ' HB3' ' HE2' ' A' ' 53' ' ' TYR . 0.3 OUTLIER -104.84 -11.74 16.61 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.433 -1.712 . . . . 1.82 110.893 -163.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 3.6 mmmp? -57.79 -55.81 41.09 Favored Pre-proline 0 C--O 1.224 -0.281 0 N-CA-C 114.521 1.304 . . . . 1.61 114.521 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 10.5 Cg_endo -48.8 -37.88 36.62 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.73 2.287 . . . . 0.66 113.44 -168.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.543 ' O ' HG13 ' A' ' 56' ' ' ILE . 16.8 m -71.29 -44.39 65.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.059 -0.519 . . . . 1.21 110.88 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.424 ' HE2' ' HB3' ' A' ' 49' ' ' ASP . 12.2 m-85 -78.26 -22.32 48.49 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.085 -0.507 . . . . 1.49 109.992 -176.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -71.96 -42.07 66.98 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.108 -0.701 . . . . 1.86 109.108 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -53.41 -52.83 58.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.125 -0.943 . . . . 2.0 109.898 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 52' ' ' THR . 15.8 mt -67.84 -31.33 51.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.109 -0.95 . . . . 1.28 110.637 -178.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -59.91 -37.38 79.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.765 -0.652 . . . . 0.52 110.774 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -70.83 -24.94 62.64 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.771 0.285 . . . . 3.37 111.771 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 p -86.23 -5.68 59.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.848 0.356 . . . . 1.41 111.399 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.476 HD11 ' OE1' ' A' ' 75' ' ' GLU . 8.8 mp -96.19 5.19 51.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.978 0.418 . . . . 1.96 110.086 175.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m 64.71 86.15 0.14 Allowed Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 115.074 -0.966 . . . . 1.74 111.567 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.28 115.24 4.19 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.103 2.535 . . . . 0.76 112.192 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.5 t -89.28 113.48 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.601 -0.518 . . . . 2.08 109.601 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 65.09 22.65 12.35 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.012 -0.54 . . . . 2.3 110.296 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.02 19.12 59.81 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.903 -0.59 . . . . 0.7 112.408 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.606 ' HZ2' ' HB3' ' A' ' 102' ' ' ASP . 32.4 tttp -144.2 131.79 21.13 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.652 -0.499 . . . . 2.76 109.652 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 101' ' ' LEU . 38.9 pt -92.71 152.54 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.36 -0.536 . . . . 1.05 111.078 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.437 ' HA ' HD22 ' A' ' 100' ' ' LEU . 37.6 p -85.07 160.46 19.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.721 -0.672 . . . . 1.09 110.982 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.18 -29.71 71.89 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.153 -0.546 . . . . 0.4 112.596 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.9 -50.57 72.12 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.029 0.442 . . . . 1.09 111.634 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.457 ' HA ' ' HG2' ' A' ' 74' ' ' LYS . 40.1 m-80 -74.69 -37.01 62.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.897 -0.592 . . . . 1.73 110.954 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.406 ' HB1' ' HZ3' ' A' ' 90' ' ' TRP . . . -69.39 -27.5 65.35 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.378 -0.374 . . . . 1.17 110.458 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.551 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 38.8 ttpt -72.6 -49.54 31.43 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.537 -0.301 . . . . 1.25 111.094 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 71' ' ' ASN . 20.2 ptmt -59.82 -36.86 77.65 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 121.132 -0.227 . . . . 2.79 110.481 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.476 ' OE1' HD11 ' A' ' 60' ' ' LEU . 17.3 tp10 -61.46 -52.46 64.44 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.492 0.663 . . . . 0.82 110.142 175.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.77 ' HG2' ' HG ' ' A' ' 86' ' ' LEU . 17.5 ttm -67.64 -27.47 66.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.426 -0.806 . . . . 1.38 111.376 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.55 -40.46 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 116.432 -0.349 . . . . 1.53 110.231 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -73.36 -8.89 57.78 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.226 -0.443 . . . . 3.56 110.742 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 7.4 t -73.31 -12.63 60.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.191 -0.459 . . . . 1.06 110.447 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 79' ' ' SER . 45.3 mmtm 73.5 26.67 1.94 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.411 0.685 . . . . 2.48 112.608 178.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.81 144.27 27.86 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.518 -0.549 . . . . 2.1 109.518 172.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.543 ' O ' HD11 ' A' ' 86' ' ' LEU . 12.6 Cg_endo -60.23 139.06 85.15 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.814 2.343 . . . . 0.9 112.563 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.425 ' HA ' HD21 ' A' ' 86' ' ' LEU . 15.9 m120 -51.83 -35.03 43.05 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.031 0.532 . . . . 1.09 112.164 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.496 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 2.7 m -57.64 -40.73 79.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.383 0.611 . . . . 1.14 110.634 177.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.573 ' O ' HG12 ' A' ' 89' ' ' ILE . 66.8 t -74.19 -38.71 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.041 -0.726 . . . . 1.19 109.041 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.77 ' HG ' ' HG2' ' A' ' 76' ' ' MET . 5.1 mp -58.77 -45.72 89.14 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.992 -1.003 . . . . 2.0 110.321 176.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.51 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -59.46 -39.68 95.21 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.528 -0.76 . . . . 0.37 112.001 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 84' ' ' THR . 55.4 mtpt -71.09 -43.95 66.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.751 0.31 . . . . 1.64 110.349 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.573 HG12 ' O ' ' A' ' 85' ' ' VAL . 45.0 mm -57.3 -47.44 84.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 1.5 110.201 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.406 ' HZ3' ' HB1' ' A' ' 72' ' ' ALA . 15.3 t-105 -66.7 -41.42 88.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 0.41 110.398 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.417 ' HZ1' ' CD ' ' B' ' 152' ' ' GLU . 3.5 tppp? -64.86 -22.49 67.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.164 -0.471 . . . . 2.0 111.101 -175.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.515 HD12 ' HG ' ' A' ' 126' ' ' LEU . 4.0 mm? -93.29 -41.63 9.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 2.23 111.018 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.14 88.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.563 -0.29 . . . . 1.1 111.648 -176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -83.51 75.52 10.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.371 -0.603 . . . . 0.59 109.371 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.4 t -67.93 -34.72 68.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.369 -0.832 . . . . 2.11 110.987 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.81 -15.37 51.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.407 -0.815 . . . . 1.45 111.866 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 60.66 72.48 0.52 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.515 0.509 . . . . 3.13 111.63 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p30 -129.26 -14.43 4.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.007 -0.542 . . . . 1.22 111.328 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.13 4.34 84.22 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.347 -0.93 . . . . 0.51 112.234 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 68' ' ' THR . 67.7 mt -127.88 160.48 31.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.447 -0.575 . . . . 1.2 109.447 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.45 HD23 ' HB3' ' A' ' 105' ' ' GLU . 51.6 mt -124.28 118.32 26.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.804 0.335 . . . . 1.38 110.565 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.606 ' HB3' ' HZ2' ' A' ' 66' ' ' LYS . 6.1 p30 -82.84 -175.25 5.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.062 -0.718 . . . . 1.42 109.062 167.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -61.67 -31.23 71.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.643 0.259 . . . . 1.73 111.115 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -72.11 -57.43 4.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.446 -0.343 . . . . 1.53 110.183 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.45 ' HB3' HD23 ' A' ' 101' ' ' LEU . 32.0 mt-10 -56.06 -44.63 79.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.075 -0.512 . . . . 1.2 111.04 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -66.9 -38.24 85.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.898 -0.592 . . . . 0.49 110.954 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.28 85.14 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.943 -0.303 . . . . 1.1 110.632 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.12 -43.83 95.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.99 -0.374 . . . . 1.96 109.99 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.33 -58.03 8.51 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.041 -0.527 . . . . 1.08 111.069 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -67.29 -33.23 74.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.436 . . . . 1.54 111.319 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.648 ' O ' HG23 ' A' ' 115' ' ' VAL . 77.3 t60 -64.17 -45.89 86.42 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 120.699 -0.4 . . . . 0.75 109.991 176.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.412 ' HB3' HD12 ' A' ' 89' ' ' ILE . 75.0 mt -60.95 -41.46 96.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.59 0.233 . . . . 1.54 111.063 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.96 -45.28 95.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.339 -0.391 . . . . 1.07 110.196 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.463 ' HE2' ' OE2' ' A' ' 118' ' ' GLU . 86.8 tttt -64.86 -35.85 82.47 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.897 -0.321 . . . . 2.6 110.795 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 111' ' ' HIS . 95.9 t -53.77 -44.27 58.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.359 -0.608 . . . . 1.16 109.359 173.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -66.83 -42.85 85.11 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.403 -0.817 . . . . 1.86 111.405 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.44 -27.27 64.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.334 -0.394 . . . . 1.46 111.605 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.463 ' OE2' ' HE2' ' A' ' 114' ' ' LYS . 34.1 mt-10 -75.84 -6.98 53.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.306 -0.406 . . . . 1.65 111.469 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.39 17.8 35.44 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.407 -0.901 . . . . 0.8 112.327 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.451 ' HB2' ' CG1' ' A' ' 115' ' ' VAL . 11.5 m-70 -109.86 176.32 5.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.459 -0.571 . . . . 1.31 109.459 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -139.63 130.77 26.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.876 0.369 . . . . 3.6 111.275 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.72 126.32 88.63 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.296 -0.631 . . . . 2.04 109.296 173.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.67 13.87 1.57 Allowed 'Trans proline' 0 N--CA 1.474 0.343 0 C-N-CA 123.202 2.601 . . . . 1.16 113.748 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 66.38 19.52 10.96 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.403 0.62 . . . . 1.47 110.719 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -111.7 137.2 49.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.566 -0.743 . . . . 1.94 109.433 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.515 ' HG ' HD12 ' A' ' 92' ' ' LEU . 92.3 mt -100.94 90.07 1.44 Allowed Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 110.193 -0.299 . . . . 1.29 110.193 168.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.455 ' HD2' HD11 ' A' ' 130' ' ' LEU . 43.9 Cg_endo -71.17 155.02 61.74 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.298 1.999 . . . . 0.91 111.713 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.25 -10.15 20.08 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 123.275 2.65 . . . . 1.02 113.583 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -92.8 1.06 57.48 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.134 0.492 . . . . 1.1 110.386 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.455 HD11 ' HD2' ' A' ' 127' ' ' PRO . 66.2 mt -117.34 -35.31 4.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 1.44 110.571 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.406 ' CG2' ' HB3' ' A' ' 126' ' ' LEU . 92.6 t . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.088 -0.505 . . . . 2.06 111.478 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 . . . . . 0 CA--C 1.519 -0.237 0 CA-C-O 121.208 0.528 . . . . 1.03 110.571 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.56 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 47.5 t-20 -96.86 112.88 61.79 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.591 -0.731 . . . . 0.55 110.055 -174.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.481 ' HB2' ' HD3' ' A' ' 73' ' ' LYS . 56.7 Cg_endo -70.47 -9.17 25.3 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.008 2.472 . . . . 0.87 112.616 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.551 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 31.4 m-85 -96.84 -7.99 32.12 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.129 -0.693 . . . . 0.55 109.129 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 28.3 tt0 . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 115.002 -0.999 . . . . 1.42 109.508 -175.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 108.969 -0.752 . . . . 0.94 108.969 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.6 t -55.63 -47.25 79.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.023 -0.535 . . . . 1.86 112.434 -172.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.589 HG22 ' HE2' ' A' ' 53' ' ' TYR . 2.7 p -69.31 -22.04 25.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.392 0.615 . . . . 2.02 110.77 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.795 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -67.65 -11.96 60.95 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.422 -0.808 . . . . 0.67 112.082 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -80.59 -27.7 37.31 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.943 -0.391 . . . . 3.38 109.943 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -100.4 10.55 41.05 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.839 -0.619 . . . . 1.82 110.0 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.795 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 15.8 mmmt -52.58 -55.46 32.21 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 114.371 1.248 . . . . 1.61 114.371 -171.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 10.6 Cg_endo -51.3 -37.36 59.95 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.532 2.155 . . . . 0.66 112.808 -174.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.445 ' O ' HG13 ' A' ' 56' ' ' ILE . 8.6 m -69.99 -43.1 72.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.82 -0.627 . . . . 1.21 110.34 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.589 ' HE2' HG22 ' A' ' 46' ' ' VAL . 13.9 m-30 -73.92 -23.21 59.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.365 -0.38 . . . . 1.49 110.436 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.483 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 22.4 m-20 -69.29 -45.48 69.5 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.237 0.541 . . . . 1.86 109.586 176.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -60.82 -38.91 87.06 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.121 -0.945 . . . . 2.0 110.892 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 52' ' ' THR . 62.7 mt -68.95 -40.96 81.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 1.28 110.568 176.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -55.82 -39.68 71.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.52 111.243 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.483 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 48.9 m-85 -75.92 -13.58 60.25 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.763 0.653 . . . . 3.37 112.763 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 64.1 p -73.93 -18.55 60.88 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.179 -0.608 . . . . 1.41 110.824 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 2.0 mm? -87.12 -9.34 55.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.418 -0.356 . . . . 1.96 110.895 175.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.6 t 67.91 94.05 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.25 0 O-C-N 123.905 0.753 . . . . 1.74 110.758 -176.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.37 134.51 42.18 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 123.009 2.473 . . . . 0.76 112.992 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.2 t -107.96 123.54 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 108.881 -0.785 . . . . 2.08 108.881 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.8 p30 45.33 33.72 1.31 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.452 0.701 . . . . 2.3 112.499 -175.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.98 -3.4 67.09 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.053 -0.594 . . . . 0.7 114.448 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -137.87 170.25 16.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.812 0.806 . . . . 2.76 110.692 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.7 pt -114.7 155.24 15.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.79 -0.364 . . . . 1.05 110.177 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.604 ' HA ' HD22 ' A' ' 100' ' ' LEU . 76.0 p -87.25 167.58 13.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.239 -0.437 . . . . 1.09 110.897 -176.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.47 -24.44 63.83 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.768 -0.73 . . . . 0.4 112.315 176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.4 -35.92 76.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.204 0.526 . . . . 1.09 110.76 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.474 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 13.5 m120 -70.58 -49.05 51.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.575 -0.739 . . . . 1.73 110.529 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.462 ' HB3' ' HZ3' ' A' ' 90' ' ' TRP . . . -73.49 -20.1 60.76 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.47 -0.492 . . . . 1.17 110.411 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.586 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 39.5 ttmt -67.3 -50.35 60.63 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.558 -0.534 . . . . 1.25 109.558 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 22.2 ptmt -64.79 -35.68 81.87 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.237 -0.438 . . . . 2.79 110.793 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.83 -51.97 62.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.362 0.601 . . . . 0.82 110.279 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.863 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -65.12 -36.51 84.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.464 -0.789 . . . . 1.38 112.384 -174.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -75.37 -26.07 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.294 -0.562 . . . . 1.53 110.339 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -85.43 -1.77 57.39 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.06 -0.518 . . . . 3.56 110.413 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 33.5 m -79.66 -7.76 58.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 1.06 109.992 171.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 79' ' ' SER . 0.1 OUTLIER 69.97 27.36 4.43 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.631 -0.713 . . . . 2.48 111.603 178.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.515 ' HB2' HD13 ' A' ' 86' ' ' LEU . 95.3 mt -110.31 157.93 36.72 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.424 . . . . 2.1 110.368 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.661 ' O ' HD11 ' A' ' 86' ' ' LEU . 60.6 Cg_endo -74.16 147.43 37.86 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.704 2.269 . . . . 0.9 113.323 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -51.46 -38.5 54.07 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.979 -0.555 . . . . 1.09 112.029 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.502 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 35.0 m -56.69 -43.23 80.29 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.107 0.48 . . . . 1.14 111.092 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.562 ' O ' HG12 ' A' ' 89' ' ' ILE . 53.5 t -73.93 -36.59 45.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.135 -0.691 . . . . 1.19 109.135 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.863 ' HG ' ' HB3' ' A' ' 76' ' ' MET . 1.7 mp -62.62 -45.3 93.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.076 -0.966 . . . . 2.0 110.546 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.499 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -58.72 -37.22 89.37 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.892 -0.595 . . . . 0.37 112.308 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 84' ' ' THR . 52.4 mtpt -71.76 -42.3 67.38 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.208 -0.293 . . . . 1.64 110.208 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.562 HG12 ' O ' ' A' ' 85' ' ' VAL . 32.7 mm -53.15 -52.54 29.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.942 -0.572 . . . . 1.5 110.132 173.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.462 ' HZ3' ' HB3' ' A' ' 72' ' ' ALA . 27.3 t-105 -64.38 -43.03 95.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.78 -0.645 . . . . 0.41 111.159 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.474 ' HZ3' ' CD ' ' B' ' 152' ' ' GLU . 35.5 ttmt -63.83 -25.05 68.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.081 0.467 . . . . 2.0 111.318 -175.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.402 HD11 ' HA ' ' A' ' 92' ' ' LEU . 3.7 mm? -89.36 -31.23 17.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.132 -0.486 . . . . 2.23 111.158 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.59 -36.45 28.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.361 -0.381 . . . . 1.1 111.883 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -84.93 57.2 4.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.824 0.821 . . . . 0.59 109.942 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.6 p -68.37 -16.12 20.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.849 -1.069 . . . . 2.11 111.483 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -89.71 -18.46 26.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.119 -0.492 . . . . 1.45 110.824 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.543 ' HB2' ' NZ ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER 61.01 73.46 0.48 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.14 0.576 . . . . 3.13 111.55 179.229 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.52 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 15.4 p-10 -132.96 -18.93 2.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.463 -0.335 . . . . 1.22 111.759 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.68 4.47 72.91 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.437 -0.887 . . . . 0.51 112.064 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.604 HD22 ' HA ' ' A' ' 68' ' ' THR . 41.4 mt -130.35 171.6 12.76 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.361 -0.607 . . . . 1.2 109.361 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.407 HD23 ' HB3' ' A' ' 105' ' ' GLU . 79.9 mt -127.06 118.45 24.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.46 -0.336 . . . . 1.38 110.702 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -83.31 -176.48 6.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.842 -0.799 . . . . 1.42 108.842 167.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.96 -29.44 69.84 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.616 -0.434 . . . . 1.73 111.798 -173.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.49 -50.12 48.22 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.316 -0.624 . . . . 1.53 109.316 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.407 ' HB3' HD23 ' A' ' 101' ' ' LEU . 36.5 mt-10 -59.96 -52.77 63.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.352 -0.84 . . . . 1.2 111.431 -178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -63.09 -35.86 81.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.941 -0.572 . . . . 0.49 110.703 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.412 ' HB2' ' HD2' ' A' ' 53' ' ' TYR . . . -65.84 -47.32 75.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 1.1 110.682 177.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.84 -37.85 88.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.355 -0.384 . . . . 1.96 109.974 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.501 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.0 -49.73 72.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.86 -0.609 . . . . 1.08 110.426 173.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -69.19 -28.46 66.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.838 -0.619 . . . . 1.54 111.846 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.586 ' O ' HG23 ' A' ' 115' ' ' VAL . 82.3 t60 -67.06 -41.97 85.54 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.395 -0.522 . . . . 0.75 109.932 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.7 mt -64.75 -38.58 91.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.994 0.426 . . . . 1.54 110.111 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.795 HD11 ' HE1' ' A' ' 76' ' ' MET . 72.0 mt -63.23 -41.23 92.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.712 -0.676 . . . . 1.07 110.505 176.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -54.77 -49.88 69.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.836 0.35 . . . . 2.6 110.585 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 111' ' ' HIS . 29.9 t -59.68 -40.49 82.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.99 -0.55 . . . . 1.16 109.926 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.685 ' HZ1' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -61.51 -42.63 99.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.492 -0.776 . . . . 1.86 111.181 175.416 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 86.4 mt -72.37 -32.11 66.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.613 0.244 . . . . 1.46 111.569 -176.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -75.36 3.41 9.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.478 -0.328 . . . . 1.65 111.543 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.69 2.5 75.64 Favored Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 120.642 -0.789 . . . . 0.8 112.478 175.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.516 ' HB2' HG11 ' A' ' 115' ' ' VAL . 28.3 m-70 -92.92 173.93 7.5 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.097 0.475 . . . . 1.31 109.887 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.33 145.39 40.12 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.0 -0.545 . . . . 3.6 110.675 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.76 125.21 56.31 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.827 -0.624 . . . . 2.04 109.634 175.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.79 -2.14 11.45 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.898 2.399 . . . . 1.16 113.165 -172.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.3 21.02 12.22 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.421 0.629 . . . . 1.47 110.25 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.438 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -115.37 131.86 56.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.048 -0.978 . . . . 1.94 109.872 -178.251 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.582 ' HB3' ' HB ' ' A' ' 131' ' ' VAL . 92.5 mt -96.85 96.57 2.85 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.139 0.274 . . . . 1.29 110.624 170.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.479 ' O ' HG11 ' A' ' 131' ' ' VAL . 57.8 Cg_endo -76.48 159.76 35.73 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.406 2.07 . . . . 0.91 111.265 177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.98 -25.57 28.63 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.998 2.466 . . . . 1.02 114.023 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -86.92 9.26 19.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.823 0.344 . . . . 1.1 111.42 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 63.1 mt -131.71 -35.37 1.28 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 1.44 110.65 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.582 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 7.1 p . . . . . 0 CA--C 1.534 0.342 0 CA-C-O 121.497 0.665 . . . . 2.06 110.693 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 108.625 -0.88 . . . . 1.03 108.625 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.499 HD22 ' HA2' ' A' ' 87' ' ' GLY . 45.9 t-20 -97.36 119.39 63.07 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 114.451 -1.249 . . . . 0.55 109.882 -173.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.548 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 9.2 Cg_exo -71.99 -10.36 25.99 Favored 'Trans proline' 0 CA--C 1.528 0.184 0 C-N-CA 123.259 2.639 . . . . 0.87 112.948 -175.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.586 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 15.0 m-85 -106.41 -16.08 14.65 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.626 0.726 . . . . 0.55 109.475 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . 0.474 ' CD ' ' HZ3' ' A' ' 91' ' ' LYS . 41.5 tt0 . . . . . 0 C--N 1.319 -0.737 0 CA-C-N 114.557 -1.202 . . . . 1.42 108.595 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 109.221 -0.659 . . . . 0.94 109.221 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.9 m -57.77 -33.66 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.667 -0.697 . . . . 1.86 112.315 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.87 -16.07 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.589 0.709 . . . . 2.02 110.745 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.509 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -72.81 -6.38 67.1 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.397 -0.819 . . . . 0.67 111.941 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -91.94 -25.44 18.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.185 0.517 . . . . 3.38 110.221 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.435 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 20.7 m-20 -91.94 1.88 56.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.708 -0.678 . . . . 1.82 110.701 -176.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.525 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 3.5 mmmp? -53.96 -49.66 88.42 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 114.062 1.134 . . . . 1.61 114.062 -172.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 11.7 Cg_endo -52.69 -39.72 75.58 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.107 1.871 . . . . 0.66 112.891 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.507 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . 58.5 m -82.62 -31.92 28.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.902 0.382 . . . . 1.21 111.414 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.743 ' HH ' ' HA ' ' A' ' 111' ' ' HIS . 16.4 m-30 -71.11 -22.38 62.09 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.09 -0.708 . . . . 1.49 109.09 175.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 16.5 t70 -71.22 -42.5 68.85 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.15 -0.932 . . . . 1.86 109.365 172.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.507 ' OE2' ' HA ' ' A' ' 52' ' ' THR . 40.3 mt-10 -58.53 -34.35 70.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.33 -0.85 . . . . 2.0 110.837 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.7 mt -78.59 -52.44 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.075 0.464 . . . . 1.28 110.512 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.419 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 74.2 t80 -50.01 -41.37 47.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.393 -0.821 . . . . 0.52 111.855 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -74.75 -22.58 58.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.742 0.645 . . . . 3.37 112.742 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.5 p -79.47 -20.82 46.44 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.018 -0.673 . . . . 1.41 110.944 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.06 -5.05 59.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 1.96 110.647 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.0 t 68.0 92.03 0.07 OUTLIER Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 115.588 -0.733 . . . . 1.74 111.0 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.67 134.08 34.03 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.988 2.459 . . . . 0.76 111.941 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.2 t -110.8 107.52 23.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.09 -0.505 . . . . 2.08 110.124 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.9 m120 64.1 41.47 6.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.547 -0.751 . . . . 2.3 111.607 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.32 -3.38 72.36 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.984 -0.627 . . . . 0.7 113.94 172.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -160.3 170.53 20.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.412 0.606 . . . . 2.76 110.476 178.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.469 HD13 ' CD1' ' A' ' 106' ' ' PHE . 25.6 pt -104.94 159.4 5.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.828 0.346 . . . . 1.05 111.227 -177.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.477 ' HA ' HD23 ' A' ' 100' ' ' LEU . 73.5 p -89.27 170.66 10.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.856 -0.611 . . . . 1.09 110.972 -177.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.93 -27.98 72.06 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.688 -0.687 . . . . 0.4 112.546 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.96 -45.15 68.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.076 0.465 . . . . 1.09 111.295 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.445 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 8.9 m120 -63.73 -46.24 86.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.509 0.671 . . . . 1.73 110.127 -177.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.52 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -75.77 -23.89 55.98 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.729 -0.669 . . . . 1.17 110.489 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.794 ' HA ' ' HZ ' ' B' ' 151' ' ' PHE . 35.1 ttmt -61.32 -50.62 72.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.893 0.377 . . . . 1.25 110.033 174.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 19.4 ptmt -70.13 -27.71 64.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.312 -0.404 . . . . 2.79 110.395 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 13.2 tp10 -68.36 -40.39 81.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.612 0.72 . . . . 0.82 109.98 174.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.594 ' HB3' HD21 ' A' ' 86' ' ' LEU . 22.3 mmt -59.8 -42.81 94.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.67 -0.695 . . . . 1.38 111.24 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 74' ' ' LYS . 15.0 m -72.0 -24.07 22.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.459 -0.496 . . . . 1.53 110.441 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 10.1 mtpm? -71.67 -20.87 61.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 3.56 110.644 175.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.9 m -84.88 1.35 47.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.08 -0.509 . . . . 1.06 111.263 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.1 mptt 62.01 25.19 15.09 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.862 0.69 . . . . 2.48 112.862 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.534 ' HB2' HD22 ' A' ' 86' ' ' LEU . 98.8 mt -98.79 140.61 21.89 Favored Pre-proline 0 C--N 1.326 -0.45 0 C-N-CA 121.06 -0.256 . . . . 2.1 110.908 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.595 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 19.3 Cg_exo -64.92 159.49 45.88 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.189 2.592 . . . . 0.9 112.614 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -56.74 -43.71 80.96 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.823 -0.626 . . . . 1.09 111.611 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.2 m -56.34 -45.92 80.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.16 0.505 . . . . 1.14 110.905 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 89' ' ' ILE . 96.3 t -64.27 -45.24 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.763 -0.653 . . . . 1.19 110.618 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 82' ' ' PRO . 31.3 mt -62.62 -38.48 90.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.088 -0.506 . . . . 2.0 110.271 177.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.709 ' HA2' ' ND2' ' B' ' 149' ' ' ASN . . . -56.56 -37.42 75.54 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.289 -0.869 . . . . 0.37 111.783 176.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -77.63 -47.69 18.68 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.927 0.394 . . . . 1.64 110.561 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.619 HD11 HG12 ' A' ' 113' ' ' ILE . 67.8 mt -57.84 -49.57 80.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.01 -0.541 . . . . 1.5 111.105 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.581 ' HB3' ' ND2' ' B' ' 149' ' ' ASN . 13.4 t-105 -66.04 -38.48 88.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.215 0.531 . . . . 0.41 110.197 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 87' ' ' GLY . 24.4 ttmm -56.91 -33.33 66.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.521 -0.763 . . . . 2.0 111.05 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.406 HD11 ' HA ' ' A' ' 92' ' ' LEU . 3.8 mm? -90.72 -43.1 10.33 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.587 0.588 . . . . 2.23 112.587 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.63 -42.45 98.15 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.5 0.556 . . . . 1.1 112.5 -171.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.624 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 36.0 t0 -90.22 99.72 12.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.327 -0.62 . . . . 0.59 109.327 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.8 m -82.83 -30.31 8.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.767 -0.651 . . . . 2.11 111.839 -170.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -102.28 -9.29 20.53 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.131 0.419 . . . . 1.45 112.131 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.624 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 67.9 mmtt 66.15 74.48 0.35 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.187 0.517 . . . . 3.13 112.326 175.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -91.82 -29.08 16.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.748 -0.66 . . . . 1.22 109.525 178.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.49 2.39 79.56 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 109.58 -1.408 . . . . 0.51 109.58 -167.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 68' ' ' THR . 23.1 mt -133.93 175.8 9.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.195 -1.003 . . . . 1.2 108.435 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.552 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 96.6 mt -131.88 118.12 19.41 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.972 -0.291 . . . . 1.38 110.413 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.535 ' HA ' ' CB ' ' A' ' 66' ' ' LYS . 1.3 p-10 -81.08 -175.82 5.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.047 -0.723 . . . . 1.42 109.047 175.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.477 ' CG ' ' HZ3' ' A' ' 50' ' ' LYS . 17.9 t70 -61.4 -35.48 77.63 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 111.865 0.32 . . . . 1.73 111.865 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -68.36 -55.45 11.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.986 0.422 . . . . 1.53 110.542 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.494 ' HG3' ' OD1' ' A' ' 102' ' ' ASP . 36.0 mt-10 -72.22 -32.25 66.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.885 -0.598 . . . . 1.2 112.383 -173.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.469 ' CD1' HD13 ' A' ' 67' ' ' ILE . 49.5 t80 -69.29 -39.0 78.6 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.091 -0.644 . . . . 0.49 109.625 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.28 96.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.41 -0.516 . . . . 1.1 110.074 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.5 mt -65.55 -36.52 84.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.492 -0.322 . . . . 1.96 111.057 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.482 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -58.51 -52.16 66.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.801 0.334 . . . . 1.08 110.305 174.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -63.64 -36.47 83.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.043 -0.526 . . . . 1.54 110.627 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.743 ' HA ' ' HH ' ' A' ' 53' ' ' TYR . 77.1 t60 -63.72 -46.19 86.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.28 -0.418 . . . . 0.75 111.008 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.559 ' HB3' HD22 ' A' ' 122' ' ' LEU . 96.1 mt -63.66 -41.02 98.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.887 0.375 . . . . 1.54 110.731 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.619 HG12 HD11 ' A' ' 89' ' ' ILE . 73.9 mt -59.72 -44.15 93.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 1.07 109.986 175.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -60.51 -42.15 95.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.814 -0.63 . . . . 2.6 111.203 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.615 HG21 ' O ' ' A' ' 111' ' ' HIS . 59.5 t -58.11 -46.35 88.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.816 0.341 . . . . 1.16 110.351 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 16.5 mtpp -62.13 -42.24 99.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.033 0.383 . . . . 1.86 112.033 175.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 97.2 mt -64.51 -28.47 69.67 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.185 0.516 . . . . 1.46 110.723 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -73.04 -2.74 22.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.651 -0.704 . . . . 1.65 111.471 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.48 32.43 9.44 Favored Glycine 0 CA--C 1.505 -0.588 0 C-N-CA 120.647 -0.787 . . . . 0.8 112.099 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.489 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 95.4 m-70 -131.14 179.72 5.84 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.389 0.614 . . . . 1.31 111.406 -176.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.85 149.79 49.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.11 -0.95 . . . . 3.6 109.404 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -79.9 144.51 59.82 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.505 -0.554 . . . . 2.04 109.505 175.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.33 -5.91 15.06 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.998 2.465 . . . . 1.16 113.315 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.42 17.83 9.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.329 0.585 . . . . 1.47 110.599 -175.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -134.78 156.58 48.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.222 -0.899 . . . . 1.94 109.496 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.83 93.87 9.56 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.399 -0.364 . . . . 1.29 110.721 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -78.2 160.19 29.7 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.39 2.06 . . . . 0.91 112.084 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -51.63 -27.42 25.77 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.422 2.748 . . . . 1.02 113.805 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -88.37 9.07 24.67 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.649 -0.42 . . . . 1.1 111.776 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.8 mt -128.25 -32.87 2.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.508 0.194 . . . . 1.44 111.028 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.1 m . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 2.06 110.56 176.647 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 . . . . . 0 CA--C 1.517 -0.325 0 CA-C-O 120.919 0.39 . . . . 1.03 110.705 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.709 ' ND2' ' HA2' ' A' ' 87' ' ' GLY . 54.9 t-20 -93.16 122.11 64.05 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.904 -0.589 . . . . 0.55 109.741 -176.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.92 -5.68 11.17 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.171 2.581 . . . . 0.87 113.394 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.794 ' HZ ' ' HA ' ' A' ' 73' ' ' LYS . 43.4 m-85 -108.09 -3.52 18.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.368 0.604 . . . . 0.55 110.108 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 46.9 tt0 . . . . . 0 C--N 1.324 -0.511 0 N-CA-C 108.329 -0.989 . . . . 1.42 108.329 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.2 t90 . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 108.374 -0.972 . . . . 0.94 108.374 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.1 m -58.56 -15.01 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.876 0.695 . . . . 1.86 112.876 -172.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.487 HG21 HD21 ' A' ' 108' ' ' LEU . 61.2 t -80.6 -26.96 11.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.996 0.427 . . . . 2.02 110.714 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.451 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -73.85 -1.64 59.45 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.694 -0.765 . . . . 0.67 111.712 177.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -97.35 -17.13 19.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.166 0.508 . . . . 3.38 110.307 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.08 20.62 5.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.773 -0.649 . . . . 1.82 110.244 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.629 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 8.3 mmmm -58.25 -43.74 98.55 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 114.751 1.389 . . . . 1.61 114.751 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.9 Cg_endo -46.47 -41.98 23.15 Favored 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 122.906 2.404 . . . . 0.66 113.654 -172.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.3 m -70.54 -40.34 73.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.101 0.477 . . . . 1.21 110.679 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.457 ' CD2' ' HB2' ' A' ' 107' ' ' ALA . 7.4 m-85 -71.11 -23.41 62.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 1.49 109.67 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -75.22 -45.69 38.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.329 -0.85 . . . . 1.86 110.102 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -58.99 -50.44 74.1 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.449 -0.796 . . . . 2.0 110.39 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.68 -41.79 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.164 -0.471 . . . . 1.28 111.259 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.409 ' HB2' ' CD2' ' A' ' 106' ' ' PHE . 90.5 t80 -58.55 -47.83 82.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.287 -0.415 . . . . 0.52 110.927 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -76.37 -20.86 56.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.225 0.454 . . . . 3.37 112.225 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.7 p -78.43 -13.0 60.04 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.214 -0.594 . . . . 1.41 111.463 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.3 mt -92.24 2.76 56.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.496 -0.32 . . . . 1.96 111.003 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.0 m 66.51 90.1 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 O-C-N 123.785 0.678 . . . . 1.74 111.468 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.9 137.16 13.75 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.064 2.51 . . . . 0.76 112.436 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.495 HG12 ' OD1' ' A' ' 64' ' ' ASN . 22.4 t -108.81 115.36 49.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.191 -0.458 . . . . 2.08 110.195 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.495 ' OD1' HG12 ' A' ' 63' ' ' VAL . 3.0 p-10 40.94 51.61 3.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.621 0.768 . . . . 2.3 112.859 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.59 -3.77 71.97 Favored Glycine 0 CA--C 1.518 0.233 0 N-CA-C 114.754 0.662 . . . . 0.7 114.754 170.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.426 ' HG2' ' CA ' ' A' ' 102' ' ' ASP . 14.0 mtmm -147.95 149.79 32.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.951 0.875 . . . . 2.76 111.173 177.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.9 pt -92.09 147.57 5.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.807 -0.442 . . . . 1.05 109.807 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.2 p -77.77 155.11 31.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.363 -0.38 . . . . 1.09 110.688 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.38 -15.37 45.36 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 121.285 -0.483 . . . . 0.4 113.387 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -63.77 -56.96 11.57 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.254 0.55 . . . . 1.09 111.081 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.65 -37.93 83.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.644 -0.707 . . . . 1.73 110.25 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.448 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -69.64 -32.55 71.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.809 -0.632 . . . . 1.17 110.551 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.562 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 39.9 ttmt -64.05 -42.71 96.93 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.4 0.619 . . . . 1.25 109.561 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.8 mtpp -67.76 -38.27 83.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.281 -0.872 . . . . 2.79 110.982 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.92 -45.39 93.91 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.481 0.658 . . . . 0.82 110.263 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.92 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 25.0 mmt -57.48 -48.11 80.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.354 -0.839 . . . . 1.38 111.274 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.12 -21.57 19.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.849 -0.34 . . . . 1.53 111.074 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 92.5 mttt -70.31 -25.12 63.17 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.545 -0.298 . . . . 3.56 110.82 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 42.5 m -81.99 -1.69 49.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.255 -0.43 . . . . 1.06 111.124 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 79' ' ' SER . 10.1 mptt 70.15 14.95 7.65 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.984 0.735 . . . . 2.48 112.984 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.99 143.62 43.24 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.57 -0.452 . . . . 2.1 110.672 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.534 ' O ' HD11 ' A' ' 86' ' ' LEU . 39.7 Cg_exo -62.27 152.07 78.59 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.292 2.661 . . . . 0.9 112.803 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.515 ' HA ' HD23 ' A' ' 86' ' ' LEU . 16.5 m120 -57.79 -38.45 75.52 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.226 -0.443 . . . . 1.09 111.33 -177.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.3 m -57.8 -37.42 73.71 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.197 0.522 . . . . 1.14 111.161 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.529 ' O ' HG12 ' A' ' 89' ' ' ILE . 70.7 t -77.08 -37.25 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.029 -0.73 . . . . 1.19 109.029 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.92 ' HG ' ' HB3' ' A' ' 76' ' ' MET . 0.4 OUTLIER -61.42 -44.85 96.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.143 -0.935 . . . . 2.0 110.715 176.023 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.575 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -61.31 -37.2 93.65 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.87 -0.681 . . . . 0.37 111.634 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -68.03 -48.31 66.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.819 0.342 . . . . 1.64 110.754 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 85' ' ' VAL . 39.8 mm -56.89 -48.82 80.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.916 -0.584 . . . . 1.5 110.253 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . 0.486 ' CH2' HD22 ' A' ' 101' ' ' LEU . 16.6 t-105 -61.94 -51.31 68.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.055 -0.521 . . . . 0.41 111.161 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -60.65 -27.64 67.96 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.122 -0.49 . . . . 2.0 111.823 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.473 HD11 HD21 ' A' ' 122' ' ' LEU . 66.3 mt -85.51 -49.97 7.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.502 -0.317 . . . . 2.23 111.214 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.89 82.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.504 -0.316 . . . . 1.1 111.834 -175.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.703 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 18.7 t70 -78.66 83.94 4.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.831 -0.803 . . . . 0.59 108.831 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.62 -25.99 13.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.91 -1.041 . . . . 2.11 110.887 -173.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.53 -15.55 30.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.901 -0.59 . . . . 1.45 111.949 -176.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.693 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 4.2 mptp? 54.74 72.07 0.49 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.31 0.576 . . . . 3.13 110.983 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -117.25 -33.16 4.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.767 -0.652 . . . . 1.22 111.932 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.12 -23.09 14.65 Favored Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 120.476 -0.869 . . . . 0.51 112.357 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -102.01 -171.74 2.02 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.881 -0.785 . . . . 1.2 108.881 174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.736 HD12 ' HG2' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -132.66 111.69 11.39 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.754 -0.462 . . . . 1.38 109.754 178.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.426 ' CA ' ' HG2' ' A' ' 66' ' ' LYS . 7.0 t70 -87.55 -177.13 5.81 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.701 -0.681 . . . . 1.42 110.843 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.34 -37.02 57.91 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.246 0.461 . . . . 1.73 112.246 -173.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -69.56 -41.92 75.24 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 122.782 1.277 . . . . 1.53 107.91 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.736 ' HG2' HD12 ' A' ' 101' ' ' LEU . 5.9 tt0 -65.4 -40.88 93.98 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 112.375 -2.193 . . . . 1.2 110.899 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.579 ' HA ' HD11 ' A' ' 101' ' ' LEU . 52.9 t80 -72.75 -35.41 67.48 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.608 0.718 . . . . 0.49 109.77 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . 0.457 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . . . -66.28 -39.82 89.67 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.733 -1.121 . . . . 1.1 110.629 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.487 HD21 HG21 ' A' ' 46' ' ' VAL . 15.7 mt -70.05 -35.42 74.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.165 -0.47 . . . . 1.96 110.47 175.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.444 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.74 -55.47 33.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 1.08 110.561 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.421 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 94.8 m-20 -70.63 -25.72 63.16 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.32 -0.4 . . . . 1.54 110.932 -177.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.584 ' O ' HG21 ' A' ' 115' ' ' VAL . 72.6 t60 -69.83 -43.82 71.19 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.408 -0.36 . . . . 0.75 110.051 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.83 -41.1 97.92 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.95 0.405 . . . . 1.54 110.077 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.48 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 80.3 mt -59.81 -43.73 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.437 -0.801 . . . . 1.07 110.437 174.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -59.72 -46.64 88.5 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.187 -0.461 . . . . 2.6 111.196 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 111' ' ' HIS . 38.4 t -60.38 -42.83 92.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.114 0.483 . . . . 1.16 110.325 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -56.16 -43.86 78.74 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.847 -0.615 . . . . 1.86 110.998 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 91.5 mt -74.04 -16.97 61.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.398 -0.365 . . . . 1.46 111.316 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.3 0.41 25.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.735 0.302 . . . . 1.65 110.421 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.52 -1.48 84.03 Favored Glycine 0 CA--C 1.503 -0.705 0 N-CA-C 111.42 -0.672 . . . . 0.8 111.42 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -97.05 -179.14 4.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.115 0.483 . . . . 1.31 111.11 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.15 144.45 50.75 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.465 -0.789 . . . . 3.6 110.179 -176.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.473 HD21 HD11 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -77.96 138.97 61.21 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 109.711 -0.477 . . . . 2.04 109.711 173.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.45 -3.43 12.45 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.537 2.158 . . . . 1.16 113.699 -170.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.22 21.55 12.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.309 0.576 . . . . 1.47 110.739 -177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.691 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 0.8 OUTLIER -127.93 142.23 51.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.099 -0.955 . . . . 1.94 108.999 178.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.2 mt -97.32 92.49 1.25 Allowed Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 121.166 0.508 . . . . 1.29 110.551 169.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.736 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 17.8 Cg_endo -94.35 165.95 1.93 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.749 2.966 . . . . 0.91 112.254 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.6 -25.04 24.52 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.523 2.815 . . . . 1.02 113.948 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . 0.403 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 20.2 p-80 -86.79 5.54 35.99 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.458 -0.497 . . . . 1.1 111.476 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.736 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 72.9 mt -129.23 -35.56 1.78 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.585 -0.28 . . . . 1.44 111.182 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--N 1.325 -0.479 0 CA-C-O 121.342 0.591 . . . . 2.06 111.352 178.945 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 CA--C 1.519 -0.215 0 N-CA-C 108.851 -0.796 . . . . 1.03 108.851 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.575 HD22 ' HA2' ' A' ' 87' ' ' GLY . 45.2 t-20 -87.91 114.51 59.51 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.822 -1.081 . . . . 0.55 109.641 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 11.0 Cg_exo -72.22 -6.55 19.31 Favored 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 123.09 2.526 . . . . 0.87 112.8 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.562 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 40.7 m-85 -105.55 0.19 26.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.452 0.644 . . . . 0.55 109.676 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 . . . . . 0 C--N 1.318 -0.803 0 CA-C-N 115.018 -0.992 . . . . 1.42 109.255 -174.387 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.411 ' HH2' ' HA ' ' A' ' 104' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.631 0 N-CA-C 109.355 -0.609 . . . . 0.94 109.355 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.5 m -56.65 -31.5 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.761 0.652 . . . . 1.86 112.761 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.649 ' HB ' ' HE2' ' A' ' 53' ' ' TYR . 22.7 m -77.1 -6.42 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.623 -0.431 . . . . 2.02 110.795 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.881 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -72.97 -20.25 79.88 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.86 -0.896 . . . . 0.67 110.86 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -84.51 -10.86 57.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.021 -0.59 . . . . 3.38 110.011 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -118.89 9.26 11.91 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.447 -0.797 . . . . 1.82 110.882 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.881 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 28.8 mmmt -53.11 -49.75 85.88 Favored Pre-proline 0 N--CA 1.471 0.582 0 N-CA-C 113.252 0.834 . . . . 1.61 113.252 -175.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 10.1 Cg_endo -51.74 -38.67 67.2 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.585 2.19 . . . . 0.66 112.432 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -70.82 -42.73 69.85 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.625 0.726 . . . . 1.21 110.102 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.649 ' HE2' ' HB ' ' A' ' 46' ' ' VAL . 15.9 m-30 -70.36 -22.63 62.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.39 -0.823 . . . . 1.49 109.86 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -73.84 -43.94 57.14 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.687 -0.688 . . . . 1.86 110.1 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.596 ' HA ' ' CE2' ' A' ' 58' ' ' TYR . 39.8 mt-10 -58.14 -33.38 69.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.728 -0.669 . . . . 2.0 111.259 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.0 mt -85.19 -22.44 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.241 0.544 . . . . 1.28 110.569 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -77.83 -55.53 5.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.315 -0.402 . . . . 0.52 112.009 -175.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.596 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 23.1 p90 -70.43 -17.14 63.0 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 120.679 -0.408 . . . . 3.37 111.509 -172.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 p -71.54 -12.61 61.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.106 0.479 . . . . 1.41 111.074 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 87.7 mt -99.92 14.62 29.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.75 -0.659 . . . . 1.96 110.648 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.9 m 65.06 88.69 0.11 Allowed Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 115.509 -0.769 . . . . 1.74 111.136 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 38.2 Cg_endo -74.54 98.74 1.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.478 2.119 . . . . 0.76 112.385 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.3 t -89.9 117.28 32.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.725 -0.472 . . . . 2.08 109.725 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 60.6 22.82 12.6 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.223 0.535 . . . . 2.3 110.856 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.95 14.35 69.83 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.706 -0.759 . . . . 0.7 113.259 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.712 ' HE3' ' HB2' ' A' ' 100' ' ' LEU . 39.5 tttp -147.26 126.36 12.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.385 0.593 . . . . 2.76 109.459 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.3 pt -83.87 146.11 7.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 120.94 0.4 . . . . 1.05 110.552 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.639 ' HA ' HD23 ' A' ' 100' ' ' LEU . 68.6 p -80.48 159.53 25.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.795 -0.639 . . . . 1.09 111.314 -177.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.41 -22.3 67.41 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.957 -0.565 . . . . 0.4 112.845 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.04 -49.75 74.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.372 0.606 . . . . 1.09 111.332 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.443 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 39.5 m-80 -73.36 -38.05 65.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.515 -0.766 . . . . 1.73 111.18 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.51 -30.93 69.85 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.496 -0.482 . . . . 1.17 109.862 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -62.64 -48.96 77.05 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.537 -0.301 . . . . 1.25 110.704 176.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.66 ' HD3' ' N ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -64.91 -31.96 73.44 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 120.482 -0.487 . . . . 2.79 111.123 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.66 ' N ' ' HD3' ' A' ' 74' ' ' LYS . 7.5 tp10 -67.57 -45.12 76.5 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.32 0.581 . . . . 0.82 109.914 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.44 ' HB3' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -64.99 -46.55 80.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.381 -0.827 . . . . 1.38 111.547 -178.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.04 -30.38 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.946 -0.302 . . . . 1.53 111.558 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -80.48 -11.31 59.69 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.101 -0.374 . . . . 3.56 110.602 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.9 t -74.22 -11.44 60.29 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.893 -0.78 . . . . 1.06 108.893 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 72.4 mmtt 66.4 35.11 5.87 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.249 -0.887 . . . . 2.48 112.208 175.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.513 ' HB2' HD23 ' A' ' 86' ' ' LEU . 89.7 mt -100.7 144.85 29.31 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.867 -0.79 . . . . 2.1 108.867 171.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.35 142.65 79.21 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.587 2.191 . . . . 0.9 112.241 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -56.23 -34.14 66.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.149 -0.478 . . . . 1.09 111.28 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 6.2 m -59.62 -48.52 81.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.198 0.523 . . . . 1.14 110.496 177.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.616 ' O ' HG12 ' A' ' 89' ' ' ILE . 58.7 t -63.05 -43.29 98.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.716 -0.674 . . . . 1.19 109.968 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' A' ' 81' ' ' LEU . 78.9 mt -59.36 -43.94 92.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.746 -0.661 . . . . 2.0 110.685 178.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.04 -34.38 83.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.982 -0.627 . . . . 0.37 112.069 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 84' ' ' THR . 27.9 mtpp -72.62 -45.32 59.64 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.83 0.348 . . . . 1.64 110.23 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.616 HG12 ' O ' ' A' ' 85' ' ' VAL . 42.7 mm -56.37 -49.39 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.725 -0.671 . . . . 1.5 110.107 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -66.79 -41.16 88.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.086 -0.506 . . . . 0.41 110.524 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.404 ' HZ3' ' CD ' ' B' ' 152' ' ' GLU . 23.6 ttmm -55.81 -29.23 59.42 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.696 -0.683 . . . . 2.0 110.695 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.475 HD11 HD23 ' A' ' 122' ' ' LEU . 82.8 mt -91.86 -42.95 9.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 2.23 112.056 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.09 -40.29 95.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 1.1 111.779 -171.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -92.05 94.23 9.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.983 -0.747 . . . . 0.59 108.983 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.5 -48.94 28.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.267 -0.879 . . . . 2.11 111.24 -172.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -83.93 -9.97 58.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.599 -0.728 . . . . 1.45 112.051 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt 73.45 76.4 0.13 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.641 0.608 . . . . 3.13 112.641 171.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.459 ' HB2' ' H ' ' A' ' 100' ' ' LEU . 3.8 m-20 -104.31 -44.85 4.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.456 0.646 . . . . 1.22 110.226 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.69 2.35 57.43 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.34 -1.104 . . . . 0.51 110.34 -167.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.712 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 36.7 mt -131.22 165.02 24.28 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.549 -0.908 . . . . 1.2 108.549 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.2 mt -125.56 122.68 37.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.267 0.555 . . . . 1.38 111.573 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.413 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 2.1 p30 -87.16 -176.29 5.63 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.74 -0.837 . . . . 1.42 108.74 167.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.02 -22.79 63.07 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.712 -0.395 . . . . 1.73 111.444 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . 0.413 ' HB2' ' OD1' ' A' ' 102' ' ' ASP . 52.2 mt-10 -72.01 -56.77 5.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.14 0.495 . . . . 1.53 109.818 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -68.28 -32.13 72.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.384 -0.826 . . . . 1.2 111.086 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -71.49 -29.79 65.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.751 -0.463 . . . . 0.49 109.751 176.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.52 -39.11 88.47 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.285 -0.416 . . . . 1.1 110.152 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.47 -42.57 99.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.035 -0.529 . . . . 1.96 110.347 172.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.12 -55.46 30.85 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 123.553 0.533 . . . . 1.08 110.672 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -63.01 -41.49 99.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.78 -0.646 . . . . 1.54 111.046 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.603 ' O ' HG22 ' A' ' 115' ' ' VAL . 81.5 t60 -61.52 -45.84 92.48 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.908 -0.317 . . . . 0.75 111.187 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.0 -40.66 87.37 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.752 0.311 . . . . 1.54 111.233 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.428 HD13 ' HE1' ' A' ' 76' ' ' MET . 80.7 mt -61.41 -42.69 94.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.082 -0.508 . . . . 1.07 109.837 175.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 52.9 tttp -55.45 -46.2 76.78 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.754 -0.657 . . . . 2.6 110.683 174.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 111' ' ' HIS . 60.4 t -58.2 -44.71 88.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 120.716 0.293 . . . . 1.16 110.702 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -65.58 -39.85 92.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.153 -0.476 . . . . 1.86 111.465 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 93.6 mt -70.68 -26.03 63.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.938 0.399 . . . . 1.46 110.8 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 68.8 mm-40 -71.02 -18.2 62.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.201 -0.454 . . . . 1.65 110.559 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.23 -13.16 48.44 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.859 -0.686 . . . . 0.8 112.007 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -85.17 172.8 10.91 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.885 -0.413 . . . . 1.31 109.885 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -121.41 134.39 55.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.899 0.38 . . . . 3.6 110.906 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.533 HD21 HD13 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -74.97 139.9 73.5 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.96 -0.564 . . . . 2.04 109.747 175.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 3.7 Cg_exo -76.85 1.32 8.72 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.911 2.407 . . . . 1.16 113.236 -173.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.75 20.38 11.34 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.549 0.69 . . . . 1.47 110.36 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.516 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 12.2 t70 -130.53 131.91 45.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.08 -0.964 . . . . 1.94 109.399 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -91.99 103.22 7.63 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.244 -0.435 . . . . 1.29 110.439 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 125' ' ' ASP . 2.5 Cg_endo -81.45 158.56 19.57 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.937 2.425 . . . . 0.91 111.897 -178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.44 -20.62 33.88 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.992 2.461 . . . . 1.02 113.426 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -91.27 11.93 21.93 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.923 -0.311 . . . . 1.1 111.29 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.412 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 37.8 mt -128.43 -21.41 3.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.555 -0.293 . . . . 1.44 110.878 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--N 1.327 -0.398 0 CA-C-O 120.825 0.345 . . . . 2.06 110.762 178.35 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 . . . . . 0 CA--C 1.52 -0.192 0 CA-C-O 120.963 0.411 . . . . 1.03 110.365 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.564 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 52.2 t-20 -97.62 113.7 63.87 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 0.55 110.081 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 10.0 Cg_exo -72.66 -7.34 20.65 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.421 2.747 . . . . 0.87 112.862 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -107.15 5.65 28.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.317 0.579 . . . . 0.55 109.861 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . 0.564 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 23.0 tt0 . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.188 -0.915 . . . . 1.42 108.643 -175.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . 0.48 ' HZ2' ' HG ' ' A' ' 108' ' ' LEU . 13.9 t90 . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 108.512 -0.921 . . . . 0.94 108.512 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.4 t -48.56 -33.35 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 115.497 -0.774 . . . . 1.86 112.848 -171.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.593 HG23 HD22 ' A' ' 108' ' ' LEU . 58.8 t -67.6 -22.71 28.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.252 -0.431 . . . . 2.02 111.722 -175.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.587 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -66.28 -22.37 70.95 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.455 -0.878 . . . . 0.67 111.503 176.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -78.54 -21.32 48.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.235 0.54 . . . . 3.38 110.889 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -119.72 15.13 12.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.73 0.776 . . . . 1.82 109.761 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 2.4 mmmm -54.04 -45.03 99.17 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.1 -0.955 . . . . 1.61 113.343 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.6 Cg_endo -48.42 -40.72 36.53 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.739 2.292 . . . . 0.66 113.15 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 m -69.66 -43.99 71.43 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-O 121.611 0.72 . . . . 1.21 110.276 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.692 ' HH ' ' HD1' ' A' ' 111' ' ' HIS . 12.0 m-85 -71.01 -22.51 62.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.342 -0.844 . . . . 1.49 109.878 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.25 -45.17 66.99 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.189 -0.671 . . . . 1.86 109.189 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -56.3 -47.5 78.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.758 -1.11 . . . . 2.0 111.379 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.3 mt -75.31 -37.86 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.728 0.299 . . . . 1.28 111.282 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -59.65 -52.28 66.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.327 -0.397 . . . . 0.52 111.431 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -71.15 -21.03 62.24 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.299 0.481 . . . . 3.37 112.299 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.4 p -78.92 -3.32 44.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.425 -0.51 . . . . 1.41 111.679 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.0 mt -100.96 7.58 43.5 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.941 0.401 . . . . 1.96 110.469 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.0 m 59.18 84.7 0.2 Allowed Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 115.475 -0.784 . . . . 1.74 112.12 176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.91 142.69 20.08 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.09 2.527 . . . . 0.76 112.309 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.3 t -114.07 118.98 60.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.609 -0.515 . . . . 2.08 109.609 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 59.98 27.21 16.58 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.088 -0.505 . . . . 2.3 111.49 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.17 -3.42 69.69 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.001 -0.619 . . . . 0.7 114.003 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.603 ' HE3' ' N ' ' A' ' 102' ' ' ASP . 30.5 mtpt -131.1 149.21 52.7 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 117.901 0.85 . . . . 2.76 110.776 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.416 HD11 ' CD1' ' A' ' 106' ' ' PHE . 43.2 pt -101.95 157.89 4.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.002 -0.545 . . . . 1.05 110.079 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.9 p -86.78 161.96 18.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.526 -0.761 . . . . 1.09 110.915 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.88 -27.39 72.07 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.645 -0.707 . . . . 0.4 112.883 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.34 -53.59 55.53 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.097 0.475 . . . . 1.09 111.866 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 45.0 m-80 -73.6 -34.32 65.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.021 -0.536 . . . . 1.73 111.094 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 76' ' ' MET . . . -73.44 -29.17 62.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.346 -0.388 . . . . 1.17 110.275 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.506 ' HA ' ' HZ ' ' B' ' 151' ' ' PHE . 39.3 ttmt -66.4 -51.16 59.95 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.702 0.287 . . . . 1.25 110.263 176.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 ptmt -63.26 -35.75 81.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.365 -0.379 . . . . 2.79 111.731 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -67.4 -45.9 74.81 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.521 0.677 . . . . 0.82 109.815 175.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.705 ' SD ' HD11 ' A' ' 113' ' ' ILE . 7.7 tpp -59.62 -42.4 92.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.392 -0.822 . . . . 1.38 111.077 -177.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.3 m -74.2 -30.39 26.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.819 0.342 . . . . 1.53 110.663 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -69.47 -17.9 63.66 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.913 -0.315 . . . . 3.56 110.983 176.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.4 m -73.83 -8.56 56.53 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.429 -0.35 . . . . 1.06 111.053 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm 73.17 21.36 3.13 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.658 0.985 . . . . 2.48 113.658 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.4 ' HB2' HD13 ' A' ' 86' ' ' LEU . 2.7 mm? -95.3 148.82 35.25 Favored Pre-proline 0 C--N 1.32 -0.682 0 C-N-CA 120.602 -0.439 . . . . 2.1 109.822 174.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.574 ' O ' HD11 ' A' ' 86' ' ' LEU . 32.9 Cg_exo -60.1 151.95 69.04 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.982 2.454 . . . . 0.9 112.432 176.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -57.67 -33.14 68.02 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.424 -0.353 . . . . 1.09 111.244 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.34 -38.68 80.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.437 0.637 . . . . 1.14 110.514 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 89' ' ' ILE . 57.3 t -75.83 -39.6 38.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.754 -0.832 . . . . 1.19 108.754 -177.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.627 ' HG ' ' CG ' ' A' ' 76' ' ' MET . 3.6 mp -60.76 -44.82 96.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.997 -1.001 . . . . 2.0 111.16 176.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.591 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -61.92 -35.35 91.24 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.888 -0.672 . . . . 0.37 111.784 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.687 ' HD3' ' HB2' ' A' ' 122' ' ' LEU . 38.6 ttmt -71.48 -45.39 62.64 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.188 0.518 . . . . 1.64 110.063 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.683 HG21 ' HB2' ' A' ' 112' ' ' LEU . 72.0 mt -61.44 -50.77 79.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.539 -0.755 . . . . 1.5 110.692 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -60.32 -43.04 96.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.89 -0.595 . . . . 0.41 110.67 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.13 -25.2 64.27 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.92 -0.312 . . . . 2.0 111.244 -175.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.34 -43.78 55.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.344 0.592 . . . . 2.23 110.026 172.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.506 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -66.97 -42.63 84.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.196 -0.911 . . . . 1.1 111.411 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.528 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 27.9 t0 -95.89 62.14 2.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.8 0.809 . . . . 0.59 109.348 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.0 p -64.66 -28.09 44.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 114.543 -1.208 . . . . 2.11 111.575 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -86.99 -10.94 51.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.997 -0.547 . . . . 1.45 111.795 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.441 ' HD2' ' O ' ' A' ' 94' ' ' ASP . 1.3 mptm? 56.17 73.64 0.43 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.715 0.406 . . . . 3.13 112.062 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -120.32 -20.94 7.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.478 -0.328 . . . . 1.22 110.753 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 100.5 -18.99 54.44 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.706 -0.759 . . . . 0.51 113.444 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.413 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 86.6 mt -110.21 169.03 9.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.013 0.406 . . . . 1.2 109.985 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 106' ' ' PHE . 76.3 mt -124.52 114.93 20.07 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.565 -0.454 . . . . 1.38 110.952 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.603 ' N ' ' HE3' ' A' ' 66' ' ' LYS . 1.0 OUTLIER -84.85 -175.78 5.93 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.119 -0.697 . . . . 1.42 109.119 171.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -62.27 -32.93 73.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.882 -0.327 . . . . 1.73 110.713 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.88 -52.29 11.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.766 0.317 . . . . 1.53 110.637 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.528 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 31.5 mt-10 -62.18 -47.36 84.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.345 -0.389 . . . . 1.2 111.606 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 92.4 t80 -63.78 -37.1 86.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.987 0.422 . . . . 0.49 110.469 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.05 90.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.843 -0.617 . . . . 1.1 110.778 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.593 HD22 HG23 ' A' ' 46' ' ' VAL . 26.1 mt -64.08 -41.52 97.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 1.96 110.632 174.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -54.94 -52.4 63.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.257 0.551 . . . . 1.08 110.281 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . 0.41 ' N ' HD21 ' A' ' 110' ' ' ASN . 0.9 OUTLIER -69.0 -21.78 64.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.614 . . . . 1.54 110.912 -177.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.692 ' HD1' ' HH ' ' A' ' 53' ' ' TYR . 9.5 t60 -60.52 -61.2 2.77 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.18 0.514 . . . . 0.75 109.626 174.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.683 ' HB2' HG21 ' A' ' 89' ' ' ILE . 3.7 mm? -60.17 -34.9 74.23 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.73 -1.123 . . . . 1.54 110.76 -176.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.705 HD11 ' SD ' ' A' ' 76' ' ' MET . 86.7 mt -60.75 -46.88 95.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.242 -0.436 . . . . 1.07 110.484 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.404 ' HA ' HD13 ' A' ' 117' ' ' LEU . 36.6 ttmt -63.06 -36.41 83.49 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.429 -0.351 . . . . 2.6 111.162 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 111' ' ' HIS . 14.1 t -62.74 -36.97 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.063 0.459 . . . . 1.16 109.793 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.7 mmtt -72.14 -28.11 63.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 1.86 111.135 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 95.4 mt -68.98 -20.59 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.125 0.488 . . . . 1.46 110.326 176.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -87.75 -1.12 57.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.185 0.516 . . . . 1.65 110.396 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.74 35.44 54.89 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.783 -0.644 . . . . 0.8 112.203 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.484 ' HB2' HG13 ' A' ' 115' ' ' VAL . 20.4 m-70 -99.49 -171.84 2.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.196 0.522 . . . . 1.31 111.99 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -118.59 152.06 36.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.376 -0.829 . . . . 3.6 110.638 -174.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.687 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 5.1 mt -118.74 122.04 30.19 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.852 -0.425 . . . . 2.04 109.852 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.45 -11.79 12.91 Favored 'Trans proline' 0 C--N 1.334 -0.22 0 C-N-CA 123.458 2.772 . . . . 1.16 112.698 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.598 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . 65.98 19.29 11.22 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.838 -0.619 . . . . 1.47 110.896 -176.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . 0.422 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 10.7 m-20 -107.0 137.34 45.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.849 -0.614 . . . . 1.94 110.573 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.4 mt -95.89 109.53 46.96 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.934 -0.575 . . . . 1.29 111.21 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.773 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -83.72 160.62 14.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.504 2.803 . . . . 0.91 111.61 176.131 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.84 -25.38 76.31 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.709 2.272 . . . . 1.02 113.057 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -89.46 8.6 30.14 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.943 -0.303 . . . . 1.1 111.586 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.773 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 30.0 mt -123.45 -19.54 5.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.734 -0.212 . . . . 1.44 111.204 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.4 t . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.983 0.42 . . . . 2.06 110.198 176.912 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 121.551 0.691 . . . . 1.03 109.404 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.591 HD22 ' HA2' ' A' ' 87' ' ' GLY . 51.7 t-20 -102.34 118.9 57.83 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.021 -0.99 . . . . 0.55 109.814 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 18.9 Cg_exo -67.45 -7.45 19.19 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.504 2.803 . . . . 0.87 112.951 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.506 ' HZ ' ' HA ' ' A' ' 73' ' ' LYS . 40.6 m-85 -107.68 4.21 25.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.295 0.569 . . . . 0.55 110.081 176.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . 0.582 ' CB ' ' HB3' ' B' ' 149' ' ' ASN . 32.8 tt0 . . . . . 0 C--N 1.321 -0.652 0 CA-C-N 115.05 -0.977 . . . . 1.42 109.393 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.3 t90 . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 108.83 -0.804 . . . . 0.94 108.83 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.7 t -57.5 -40.66 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 113.614 0.968 . . . . 1.86 113.614 -167.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.493 HG12 ' CG ' ' A' ' 111' ' ' HIS . 5.3 m -69.87 -10.76 14.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.893 -0.323 . . . . 2.02 111.723 -171.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.75 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -69.53 -15.94 71.22 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.745 -0.741 . . . . 0.67 111.895 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -78.33 -28.2 47.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 3.38 110.628 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -121.16 23.4 10.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.538 0.685 . . . . 1.82 109.959 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.75 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 4.4 mmmp? -52.61 -41.98 86.17 Favored Pre-proline 0 C--O 1.218 -0.556 0 CA-C-N 115.342 -0.845 . . . . 1.61 112.942 177.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 7.8 Cg_endo -48.8 -43.31 35.14 Favored 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 122.582 2.188 . . . . 0.66 112.671 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.583 ' O ' HG13 ' A' ' 56' ' ' ILE . 14.3 m -70.18 -44.58 68.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.035 0.445 . . . . 1.21 110.889 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -71.07 -22.74 62.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.352 0.596 . . . . 1.49 109.809 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.413 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 9.3 t70 -73.67 -44.3 57.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.031 -0.986 . . . . 1.86 108.85 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -55.31 -53.44 56.16 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 114.916 -1.038 . . . . 2.0 110.318 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.583 HG13 ' O ' ' A' ' 52' ' ' THR . 17.3 mt -64.56 -40.0 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 114.962 -1.017 . . . . 1.28 110.668 -175.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 62' ' ' PRO . 79.9 t80 -59.03 -38.13 78.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.066 -0.516 . . . . 0.52 110.783 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 17.5 m-85 -82.07 -22.99 36.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.445 -0.343 . . . . 3.37 111.892 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.3 p -77.62 -18.71 56.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.14 0.495 . . . . 1.41 111.006 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.0 mp -91.08 4.1 53.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.972 -0.558 . . . . 1.96 110.465 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.7 m 68.01 91.43 0.07 OUTLIER Pre-proline 0 CA--C 1.529 0.165 0 O-C-N 124.047 0.842 . . . . 1.74 111.726 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.471 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 1.9 Cg_endo -81.14 96.36 0.96 Allowed 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.599 2.2 . . . . 0.76 111.299 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.5 m -86.87 117.44 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.34 0.591 . . . . 2.08 110.205 -175.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 64.2 23.87 13.25 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.231 -0.895 . . . . 2.3 110.819 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.48 33.42 19.61 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.931 -0.652 . . . . 0.7 113.36 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.779 ' HZ3' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -165.08 145.58 7.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.079 -0.711 . . . . 2.76 109.079 175.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.4 pt -102.69 145.92 11.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.492 -0.483 . . . . 1.05 110.13 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.769 ' HA ' HD22 ' A' ' 100' ' ' LEU . 44.3 p -84.91 165.91 17.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.11 0.481 . . . . 1.09 111.108 -176.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.2 -17.75 64.13 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.67 -0.695 . . . . 0.4 112.663 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.03 -54.34 22.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.113 0.482 . . . . 1.09 110.656 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.52 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 1.0 OUTLIER -69.97 -41.29 74.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.769 -0.651 . . . . 1.73 110.593 -174.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -68.19 -29.34 68.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.012 -0.54 . . . . 1.17 110.831 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.535 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 40.8 ttmt -65.38 -40.22 93.24 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.645 -0.502 . . . . 1.25 109.645 174.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.588 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.2 mtpp -60.1 -43.28 95.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.51 -0.768 . . . . 2.79 110.669 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.43 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 4.2 tp10 -65.74 -44.94 84.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.344 0.592 . . . . 0.82 110.692 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.731 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 25.6 mmt -56.35 -46.48 79.97 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.769 -0.651 . . . . 1.38 111.243 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.7 m -75.3 -17.69 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.393 -0.367 . . . . 1.53 110.944 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 93.4 mttt -70.4 -30.33 67.19 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 120.402 -0.519 . . . . 3.56 109.831 172.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.0 m -76.3 -9.07 58.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.596 -0.729 . . . . 1.06 110.999 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm 62.46 26.95 16.04 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.64 0.734 . . . . 2.48 110.665 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.45 ' HB3' HD12 ' A' ' 86' ' ' LEU . 7.9 tp -89.75 137.44 28.5 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.039 -0.982 . . . . 2.1 109.893 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.526 ' O ' HD13 ' A' ' 86' ' ' LEU . 45.1 Cg_exo -55.52 145.46 68.99 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 123.23 2.62 . . . . 0.9 113.406 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -52.75 -39.96 62.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.98 -0.555 . . . . 1.09 112.145 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.5 m -58.08 -35.09 70.89 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.3 0.572 . . . . 1.14 110.93 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.608 ' O ' HG12 ' A' ' 89' ' ' ILE . 57.4 t -76.11 -40.96 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 108.867 -0.79 . . . . 1.19 108.867 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.731 ' HG ' ' HB3' ' A' ' 76' ' ' MET . 2.2 mp -57.17 -45.37 83.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.309 -0.859 . . . . 2.0 110.05 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.567 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -56.35 -41.68 87.89 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.746 -0.661 . . . . 0.37 112.572 175.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -71.16 -46.41 61.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.979 0.39 . . . . 1.64 110.664 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ILE . . . . . 0.608 HG12 ' O ' ' A' ' 85' ' ' VAL . 49.0 mm -55.89 -50.86 66.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.76 -0.655 . . . . 1.5 110.122 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -65.11 -41.98 94.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 0.41 110.658 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -65.2 -32.62 74.39 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.207 -0.451 . . . . 2.0 111.45 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.493 HD23 HD11 ' A' ' 122' ' ' LEU . 8.3 mp -86.75 -41.98 13.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.42 -0.354 . . . . 2.23 111.367 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 105' ' ' GLU . . . -64.9 -43.22 93.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.464 -0.335 . . . . 1.1 111.797 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . 0.509 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 34.4 t70 -84.7 88.59 7.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.536 0.684 . . . . 0.59 109.831 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.0 t -83.16 -38.0 14.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.984 -1.007 . . . . 2.11 111.141 -176.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -76.82 -17.25 59.13 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.91 -0.586 . . . . 1.45 110.741 -173.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.5 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 71.8 mmtt 63.16 50.86 2.91 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.571 -0.741 . . . . 3.13 111.154 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.4 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 6.8 p-10 -92.91 -16.48 25.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.583 -0.735 . . . . 1.22 109.796 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.71 -1.87 66.4 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.745 -0.662 . . . . 0.51 112.464 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.769 HD22 ' HA ' ' A' ' 68' ' ' THR . 56.6 mt -128.06 177.75 6.68 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.331 -0.618 . . . . 1.2 109.331 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.2 mt -114.56 113.86 24.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.201 0.524 . . . . 1.38 110.832 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.465 ' CA ' ' HD3' ' A' ' 66' ' ' LYS . 12.7 t70 -84.81 -177.8 6.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.342 -0.845 . . . . 1.42 109.21 173.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -66.62 -35.89 81.28 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.186 0.448 . . . . 1.73 111.719 -170.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -71.92 -42.61 66.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.225 0.536 . . . . 1.53 110.361 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.509 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 19.2 mt-10 -68.05 -45.15 74.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.325 -0.852 . . . . 1.2 110.794 -175.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -68.84 -36.51 78.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.032 -0.531 . . . . 0.49 110.908 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.8 -40.81 98.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.903 0.382 . . . . 1.1 110.413 176.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.2 mt -66.99 -36.29 81.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.021 -0.536 . . . . 1.96 110.545 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.404 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.85 -52.34 65.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 1.08 110.455 175.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -61.42 -39.65 91.53 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.691 0.281 . . . . 1.54 110.661 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' HIS . . . . . 0.607 ' O ' HG21 ' A' ' 115' ' ' VAL . 83.5 t60 -59.74 -47.79 84.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.472 . . . . 0.75 110.807 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.735 HD12 HD13 ' A' ' 122' ' ' LEU . 96.3 mt -64.53 -41.81 96.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.367 -0.379 . . . . 1.54 111.116 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 109' ' ' ALA . 85.4 mt -60.75 -40.68 85.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.133 0.492 . . . . 1.07 109.713 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.643 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 59.7 tttp -59.31 -42.11 90.61 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.715 -0.675 . . . . 2.6 110.428 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.607 HG21 ' O ' ' A' ' 111' ' ' HIS . 25.5 t -56.79 -40.15 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.816 0.341 . . . . 1.16 110.116 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 2.3 mmmp? -60.68 -45.49 93.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 1.86 109.912 175.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.9 -25.2 65.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.555 -0.748 . . . . 1.46 111.07 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.643 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 45.0 mm-40 -70.85 -21.71 62.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.348 -0.387 . . . . 1.65 110.461 176.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 111.62 12.54 14.57 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.0 -0.619 . . . . 0.8 112.38 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.557 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 29.6 m-70 -121.4 -179.35 4.04 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.553 -0.536 . . . . 1.31 109.553 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.444 ' HA ' ' HD2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -140.44 160.18 40.56 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 110.048 -0.353 . . . . 3.6 110.048 174.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.735 HD13 HD12 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -92.69 123.94 60.26 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.46 -0.336 . . . . 2.04 110.238 -177.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.38 15.42 0.27 Allowed 'Trans proline' 0 N--CA 1.48 0.695 0 C-N-CA 123.934 3.089 . . . . 1.16 114.229 -169.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 67.01 18.34 10.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.386 0.612 . . . . 1.47 110.489 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.57 147.59 43.55 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.375 -0.829 . . . . 1.94 109.506 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.648 ' HB3' ' HB ' ' A' ' 131' ' ' VAL . 96.2 mt -101.31 97.81 8.0 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.574 -0.285 . . . . 1.29 110.432 172.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.5 147.97 87.26 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.217 1.945 . . . . 0.91 111.416 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.53 -27.45 25.18 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 123.295 2.663 . . . . 1.02 114.173 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -85.01 7.58 20.85 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.061 0.458 . . . . 1.1 111.247 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.8 mt -132.39 -31.46 1.41 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.215 -0.448 . . . . 1.44 111.327 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.648 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 7.7 p . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 121.117 0.484 . . . . 2.06 110.923 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 CA--C 1.52 -0.191 0 CA-C-O 121.208 0.528 . . . . 1.03 110.288 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 149' ' ' ASN . . . . . 0.648 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 34.1 t-20 -96.2 114.92 65.19 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.412 -0.813 . . . . 0.55 111.101 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 150' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 10.4 Cg_exo -72.08 -2.65 11.9 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.351 2.701 . . . . 0.87 113.007 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 151' ' ' PHE . . . . . 0.535 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 68.8 m-85 -107.02 -23.34 12.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.511 0.672 . . . . 0.55 110.333 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 152' ' ' GLU . . . . . 0.648 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 41.7 tt0 . . . . . 0 C--N 1.316 -0.87 0 CA-C-N 114.975 -1.011 . . . . 1.42 109.397 -173.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.48 1.568 0 N-CA-C 112.337 -0.305 . . . . 11.96 112.337 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 4.9 Cg_exo -74.65 102.13 1.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.79 2.327 . . . . 11.91 111.401 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.67 145.3 31.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.955 -0.566 . . . . 8.98 110.294 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.86 170.49 54.97 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.159 -0.544 . . . . 6.64 113.044 -176.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 p -88.72 125.28 34.79 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.163 -0.31 . . . . 6.11 110.163 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -86.71 97.11 10.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.081 0.467 . . . . 4.1 110.205 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -101.51 97.46 7.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.858 -0.61 . . . . 3.87 109.964 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.0 p -89.19 154.06 3.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.407 -0.815 . . . . 2.46 109.879 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -79.19 87.2 4.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.552 0.691 . . . . 3.02 111.159 -178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -82.22 95.32 7.51 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.526 -0.916 . . . . 0.94 108.526 174.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.2 m -56.79 -26.06 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.911 -0.586 . . . . 1.86 112.28 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.633 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 40.8 t -62.77 -19.42 23.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.898 0.38 . . . . 2.02 110.829 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.34 -23.38 64.4 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.789 -0.72 . . . . 0.67 111.982 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -84.11 -28.13 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.794 0.807 . . . . 3.38 109.314 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.909 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.1 m-20 -84.29 -28.08 27.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.288 -1.324 . . . . 1.82 111.455 -175.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 4.2 mmmp? -47.06 -54.73 18.64 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 115.342 1.608 . . . . 1.61 115.342 -168.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.5 Cg_endo -50.21 -41.77 49.0 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.279 1.986 . . . . 0.66 112.792 -173.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.4 m -70.63 -43.98 68.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.759 -0.655 . . . . 1.21 111.026 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.909 ' CE2' ' HB3' ' A' ' 49' ' ' ASP . 16.6 m-85 -76.74 -19.79 57.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.074 -0.512 . . . . 1.49 110.229 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.96 -44.65 80.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.894 -0.78 . . . . 1.86 108.894 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -61.91 -45.51 93.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.382 -0.826 . . . . 2.0 110.536 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.11 -39.48 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.153 0.501 . . . . 1.28 110.58 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.59 -37.23 75.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.625 -0.716 . . . . 0.52 110.619 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -75.82 -24.69 55.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 3.37 112.11 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.1 p -81.63 -14.95 56.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.575 -0.45 . . . . 1.41 111.393 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.7 mt -90.88 3.92 53.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.444 -0.344 . . . . 1.96 110.75 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.1 t 68.76 84.86 0.14 Allowed Pre-proline 0 C--O 1.232 0.151 0 O-C-N 123.949 0.78 . . . . 1.74 111.246 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -75.67 110.84 3.17 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.368 2.045 . . . . 0.76 112.27 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.22 116.07 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.258 0.552 . . . . 2.08 110.195 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 60.31 23.18 12.64 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.608 -0.724 . . . . 2.3 111.257 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.26 18.53 60.53 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.959 -0.564 . . . . 0.7 113.645 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.503 ' HG2' ' HB3' ' A' ' 100' ' ' LEU . 37.3 tttt -153.84 125.19 7.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.301 0.551 . . . . 2.76 109.765 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.4 pt -85.32 155.46 3.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.159 0.504 . . . . 1.05 110.874 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.466 ' HA ' HD22 ' A' ' 100' ' ' LEU . 73.5 p -87.37 176.19 7.63 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.375 -0.83 . . . . 1.09 110.995 -176.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.446 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -66.24 -26.91 72.65 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.847 -0.692 . . . . 0.4 112.468 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.481 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -69.84 -43.62 71.6 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.922 0.391 . . . . 1.09 111.145 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -60.92 -51.89 67.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.714 0.769 . . . . 1.73 109.996 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.434 ' HB3' ' HZ3' ' A' ' 90' ' ' TRP . . . -73.54 -24.29 60.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.481 -0.781 . . . . 1.17 110.985 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.654 ' HD3' ' HB2' ' B' ' 150' ' ' PRO . 34.0 ttpt -64.1 -46.84 82.47 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.586 -0.446 . . . . 1.25 110.278 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.692 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 5.4 ptpp? -71.09 -27.32 63.53 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 120.232 -0.587 . . . . 2.79 110.728 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.541 ' HA ' ' HZ1' ' A' ' 78' ' ' LYS . 17.7 tp10 -67.3 -44.12 80.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.228 0.537 . . . . 0.82 109.851 174.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.477 ' HE1' ' HB1' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -61.45 -39.57 91.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.427 -0.806 . . . . 1.38 111.674 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.439 HG23 ' HA ' ' A' ' 74' ' ' LYS . 19.2 m -73.72 -23.03 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.366 -0.534 . . . . 1.53 110.71 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.692 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 32.6 mtmm -73.17 -24.14 60.52 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.981 0.419 . . . . 3.56 110.147 174.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.2 m -68.84 -16.04 63.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 1.06 111.089 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? 67.59 31.08 6.31 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.441 0.534 . . . . 2.48 112.441 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.411 HD11 ' HA ' ' A' ' 81' ' ' LEU . 3.6 mm? -97.66 152.92 38.41 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.486 -0.325 . . . . 2.1 110.16 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.537 ' O ' HD12 ' A' ' 86' ' ' LEU . 35.5 Cg_exo -57.64 143.12 95.67 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.552 2.168 . . . . 0.9 111.616 174.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -57.38 -34.77 69.19 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.85 0.357 . . . . 1.09 111.436 -173.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.0 m -58.6 -38.86 78.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.872 -0.604 . . . . 1.14 110.948 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.593 ' O ' HG12 ' A' ' 89' ' ' ILE . 98.6 t -70.21 -39.24 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.81 -0.632 . . . . 1.19 109.426 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.537 HD12 ' O ' ' A' ' 82' ' ' PRO . 6.5 mp -57.67 -47.02 83.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.462 -0.79 . . . . 2.0 110.527 178.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.53 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -60.67 -39.92 97.28 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.033 -0.603 . . . . 0.37 112.401 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -69.96 -45.34 67.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.664 0.269 . . . . 1.64 110.604 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.593 HG12 ' O ' ' A' ' 85' ' ' VAL . 46.0 mm -56.64 -47.09 82.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 1.5 110.266 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.446 ' CH2' ' HA2' ' A' ' 69' ' ' GLY . 22.9 t-105 -64.46 -46.62 82.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.855 -0.611 . . . . 0.41 110.906 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -66.32 -24.1 66.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 2.0 111.38 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.475 ' O ' HD12 ' A' ' 126' ' ' LEU . 4.3 mm? -86.72 -47.44 9.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.349 -0.387 . . . . 2.23 110.841 173.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.48 -38.16 83.96 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.95 0.722 . . . . 1.1 112.95 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.645 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 35.2 t70 -76.59 86.28 3.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.274 0.559 . . . . 0.59 109.719 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.0 t -76.62 -25.01 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.648 -0.706 . . . . 2.11 110.786 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.672 ' OD1' ' HE2' ' A' ' 135' ' ' LYS . 67.1 m-20 -70.49 -24.82 62.92 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.606 -0.438 . . . . 1.45 110.871 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 97' ' ' LYS . 41.2 mmtm 56.27 35.78 26.36 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.776 0.798 . . . . 3.13 108.997 -170.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.633 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 9.0 p-10 -99.6 -18.72 17.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.486 -1.234 . . . . 1.22 110.692 -173.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.72 -6.85 77.34 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.613 -0.803 . . . . 0.51 112.777 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.503 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . 67.8 mt -117.67 160.15 21.79 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.458 -0.571 . . . . 1.2 109.458 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.41 HD23 ' HB3' ' A' ' 105' ' ' GLU . 65.0 mt -121.54 113.96 20.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.977 0.417 . . . . 1.38 110.321 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.727 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 3.4 p30 -84.29 -176.28 6.18 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.56 -0.904 . . . . 1.42 108.56 171.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -63.7 -28.16 69.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.623 0.601 . . . . 1.73 112.623 -170.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.727 ' HG2' ' OD1' ' A' ' 102' ' ' ASP . 13.3 pt-20 -85.42 -39.07 17.95 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 119.841 -0.744 . . . . 1.53 110.704 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.41 ' HB3' HD23 ' A' ' 101' ' ' LEU . 46.0 mt-10 -63.61 -45.84 88.52 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.361 0.601 . . . . 1.2 110.27 175.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -64.44 -39.33 93.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.197 -0.91 . . . . 0.49 110.657 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.79 79.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.143 -0.481 . . . . 1.1 110.734 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.2 mt -68.98 -41.42 77.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.623 -0.262 . . . . 1.96 110.462 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.477 ' HB1' ' HE1' ' A' ' 76' ' ' MET . . . -54.01 -52.07 61.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 1.08 110.509 174.239 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -65.6 -39.78 91.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.273 -0.421 . . . . 1.54 110.95 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.634 ' O ' HG23 ' A' ' 115' ' ' VAL . 79.1 t60 -57.87 -47.29 83.17 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.534 -0.303 . . . . 0.75 110.428 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.468 HD11 HD12 ' A' ' 122' ' ' LEU . 92.5 mt -65.18 -43.3 92.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.526 -0.306 . . . . 1.54 111.018 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.451 HD11 ' HE2' ' A' ' 76' ' ' MET . 73.9 mt -56.63 -44.24 80.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 120.989 0.423 . . . . 1.07 110.304 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.648 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 62.9 tttp -61.35 -42.87 99.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.898 -0.592 . . . . 2.6 110.833 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.634 HG23 ' O ' ' A' ' 111' ' ' HIS . 29.8 t -55.92 -42.02 69.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.889 0.376 . . . . 1.16 110.062 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.594 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 29.1 mmmt -62.61 -43.77 97.98 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.748 -0.66 . . . . 1.86 110.802 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.96 -29.59 70.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.36 -0.382 . . . . 1.46 111.494 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.648 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 53.9 mm-40 -72.18 -4.77 31.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.24 -0.436 . . . . 1.65 110.753 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.34 2.24 56.71 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.851 -0.69 . . . . 0.8 112.295 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.594 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 72.3 m-70 -112.33 -178.36 3.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.755 0.312 . . . . 1.31 110.177 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.43 156.45 46.96 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.967 0.413 . . . . 3.6 110.649 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.468 HD12 HD11 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -80.81 140.25 50.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.691 -0.686 . . . . 2.04 109.271 177.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.53 8.09 2.02 Favored 'Trans proline' 0 N--CA 1.476 0.483 0 C-N-CA 122.997 2.465 . . . . 1.16 113.655 -174.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.7 19.15 11.58 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.242 0.544 . . . . 1.47 111.027 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.474 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 39.6 m-20 -120.48 127.38 52.16 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.862 -0.608 . . . . 1.94 110.088 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.475 HD12 ' O ' ' A' ' 92' ' ' LEU . 86.6 mt -94.18 97.34 2.17 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.317 -0.401 . . . . 1.29 110.284 167.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.698 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 86.0 Cg_endo -83.02 173.03 10.41 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.666 2.244 . . . . 0.91 111.542 175.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.96 -31.32 52.47 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.811 2.34 . . . . 1.02 113.225 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -90.8 14.16 14.36 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.759 0.314 . . . . 1.1 111.627 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.698 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 31.2 mt -131.06 -28.91 1.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.413 -0.358 . . . . 1.44 110.504 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 85.8 t -74.61 120.5 81.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 110.062 -0.347 . . . . 2.06 110.062 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -61.81 147.05 96.11 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.381 2.054 . . . . 1.43 111.704 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -57.85 -24.7 65.61 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.047 2.498 . . . . 2.08 112.417 -178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.8 t -66.91 -20.51 65.92 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.281 -0.418 . . . . 2.5 110.912 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.672 ' HE2' ' OD1' ' A' ' 96' ' ' ASP . 3.0 mptt -120.3 26.23 9.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.46 -0.336 . . . . 1.91 111.554 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 30.7 mmm180 -92.02 110.18 21.54 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.988 0.423 . . . . 3.72 110.65 177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -75.14 119.8 19.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.721 -0.672 . . . . 6.1 111.612 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -102.87 126.82 50.17 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.408 -0.59 . . . . 6.4 109.408 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 . . . . . 0 C--O 1.251 1.169 0 O-C-N 123.8 0.687 . . . . 6.93 110.693 -179.352 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . 0.617 HD23 ' H3 ' ' B' ' 143' ' ' LEU . 2.6 pt? . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.545 0.212 . . . . 10.99 111.284 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -84.97 -31.84 23.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.636 -0.426 . . . . 8.04 111.432 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 14.7 m -72.61 105.41 4.23 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.26 -1.015 . . . . 5.48 108.26 172.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' B' ' 147' ' ' PRO . 49.5 mmtm -86.16 107.28 12.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.169 0.509 . . . . 7.03 111.041 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' B' ' 146' ' ' LYS . 6.2 Cg_endo -85.35 15.68 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.382 2.721 . . . . 2.56 112.986 -173.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -98.93 2.32 46.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.253 0.549 . . . . 1.03 109.813 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.556 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 53.7 t-20 -114.97 117.76 41.35 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.202 -0.908 . . . . 0.55 109.772 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.654 ' HB2' ' HD3' ' A' ' 73' ' ' LYS . 59.1 Cg_endo -72.11 -2.76 12.09 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.955 2.437 . . . . 0.87 112.596 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 29.7 m-85 -107.87 5.96 26.93 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.287 -0.634 . . . . 0.55 109.287 175.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . 0.556 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 29.0 tt0 -129.51 17.44 5.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.851 -1.068 . . . . 1.42 108.508 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.62 86.87 3.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.096 -0.956 . . . . 1.71 111.414 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 72.22 148.93 0.09 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.823 -1.081 . . . . 4.81 111.696 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -105.47 -73.07 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 5.98 111.362 -173.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -117.8 -25.79 6.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.231 0.539 . . . . 7.19 110.301 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.246 0.882 0 CA-C-N 114.828 -1.078 . . . . 7.32 108.742 179.653 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.645 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 N-CA-C 112.091 -0.404 . . . . 11.96 112.091 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.32 127.23 11.0 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.577 2.185 . . . . 11.91 111.669 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 89.9 mt -94.0 120.07 33.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.98 0.419 . . . . 8.98 111.222 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -105.66 136.62 13.31 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.997 -0.841 . . . . 6.64 110.997 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.3 p -79.46 115.48 19.12 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.162 0.506 . . . . 6.11 111.717 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -88.15 93.88 9.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.866 -0.606 . . . . 4.1 109.484 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -144.81 107.94 4.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.419 -0.809 . . . . 3.87 109.582 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.511 HG11 ' HA ' ' A' ' 129' ' ' HIS . 62.5 t -103.06 124.46 57.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.963 -0.562 . . . . 2.46 110.776 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.76 105.99 16.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.336 0.589 . . . . 3.02 109.835 174.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -87.59 93.72 9.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.534 0.683 . . . . 0.94 109.212 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.87 5.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.148 -0.933 . . . . 1.86 112.827 -173.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.488 HG13 ' HE2' ' A' ' 53' ' ' TYR . 24.6 t -93.95 -17.04 7.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.935 0.398 . . . . 2.02 110.091 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.18 -18.87 71.6 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.506 -0.854 . . . . 0.67 112.67 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -87.18 -26.83 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.917 0.389 . . . . 3.38 111.759 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.405 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 22.9 m-20 -101.1 -2.71 30.79 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.324 0.583 . . . . 1.82 109.878 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.566 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 2.8 tmtp? -55.17 -50.06 88.75 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 114.932 -1.031 . . . . 1.61 112.635 -175.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.9 Cg_endo -51.45 -38.63 64.15 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.546 2.164 . . . . 0.66 112.095 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 m -69.24 -40.08 78.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.829 -0.623 . . . . 1.21 110.716 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.488 ' HE2' HG13 ' A' ' 46' ' ' VAL . 14.5 m-85 -70.33 -24.29 62.97 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.127 0.489 . . . . 1.49 109.763 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.67 -44.74 61.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.478 -0.783 . . . . 1.86 109.989 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.09 -45.77 90.0 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.6 -0.727 . . . . 2.0 110.388 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.9 mt -64.33 -44.58 97.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 121.207 0.527 . . . . 1.28 110.73 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -52.06 -45.19 64.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.495 -0.775 . . . . 0.52 111.476 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -81.78 -23.71 36.41 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.36 0.504 . . . . 3.37 112.36 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.3 p -75.33 -16.79 60.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.136 0.493 . . . . 1.41 110.627 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 72.4 mt -84.46 -10.0 57.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.893 -0.594 . . . . 1.96 110.307 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.0 m 70.07 93.09 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.314 0 O-C-N 124.161 0.913 . . . . 1.74 111.311 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.428 ' HA ' HG23 ' A' ' 67' ' ' ILE . 1.0 OUTLIER -84.23 140.67 8.79 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.654 2.903 . . . . 0.76 111.653 178.641 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.2 m -97.37 107.62 20.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.443 0.64 . . . . 2.08 110.326 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 m120 63.55 31.22 14.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.194 -0.912 . . . . 2.3 111.014 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.15 -0.01 66.09 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.726 -0.75 . . . . 0.7 114.37 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.522 ' HE2' ' HB2' ' A' ' 100' ' ' LEU . 71.8 tttt -137.47 138.21 39.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.755 0.778 . . . . 2.76 109.371 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.428 HG23 ' HA ' ' A' ' 62' ' ' PRO . 46.2 pt -93.14 156.71 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.632 -0.427 . . . . 1.05 111.102 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.402 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 50.0 p -88.24 -179.65 6.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.512 -0.767 . . . . 1.09 110.322 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.81 -14.46 81.48 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.554 -0.831 . . . . 0.4 111.808 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.03 -39.88 28.94 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.947 0.403 . . . . 1.09 110.745 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.7 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 5.4 m120 -63.44 -52.22 62.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.981 0.896 . . . . 1.73 109.653 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.436 ' HB2' ' HZ3' ' A' ' 90' ' ' TRP . . . -67.66 -26.45 66.21 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.267 -0.879 . . . . 1.17 110.732 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.436 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 35.7 ttmt -65.42 -47.79 75.02 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.743 -0.383 . . . . 1.25 110.739 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.7 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 19.8 ptmt -64.74 -31.0 72.02 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.928 0.394 . . . . 2.79 110.477 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HA ' ' HZ3' ' A' ' 78' ' ' LYS . 17.1 tp10 -71.11 -48.38 52.59 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.251 0.548 . . . . 0.82 110.21 175.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.421 ' HG3' HD21 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -58.13 -47.3 83.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.532 -0.758 . . . . 1.38 111.604 -178.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.8 m -67.47 -34.74 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.671 0.272 . . . . 1.53 110.804 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.467 ' HZ3' ' HA ' ' A' ' 75' ' ' GLU . 3.2 mtpm? -64.38 -18.7 64.92 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 112.282 0.475 . . . . 3.56 112.282 174.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.4 m -84.18 2.32 40.26 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.744 0.307 . . . . 1.06 111.127 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? 54.92 50.36 15.74 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.76 0.652 . . . . 2.48 112.76 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.476 ' HB2' HD22 ' A' ' 86' ' ' LEU . 96.3 mt -120.49 141.44 32.1 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 110.092 -0.336 . . . . 2.1 110.092 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.514 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 37.1 Cg_exo -59.62 151.41 69.93 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.061 2.507 . . . . 0.9 112.82 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -51.41 -45.27 62.5 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.822 -0.627 . . . . 1.09 111.77 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.0 m -58.25 -41.39 84.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.01 0.434 . . . . 1.14 111.285 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.499 ' O ' HG12 ' A' ' 89' ' ' ILE . 46.2 t -68.88 -42.08 82.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.981 0.42 . . . . 1.19 109.881 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.514 ' HG ' ' O ' ' A' ' 82' ' ' PRO . 67.3 mt -62.31 -38.94 91.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.652 -0.704 . . . . 2.0 110.033 177.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.96 -37.22 94.04 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.792 -0.64 . . . . 0.37 112.251 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -66.6 -47.06 73.9 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.894 0.378 . . . . 1.64 110.034 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 85' ' ' VAL . 38.2 mm -55.08 -50.05 66.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.355 -0.839 . . . . 1.5 109.962 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.436 ' HZ3' ' HB2' ' A' ' 72' ' ' ALA . 34.9 t-105 -65.81 -44.5 85.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.919 -0.582 . . . . 0.41 111.545 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ttpt -67.46 -21.37 65.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.079 0.466 . . . . 2.0 110.738 -174.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.602 HD11 HD11 ' A' ' 122' ' ' LEU . 24.7 mt -91.92 -38.37 12.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.767 -0.651 . . . . 2.23 111.139 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.77 -35.36 67.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 1.1 111.781 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.66 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 22.0 t0 -85.09 82.28 8.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.744 0.783 . . . . 0.59 109.289 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.2 t -74.1 -27.68 22.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.072 -0.967 . . . . 2.11 110.951 -173.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 55.3 p30 -86.81 -10.14 54.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.565 -0.289 . . . . 1.45 111.191 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 53.51 51.52 15.1 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.493 0.495 . . . . 3.13 110.808 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -111.98 -8.68 14.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.061 -0.518 . . . . 1.22 111.089 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.1 4.84 86.42 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.97 -0.633 . . . . 0.51 112.529 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.522 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 52.3 mt -129.68 162.53 28.14 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.828 -0.434 . . . . 1.2 109.828 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.4 mt -122.66 117.52 25.97 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.801 -0.359 . . . . 1.38 110.946 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.05 -178.04 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.419 -0.956 . . . . 1.42 108.419 169.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -60.51 -29.23 68.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.892 0.331 . . . . 1.73 111.892 -173.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.78 -42.23 18.18 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.811 -0.356 . . . . 1.53 110.464 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -65.72 -40.44 92.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.22 0.534 . . . . 1.2 110.265 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -69.4 -34.48 74.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.678 -0.692 . . . . 0.49 109.998 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.33 -42.25 98.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.329 -0.396 . . . . 1.1 110.284 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 1.8 mm? -59.5 -44.16 93.17 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.713 -0.477 . . . . 1.96 109.713 173.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.443 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.58 -54.24 48.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.651 -0.704 . . . . 1.08 110.978 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -66.33 -34.88 78.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.736 0.303 . . . . 1.54 110.855 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 115' ' ' VAL . 85.4 t60 -63.7 -43.1 97.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.403 -0.362 . . . . 0.75 110.282 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.44 ' HG ' ' O ' ' A' ' 108' ' ' LEU . 96.1 mt -66.62 -39.83 88.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.305 -0.407 . . . . 1.54 110.624 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 109' ' ' ALA . 77.9 mt -61.39 -40.35 85.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.499 . . . . 1.07 109.951 174.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -59.6 -47.35 85.91 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.74 -0.664 . . . . 2.6 110.391 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 111' ' ' HIS . 21.1 t -56.54 -43.93 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.353 0.597 . . . . 1.16 110.263 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.68 -46.97 83.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.04 -0.982 . . . . 1.86 111.041 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.65 -17.24 51.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 1.46 111.384 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.501 ' HB3' ' HD2' ' A' ' 120' ' ' HIS . 11.7 mm-40 -70.01 -8.01 45.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.179 -0.464 . . . . 1.65 111.183 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.87 23.06 34.01 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.51 -0.853 . . . . 0.8 111.402 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.501 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 85.0 m-70 -129.67 -173.3 2.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.004 0.43 . . . . 1.31 110.123 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -134.18 160.08 38.92 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.618 -0.719 . . . . 3.6 110.441 -171.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.602 HD11 HD11 ' A' ' 92' ' ' LEU . 0.1 OUTLIER -106.8 115.32 60.6 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 115.039 -0.982 . . . . 2.04 108.806 173.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.07 24.3 0.3 Allowed 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.664 2.909 . . . . 1.16 114.445 -167.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 59.16 25.58 14.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.113 0.482 . . . . 1.47 111.036 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -131.28 138.78 49.43 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.03 -0.532 . . . . 1.94 110.047 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.457 ' HB3' ' CG1' ' A' ' 131' ' ' VAL . 96.7 mt -106.14 90.22 4.44 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.623 -0.262 . . . . 1.29 110.677 172.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -73.59 158.97 46.85 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.844 2.363 . . . . 0.91 112.33 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -57.55 -28.55 81.49 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.47 2.78 . . . . 1.02 114.177 -175.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.511 ' HA ' HG11 ' A' ' 42' ' ' VAL . 36.2 p-80 -85.94 6.68 27.42 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.736 -0.385 . . . . 1.1 111.605 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 62.0 mt -122.92 -22.97 5.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.519 0.199 . . . . 1.44 111.397 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.457 ' CG1' ' HB3' ' A' ' 126' ' ' LEU . 29.3 m -83.68 142.08 42.22 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.741 0.305 . . . . 2.06 111.318 -178.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.694 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 24.6 Cg_exo -63.42 136.05 52.93 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.768 2.312 . . . . 1.43 111.627 175.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -59.12 -31.45 95.49 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.746 2.297 . . . . 2.08 112.406 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.8 p -66.58 -30.25 70.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.915 -0.584 . . . . 2.5 111.309 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.694 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 13.8 mptt -85.99 9.42 17.1 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.973 -0.558 . . . . 1.91 112.041 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -85.47 105.22 15.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.042 0.448 . . . . 3.72 111.226 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -108.83 149.05 29.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.784 -0.644 . . . . 6.1 109.731 176.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.545 ' O ' ' HB2' ' A' ' 139' ' ' GLU . 28.8 t60 -94.66 98.2 10.63 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.958 0.355 . . . . 6.4 111.958 -174.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 138' ' ' HIS . 21.7 tt0 . . . . . 0 C--O 1.248 0.997 0 O-C-N 124.396 1.06 . . . . 6.93 109.12 170.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 109.586 -0.524 . . . . 10.99 109.586 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -143.64 162.95 34.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.504 -0.771 . . . . 8.04 109.661 -171.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 47.5 m -66.7 98.58 0.53 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.82 -0.808 . . . . 5.48 108.82 171.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 0.453 ' C ' ' H ' ' B' ' 148' ' ' TYR . 10.2 tptm -64.23 115.26 18.18 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.629 -0.714 . . . . 7.03 111.133 -172.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.29 23.58 0.31 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.079 2.519 . . . . 2.56 112.851 -176.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . 0.453 ' H ' ' C ' ' B' ' 146' ' ' LYS . 85.5 m-85 -129.53 -16.25 3.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.975 -0.557 . . . . 1.03 110.352 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 53.2 t-20 -115.96 108.62 46.11 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.55 109.795 -175.149 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.23 -5.95 17.7 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.191 2.594 . . . . 0.87 112.65 -177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 29.6 m-85 -107.01 -4.43 19.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.918 0.39 . . . . 0.55 110.221 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 30.6 tt0 -108.88 22.9 15.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.879 0.847 . . . . 1.42 108.926 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -75.22 -72.86 0.28 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.891 -1.05 . . . . 1.71 110.402 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 45.82 -100.41 0.05 OUTLIER 'General case' 0 C--O 1.235 0.297 0 O-C-N 124.125 0.891 . . . . 4.81 112.579 -177.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -167.29 -171.87 1.84 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.058 -0.349 . . . . 5.98 110.058 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -79.72 84.82 5.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.224 0.535 . . . . 7.19 110.228 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 27.7 t70 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.434 -0.793 . . . . 7.32 109.975 -179.079 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.66 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.445 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.484 1.84 0 N-CA-C 112.349 -0.3 . . . . 11.96 112.349 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.445 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 9.3 Cg_exo -73.8 107.47 2.42 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.625 2.217 . . . . 11.91 111.452 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.63 149.55 27.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.301 -0.409 . . . . 8.98 110.91 -177.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.79 71.2 2.76 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.564 -0.827 . . . . 6.64 112.099 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.9 m -132.95 113.89 13.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.831 -0.433 . . . . 6.11 109.831 175.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -105.17 102.9 12.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.606 0.717 . . . . 4.1 111.486 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -87.43 135.5 33.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.285 -0.87 . . . . 3.87 108.82 171.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 52.6 t -76.54 113.1 15.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.025 0.44 . . . . 2.46 110.821 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -115.33 136.62 52.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.858 -0.61 . . . . 3.02 109.716 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -81.83 104.58 12.31 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.013 -1.106 . . . . 0.94 108.013 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.524 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 90.6 t -56.51 -29.56 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.843 -0.617 . . . . 1.86 112.229 -171.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.529 HG12 ' HB2' ' A' ' 111' ' ' HIS . 18.9 m -77.69 -13.36 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 122.179 -0.326 . . . . 2.02 111.109 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.8 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -65.09 -24.46 70.34 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.063 -0.589 . . . . 0.67 112.255 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 18.5 ptpt -87.17 0.34 55.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.746 0.307 . . . . 3.38 111.234 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -138.71 21.24 2.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.694 0.759 . . . . 1.82 109.767 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.8 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 5.0 mmmp? -57.86 -40.15 81.56 Favored Pre-proline 0 C--O 1.22 -0.484 0 CA-C-N 115.353 -0.84 . . . . 1.61 112.491 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 8.9 Cg_endo -50.35 -42.26 48.52 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 122.308 2.005 . . . . 0.66 112.527 176.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.7 m -69.59 -44.05 71.55 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.12 -0.491 . . . . 1.21 110.295 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -71.18 -22.65 62.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.953 -0.567 . . . . 1.49 110.416 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.71 -45.53 29.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.893 -0.781 . . . . 1.86 108.893 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.69 -54.07 43.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.3 -0.864 . . . . 2.0 110.629 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.2 mt -64.88 -44.52 96.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.234 -0.439 . . . . 1.28 111.435 -176.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.411 ' HE1' HG12 ' A' ' 67' ' ' ILE . 51.2 t80 -58.56 -44.18 89.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.52 110.79 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 13.1 m-85 -76.34 -24.33 54.25 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.122 0.416 . . . . 3.37 112.122 -177.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 p -76.3 -15.97 59.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.025 0.44 . . . . 1.41 111.035 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mp -88.29 -4.25 58.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.979 -0.555 . . . . 1.96 110.516 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m 69.29 89.32 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.314 0 CA-C-N 115.232 -0.895 . . . . 1.74 111.735 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 58.7 Cg_endo -86.65 117.01 1.4 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.705 2.27 . . . . 0.76 112.747 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.1 t -91.45 132.79 34.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.258 -0.645 . . . . 2.08 109.258 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.8 p30 49.48 23.71 0.96 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.726 0.81 . . . . 2.3 112.108 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.78 6.75 61.95 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.073 -0.584 . . . . 0.7 113.403 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -135.74 155.58 50.15 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.673 0.749 . . . . 2.76 112.316 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.411 HG12 ' HE1' ' A' ' 57' ' ' PHE . 41.3 pt -114.13 152.82 15.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.749 -1.114 . . . . 1.05 108.775 171.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -88.0 175.65 7.67 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 120.449 -0.501 . . . . 1.09 110.23 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.94 -27.25 71.0 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.641 -0.79 . . . . 0.4 112.528 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.63 -48.36 82.13 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.954 0.407 . . . . 1.09 111.915 -176.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -71.8 -40.78 68.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.282 0.563 . . . . 1.73 110.571 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.537 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -72.07 -28.79 63.55 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.465 -0.494 . . . . 1.17 110.095 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.405 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 40.7 ttmt -64.79 -50.15 67.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.725 -0.216 . . . . 1.25 110.533 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -62.18 -38.22 88.27 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.508 -0.315 . . . . 2.79 110.58 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.93 -50.64 72.96 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.423 0.63 . . . . 0.82 110.22 174.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.793 ' HB3' HD23 ' A' ' 86' ' ' LEU . 22.8 mmt -58.52 -45.24 89.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.528 -0.76 . . . . 1.38 112.197 -177.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.87 -16.6 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.946 0.403 . . . . 1.53 110.796 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -91.19 -5.76 54.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.169 -0.469 . . . . 3.56 111.063 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.408 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 7.1 t -89.54 -1.18 57.95 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.271 0.558 . . . . 1.06 110.135 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 79' ' ' SER . 9.1 mptt 70.82 16.61 6.61 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.236 0.828 . . . . 2.48 113.236 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.486 ' HB2' HD21 ' A' ' 86' ' ' LEU . 2.6 mm? -91.29 142.85 27.49 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.574 -0.45 . . . . 2.1 111.124 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.577 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 21.3 Cg_exo -65.49 154.87 71.77 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.263 2.642 . . . . 0.9 112.474 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -56.12 -41.23 74.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.223 -0.444 . . . . 1.09 111.55 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.462 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 7.9 m -58.21 -48.25 80.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.218 0.532 . . . . 1.14 110.938 178.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.564 ' O ' HG12 ' A' ' 89' ' ' ILE . 96.4 t -63.57 -42.06 94.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.731 -0.668 . . . . 1.19 110.479 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.793 HD23 ' HB3' ' A' ' 76' ' ' MET . 79.0 mt -61.92 -44.06 97.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.062 -0.517 . . . . 2.0 110.762 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.7 -31.63 71.85 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 121.027 -0.606 . . . . 0.37 112.308 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 84' ' ' THR . 55.4 mtpt -72.66 -46.56 53.26 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.747 0.308 . . . . 1.64 110.479 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 85' ' ' VAL . 43.5 mm -55.53 -52.08 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.66 -0.7 . . . . 1.5 109.899 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -63.78 -39.49 94.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.983 -0.553 . . . . 0.41 110.841 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -59.72 -35.62 74.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.773 0.32 . . . . 2.0 111.194 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.422 ' O ' HD13 ' A' ' 126' ' ' LEU . 6.3 mp -88.75 -34.6 17.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.146 -0.479 . . . . 2.23 111.343 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.21 -42.71 65.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.967 0.413 . . . . 1.1 111.757 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.628 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 24.9 t70 -89.33 91.11 8.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.385 0.612 . . . . 0.59 109.545 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.503 HG22 ' HG2' ' A' ' 135' ' ' LYS . 34.0 m -82.48 -29.78 9.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.118 -0.946 . . . . 2.11 112.204 -171.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -86.99 -13.11 45.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.665 -0.243 . . . . 1.45 111.151 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.566 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 17.0 mmmt 57.84 45.07 19.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.847 -0.615 . . . . 3.13 110.718 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.538 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 11.4 p-10 -93.29 -13.22 28.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.612 -0.722 . . . . 1.22 110.965 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.63 5.47 74.76 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.797 -0.716 . . . . 0.51 111.993 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.538 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 30.9 mt -128.27 166.27 18.91 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.241 -0.281 . . . . 1.2 110.241 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.0 mt -122.35 119.85 32.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.322 -0.399 . . . . 1.38 110.157 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -95.79 -175.86 3.55 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.168 -0.678 . . . . 1.42 109.168 171.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.34 -33.64 67.95 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.835 0.35 . . . . 1.73 111.495 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.96 -56.56 4.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.278 -0.419 . . . . 1.53 110.28 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.427 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 25.6 mt-10 -59.27 -37.0 76.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.732 -0.667 . . . . 1.2 111.096 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -71.23 -35.28 71.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.417 -0.356 . . . . 0.49 110.865 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.63 -38.32 90.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.735 0.302 . . . . 1.1 110.436 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.39 -41.03 96.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 1.96 110.12 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.422 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.06 -52.48 64.1 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.765 -0.652 . . . . 1.08 110.941 177.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.07 -30.1 69.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.452 . . . . 1.54 111.355 -176.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.53 ' O ' HG21 ' A' ' 115' ' ' VAL . 83.9 t60 -62.02 -45.86 91.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.776 0.322 . . . . 0.75 110.377 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.6 mt -68.87 -41.55 78.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.872 -0.604 . . . . 1.54 110.856 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 109' ' ' ALA . 78.1 mt -61.17 -39.97 84.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.951 -0.568 . . . . 1.07 110.034 176.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.597 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 32.3 tttm -56.26 -50.4 71.45 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.93 -0.577 . . . . 2.6 110.606 175.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.53 HG21 ' O ' ' A' ' 111' ' ' HIS . 46.0 t -51.34 -39.11 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.101 -0.5 . . . . 1.16 111.145 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -68.58 -30.39 69.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.722 0.296 . . . . 1.86 111.469 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.1 mt -72.4 -34.55 67.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.97 0.414 . . . . 1.46 110.07 174.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.597 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 41.7 mm-40 -68.4 -25.96 65.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.884 -0.598 . . . . 1.65 109.611 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.52 35.08 4.5 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.604 -0.726 . . . . 0.8 112.802 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -132.99 173.55 11.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.066 0.433 . . . . 1.31 110.638 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.88 156.14 20.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.862 -0.608 . . . . 3.6 109.985 -177.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.26 135.18 24.65 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.546 -0.538 . . . . 2.04 109.546 176.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.36 4.66 4.22 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.013 2.476 . . . . 1.16 113.726 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 65.33 19.65 11.69 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.488 0.492 . . . . 1.47 111.425 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -131.27 148.63 52.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.048 -0.524 . . . . 1.94 110.126 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 92' ' ' LEU . 79.1 mt -109.05 108.81 60.78 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.867 -0.606 . . . . 1.29 110.38 173.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.631 ' HD2' HD13 ' A' ' 130' ' ' LEU . 26.4 Cg_exo -61.03 154.06 59.67 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.592 2.195 . . . . 0.91 111.662 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -64.49 -4.93 9.04 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.811 2.341 . . . . 1.02 113.116 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -100.94 4.03 42.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.981 0.419 . . . . 1.1 110.38 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.631 HD13 ' HD2' ' A' ' 127' ' ' PRO . 35.5 mt -116.21 -8.3 11.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 1.44 111.095 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 27.0 m -103.92 123.14 42.03 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.433 0.635 . . . . 2.06 110.267 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.18 156.85 63.61 Favored 'Trans proline' 0 C--N 1.33 -0.399 0 C-N-CA 122.926 2.417 . . . . 1.43 111.453 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.464 ' HA ' ' HB2' ' A' ' 136' ' ' ARG . 32.1 Cg_exo -58.66 -21.38 55.38 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.96 2.44 . . . . 2.08 112.112 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.6 t -60.21 -26.95 66.79 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.666 -0.697 . . . . 2.5 110.799 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.503 ' HG2' HG22 ' A' ' 95' ' ' VAL . 10.4 mptt -112.46 14.22 20.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.998 0.427 . . . . 1.91 110.785 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.464 ' HB2' ' HA ' ' A' ' 133' ' ' PRO . 50.9 mtp180 -111.47 151.61 28.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.099 0.476 . . . . 3.72 111.772 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.83 130.13 41.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.728 -0.669 . . . . 6.1 110.021 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -101.71 131.66 47.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.885 0.374 . . . . 6.4 110.79 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--O 1.25 1.085 0 N-CA-C 109.07 -0.715 . . . . 6.93 109.07 171.84 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 51.4 tp . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.704 0.288 . . . . 10.99 110.759 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -99.9 134.89 42.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.666 0.27 . . . . 8.04 110.881 -179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 5.6 p -75.72 -55.75 5.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.969 -0.56 . . . . 5.48 109.992 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 67.3 mttm 58.58 79.54 0.31 Allowed Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.331 -0.85 . . . . 7.03 111.627 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . 0.412 ' CG ' ' HA ' ' B' ' 153' ' ' GLU . 81.1 Cg_endo -77.75 170.89 18.3 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.498 2.132 . . . . 2.56 112.351 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -120.7 33.1 5.7 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.109 -0.496 . . . . 1.03 110.27 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.687 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 55.9 t-20 -138.52 116.17 9.17 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.474 -0.785 . . . . 0.55 109.39 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.43 ' HA ' ' OE1' ' B' ' 153' ' ' GLU . 23.1 Cg_exo -66.1 -14.48 44.59 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 123.442 2.761 . . . . 0.87 113.362 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.665 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 17.9 m-85 -107.33 -1.62 21.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.498 0.666 . . . . 0.55 110.133 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . 0.687 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 42.4 tt0 -133.92 23.64 3.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.673 -1.149 . . . . 1.42 108.39 -175.721 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . 0.43 ' OE1' ' HA ' ' B' ' 150' ' ' PRO . 8.5 pt-20 -80.46 -13.51 59.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.9 -1.045 . . . . 1.71 111.12 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 57.37 -154.3 0.35 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.013 -0.539 . . . . 4.81 111.643 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -116.07 -68.35 0.93 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.558 -0.292 . . . . 5.98 110.598 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -141.16 58.79 1.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.852 -0.796 . . . . 7.19 108.852 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 C--O 1.246 0.881 0 CA-C-N 115.182 -0.917 . . . . 7.32 110.977 -172.718 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.628 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 111.533 -0.627 . . . . 11.96 111.533 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.69 141.73 13.86 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.465 2.11 . . . . 11.91 111.827 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.8 mp -115.0 147.88 39.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.245 -0.434 . . . . 8.98 110.383 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -131.34 136.95 9.11 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.471 -0.652 . . . . 6.64 111.471 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.7 m -77.91 134.52 37.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.852 0.358 . . . . 6.11 110.171 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -77.0 134.48 38.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.096 -0.502 . . . . 4.1 111.07 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -119.8 107.6 13.38 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.181 -0.463 . . . . 3.87 109.921 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.0 t -101.34 118.93 48.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.277 -0.419 . . . . 2.46 110.676 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -89.97 125.77 35.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.195 -0.457 . . . . 3.02 109.981 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -75.02 104.52 5.63 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.587 -0.894 . . . . 0.94 108.587 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.1 t -54.82 -32.25 25.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.951 -0.568 . . . . 1.86 111.164 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 45.2 t -79.04 -15.21 13.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.93 -0.577 . . . . 2.02 111.321 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.83 -23.88 71.11 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.798 -0.715 . . . . 0.67 111.813 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -87.09 -16.02 36.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 122.304 1.049 . . . . 3.38 109.881 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' HB3' ' HE2' ' A' ' 53' ' ' TYR . 0.3 OUTLIER -104.84 -11.74 16.61 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.433 -1.712 . . . . 1.82 110.893 -163.691 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 3.6 mmmp? -57.79 -55.81 41.09 Favored Pre-proline 0 C--O 1.224 -0.281 0 N-CA-C 114.521 1.304 . . . . 1.61 114.521 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 10.5 Cg_endo -48.8 -37.88 36.62 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.73 2.287 . . . . 0.66 113.44 -168.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.543 ' O ' HG13 ' A' ' 56' ' ' ILE . 16.8 m -71.29 -44.39 65.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.059 -0.519 . . . . 1.21 110.88 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.424 ' HE2' ' HB3' ' A' ' 49' ' ' ASP . 12.2 m-85 -78.26 -22.32 48.49 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.085 -0.507 . . . . 1.49 109.992 -176.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -71.96 -42.07 66.98 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.108 -0.701 . . . . 1.86 109.108 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -53.41 -52.83 58.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.125 -0.943 . . . . 2.0 109.898 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 52' ' ' THR . 15.8 mt -67.84 -31.33 51.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.109 -0.95 . . . . 1.28 110.637 -178.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -59.91 -37.38 79.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.765 -0.652 . . . . 0.52 110.774 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -70.83 -24.94 62.64 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.771 0.285 . . . . 3.37 111.771 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 p -86.23 -5.68 59.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.848 0.356 . . . . 1.41 111.399 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.476 HD11 ' OE1' ' A' ' 75' ' ' GLU . 8.8 mp -96.19 5.19 51.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.978 0.418 . . . . 1.96 110.086 175.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m 64.71 86.15 0.14 Allowed Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 115.074 -0.966 . . . . 1.74 111.567 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.28 115.24 4.19 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.103 2.535 . . . . 0.76 112.192 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.5 t -89.28 113.48 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.601 -0.518 . . . . 2.08 109.601 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 65.09 22.65 12.35 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.012 -0.54 . . . . 2.3 110.296 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.02 19.12 59.81 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.903 -0.59 . . . . 0.7 112.408 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.606 ' HZ2' ' HB3' ' A' ' 102' ' ' ASP . 32.4 tttp -144.2 131.79 21.13 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.652 -0.499 . . . . 2.76 109.652 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 101' ' ' LEU . 38.9 pt -92.71 152.54 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.36 -0.536 . . . . 1.05 111.078 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.437 ' HA ' HD22 ' A' ' 100' ' ' LEU . 37.6 p -85.07 160.46 19.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.721 -0.672 . . . . 1.09 110.982 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.18 -29.71 71.89 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.153 -0.546 . . . . 0.4 112.596 178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.9 -50.57 72.12 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.029 0.442 . . . . 1.09 111.634 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.457 ' HA ' ' HG2' ' A' ' 74' ' ' LYS . 40.1 m-80 -74.69 -37.01 62.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.897 -0.592 . . . . 1.73 110.954 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.406 ' HB1' ' HZ3' ' A' ' 90' ' ' TRP . . . -69.39 -27.5 65.35 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.378 -0.374 . . . . 1.17 110.458 177.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.551 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 38.8 ttpt -72.6 -49.54 31.43 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.537 -0.301 . . . . 1.25 111.094 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.457 ' HG2' ' HA ' ' A' ' 71' ' ' ASN . 20.2 ptmt -59.82 -36.86 77.65 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 121.132 -0.227 . . . . 2.79 110.481 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.476 ' OE1' HD11 ' A' ' 60' ' ' LEU . 17.3 tp10 -61.46 -52.46 64.44 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.492 0.663 . . . . 0.82 110.142 175.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.77 ' HG2' ' HG ' ' A' ' 86' ' ' LEU . 17.5 ttm -67.64 -27.47 66.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.426 -0.806 . . . . 1.38 111.376 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.55 -40.46 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 116.432 -0.349 . . . . 1.53 110.231 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -73.36 -8.89 57.78 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.226 -0.443 . . . . 3.56 110.742 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 7.4 t -73.31 -12.63 60.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.191 -0.459 . . . . 1.06 110.447 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 79' ' ' SER . 45.3 mmtm 73.5 26.67 1.94 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.411 0.685 . . . . 2.48 112.608 178.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.81 144.27 27.86 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.518 -0.549 . . . . 2.1 109.518 172.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.543 ' O ' HD11 ' A' ' 86' ' ' LEU . 12.6 Cg_endo -60.23 139.06 85.15 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.814 2.343 . . . . 0.9 112.563 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.425 ' HA ' HD21 ' A' ' 86' ' ' LEU . 15.9 m120 -51.83 -35.03 43.05 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.031 0.532 . . . . 1.09 112.164 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.496 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 2.7 m -57.64 -40.73 79.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.383 0.611 . . . . 1.14 110.634 177.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.573 ' O ' HG12 ' A' ' 89' ' ' ILE . 66.8 t -74.19 -38.71 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.041 -0.726 . . . . 1.19 109.041 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.77 ' HG ' ' HG2' ' A' ' 76' ' ' MET . 5.1 mp -58.77 -45.72 89.14 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.992 -1.003 . . . . 2.0 110.321 176.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.51 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -59.46 -39.68 95.21 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.528 -0.76 . . . . 0.37 112.001 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 84' ' ' THR . 55.4 mtpt -71.09 -43.95 66.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.751 0.31 . . . . 1.64 110.349 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.573 HG12 ' O ' ' A' ' 85' ' ' VAL . 45.0 mm -57.3 -47.44 84.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 1.5 110.201 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.406 ' HZ3' ' HB1' ' A' ' 72' ' ' ALA . 15.3 t-105 -66.7 -41.42 88.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 0.41 110.398 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.417 ' HZ1' ' CD ' ' B' ' 152' ' ' GLU . 3.5 tppp? -64.86 -22.49 67.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.164 -0.471 . . . . 2.0 111.101 -175.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.515 HD12 ' HG ' ' A' ' 126' ' ' LEU . 4.0 mm? -93.29 -41.63 9.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 2.23 111.018 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.14 88.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.563 -0.29 . . . . 1.1 111.648 -176.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.62 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 41.6 t0 -83.51 75.52 10.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.371 -0.603 . . . . 0.59 109.371 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.4 t -67.93 -34.72 68.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.369 -0.832 . . . . 2.11 110.987 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.627 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.7 OUTLIER -82.81 -15.37 51.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.407 -0.815 . . . . 1.45 111.866 -175.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 60.66 72.48 0.52 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.515 0.509 . . . . 3.13 111.63 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p30 -129.26 -14.43 4.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.007 -0.542 . . . . 1.22 111.328 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.13 4.34 84.22 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.347 -0.93 . . . . 0.51 112.234 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 68' ' ' THR . 67.7 mt -127.88 160.48 31.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.447 -0.575 . . . . 1.2 109.447 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.45 HD23 ' HB3' ' A' ' 105' ' ' GLU . 51.6 mt -124.28 118.32 26.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.804 0.335 . . . . 1.38 110.565 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.606 ' HB3' ' HZ2' ' A' ' 66' ' ' LYS . 6.1 p30 -82.84 -175.25 5.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.062 -0.718 . . . . 1.42 109.062 167.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -61.67 -31.23 71.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.643 0.259 . . . . 1.73 111.115 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.43 ' CD ' ' HG2' ' A' ' 132' ' ' PRO . 11.1 tt0 -72.11 -57.43 4.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.446 -0.343 . . . . 1.53 110.183 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.67 ' OE1' 'CA ' ' A' ' 141' ' ' ' CA' . 32.0 mt-10 -56.06 -44.63 79.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.075 -0.512 . . . . 1.2 111.04 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -66.9 -38.24 85.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.898 -0.592 . . . . 0.49 110.954 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.28 85.14 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.943 -0.303 . . . . 1.1 110.632 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.12 -43.83 95.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.99 -0.374 . . . . 1.96 109.99 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.33 -58.03 8.51 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.041 -0.527 . . . . 1.08 111.069 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -67.29 -33.23 74.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.436 . . . . 1.54 111.319 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.648 ' O ' HG23 ' A' ' 115' ' ' VAL . 77.3 t60 -64.17 -45.89 86.42 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 120.699 -0.4 . . . . 0.75 109.991 176.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.412 ' HB3' HD12 ' A' ' 89' ' ' ILE . 75.0 mt -60.95 -41.46 96.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.59 0.233 . . . . 1.54 111.063 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.96 -45.28 95.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.339 -0.391 . . . . 1.07 110.196 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.463 ' HE2' ' OE2' ' A' ' 118' ' ' GLU . 86.8 tttt -64.86 -35.85 82.47 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.897 -0.321 . . . . 2.6 110.795 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 111' ' ' HIS . 95.9 t -53.77 -44.27 58.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.359 -0.608 . . . . 1.16 109.359 173.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -66.83 -42.85 85.11 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.403 -0.817 . . . . 1.86 111.405 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.44 -27.27 64.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.334 -0.394 . . . . 1.46 111.605 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.463 ' OE2' ' HE2' ' A' ' 114' ' ' LYS . 34.1 mt-10 -75.84 -6.98 53.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.306 -0.406 . . . . 1.65 111.469 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.39 17.8 35.44 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.407 -0.901 . . . . 0.8 112.327 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.451 ' HB2' ' CG1' ' A' ' 115' ' ' VAL . 11.5 m-70 -109.86 176.32 5.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.459 -0.571 . . . . 1.31 109.459 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -139.63 130.77 26.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.876 0.369 . . . . 3.6 111.275 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.72 126.32 88.63 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.296 -0.631 . . . . 2.04 109.296 173.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.67 13.87 1.57 Allowed 'Trans proline' 0 N--CA 1.474 0.343 0 C-N-CA 123.202 2.601 . . . . 1.16 113.748 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 66.38 19.52 10.96 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.403 0.62 . . . . 1.47 110.719 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -111.7 137.2 49.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.566 -0.743 . . . . 1.94 109.433 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.515 ' HG ' HD12 ' A' ' 92' ' ' LEU . 92.3 mt -100.94 90.07 1.44 Allowed Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 110.193 -0.299 . . . . 1.29 110.193 168.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.455 ' HD2' HD11 ' A' ' 130' ' ' LEU . 43.9 Cg_endo -71.17 155.02 61.74 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.298 1.999 . . . . 0.91 111.713 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.25 -10.15 20.08 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 123.275 2.65 . . . . 1.02 113.583 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -92.8 1.06 57.48 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.134 0.492 . . . . 1.1 110.386 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.455 HD11 ' HD2' ' A' ' 127' ' ' PRO . 66.2 mt -117.34 -35.31 4.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 1.44 110.571 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 92.6 t -88.75 124.03 66.46 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.088 -0.505 . . . . 2.06 111.478 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.43 ' HG2' ' CD ' ' A' ' 104' ' ' GLU . 18.5 Cg_exo -67.86 153.85 74.48 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.885 2.39 . . . . 1.43 111.43 172.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.653 ' HA ' ' HB2' ' A' ' 136' ' ' ARG . 61.3 Cg_endo -67.85 11.28 0.25 Allowed 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 123.594 2.862 . . . . 2.08 113.51 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 132' ' ' PRO . 1.7 p -75.85 -33.94 60.04 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.96 0.409 . . . . 2.5 110.709 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.91 20.89 12.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.251 0.548 . . . . 1.91 110.706 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.653 ' HB2' ' HA ' ' A' ' 133' ' ' PRO . 78.8 mtp180 -104.07 149.99 24.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.581 -0.736 . . . . 3.72 109.612 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -87.74 160.98 17.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.934 0.397 . . . . 6.1 110.608 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -109.01 114.87 28.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.961 -0.563 . . . . 6.4 110.635 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.274 -0.87 . . . . 6.93 109.805 175.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . 0.628 ' H1 ' HD22 ' B' ' 143' ' ' LEU . 1.3 mm? . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.24 -0.652 . . . . 10.99 109.24 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -119.84 156.58 30.4 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.517 -0.765 . . . . 8.04 110.331 -168.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 13.6 p -108.81 127.28 53.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.103 -0.499 . . . . 5.48 110.88 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' B' ' 147' ' ' PRO . 16.5 ttmm -108.25 111.46 61.72 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.459 -0.571 . . . . 7.03 109.459 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' B' ' 146' ' ' LYS . 4.0 Cg_exo -78.11 -167.21 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.248 2.632 . . . . 2.56 113.454 -176.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -83.74 -3.99 58.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.216 -0.902 . . . . 1.03 110.571 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.56 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 47.5 t-20 -96.86 112.88 61.79 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.591 -0.731 . . . . 0.55 110.055 -174.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.481 ' HB2' ' HD3' ' A' ' 73' ' ' LYS . 56.7 Cg_endo -70.47 -9.17 25.3 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.008 2.472 . . . . 0.87 112.616 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.551 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 31.4 m-85 -96.84 -7.99 32.12 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.129 -0.693 . . . . 0.55 109.129 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . 0.56 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 28.3 tt0 -115.2 28.06 8.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.002 -0.999 . . . . 1.42 109.508 -175.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -72.49 82.56 1.09 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.426 -0.806 . . . . 1.71 110.674 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . 0.411 ' O ' ' HB2' ' B' ' 155' ' ' GLU . 15.8 mt-10 73.17 174.46 0.28 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.608 -0.724 . . . . 4.81 111.959 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 155' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' B' ' 154' ' ' GLU . 47.9 mm-40 72.2 151.18 0.11 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.14 -0.936 . . . . 5.98 113.189 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 69.3 107.14 0.06 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.328 -1.305 . . . . 7.19 112.158 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 114.933 -1.03 . . . . 7.32 109.169 175.942 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.67 'CA ' ' OE1' ' A' ' 105' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 112.054 -0.418 . . . . 11.96 112.054 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.36 142.92 30.69 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.865 2.377 . . . . 11.91 112.29 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.2 mp -96.69 121.51 38.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.044 -0.526 . . . . 8.98 109.999 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.57 159.58 27.18 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.756 -0.735 . . . . 6.64 112.187 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.4 m -106.77 143.31 35.05 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.245 -0.28 . . . . 6.11 110.245 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.86 118.7 19.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.209 -0.451 . . . . 4.1 109.982 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -88.06 117.99 27.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.519 0.676 . . . . 3.87 111.324 -175.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.03 114.93 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.499 -0.773 . . . . 2.46 110.23 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -85.42 137.92 32.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.86 0.362 . . . . 3.02 110.603 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -75.19 104.88 5.94 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.969 -0.752 . . . . 0.94 108.969 175.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.6 t -55.63 -47.25 79.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.023 -0.535 . . . . 1.86 112.434 -172.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.589 HG22 ' HE2' ' A' ' 53' ' ' TYR . 2.7 p -69.31 -22.04 25.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.392 0.615 . . . . 2.02 110.77 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.795 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -67.65 -11.96 60.95 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.422 -0.808 . . . . 0.67 112.082 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -80.59 -27.7 37.31 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.943 -0.391 . . . . 3.38 109.943 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -100.4 10.55 41.05 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.839 -0.619 . . . . 1.82 110.0 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.795 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 15.8 mmmt -52.58 -55.46 32.21 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 114.371 1.248 . . . . 1.61 114.371 -171.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 10.6 Cg_endo -51.3 -37.36 59.95 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.532 2.155 . . . . 0.66 112.808 -174.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.445 ' O ' HG13 ' A' ' 56' ' ' ILE . 8.6 m -69.99 -43.1 72.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.82 -0.627 . . . . 1.21 110.34 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.589 ' HE2' HG22 ' A' ' 46' ' ' VAL . 13.9 m-30 -73.92 -23.21 59.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.365 -0.38 . . . . 1.49 110.436 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.483 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 22.4 m-20 -69.29 -45.48 69.5 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.237 0.541 . . . . 1.86 109.586 176.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -60.82 -38.91 87.06 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.121 -0.945 . . . . 2.0 110.892 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 52' ' ' THR . 62.7 mt -68.95 -40.96 81.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 1.28 110.568 176.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -55.82 -39.68 71.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.52 111.243 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.483 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 48.9 m-85 -75.92 -13.58 60.25 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.763 0.653 . . . . 3.37 112.763 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 64.1 p -73.93 -18.55 60.88 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.179 -0.608 . . . . 1.41 110.824 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 2.0 mm? -87.12 -9.34 55.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.418 -0.356 . . . . 1.96 110.895 175.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.6 t 67.91 94.05 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.25 0 O-C-N 123.905 0.753 . . . . 1.74 110.758 -176.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.37 134.51 42.18 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 123.009 2.473 . . . . 0.76 112.992 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.2 t -107.96 123.54 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 108.881 -0.785 . . . . 2.08 108.881 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.8 p30 45.33 33.72 1.31 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.452 0.701 . . . . 2.3 112.499 -175.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.98 -3.4 67.09 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.053 -0.594 . . . . 0.7 114.448 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -137.87 170.25 16.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.812 0.806 . . . . 2.76 110.692 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.7 pt -114.7 155.24 15.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.79 -0.364 . . . . 1.05 110.177 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.604 ' HA ' HD22 ' A' ' 100' ' ' LEU . 76.0 p -87.25 167.58 13.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.239 -0.437 . . . . 1.09 110.897 -176.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.47 -24.44 63.83 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.768 -0.73 . . . . 0.4 112.315 176.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.4 -35.92 76.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.204 0.526 . . . . 1.09 110.76 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.474 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 13.5 m120 -70.58 -49.05 51.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.575 -0.739 . . . . 1.73 110.529 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.462 ' HB3' ' HZ3' ' A' ' 90' ' ' TRP . . . -73.49 -20.1 60.76 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.47 -0.492 . . . . 1.17 110.411 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.586 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 39.5 ttmt -67.3 -50.35 60.63 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.558 -0.534 . . . . 1.25 109.558 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 22.2 ptmt -64.79 -35.68 81.87 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.237 -0.438 . . . . 2.79 110.793 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.83 -51.97 62.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.362 0.601 . . . . 0.82 110.279 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.863 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -65.12 -36.51 84.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.464 -0.789 . . . . 1.38 112.384 -174.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -75.37 -26.07 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.294 -0.562 . . . . 1.53 110.339 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -85.43 -1.77 57.39 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.06 -0.518 . . . . 3.56 110.413 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 33.5 m -79.66 -7.76 58.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 1.06 109.992 171.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 79' ' ' SER . 0.1 OUTLIER 69.97 27.36 4.43 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.631 -0.713 . . . . 2.48 111.603 178.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.515 ' HB2' HD13 ' A' ' 86' ' ' LEU . 95.3 mt -110.31 157.93 36.72 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.424 . . . . 2.1 110.368 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.661 ' O ' HD11 ' A' ' 86' ' ' LEU . 60.6 Cg_endo -74.16 147.43 37.86 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.704 2.269 . . . . 0.9 113.323 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -51.46 -38.5 54.07 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.979 -0.555 . . . . 1.09 112.029 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.502 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 35.0 m -56.69 -43.23 80.29 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.107 0.48 . . . . 1.14 111.092 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.562 ' O ' HG12 ' A' ' 89' ' ' ILE . 53.5 t -73.93 -36.59 45.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.135 -0.691 . . . . 1.19 109.135 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.863 ' HG ' ' HB3' ' A' ' 76' ' ' MET . 1.7 mp -62.62 -45.3 93.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.076 -0.966 . . . . 2.0 110.546 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.499 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -58.72 -37.22 89.37 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.892 -0.595 . . . . 0.37 112.308 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 84' ' ' THR . 52.4 mtpt -71.76 -42.3 67.38 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.208 -0.293 . . . . 1.64 110.208 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.562 HG12 ' O ' ' A' ' 85' ' ' VAL . 32.7 mm -53.15 -52.54 29.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.942 -0.572 . . . . 1.5 110.132 173.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.462 ' HZ3' ' HB3' ' A' ' 72' ' ' ALA . 27.3 t-105 -64.38 -43.03 95.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.78 -0.645 . . . . 0.41 111.159 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.474 ' HZ3' ' CD ' ' B' ' 152' ' ' GLU . 35.5 ttmt -63.83 -25.05 68.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.081 0.467 . . . . 2.0 111.318 -175.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.402 HD11 ' HA ' ' A' ' 92' ' ' LEU . 3.7 mm? -89.36 -31.23 17.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.132 -0.486 . . . . 2.23 111.158 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.59 -36.45 28.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.361 -0.381 . . . . 1.1 111.883 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.62 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 24.7 t0 -84.93 57.2 4.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.824 0.821 . . . . 0.59 109.942 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.444 HG13 ' HG2' ' A' ' 135' ' ' LYS . 13.6 p -68.37 -16.12 20.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.849 -1.069 . . . . 2.11 111.483 -177.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -89.71 -18.46 26.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.119 -0.492 . . . . 1.45 110.824 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.543 ' HB2' ' NZ ' ' A' ' 97' ' ' LYS . 0.1 OUTLIER 61.01 73.46 0.48 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.14 0.576 . . . . 3.13 111.55 179.229 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.647 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 15.4 p-10 -132.96 -18.93 2.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.463 -0.335 . . . . 1.22 111.759 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.68 4.47 72.91 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.437 -0.887 . . . . 0.51 112.064 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.604 HD22 ' HA ' ' A' ' 68' ' ' THR . 41.4 mt -130.35 171.6 12.76 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.361 -0.607 . . . . 1.2 109.361 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.407 HD23 ' HB3' ' A' ' 105' ' ' GLU . 79.9 mt -127.06 118.45 24.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.46 -0.336 . . . . 1.38 110.702 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -83.31 -176.48 6.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.842 -0.799 . . . . 1.42 108.842 167.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.96 -29.44 69.84 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.616 -0.434 . . . . 1.73 111.798 -173.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.49 -50.12 48.22 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.316 -0.624 . . . . 1.53 109.316 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.407 ' HB3' HD23 ' A' ' 101' ' ' LEU . 36.5 mt-10 -59.96 -52.77 63.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.352 -0.84 . . . . 1.2 111.431 -178.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -63.09 -35.86 81.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.941 -0.572 . . . . 0.49 110.703 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.412 ' HB2' ' HD2' ' A' ' 53' ' ' TYR . . . -65.84 -47.32 75.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 1.1 110.682 177.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.84 -37.85 88.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.355 -0.384 . . . . 1.96 109.974 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.501 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.0 -49.73 72.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.86 -0.609 . . . . 1.08 110.426 173.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -69.19 -28.46 66.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.838 -0.619 . . . . 1.54 111.846 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.586 ' O ' HG23 ' A' ' 115' ' ' VAL . 82.3 t60 -67.06 -41.97 85.54 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.395 -0.522 . . . . 0.75 109.932 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.7 mt -64.75 -38.58 91.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.994 0.426 . . . . 1.54 110.111 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.795 HD11 ' HE1' ' A' ' 76' ' ' MET . 72.0 mt -63.23 -41.23 92.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.712 -0.676 . . . . 1.07 110.505 176.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -54.77 -49.88 69.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.836 0.35 . . . . 2.6 110.585 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.586 HG23 ' O ' ' A' ' 111' ' ' HIS . 29.9 t -59.68 -40.49 82.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.99 -0.55 . . . . 1.16 109.926 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.685 ' HZ1' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -61.51 -42.63 99.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.492 -0.776 . . . . 1.86 111.181 175.416 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 86.4 mt -72.37 -32.11 66.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.613 0.244 . . . . 1.46 111.569 -176.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -75.36 3.41 9.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.478 -0.328 . . . . 1.65 111.543 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.69 2.5 75.64 Favored Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 120.642 -0.789 . . . . 0.8 112.478 175.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.516 ' HB2' HG11 ' A' ' 115' ' ' VAL . 28.3 m-70 -92.92 173.93 7.5 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.097 0.475 . . . . 1.31 109.887 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.33 145.39 40.12 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.0 -0.545 . . . . 3.6 110.675 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.76 125.21 56.31 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.827 -0.624 . . . . 2.04 109.634 175.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.79 -2.14 11.45 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.898 2.399 . . . . 1.16 113.165 -172.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.3 21.02 12.22 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.421 0.629 . . . . 1.47 110.25 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.438 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -115.37 131.86 56.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.048 -0.978 . . . . 1.94 109.872 -178.251 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.582 ' HB3' ' HB ' ' A' ' 131' ' ' VAL . 92.5 mt -96.85 96.57 2.85 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.139 0.274 . . . . 1.29 110.624 170.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.479 ' O ' HG11 ' A' ' 131' ' ' VAL . 57.8 Cg_endo -76.48 159.76 35.73 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.406 2.07 . . . . 0.91 111.265 177.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.98 -25.57 28.63 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.998 2.466 . . . . 1.02 114.023 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -86.92 9.26 19.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.823 0.344 . . . . 1.1 111.42 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.449 ' O ' ' HD3' ' A' ' 132' ' ' PRO . 63.1 mt -131.71 -35.37 1.28 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 1.44 110.65 174.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.582 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 7.1 p -91.14 108.45 28.5 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 121.497 0.665 . . . . 2.06 110.693 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.451 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 16.8 Cg_exo -67.86 151.29 78.49 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.661 2.24 . . . . 1.43 111.48 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.47 ' HA ' ' HD2' ' A' ' 136' ' ' ARG . 41.6 Cg_exo -56.38 -27.3 66.95 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.969 2.446 . . . . 2.08 112.837 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.8 t -69.4 -17.7 63.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.886 -0.597 . . . . 2.5 111.041 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.444 ' HG2' HG13 ' A' ' 95' ' ' VAL . 1.0 OUTLIER -114.09 12.72 17.95 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.845 0.355 . . . . 1.91 110.926 179.547 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.47 ' HD2' ' HA ' ' A' ' 133' ' ' PRO . 98.8 mtt180 -95.77 116.35 28.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.629 0.252 . . . . 3.72 110.815 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -109.4 133.52 52.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.996 0.427 . . . . 6.1 110.575 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -94.8 115.93 28.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.053 -0.721 . . . . 6.4 109.053 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 C--O 1.247 0.969 0 O-C-N 123.949 0.78 . . . . 6.93 109.842 -175.256 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 110.29 -0.263 . . . . 10.99 110.29 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -90.44 -75.88 0.45 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.493 -0.558 . . . . 8.04 109.493 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 45.7 m -118.6 -97.66 0.46 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.961 -0.563 . . . . 5.48 110.088 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 68.1 mttm 52.16 72.4 1.2 Allowed Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 122.756 0.422 . . . . 7.03 111.13 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.02 171.55 13.99 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.458 2.105 . . . . 2.56 113.032 -176.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -99.75 21.34 12.6 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.625 -0.88 . . . . 1.03 108.625 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.499 HD22 ' HA2' ' A' ' 87' ' ' GLY . 45.9 t-20 -97.36 119.39 63.07 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 114.451 -1.249 . . . . 0.55 109.882 -173.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.548 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 9.2 Cg_exo -71.99 -10.36 25.99 Favored 'Trans proline' 0 CA--C 1.528 0.184 0 C-N-CA 123.259 2.639 . . . . 0.87 112.948 -175.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.586 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 15.0 m-85 -106.41 -16.08 14.65 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.626 0.726 . . . . 0.55 109.475 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . 0.474 ' CD ' ' HZ3' ' A' ' 91' ' ' LYS . 41.5 tt0 -123.33 54.6 1.26 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.557 -1.202 . . . . 1.42 108.595 177.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -74.61 -15.43 60.83 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 114.756 -1.111 . . . . 1.71 110.651 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 68.85 151.43 0.09 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.191 -0.913 . . . . 4.81 110.996 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -99.34 -68.21 0.81 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.623 0.601 . . . . 5.98 112.623 -170.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -110.2 109.36 19.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.974 0.416 . . . . 7.19 111.608 -172.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.802 -0.618 . . . . 7.32 109.615 172.912 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.647 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 112.06 -0.416 . . . . 11.96 112.06 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.69 113.42 3.79 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.625 2.217 . . . . 11.91 111.619 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 pp -85.9 159.09 19.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.859 -0.609 . . . . 8.98 110.882 -178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -106.83 133.62 11.74 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.645 -0.788 . . . . 6.64 111.488 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.9 p -91.19 136.73 32.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.019 0.438 . . . . 6.11 110.896 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.91 92.69 6.18 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.168 0.509 . . . . 4.1 110.013 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -123.45 69.37 1.02 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.741 -0.663 . . . . 3.87 109.461 176.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.736 HG21 ' HA ' ' A' ' 129' ' ' HIS . 4.3 p -124.15 126.04 71.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.042 -0.527 . . . . 2.46 112.178 -177.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -122.53 124.88 44.57 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.614 -0.721 . . . . 3.02 109.094 169.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.56 90.36 4.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.221 -0.659 . . . . 0.94 109.221 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.9 m -57.77 -33.66 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.667 -0.697 . . . . 1.86 112.315 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.87 -16.07 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.589 0.709 . . . . 2.02 110.745 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.509 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -72.81 -6.38 67.1 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.397 -0.819 . . . . 0.67 111.941 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -91.94 -25.44 18.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.185 0.517 . . . . 3.38 110.221 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.435 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 20.7 m-20 -91.94 1.88 56.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.708 -0.678 . . . . 1.82 110.701 -176.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.525 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 3.5 mmmp? -53.96 -49.66 88.42 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 114.062 1.134 . . . . 1.61 114.062 -172.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.525 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 11.7 Cg_endo -52.69 -39.72 75.58 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.107 1.871 . . . . 0.66 112.891 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.507 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . 58.5 m -82.62 -31.92 28.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.902 0.382 . . . . 1.21 111.414 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.743 ' HH ' ' HA ' ' A' ' 111' ' ' HIS . 16.4 m-30 -71.11 -22.38 62.09 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.09 -0.708 . . . . 1.49 109.09 175.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.42 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 16.5 t70 -71.22 -42.5 68.85 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.15 -0.932 . . . . 1.86 109.365 172.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.507 ' OE2' ' HA ' ' A' ' 52' ' ' THR . 40.3 mt-10 -58.53 -34.35 70.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.33 -0.85 . . . . 2.0 110.837 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.7 mt -78.59 -52.44 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.075 0.464 . . . . 1.28 110.512 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.419 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 74.2 t80 -50.01 -41.37 47.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.393 -0.821 . . . . 0.52 111.855 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -74.75 -22.58 58.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.742 0.645 . . . . 3.37 112.742 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.5 p -79.47 -20.82 46.44 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.018 -0.673 . . . . 1.41 110.944 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.06 -5.05 59.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 1.96 110.647 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.0 t 68.0 92.03 0.07 OUTLIER Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 115.588 -0.733 . . . . 1.74 111.0 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.67 134.08 34.03 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.988 2.459 . . . . 0.76 111.941 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.2 t -110.8 107.52 23.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.09 -0.505 . . . . 2.08 110.124 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.9 m120 64.1 41.47 6.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.547 -0.751 . . . . 2.3 111.607 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.32 -3.38 72.36 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.984 -0.627 . . . . 0.7 113.94 172.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -160.3 170.53 20.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.412 0.606 . . . . 2.76 110.476 178.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.469 HD13 ' CD1' ' A' ' 106' ' ' PHE . 25.6 pt -104.94 159.4 5.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.828 0.346 . . . . 1.05 111.227 -177.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.477 ' HA ' HD23 ' A' ' 100' ' ' LEU . 73.5 p -89.27 170.66 10.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.856 -0.611 . . . . 1.09 110.972 -177.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.93 -27.98 72.06 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.688 -0.687 . . . . 0.4 112.546 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.96 -45.15 68.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.076 0.465 . . . . 1.09 111.295 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.445 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 8.9 m120 -63.73 -46.24 86.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.509 0.671 . . . . 1.73 110.127 -177.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.52 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -75.77 -23.89 55.98 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.729 -0.669 . . . . 1.17 110.489 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.794 ' HA ' ' HZ ' ' B' ' 151' ' ' PHE . 35.1 ttmt -61.32 -50.62 72.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.893 0.377 . . . . 1.25 110.033 174.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 19.4 ptmt -70.13 -27.71 64.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.312 -0.404 . . . . 2.79 110.395 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 13.2 tp10 -68.36 -40.39 81.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.612 0.72 . . . . 0.82 109.98 174.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.594 ' HB3' HD21 ' A' ' 86' ' ' LEU . 22.3 mmt -59.8 -42.81 94.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.67 -0.695 . . . . 1.38 111.24 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 74' ' ' LYS . 15.0 m -72.0 -24.07 22.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.459 -0.496 . . . . 1.53 110.441 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 10.1 mtpm? -71.67 -20.87 61.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 3.56 110.644 175.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.9 m -84.88 1.35 47.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.08 -0.509 . . . . 1.06 111.263 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.1 mptt 62.01 25.19 15.09 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.862 0.69 . . . . 2.48 112.862 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.534 ' HB2' HD22 ' A' ' 86' ' ' LEU . 98.8 mt -98.79 140.61 21.89 Favored Pre-proline 0 C--N 1.326 -0.45 0 C-N-CA 121.06 -0.256 . . . . 2.1 110.908 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.595 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 19.3 Cg_exo -64.92 159.49 45.88 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.189 2.592 . . . . 0.9 112.614 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -56.74 -43.71 80.96 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.823 -0.626 . . . . 1.09 111.611 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.2 m -56.34 -45.92 80.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.16 0.505 . . . . 1.14 110.905 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 89' ' ' ILE . 96.3 t -64.27 -45.24 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.763 -0.653 . . . . 1.19 110.618 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 82' ' ' PRO . 31.3 mt -62.62 -38.48 90.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.088 -0.506 . . . . 2.0 110.271 177.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.709 ' HA2' ' ND2' ' B' ' 149' ' ' ASN . . . -56.56 -37.42 75.54 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.289 -0.869 . . . . 0.37 111.783 176.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -77.63 -47.69 18.68 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.927 0.394 . . . . 1.64 110.561 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.619 HD11 HG12 ' A' ' 113' ' ' ILE . 67.8 mt -57.84 -49.57 80.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.01 -0.541 . . . . 1.5 111.105 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.581 ' HB3' ' ND2' ' B' ' 149' ' ' ASN . 13.4 t-105 -66.04 -38.48 88.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.215 0.531 . . . . 0.41 110.197 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 87' ' ' GLY . 24.4 ttmm -56.91 -33.33 66.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.521 -0.763 . . . . 2.0 111.05 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.406 HD11 ' HA ' ' A' ' 92' ' ' LEU . 3.8 mm? -90.72 -43.1 10.33 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.587 0.588 . . . . 2.23 112.587 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.63 -42.45 98.15 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.5 0.556 . . . . 1.1 112.5 -171.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.624 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 36.0 t0 -90.22 99.72 12.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.327 -0.62 . . . . 0.59 109.327 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.8 m -82.83 -30.31 8.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.767 -0.651 . . . . 2.11 111.839 -170.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.646 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 1.2 p30 -102.28 -9.29 20.53 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.131 0.419 . . . . 1.45 112.131 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.624 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 67.9 mmtt 66.15 74.48 0.35 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.187 0.517 . . . . 3.13 112.326 175.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.652 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 5.5 m-20 -91.82 -29.08 16.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.748 -0.66 . . . . 1.22 109.525 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.49 2.39 79.56 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 109.58 -1.408 . . . . 0.51 109.58 -167.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.477 HD23 ' HA ' ' A' ' 68' ' ' THR . 23.1 mt -133.93 175.8 9.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.195 -1.003 . . . . 1.2 108.435 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.552 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 96.6 mt -131.88 118.12 19.41 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.972 -0.291 . . . . 1.38 110.413 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.535 ' HA ' ' CB ' ' A' ' 66' ' ' LYS . 1.3 p-10 -81.08 -175.82 5.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.047 -0.723 . . . . 1.42 109.047 175.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.477 ' CG ' ' HZ3' ' A' ' 50' ' ' LYS . 17.9 t70 -61.4 -35.48 77.63 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 111.865 0.32 . . . . 1.73 111.865 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.416 ' OE2' ' HB3' ' A' ' 132' ' ' PRO . 48.4 mt-10 -68.36 -55.45 11.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.986 0.422 . . . . 1.53 110.542 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.494 ' HG3' ' OD1' ' A' ' 102' ' ' ASP . 36.0 mt-10 -72.22 -32.25 66.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.885 -0.598 . . . . 1.2 112.383 -173.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.469 ' CD1' HD13 ' A' ' 67' ' ' ILE . 49.5 t80 -69.29 -39.0 78.6 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.091 -0.644 . . . . 0.49 109.625 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.28 96.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.41 -0.516 . . . . 1.1 110.074 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.5 mt -65.55 -36.52 84.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.492 -0.322 . . . . 1.96 111.057 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.482 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -58.51 -52.16 66.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.801 0.334 . . . . 1.08 110.305 174.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -63.64 -36.47 83.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.043 -0.526 . . . . 1.54 110.627 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.743 ' HA ' ' HH ' ' A' ' 53' ' ' TYR . 77.1 t60 -63.72 -46.19 86.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.28 -0.418 . . . . 0.75 111.008 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.559 ' HB3' HD22 ' A' ' 122' ' ' LEU . 96.1 mt -63.66 -41.02 98.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.887 0.375 . . . . 1.54 110.731 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.619 HG12 HD11 ' A' ' 89' ' ' ILE . 73.9 mt -59.72 -44.15 93.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 1.07 109.986 175.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -60.51 -42.15 95.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.814 -0.63 . . . . 2.6 111.203 177.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.615 HG21 ' O ' ' A' ' 111' ' ' HIS . 59.5 t -58.11 -46.35 88.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.816 0.341 . . . . 1.16 110.351 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 16.5 mtpp -62.13 -42.24 99.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.033 0.383 . . . . 1.86 112.033 175.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 97.2 mt -64.51 -28.47 69.67 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.185 0.516 . . . . 1.46 110.723 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 58.2 mm-40 -73.04 -2.74 22.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.651 -0.704 . . . . 1.65 111.471 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.48 32.43 9.44 Favored Glycine 0 CA--C 1.505 -0.588 0 C-N-CA 120.647 -0.787 . . . . 0.8 112.099 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.489 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 95.4 m-70 -131.14 179.72 5.84 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.389 0.614 . . . . 1.31 111.406 -176.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.85 149.79 49.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.11 -0.95 . . . . 3.6 109.404 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.559 HD22 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -79.9 144.51 59.82 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.505 -0.554 . . . . 2.04 109.505 175.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.33 -5.91 15.06 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.998 2.465 . . . . 1.16 113.315 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.42 17.83 9.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.329 0.585 . . . . 1.47 110.599 -175.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -134.78 156.58 48.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.222 -0.899 . . . . 1.94 109.496 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.83 93.87 9.56 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.399 -0.364 . . . . 1.29 110.721 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -78.2 160.19 29.7 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.39 2.06 . . . . 0.91 112.084 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -51.63 -27.42 25.77 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.422 2.748 . . . . 1.02 113.805 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.736 ' HA ' HG21 ' A' ' 42' ' ' VAL . 28.0 p-80 -88.37 9.07 24.67 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.649 -0.42 . . . . 1.1 111.776 -177.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.8 mt -128.25 -32.87 2.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.508 0.194 . . . . 1.44 111.028 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 28.1 m -61.93 133.07 93.75 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 2.06 110.56 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.416 ' HB3' ' OE2' ' A' ' 104' ' ' GLU . 37.9 Cg_exo -58.2 142.73 97.44 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.281 1.987 . . . . 1.43 110.829 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.444 ' HA ' ' HD3' ' A' ' 136' ' ' ARG . 31.3 Cg_exo -56.99 -22.53 47.11 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.643 2.229 . . . . 2.08 112.15 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.7 t -77.84 -16.9 57.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.742 -0.663 . . . . 2.5 111.279 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.455 ' HE2' ' OD2' ' A' ' 96' ' ' ASP . 6.1 mptt -120.29 23.5 10.88 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.318 0.488 . . . . 1.91 112.318 -174.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . 0.444 ' HD3' ' HA ' ' A' ' 133' ' ' PRO . 31.3 ptt180 -110.32 151.85 26.91 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.638 -0.425 . . . . 3.72 111.664 -177.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -64.17 174.02 1.74 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.415 0.626 . . . . 6.1 112.238 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -133.79 128.62 35.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.385 -0.825 . . . . 6.4 109.091 167.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 . . . . . 0 C--O 1.253 1.286 0 O-C-N 123.801 0.688 . . . . 6.93 111.808 -179.381 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.006 -0.738 . . . . 10.99 109.006 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -154.84 111.82 3.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.233 -0.44 . . . . 8.04 110.456 -170.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 8.1 t -162.27 158.48 24.36 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.55 -0.537 . . . . 5.48 109.55 -178.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -105.6 154.19 39.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.559 -0.291 . . . . 7.03 110.811 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -82.88 -176.67 2.98 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.137 2.558 . . . . 2.56 112.386 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -130.46 1.45 4.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.057 -0.52 . . . . 1.03 110.705 -175.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.709 ' ND2' ' HA2' ' A' ' 87' ' ' GLY . 54.9 t-20 -93.16 122.11 64.05 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.904 -0.589 . . . . 0.55 109.741 -176.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.92 -5.68 11.17 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.171 2.581 . . . . 0.87 113.394 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.794 ' HZ ' ' HA ' ' A' ' 73' ' ' LYS . 43.4 m-85 -108.09 -3.52 18.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.368 0.604 . . . . 0.55 110.108 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . 0.562 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 46.9 tt0 -123.19 29.36 6.74 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.329 -0.989 . . . . 1.42 108.329 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -62.03 -40.3 95.24 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.185 -0.916 . . . . 1.71 111.352 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 65.05 -79.69 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 122.987 0.515 . . . . 4.81 112.168 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -94.94 106.84 18.85 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.068 -0.345 . . . . 5.98 110.068 -175.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -95.54 -55.93 2.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.917 -0.583 . . . . 7.19 109.803 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 C--O 1.251 1.152 0 CA-C-N 115.024 -0.989 . . . . 7.32 108.91 175.959 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.652 'CA ' ' OD2' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 111.694 -0.562 . . . . 11.96 111.694 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.89 136.4 25.07 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.82 2.347 . . . . 11.91 111.75 -176.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.684 ' H ' HD23 ' A' ' 37' ' ' LEU . 2.2 pt? -84.44 134.14 34.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.935 -0.575 . . . . 8.98 110.812 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.08 143.06 16.54 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.376 -0.69 . . . . 6.64 111.376 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.9 m -131.22 124.13 29.92 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.889 0.344 . . . . 6.11 111.226 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.33 93.11 7.66 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.672 -0.492 . . . . 4.1 109.672 173.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -125.2 78.76 1.74 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.548 0.69 . . . . 3.87 110.873 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.61 138.28 54.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.204 -0.907 . . . . 2.46 110.402 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -105.71 136.25 45.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.468 -0.333 . . . . 3.02 110.392 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -76.13 96.7 3.92 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.374 -0.972 . . . . 0.94 108.374 173.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.1 m -58.56 -15.01 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.876 0.695 . . . . 1.86 112.876 -172.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.487 HG21 HD21 ' A' ' 108' ' ' LEU . 61.2 t -80.6 -26.96 11.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.996 0.427 . . . . 2.02 110.714 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.451 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -73.85 -1.64 59.45 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.694 -0.765 . . . . 0.67 111.712 177.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -97.35 -17.13 19.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.166 0.508 . . . . 3.38 110.307 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.08 20.62 5.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.773 -0.649 . . . . 1.82 110.244 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.629 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 8.3 mmmm -58.25 -43.74 98.55 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 114.751 1.389 . . . . 1.61 114.751 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.629 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.9 Cg_endo -46.47 -41.98 23.15 Favored 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 122.906 2.404 . . . . 0.66 113.654 -172.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.3 m -70.54 -40.34 73.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.101 0.477 . . . . 1.21 110.679 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.457 ' CD2' ' HB2' ' A' ' 107' ' ' ALA . 7.4 m-85 -71.11 -23.41 62.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 1.49 109.67 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -75.22 -45.69 38.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.329 -0.85 . . . . 1.86 110.102 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -58.99 -50.44 74.1 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.449 -0.796 . . . . 2.0 110.39 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.68 -41.79 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.164 -0.471 . . . . 1.28 111.259 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.409 ' HB2' ' CD2' ' A' ' 106' ' ' PHE . 90.5 t80 -58.55 -47.83 82.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.287 -0.415 . . . . 0.52 110.927 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -76.37 -20.86 56.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.225 0.454 . . . . 3.37 112.225 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.7 p -78.43 -13.0 60.04 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.214 -0.594 . . . . 1.41 111.463 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.3 mt -92.24 2.76 56.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.496 -0.32 . . . . 1.96 111.003 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.0 m 66.51 90.1 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 O-C-N 123.785 0.678 . . . . 1.74 111.468 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.9 137.16 13.75 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.064 2.51 . . . . 0.76 112.436 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.495 HG12 ' OD1' ' A' ' 64' ' ' ASN . 22.4 t -108.81 115.36 49.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.191 -0.458 . . . . 2.08 110.195 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.495 ' OD1' HG12 ' A' ' 63' ' ' VAL . 3.0 p-10 40.94 51.61 3.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.621 0.768 . . . . 2.3 112.859 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.59 -3.77 71.97 Favored Glycine 0 CA--C 1.518 0.233 0 N-CA-C 114.754 0.662 . . . . 0.7 114.754 170.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.426 ' HG2' ' CA ' ' A' ' 102' ' ' ASP . 14.0 mtmm -147.95 149.79 32.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.951 0.875 . . . . 2.76 111.173 177.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.9 pt -92.09 147.57 5.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.807 -0.442 . . . . 1.05 109.807 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.2 p -77.77 155.11 31.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.363 -0.38 . . . . 1.09 110.688 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.38 -15.37 45.36 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 121.285 -0.483 . . . . 0.4 113.387 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -63.77 -56.96 11.57 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.254 0.55 . . . . 1.09 111.081 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.65 -37.93 83.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.644 -0.707 . . . . 1.73 110.25 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.448 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -69.64 -32.55 71.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.809 -0.632 . . . . 1.17 110.551 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.562 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 39.9 ttmt -64.05 -42.71 96.93 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.4 0.619 . . . . 1.25 109.561 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.8 mtpp -67.76 -38.27 83.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.281 -0.872 . . . . 2.79 110.982 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.92 -45.39 93.91 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.481 0.658 . . . . 0.82 110.263 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.92 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 25.0 mmt -57.48 -48.11 80.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.354 -0.839 . . . . 1.38 111.274 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.12 -21.57 19.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.849 -0.34 . . . . 1.53 111.074 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.529 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 92.5 mttt -70.31 -25.12 63.17 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.545 -0.298 . . . . 3.56 110.82 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.405 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 42.5 m -81.99 -1.69 49.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.255 -0.43 . . . . 1.06 111.124 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 79' ' ' SER . 10.1 mptt 70.15 14.95 7.65 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.984 0.735 . . . . 2.48 112.984 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.99 143.62 43.24 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.57 -0.452 . . . . 2.1 110.672 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.534 ' O ' HD11 ' A' ' 86' ' ' LEU . 39.7 Cg_exo -62.27 152.07 78.59 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.292 2.661 . . . . 0.9 112.803 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.515 ' HA ' HD23 ' A' ' 86' ' ' LEU . 16.5 m120 -57.79 -38.45 75.52 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.226 -0.443 . . . . 1.09 111.33 -177.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.3 m -57.8 -37.42 73.71 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.197 0.522 . . . . 1.14 111.161 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.529 ' O ' HG12 ' A' ' 89' ' ' ILE . 70.7 t -77.08 -37.25 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.029 -0.73 . . . . 1.19 109.029 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.92 ' HG ' ' HB3' ' A' ' 76' ' ' MET . 0.4 OUTLIER -61.42 -44.85 96.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.143 -0.935 . . . . 2.0 110.715 176.023 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.575 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -61.31 -37.2 93.65 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.87 -0.681 . . . . 0.37 111.634 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -68.03 -48.31 66.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.819 0.342 . . . . 1.64 110.754 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.529 HG12 ' O ' ' A' ' 85' ' ' VAL . 39.8 mm -56.89 -48.82 80.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.916 -0.584 . . . . 1.5 110.253 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . 0.486 ' CH2' HD22 ' A' ' 101' ' ' LEU . 16.6 t-105 -61.94 -51.31 68.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.055 -0.521 . . . . 0.41 111.161 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -60.65 -27.64 67.96 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.122 -0.49 . . . . 2.0 111.823 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.473 HD11 HD21 ' A' ' 122' ' ' LEU . 66.3 mt -85.51 -49.97 7.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.502 -0.317 . . . . 2.23 111.214 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.89 82.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.504 -0.316 . . . . 1.1 111.834 -175.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.703 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 18.7 t70 -78.66 83.94 4.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.831 -0.803 . . . . 0.59 108.831 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.62 -25.99 13.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.91 -1.041 . . . . 2.11 110.887 -173.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.611 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.7 OUTLIER -90.53 -15.55 30.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.901 -0.59 . . . . 1.45 111.949 -176.176 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.693 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 4.2 mptp? 54.74 72.07 0.49 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.31 0.576 . . . . 3.13 110.983 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.62 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 7.3 p-10 -117.25 -33.16 4.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.767 -0.652 . . . . 1.22 111.932 -173.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.12 -23.09 14.65 Favored Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 120.476 -0.869 . . . . 0.51 112.357 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -102.01 -171.74 2.02 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.881 -0.785 . . . . 1.2 108.881 174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.736 HD12 ' HG2' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -132.66 111.69 11.39 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.754 -0.462 . . . . 1.38 109.754 178.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.426 ' CA ' ' HG2' ' A' ' 66' ' ' LYS . 7.0 t70 -87.55 -177.13 5.81 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.701 -0.681 . . . . 1.42 110.843 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.34 -37.02 57.91 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.246 0.461 . . . . 1.73 112.246 -173.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -69.56 -41.92 75.24 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 122.782 1.277 . . . . 1.53 107.91 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.736 ' HG2' HD12 ' A' ' 101' ' ' LEU . 5.9 tt0 -65.4 -40.88 93.98 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 112.375 -2.193 . . . . 1.2 110.899 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.579 ' HA ' HD11 ' A' ' 101' ' ' LEU . 52.9 t80 -72.75 -35.41 67.48 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.608 0.718 . . . . 0.49 109.77 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . 0.457 ' HB2' ' CD2' ' A' ' 53' ' ' TYR . . . -66.28 -39.82 89.67 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.733 -1.121 . . . . 1.1 110.629 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.487 HD21 HG21 ' A' ' 46' ' ' VAL . 15.7 mt -70.05 -35.42 74.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.165 -0.47 . . . . 1.96 110.47 175.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.444 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.74 -55.47 33.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 1.08 110.561 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.421 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 94.8 m-20 -70.63 -25.72 63.16 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.32 -0.4 . . . . 1.54 110.932 -177.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.584 ' O ' HG21 ' A' ' 115' ' ' VAL . 72.6 t60 -69.83 -43.82 71.19 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.408 -0.36 . . . . 0.75 110.051 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.83 -41.1 97.92 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.95 0.405 . . . . 1.54 110.077 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.48 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 80.3 mt -59.81 -43.73 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.437 -0.801 . . . . 1.07 110.437 174.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -59.72 -46.64 88.5 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.187 -0.461 . . . . 2.6 111.196 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.584 HG21 ' O ' ' A' ' 111' ' ' HIS . 38.4 t -60.38 -42.83 92.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.114 0.483 . . . . 1.16 110.325 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -56.16 -43.86 78.74 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.847 -0.615 . . . . 1.86 110.998 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 91.5 mt -74.04 -16.97 61.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.398 -0.365 . . . . 1.46 111.316 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.3 0.41 25.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.735 0.302 . . . . 1.65 110.421 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.52 -1.48 84.03 Favored Glycine 0 CA--C 1.503 -0.705 0 N-CA-C 111.42 -0.672 . . . . 0.8 111.42 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -97.05 -179.14 4.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.115 0.483 . . . . 1.31 111.11 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.15 144.45 50.75 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.465 -0.789 . . . . 3.6 110.179 -176.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.473 HD21 HD11 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -77.96 138.97 61.21 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 109.711 -0.477 . . . . 2.04 109.711 173.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.45 -3.43 12.45 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.537 2.158 . . . . 1.16 113.699 -170.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.22 21.55 12.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.309 0.576 . . . . 1.47 110.739 -177.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.691 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 0.8 OUTLIER -127.93 142.23 51.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.099 -0.955 . . . . 1.94 108.999 178.287 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.2 mt -97.32 92.49 1.25 Allowed Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 121.166 0.508 . . . . 1.29 110.551 169.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.736 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 17.8 Cg_endo -94.35 165.95 1.93 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.749 2.966 . . . . 0.91 112.254 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.6 -25.04 24.52 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.523 2.815 . . . . 1.02 113.948 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.403 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 20.2 p-80 -86.79 5.54 35.99 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.458 -0.497 . . . . 1.1 111.476 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.736 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 72.9 mt -129.23 -35.56 1.78 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.585 -0.28 . . . . 1.44 111.182 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 31.0 m -75.99 122.01 86.11 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 121.342 0.591 . . . . 2.06 111.352 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.467 ' HG2' ' HE2' ' A' ' 135' ' ' LYS . 24.5 Cg_exo -63.25 140.97 80.25 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.581 2.187 . . . . 1.43 111.88 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 37.9 Cg_exo -59.04 -19.82 50.54 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.936 2.424 . . . . 2.08 112.663 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.3 p -67.45 -22.12 65.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.045 -0.525 . . . . 2.5 111.601 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.467 ' HE2' ' HG2' ' A' ' 132' ' ' PRO . 0.7 OUTLIER -99.37 -6.91 26.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.789 0.328 . . . . 1.91 110.744 179.56 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -77.88 132.78 38.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.109 0.48 . . . . 3.72 111.181 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -117.68 132.73 56.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.875 -0.602 . . . . 6.1 110.626 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -103.61 141.79 35.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.297 -0.411 . . . . 6.4 110.784 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.428 -0.796 . . . . 6.93 109.601 175.793 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 57.0 tp . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.642 0.258 . . . . 10.99 110.808 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -136.43 -8.88 1.95 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.22 0.533 . . . . 8.04 110.611 177.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 4.0 p -102.18 156.76 17.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.438 -0.801 . . . . 5.48 110.264 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -145.89 128.79 8.13 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.779 0.324 . . . . 7.03 110.409 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -84.34 -79.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.687 2.258 . . . . 2.56 111.191 175.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -139.13 -36.83 0.52 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.851 -0.796 . . . . 1.03 108.851 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.575 HD22 ' HA2' ' A' ' 87' ' ' GLY . 45.2 t-20 -87.91 114.51 59.51 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.822 -1.081 . . . . 0.55 109.641 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 11.0 Cg_exo -72.22 -6.55 19.31 Favored 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 123.09 2.526 . . . . 0.87 112.8 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.562 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 40.7 m-85 -105.55 0.19 26.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.452 0.644 . . . . 0.55 109.676 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -117.68 35.25 4.77 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.018 -0.992 . . . . 1.42 109.255 -174.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -82.79 -7.36 59.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.05 -0.977 . . . . 1.71 111.775 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 68.92 149.66 0.07 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.705 0.764 . . . . 4.81 112.873 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -113.73 -165.04 0.97 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.299 -0.864 . . . . 5.98 110.29 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.75 143.24 42.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.328 0.585 . . . . 7.19 111.314 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 21.9 t70 . . . . . 0 C--O 1.247 0.974 0 CA-C-N 115.258 -0.883 . . . . 7.32 108.992 174.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.62 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.47 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 111.67 -0.572 . . . . 11.96 111.67 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 7.0 Cg_exo -73.87 109.41 2.86 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.623 2.215 . . . . 11.91 111.932 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.41 HD22 ' HA ' ' A' ' 37' ' ' LEU . 1.9 tm? -102.2 120.02 39.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.015 -0.539 . . . . 8.98 109.592 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.28 137.52 13.66 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.713 -0.756 . . . . 6.64 112.102 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.5 m -131.67 134.07 45.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.687 0.28 . . . . 6.11 110.919 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -85.65 93.21 8.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.866 -0.79 . . . . 4.1 108.866 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -107.85 130.64 54.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.085 -0.507 . . . . 3.87 110.608 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.449 ' CG1' ' HA ' ' A' ' 129' ' ' HIS . 90.3 t -123.19 121.12 62.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.463 -0.79 . . . . 2.46 110.087 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.22 120.33 24.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.534 0.683 . . . . 3.02 109.576 174.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.411 ' HH2' ' HA ' ' A' ' 104' ' ' GLU . 0.6 OUTLIER -79.81 98.75 7.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.82 -0.627 . . . . 0.94 109.355 -178.647 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.5 m -56.65 -31.5 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.761 0.652 . . . . 1.86 112.761 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.649 ' HB ' ' HE2' ' A' ' 53' ' ' TYR . 22.7 m -77.1 -6.42 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.623 -0.431 . . . . 2.02 110.795 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.881 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -72.97 -20.25 79.88 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.86 -0.896 . . . . 0.67 110.86 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -84.51 -10.86 57.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.021 -0.59 . . . . 3.38 110.011 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -118.89 9.26 11.91 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.447 -0.797 . . . . 1.82 110.882 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.881 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 28.8 mmmt -53.11 -49.75 85.88 Favored Pre-proline 0 N--CA 1.471 0.582 0 N-CA-C 113.252 0.834 . . . . 1.61 113.252 -175.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 10.1 Cg_endo -51.74 -38.67 67.2 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.585 2.19 . . . . 0.66 112.432 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -70.82 -42.73 69.85 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.625 0.726 . . . . 1.21 110.102 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.649 ' HE2' ' HB ' ' A' ' 46' ' ' VAL . 15.9 m-30 -70.36 -22.63 62.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.39 -0.823 . . . . 1.49 109.86 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -73.84 -43.94 57.14 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.687 -0.688 . . . . 1.86 110.1 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.596 ' HA ' ' CE2' ' A' ' 58' ' ' TYR . 39.8 mt-10 -58.14 -33.38 69.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.728 -0.669 . . . . 2.0 111.259 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.0 mt -85.19 -22.44 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.241 0.544 . . . . 1.28 110.569 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -77.83 -55.53 5.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.315 -0.402 . . . . 0.52 112.009 -175.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.596 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 23.1 p90 -70.43 -17.14 63.0 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 120.679 -0.408 . . . . 3.37 111.509 -172.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 p -71.54 -12.61 61.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.106 0.479 . . . . 1.41 111.074 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 87.7 mt -99.92 14.62 29.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.75 -0.659 . . . . 1.96 110.648 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.9 m 65.06 88.69 0.11 Allowed Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 115.509 -0.769 . . . . 1.74 111.136 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 38.2 Cg_endo -74.54 98.74 1.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.478 2.119 . . . . 0.76 112.385 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.3 t -89.9 117.28 32.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.725 -0.472 . . . . 2.08 109.725 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 60.6 22.82 12.6 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.223 0.535 . . . . 2.3 110.856 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.95 14.35 69.83 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.706 -0.759 . . . . 0.7 113.259 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.712 ' HE3' ' HB2' ' A' ' 100' ' ' LEU . 39.5 tttp -147.26 126.36 12.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.385 0.593 . . . . 2.76 109.459 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 35.3 pt -83.87 146.11 7.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 120.94 0.4 . . . . 1.05 110.552 -177.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.639 ' HA ' HD23 ' A' ' 100' ' ' LEU . 68.6 p -80.48 159.53 25.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.795 -0.639 . . . . 1.09 111.314 -177.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.41 -22.3 67.41 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.957 -0.565 . . . . 0.4 112.845 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.04 -49.75 74.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.372 0.606 . . . . 1.09 111.332 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.443 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 39.5 m-80 -73.36 -38.05 65.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.515 -0.766 . . . . 1.73 111.18 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.51 -30.93 69.85 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.496 -0.482 . . . . 1.17 109.862 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -62.64 -48.96 77.05 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.537 -0.301 . . . . 1.25 110.704 176.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.66 ' HD3' ' N ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -64.91 -31.96 73.44 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 120.482 -0.487 . . . . 2.79 111.123 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.66 ' N ' ' HD3' ' A' ' 74' ' ' LYS . 7.5 tp10 -67.57 -45.12 76.5 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.32 0.581 . . . . 0.82 109.914 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.44 ' HB3' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -64.99 -46.55 80.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.381 -0.827 . . . . 1.38 111.547 -178.17 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.04 -30.38 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.946 -0.302 . . . . 1.53 111.558 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -80.48 -11.31 59.69 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.101 -0.374 . . . . 3.56 110.602 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.9 t -74.22 -11.44 60.29 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.893 -0.78 . . . . 1.06 108.893 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.407 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 72.4 mmtt 66.4 35.11 5.87 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.249 -0.887 . . . . 2.48 112.208 175.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.513 ' HB2' HD23 ' A' ' 86' ' ' LEU . 89.7 mt -100.7 144.85 29.31 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.867 -0.79 . . . . 2.1 108.867 171.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.35 142.65 79.21 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.587 2.191 . . . . 0.9 112.241 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -56.23 -34.14 66.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.149 -0.478 . . . . 1.09 111.28 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 6.2 m -59.62 -48.52 81.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.198 0.523 . . . . 1.14 110.496 177.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.616 ' O ' HG12 ' A' ' 89' ' ' ILE . 58.7 t -63.05 -43.29 98.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.716 -0.674 . . . . 1.19 109.968 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' A' ' 81' ' ' LEU . 78.9 mt -59.36 -43.94 92.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.746 -0.661 . . . . 2.0 110.685 178.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.04 -34.38 83.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.982 -0.627 . . . . 0.37 112.069 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 84' ' ' THR . 27.9 mtpp -72.62 -45.32 59.64 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.83 0.348 . . . . 1.64 110.23 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.616 HG12 ' O ' ' A' ' 85' ' ' VAL . 42.7 mm -56.37 -49.39 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.725 -0.671 . . . . 1.5 110.107 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -66.79 -41.16 88.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.086 -0.506 . . . . 0.41 110.524 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.404 ' HZ3' ' CD ' ' B' ' 152' ' ' GLU . 23.6 ttmm -55.81 -29.23 59.42 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.696 -0.683 . . . . 2.0 110.695 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.475 HD11 HD23 ' A' ' 122' ' ' LEU . 82.8 mt -91.86 -42.95 9.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 2.23 112.056 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.09 -40.29 95.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 1.1 111.779 -171.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -92.05 94.23 9.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.983 -0.747 . . . . 0.59 108.983 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.5 -48.94 28.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.267 -0.879 . . . . 2.11 111.24 -172.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.624 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 4.4 p30 -83.93 -9.97 58.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.599 -0.728 . . . . 1.45 112.051 -174.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt 73.45 76.4 0.13 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.641 0.608 . . . . 3.13 112.641 171.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.652 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 3.8 m-20 -104.31 -44.85 4.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.456 0.646 . . . . 1.22 110.226 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.69 2.35 57.43 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.34 -1.104 . . . . 0.51 110.34 -167.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.712 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 36.7 mt -131.22 165.02 24.28 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.549 -0.908 . . . . 1.2 108.549 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 96.2 mt -125.56 122.68 37.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.267 0.555 . . . . 1.38 111.573 178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.413 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 2.1 p30 -87.16 -176.29 5.63 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.74 -0.837 . . . . 1.42 108.74 167.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.02 -22.79 63.07 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.712 -0.395 . . . . 1.73 111.444 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . 0.413 ' HB2' ' OD1' ' A' ' 102' ' ' ASP . 52.2 mt-10 -72.01 -56.77 5.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.14 0.495 . . . . 1.53 109.818 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -68.28 -32.13 72.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.384 -0.826 . . . . 1.2 111.086 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -71.49 -29.79 65.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.751 -0.463 . . . . 0.49 109.751 176.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.52 -39.11 88.47 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.285 -0.416 . . . . 1.1 110.152 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.47 -42.57 99.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.035 -0.529 . . . . 1.96 110.347 172.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.12 -55.46 30.85 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 123.553 0.533 . . . . 1.08 110.672 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -63.01 -41.49 99.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.78 -0.646 . . . . 1.54 111.046 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.603 ' O ' HG22 ' A' ' 115' ' ' VAL . 81.5 t60 -61.52 -45.84 92.48 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.908 -0.317 . . . . 0.75 111.187 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.0 -40.66 87.37 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.752 0.311 . . . . 1.54 111.233 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.428 HD13 ' HE1' ' A' ' 76' ' ' MET . 80.7 mt -61.41 -42.69 94.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.082 -0.508 . . . . 1.07 109.837 175.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 52.9 tttp -55.45 -46.2 76.78 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.754 -0.657 . . . . 2.6 110.683 174.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.603 HG22 ' O ' ' A' ' 111' ' ' HIS . 60.4 t -58.2 -44.71 88.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 120.716 0.293 . . . . 1.16 110.702 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -65.58 -39.85 92.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.153 -0.476 . . . . 1.86 111.465 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 93.6 mt -70.68 -26.03 63.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.938 0.399 . . . . 1.46 110.8 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 68.8 mm-40 -71.02 -18.2 62.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.201 -0.454 . . . . 1.65 110.559 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.23 -13.16 48.44 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.859 -0.686 . . . . 0.8 112.007 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -85.17 172.8 10.91 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.885 -0.413 . . . . 1.31 109.885 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -121.41 134.39 55.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.899 0.38 . . . . 3.6 110.906 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.533 HD21 HD13 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -74.97 139.9 73.5 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.96 -0.564 . . . . 2.04 109.747 175.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 3.7 Cg_exo -76.85 1.32 8.72 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.911 2.407 . . . . 1.16 113.236 -173.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.75 20.38 11.34 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.549 0.69 . . . . 1.47 110.36 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.516 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 12.2 t70 -130.53 131.91 45.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.08 -0.964 . . . . 1.94 109.399 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -91.99 103.22 7.63 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.244 -0.435 . . . . 1.29 110.439 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 125' ' ' ASP . 2.5 Cg_endo -81.45 158.56 19.57 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.937 2.425 . . . . 0.91 111.897 -178.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.44 -20.62 33.88 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.992 2.461 . . . . 1.02 113.426 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.449 ' HA ' ' CG1' ' A' ' 42' ' ' VAL . 10.5 p-80 -91.27 11.93 21.93 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.923 -0.311 . . . . 1.1 111.29 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.412 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 37.8 mt -128.43 -21.41 3.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.555 -0.293 . . . . 1.44 110.878 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.4 m -100.48 128.49 30.1 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.825 0.345 . . . . 2.06 110.762 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -62.16 154.09 65.13 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.624 2.216 . . . . 1.43 111.349 176.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.02 -29.53 65.4 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.819 2.346 . . . . 2.08 112.37 -177.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.4 m -58.83 -32.47 69.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.017 -0.538 . . . . 2.5 111.029 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -97.46 7.08 47.19 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.438 -0.346 . . . . 1.91 111.218 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -100.1 151.69 21.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 3.72 111.301 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -100.63 158.98 15.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.941 -0.572 . . . . 6.1 110.221 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -133.76 129.16 36.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.397 -0.365 . . . . 6.4 110.231 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.823 -0.608 . . . . 6.93 109.876 174.499 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . 0.43 HD12 ' H1 ' ' B' ' 143' ' ' LEU . 11.0 mp . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 121.26 0.552 . . . . 10.99 110.479 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -111.05 162.72 14.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.589 -0.732 . . . . 8.04 110.396 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 96.9 p 54.19 -166.04 0.09 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.029 0.831 . . . . 5.48 111.547 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 43.9 mttp 63.27 92.79 0.06 OUTLIER Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.017 -0.538 . . . . 7.03 111.373 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -73.85 -173.66 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.925 2.417 . . . . 2.56 112.543 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -87.54 -11.25 49.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.908 -0.587 . . . . 1.03 110.365 -177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.564 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 52.2 t-20 -97.62 113.7 63.87 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 0.55 110.081 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 10.0 Cg_exo -72.66 -7.34 20.65 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.421 2.747 . . . . 0.87 112.862 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -107.15 5.65 28.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.317 0.579 . . . . 0.55 109.861 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . 0.564 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 23.0 tt0 -130.36 26.65 5.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.188 -0.915 . . . . 1.42 108.643 -175.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -91.46 138.81 31.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.002 -0.999 . . . . 1.71 111.274 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 67.25 -175.56 0.2 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.371 -0.831 . . . . 4.81 112.32 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -119.58 -62.21 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.741 -0.663 . . . . 5.98 111.259 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 55.64 41.48 30.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.57 0.7 . . . . 7.19 111.051 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.25 1.103 0 CA-C-N 115.002 -0.999 . . . . 7.32 110.169 178.827 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.652 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 112.162 -0.375 . . . . 11.96 112.162 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.39 102.31 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.619 2.212 . . . . 11.91 111.726 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.5 mt -66.41 121.46 15.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.896 -0.593 . . . . 8.98 111.642 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -98.32 117.98 6.0 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.759 -0.734 . . . . 6.64 111.785 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.7 t -129.48 115.85 18.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.801 0.334 . . . . 6.11 110.392 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.07 95.04 9.55 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.256 -0.646 . . . . 4.1 109.256 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -77.31 121.8 24.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.451 0.643 . . . . 3.87 109.815 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.487 HG13 ' HB3' ' A' ' 129' ' ' HIS . 24.7 t -98.17 133.59 39.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.673 -0.694 . . . . 2.46 110.66 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -72.56 139.65 47.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.06 -0.518 . . . . 3.02 110.427 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . 0.48 ' HZ2' ' HG ' ' A' ' 108' ' ' LEU . 13.9 t90 -70.32 101.95 2.03 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.512 -0.921 . . . . 0.94 108.512 175.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.4 t -48.56 -33.35 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 115.497 -0.774 . . . . 1.86 112.848 -171.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.593 HG23 HD22 ' A' ' 108' ' ' LEU . 58.8 t -67.6 -22.71 28.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.252 -0.431 . . . . 2.02 111.722 -175.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.587 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -66.28 -22.37 70.95 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.455 -0.878 . . . . 0.67 111.503 176.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -78.54 -21.32 48.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.235 0.54 . . . . 3.38 110.889 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -119.72 15.13 12.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.73 0.776 . . . . 1.82 109.761 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.605 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 2.4 mmmm -54.04 -45.03 99.17 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.1 -0.955 . . . . 1.61 113.343 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.6 Cg_endo -48.42 -40.72 36.53 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.739 2.292 . . . . 0.66 113.15 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 m -69.66 -43.99 71.43 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-O 121.611 0.72 . . . . 1.21 110.276 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.692 ' HH ' ' HD1' ' A' ' 111' ' ' HIS . 12.0 m-85 -71.01 -22.51 62.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.342 -0.844 . . . . 1.49 109.878 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.25 -45.17 66.99 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.189 -0.671 . . . . 1.86 109.189 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -56.3 -47.5 78.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.758 -1.11 . . . . 2.0 111.379 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.3 mt -75.31 -37.86 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.728 0.299 . . . . 1.28 111.282 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -59.65 -52.28 66.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.327 -0.397 . . . . 0.52 111.431 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -71.15 -21.03 62.24 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.299 0.481 . . . . 3.37 112.299 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.4 p -78.92 -3.32 44.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.425 -0.51 . . . . 1.41 111.679 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.0 mt -100.96 7.58 43.5 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.941 0.401 . . . . 1.96 110.469 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.0 m 59.18 84.7 0.2 Allowed Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 115.475 -0.784 . . . . 1.74 112.12 176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.91 142.69 20.08 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.09 2.527 . . . . 0.76 112.309 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.3 t -114.07 118.98 60.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.609 -0.515 . . . . 2.08 109.609 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 59.98 27.21 16.58 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.088 -0.505 . . . . 2.3 111.49 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.17 -3.42 69.69 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.001 -0.619 . . . . 0.7 114.003 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.603 ' HE3' ' N ' ' A' ' 102' ' ' ASP . 30.5 mtpt -131.1 149.21 52.7 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 117.901 0.85 . . . . 2.76 110.776 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.416 HD11 ' CD1' ' A' ' 106' ' ' PHE . 43.2 pt -101.95 157.89 4.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.002 -0.545 . . . . 1.05 110.079 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.9 p -86.78 161.96 18.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.526 -0.761 . . . . 1.09 110.915 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.88 -27.39 72.07 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.645 -0.707 . . . . 0.4 112.883 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.34 -53.59 55.53 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.097 0.475 . . . . 1.09 111.866 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.453 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 45.0 m-80 -73.6 -34.32 65.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.021 -0.536 . . . . 1.73 111.094 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 76' ' ' MET . . . -73.44 -29.17 62.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.346 -0.388 . . . . 1.17 110.275 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.506 ' HA ' ' HZ ' ' B' ' 151' ' ' PHE . 39.3 ttmt -66.4 -51.16 59.95 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.702 0.287 . . . . 1.25 110.263 176.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.453 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 ptmt -63.26 -35.75 81.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.365 -0.379 . . . . 2.79 111.731 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -67.4 -45.9 74.81 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.521 0.677 . . . . 0.82 109.815 175.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.705 ' SD ' HD11 ' A' ' 113' ' ' ILE . 7.7 tpp -59.62 -42.4 92.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.392 -0.822 . . . . 1.38 111.077 -177.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.3 m -74.2 -30.39 26.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.819 0.342 . . . . 1.53 110.663 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -69.47 -17.9 63.66 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.913 -0.315 . . . . 3.56 110.983 176.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.4 m -73.83 -8.56 56.53 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.429 -0.35 . . . . 1.06 111.053 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm 73.17 21.36 3.13 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.658 0.985 . . . . 2.48 113.658 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.4 ' HB2' HD13 ' A' ' 86' ' ' LEU . 2.7 mm? -95.3 148.82 35.25 Favored Pre-proline 0 C--N 1.32 -0.682 0 C-N-CA 120.602 -0.439 . . . . 2.1 109.822 174.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.574 ' O ' HD11 ' A' ' 86' ' ' LEU . 32.9 Cg_exo -60.1 151.95 69.04 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.982 2.454 . . . . 0.9 112.432 176.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -57.67 -33.14 68.02 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.424 -0.353 . . . . 1.09 111.244 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.34 -38.68 80.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.437 0.637 . . . . 1.14 110.514 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.533 ' O ' HG13 ' A' ' 89' ' ' ILE . 57.3 t -75.83 -39.6 38.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.754 -0.832 . . . . 1.19 108.754 -177.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.627 ' HG ' ' CG ' ' A' ' 76' ' ' MET . 3.6 mp -60.76 -44.82 96.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.997 -1.001 . . . . 2.0 111.16 176.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.591 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -61.92 -35.35 91.24 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.888 -0.672 . . . . 0.37 111.784 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.687 ' HD3' ' HB2' ' A' ' 122' ' ' LEU . 38.6 ttmt -71.48 -45.39 62.64 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.188 0.518 . . . . 1.64 110.063 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.683 HG21 ' HB2' ' A' ' 112' ' ' LEU . 72.0 mt -61.44 -50.77 79.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.539 -0.755 . . . . 1.5 110.692 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -60.32 -43.04 96.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.89 -0.595 . . . . 0.41 110.67 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.13 -25.2 64.27 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.92 -0.312 . . . . 2.0 111.244 -175.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.34 -43.78 55.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.344 0.592 . . . . 2.23 110.026 172.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.506 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -66.97 -42.63 84.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.196 -0.911 . . . . 1.1 111.411 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.647 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 27.9 t0 -95.89 62.14 2.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.8 0.809 . . . . 0.59 109.348 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.546 HG12 ' HG2' ' A' ' 135' ' ' LYS . 3.0 p -64.66 -28.09 44.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 114.543 -1.208 . . . . 2.11 111.575 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.618 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 3.9 p30 -86.99 -10.94 51.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.997 -0.547 . . . . 1.45 111.795 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.441 ' HD2' ' O ' ' A' ' 94' ' ' ASP . 1.3 mptm? 56.17 73.64 0.43 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.715 0.406 . . . . 3.13 112.062 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.634 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 5.4 p-10 -120.32 -20.94 7.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.478 -0.328 . . . . 1.22 110.753 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 100.5 -18.99 54.44 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.706 -0.759 . . . . 0.51 113.444 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.413 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 86.6 mt -110.21 169.03 9.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.013 0.406 . . . . 1.2 109.985 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.441 ' HB3' ' HB2' ' A' ' 106' ' ' PHE . 76.3 mt -124.52 114.93 20.07 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.565 -0.454 . . . . 1.38 110.952 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.603 ' N ' ' HE3' ' A' ' 66' ' ' LYS . 1.0 OUTLIER -84.85 -175.78 5.93 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.119 -0.697 . . . . 1.42 109.119 171.473 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -62.27 -32.93 73.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.882 -0.327 . . . . 1.73 110.713 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.88 -52.29 11.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.766 0.317 . . . . 1.53 110.637 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.528 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 31.5 mt-10 -62.18 -47.36 84.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.345 -0.389 . . . . 1.2 111.606 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 92.4 t80 -63.78 -37.1 86.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.987 0.422 . . . . 0.49 110.469 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.05 90.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.843 -0.617 . . . . 1.1 110.778 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.593 HD22 HG23 ' A' ' 46' ' ' VAL . 26.1 mt -64.08 -41.52 97.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 1.96 110.632 174.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.464 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -54.94 -52.4 63.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.257 0.551 . . . . 1.08 110.281 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . 0.41 ' N ' HD21 ' A' ' 110' ' ' ASN . 0.9 OUTLIER -69.0 -21.78 64.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.614 . . . . 1.54 110.912 -177.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.692 ' HD1' ' HH ' ' A' ' 53' ' ' TYR . 9.5 t60 -60.52 -61.2 2.77 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.18 0.514 . . . . 0.75 109.626 174.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.683 ' HB2' HG21 ' A' ' 89' ' ' ILE . 3.7 mm? -60.17 -34.9 74.23 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.73 -1.123 . . . . 1.54 110.76 -176.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.705 HD11 ' SD ' ' A' ' 76' ' ' MET . 86.7 mt -60.75 -46.88 95.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.242 -0.436 . . . . 1.07 110.484 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.404 ' HA ' HD13 ' A' ' 117' ' ' LEU . 36.6 ttmt -63.06 -36.41 83.49 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.429 -0.351 . . . . 2.6 111.162 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 111' ' ' HIS . 14.1 t -62.74 -36.97 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.063 0.459 . . . . 1.16 109.793 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.7 mmtt -72.14 -28.11 63.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 1.86 111.135 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 95.4 mt -68.98 -20.59 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.125 0.488 . . . . 1.46 110.326 176.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -87.75 -1.12 57.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.185 0.516 . . . . 1.65 110.396 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.74 35.44 54.89 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.783 -0.644 . . . . 0.8 112.203 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.484 ' HB2' HG13 ' A' ' 115' ' ' VAL . 20.4 m-70 -99.49 -171.84 2.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.196 0.522 . . . . 1.31 111.99 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -118.59 152.06 36.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.376 -0.829 . . . . 3.6 110.638 -174.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.687 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 5.1 mt -118.74 122.04 30.19 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.852 -0.425 . . . . 2.04 109.852 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.45 -11.79 12.91 Favored 'Trans proline' 0 C--N 1.334 -0.22 0 C-N-CA 123.458 2.772 . . . . 1.16 112.698 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.598 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . 65.98 19.29 11.22 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.838 -0.619 . . . . 1.47 110.896 -176.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . 0.422 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 10.7 m-20 -107.0 137.34 45.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.849 -0.614 . . . . 1.94 110.573 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.4 mt -95.89 109.53 46.96 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.934 -0.575 . . . . 1.29 111.21 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.773 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -83.72 160.62 14.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.504 2.803 . . . . 0.91 111.61 176.131 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.84 -25.38 76.31 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.709 2.272 . . . . 1.02 113.057 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . 0.487 ' HB3' HG13 ' A' ' 42' ' ' VAL . 12.1 p-80 -89.46 8.6 30.14 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.943 -0.303 . . . . 1.1 111.586 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.773 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 30.0 mt -123.45 -19.54 5.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.734 -0.212 . . . . 1.44 111.204 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.4 t -87.5 108.96 22.52 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.983 0.42 . . . . 2.06 110.198 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 10.2 Cg_exo -69.81 146.75 60.84 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.789 2.326 . . . . 1.43 111.933 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 36.2 Cg_exo -59.85 -22.45 68.38 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.016 2.477 . . . . 2.08 111.965 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.2 t -64.93 -19.91 66.18 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.856 -0.611 . . . . 2.5 110.801 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.546 ' HG2' HG12 ' A' ' 95' ' ' VAL . 2.5 mptp? -110.35 18.74 19.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.904 0.383 . . . . 1.91 110.621 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -95.33 123.63 38.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.855 0.36 . . . . 3.72 111.148 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -82.18 106.05 13.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.078 0.465 . . . . 6.1 111.453 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -110.67 107.26 16.77 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.648 -0.871 . . . . 6.4 108.648 172.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.332 -0.842 . . . . 6.93 110.208 -177.061 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 120.974 0.416 . . . . 10.99 109.908 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -91.52 143.26 26.77 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.159 0.504 . . . . 8.04 111.101 -171.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 19.6 t -145.74 80.61 1.59 Allowed 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.357 -0.979 . . . . 5.48 108.357 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 0.451 ' HA ' ' HD3' ' B' ' 147' ' ' PRO . 21.4 pttp -91.38 146.64 33.75 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 7.03 109.777 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' B' ' 146' ' ' LYS . 12.1 Cg_exo -69.56 -179.74 3.03 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.793 2.328 . . . . 2.56 112.824 -175.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -107.08 2.72 25.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.499 -0.773 . . . . 1.03 109.404 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.591 HD22 ' HA2' ' A' ' 87' ' ' GLY . 51.7 t-20 -102.34 118.9 57.83 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.021 -0.99 . . . . 0.55 109.814 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 18.9 Cg_exo -67.45 -7.45 19.19 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.504 2.803 . . . . 0.87 112.951 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.506 ' HZ ' ' HA ' ' A' ' 73' ' ' LYS . 40.6 m-85 -107.68 4.21 25.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.295 0.569 . . . . 0.55 110.081 176.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . 0.582 ' CB ' ' HB3' ' B' ' 149' ' ' ASN . 32.8 tt0 -118.5 13.77 13.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.05 -0.977 . . . . 1.42 109.393 -174.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -82.97 105.55 14.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.584 -0.735 . . . . 1.71 111.846 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 75.3 111.4 0.07 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.906 -1.043 . . . . 4.81 112.023 173.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -147.45 -72.56 0.21 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.391 -0.822 . . . . 5.98 109.987 173.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . 0.798 ' HG3' ' H ' ' B' ' 157' ' ' ASP . 4.5 pt-20 -112.84 -74.69 0.62 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.713 -0.676 . . . . 7.19 110.509 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 157' ' ' ASP . . . . . 0.798 ' H ' ' HG3' ' B' ' 156' ' ' GLU . 28.2 t70 . . . . . 0 C--O 1.244 0.811 0 CA-C-O 118.155 -0.926 . . . . 7.32 109.193 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.647 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.421 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.48 1.573 0 N-CA-C 111.781 -0.528 . . . . 11.96 111.781 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.421 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 4.4 Cg_exo -74.85 126.49 10.09 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.008 2.472 . . . . 11.91 112.208 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.2 mp -96.2 148.74 22.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.9 0.381 . . . . 8.98 110.577 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.63 130.91 10.42 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.97 -0.852 . . . . 6.64 110.97 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.8 m -71.29 111.78 6.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.872 0.367 . . . . 6.11 110.538 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -94.61 92.24 6.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.864 0.364 . . . . 4.1 110.765 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -144.56 120.62 10.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.287 0.565 . . . . 3.87 109.69 172.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 p -124.08 156.63 31.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.472 -0.785 . . . . 2.46 110.046 -173.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.419 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 1.3 pm0 -74.58 105.25 5.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.252 0.549 . . . . 3.02 110.954 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -82.35 99.31 9.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.83 -0.804 . . . . 0.94 108.83 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.7 t -57.5 -40.66 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 113.614 0.968 . . . . 1.86 113.614 -167.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.493 HG12 ' CG ' ' A' ' 111' ' ' HIS . 5.3 m -69.87 -10.76 14.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.893 -0.323 . . . . 2.02 111.723 -171.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.75 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -69.53 -15.94 71.22 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.745 -0.741 . . . . 0.67 111.895 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -78.33 -28.2 47.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 3.38 110.628 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -121.16 23.4 10.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.538 0.685 . . . . 1.82 109.959 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.75 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 4.4 mmmp? -52.61 -41.98 86.17 Favored Pre-proline 0 C--O 1.218 -0.556 0 CA-C-N 115.342 -0.845 . . . . 1.61 112.942 177.032 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.639 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 7.8 Cg_endo -48.8 -43.31 35.14 Favored 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 122.582 2.188 . . . . 0.66 112.671 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.583 ' O ' HG13 ' A' ' 56' ' ' ILE . 14.3 m -70.18 -44.58 68.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.035 0.445 . . . . 1.21 110.889 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -71.07 -22.74 62.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.352 0.596 . . . . 1.49 109.809 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.413 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 9.3 t70 -73.67 -44.3 57.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.031 -0.986 . . . . 1.86 108.85 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -55.31 -53.44 56.16 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 114.916 -1.038 . . . . 2.0 110.318 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.583 HG13 ' O ' ' A' ' 52' ' ' THR . 17.3 mt -64.56 -40.0 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 114.962 -1.017 . . . . 1.28 110.668 -175.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.425 ' CE2' ' HB3' ' A' ' 62' ' ' PRO . 79.9 t80 -59.03 -38.13 78.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.066 -0.516 . . . . 0.52 110.783 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.471 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 17.5 m-85 -82.07 -22.99 36.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.445 -0.343 . . . . 3.37 111.892 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.3 p -77.62 -18.71 56.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.14 0.495 . . . . 1.41 111.006 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.0 mp -91.08 4.1 53.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.972 -0.558 . . . . 1.96 110.465 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.7 m 68.01 91.43 0.07 OUTLIER Pre-proline 0 CA--C 1.529 0.165 0 O-C-N 124.047 0.842 . . . . 1.74 111.726 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.471 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 1.9 Cg_endo -81.14 96.36 0.96 Allowed 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.599 2.2 . . . . 0.76 111.299 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.5 m -86.87 117.44 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.34 0.591 . . . . 2.08 110.205 -175.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 64.2 23.87 13.25 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.231 -0.895 . . . . 2.3 110.819 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.48 33.42 19.61 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.931 -0.652 . . . . 0.7 113.36 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.779 ' HZ3' ' HB2' ' A' ' 66' ' ' LYS . 0.0 OUTLIER -165.08 145.58 7.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.079 -0.711 . . . . 2.76 109.079 175.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.4 pt -102.69 145.92 11.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.492 -0.483 . . . . 1.05 110.13 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.769 ' HA ' HD22 ' A' ' 100' ' ' LEU . 44.3 p -84.91 165.91 17.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.11 0.481 . . . . 1.09 111.108 -176.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.2 -17.75 64.13 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.67 -0.695 . . . . 0.4 112.663 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.03 -54.34 22.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.113 0.482 . . . . 1.09 110.656 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.52 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 1.0 OUTLIER -69.97 -41.29 74.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.769 -0.651 . . . . 1.73 110.593 -174.153 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.509 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -68.19 -29.34 68.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.012 -0.54 . . . . 1.17 110.831 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.535 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 40.8 ttmt -65.38 -40.22 93.24 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.645 -0.502 . . . . 1.25 109.645 174.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.588 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.2 mtpp -60.1 -43.28 95.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.51 -0.768 . . . . 2.79 110.669 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.43 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 4.2 tp10 -65.74 -44.94 84.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.344 0.592 . . . . 0.82 110.692 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.731 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 25.6 mmt -56.35 -46.48 79.97 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.769 -0.651 . . . . 1.38 111.243 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.7 m -75.3 -17.69 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.393 -0.367 . . . . 1.53 110.944 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.588 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 93.4 mttt -70.4 -30.33 67.19 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 120.402 -0.519 . . . . 3.56 109.831 172.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.0 m -76.3 -9.07 58.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.596 -0.729 . . . . 1.06 110.999 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm 62.46 26.95 16.04 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.64 0.734 . . . . 2.48 110.665 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.45 ' HB3' HD12 ' A' ' 86' ' ' LEU . 7.9 tp -89.75 137.44 28.5 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.039 -0.982 . . . . 2.1 109.893 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.526 ' O ' HD13 ' A' ' 86' ' ' LEU . 45.1 Cg_exo -55.52 145.46 68.99 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 123.23 2.62 . . . . 0.9 113.406 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -52.75 -39.96 62.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.98 -0.555 . . . . 1.09 112.145 -178.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.5 m -58.08 -35.09 70.89 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.3 0.572 . . . . 1.14 110.93 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.608 ' O ' HG12 ' A' ' 89' ' ' ILE . 57.4 t -76.11 -40.96 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 108.867 -0.79 . . . . 1.19 108.867 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.731 ' HG ' ' HB3' ' A' ' 76' ' ' MET . 2.2 mp -57.17 -45.37 83.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.309 -0.859 . . . . 2.0 110.05 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.567 ' HA2' HD22 ' B' ' 149' ' ' ASN . . . -56.35 -41.68 87.89 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.746 -0.661 . . . . 0.37 112.572 175.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -71.16 -46.41 61.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.979 0.39 . . . . 1.64 110.664 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ILE . . . . . 0.608 HG12 ' O ' ' A' ' 85' ' ' VAL . 49.0 mm -55.89 -50.86 66.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.76 -0.655 . . . . 1.5 110.122 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -65.11 -41.98 94.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 0.41 110.658 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -65.2 -32.62 74.39 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.207 -0.451 . . . . 2.0 111.45 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.493 HD23 HD11 ' A' ' 122' ' ' LEU . 8.3 mp -86.75 -41.98 13.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.42 -0.354 . . . . 2.23 111.367 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 105' ' ' GLU . . . -64.9 -43.22 93.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.464 -0.335 . . . . 1.1 111.797 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . 0.634 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 34.4 t70 -84.7 88.59 7.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.536 0.684 . . . . 0.59 109.831 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.0 t -83.16 -38.0 14.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.984 -1.007 . . . . 2.11 111.141 -176.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.581 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 18.5 p-10 -76.82 -17.25 59.13 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.91 -0.586 . . . . 1.45 110.741 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.5 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 71.8 mmtt 63.16 50.86 2.91 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.571 -0.741 . . . . 3.13 111.154 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.623 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 6.8 p-10 -92.91 -16.48 25.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.583 -0.735 . . . . 1.22 109.796 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.71 -1.87 66.4 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.745 -0.662 . . . . 0.51 112.464 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.769 HD22 ' HA ' ' A' ' 68' ' ' THR . 56.6 mt -128.06 177.75 6.68 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.331 -0.618 . . . . 1.2 109.331 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.2 mt -114.56 113.86 24.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.201 0.524 . . . . 1.38 110.832 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.465 ' CA ' ' HD3' ' A' ' 66' ' ' LYS . 12.7 t70 -84.81 -177.8 6.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.342 -0.845 . . . . 1.42 109.21 173.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -66.62 -35.89 81.28 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.186 0.448 . . . . 1.73 111.719 -170.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -71.92 -42.61 66.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.225 0.536 . . . . 1.53 110.361 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.509 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 19.2 mt-10 -68.05 -45.15 74.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.325 -0.852 . . . . 1.2 110.794 -175.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -68.84 -36.51 78.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.032 -0.531 . . . . 0.49 110.908 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.8 -40.81 98.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.903 0.382 . . . . 1.1 110.413 176.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.2 mt -66.99 -36.29 81.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.021 -0.536 . . . . 1.96 110.545 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.404 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -57.85 -52.34 65.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 1.08 110.455 175.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -61.42 -39.65 91.53 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.691 0.281 . . . . 1.54 110.661 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.607 ' O ' HG21 ' A' ' 115' ' ' VAL . 83.5 t60 -59.74 -47.79 84.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.472 . . . . 0.75 110.807 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.735 HD12 HD13 ' A' ' 122' ' ' LEU . 96.3 mt -64.53 -41.81 96.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.367 -0.379 . . . . 1.54 111.116 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.404 HG13 ' O ' ' A' ' 109' ' ' ALA . 85.4 mt -60.75 -40.68 85.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.133 0.492 . . . . 1.07 109.713 175.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.643 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 59.7 tttp -59.31 -42.11 90.61 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.715 -0.675 . . . . 2.6 110.428 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.607 HG21 ' O ' ' A' ' 111' ' ' HIS . 25.5 t -56.79 -40.15 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.816 0.341 . . . . 1.16 110.116 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.557 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 2.3 mmmp? -60.68 -45.49 93.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 1.86 109.912 175.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.9 -25.2 65.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.555 -0.748 . . . . 1.46 111.07 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.643 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 45.0 mm-40 -70.85 -21.71 62.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.348 -0.387 . . . . 1.65 110.461 176.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 111.62 12.54 14.57 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.0 -0.619 . . . . 0.8 112.38 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.557 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 29.6 m-70 -121.4 -179.35 4.04 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.553 -0.536 . . . . 1.31 109.553 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.444 ' HA ' ' HD2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -140.44 160.18 40.56 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 110.048 -0.353 . . . . 3.6 110.048 174.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.735 HD13 HD12 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -92.69 123.94 60.26 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.46 -0.336 . . . . 2.04 110.238 -177.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.38 15.42 0.27 Allowed 'Trans proline' 0 N--CA 1.48 0.695 0 C-N-CA 123.934 3.089 . . . . 1.16 114.229 -169.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 67.01 18.34 10.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.386 0.612 . . . . 1.47 110.489 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.57 147.59 43.55 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.375 -0.829 . . . . 1.94 109.506 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.648 ' HB3' ' HB ' ' A' ' 131' ' ' VAL . 96.2 mt -101.31 97.81 8.0 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.574 -0.285 . . . . 1.29 110.432 172.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.5 147.97 87.26 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.217 1.945 . . . . 0.91 111.416 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.53 -27.45 25.18 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 123.295 2.663 . . . . 1.02 114.173 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -85.01 7.58 20.85 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.061 0.458 . . . . 1.1 111.247 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.8 mt -132.39 -31.46 1.41 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.215 -0.448 . . . . 1.44 111.327 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.648 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 7.7 p -82.95 123.42 77.77 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 121.117 0.484 . . . . 2.06 110.923 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' PRO . . . . . 0.701 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 44.4 Cg_exo -57.02 130.0 37.47 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.934 2.423 . . . . 1.43 112.123 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 33.3 Cg_exo -58.61 -27.53 83.08 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.613 2.875 . . . . 2.08 112.933 -175.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.7 t -67.11 -27.14 67.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 2.5 111.137 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.701 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 12.8 mptt -96.29 29.69 2.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.089 -0.505 . . . . 1.91 111.021 -175.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -101.6 112.0 24.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.161 0.505 . . . . 3.72 111.409 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -112.02 158.56 19.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.651 -0.704 . . . . 6.1 109.87 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -99.97 114.64 28.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.85 0.357 . . . . 6.4 111.672 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--O 1.25 1.082 0 CA-C-N 115.284 -0.871 . . . . 6.93 109.683 174.461 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.734 -0.469 . . . . 10.99 109.734 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -119.46 166.51 13.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.016 -0.538 . . . . 8.04 110.592 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 16.3 m -106.88 -165.27 1.06 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 5.48 110.936 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 146' ' ' LYS . . . . . 0.41 ' HB3' ' HE2' ' B' ' 146' ' ' LYS . 49.8 mtpt -117.73 157.98 46.65 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.115 -0.493 . . . . 7.03 110.426 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.62 169.67 18.19 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.518 2.145 . . . . 2.56 112.374 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -89.13 -13.66 37.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.018 -0.537 . . . . 1.03 110.288 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 149' ' ' ASN . . . . . 0.648 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 34.1 t-20 -96.2 114.92 65.19 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.412 -0.813 . . . . 0.55 111.101 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 150' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 10.4 Cg_exo -72.08 -2.65 11.9 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.351 2.701 . . . . 0.87 113.007 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 151' ' ' PHE . . . . . 0.535 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 68.8 m-85 -107.02 -23.34 12.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.511 0.672 . . . . 0.55 110.333 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . 0.648 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 41.7 tt0 -109.46 22.38 15.85 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.975 -1.011 . . . . 1.42 109.397 -173.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.0 142.96 56.2 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.401 -0.818 . . . . 1.71 110.731 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 74.3 79.28 0.12 Allowed 'General case' 0 C--O 1.234 0.287 0 O-C-N 124.046 0.841 . . . . 4.81 110.654 175.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -106.57 161.32 14.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.439 -0.8 . . . . 5.98 110.284 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -119.3 -66.87 1.03 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.393 -0.595 . . . . 7.19 109.393 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.359 -0.837 . . . . 7.32 109.477 173.33 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ' CA' . . . . . 0.634 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.407 ' HH2' ' HB2' ' A' ' 104' ' ' GLU . 6.2 t90 . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 108.526 -0.916 . . . . 0.84999999999999998 108.526 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.2 m -56.79 -26.06 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.911 -0.586 . . . . 1.24 112.28 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.637 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 40.8 t -62.77 -19.42 23.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.898 0.38 . . . . 1.3 110.829 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.34 -23.38 64.4 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.789 -0.72 . . . . 0.62 111.982 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -84.11 -28.13 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.794 0.807 . . . . 2.9900000000000002 109.314 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.919 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.1 m-20 -84.29 -28.08 27.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.288 -1.324 . . . . 1.8200000000000001 111.455 -175.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 4.2 mmmp? -47.06 -54.73 18.64 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 115.342 1.608 . . . . 0.93000000000000005 115.342 -168.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.5 Cg_endo -50.21 -41.77 49.0 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.279 1.986 . . . . 0.56999999999999995 112.792 -173.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.4 m -70.63 -43.98 68.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.759 -0.655 . . . . 0.67000000000000004 111.026 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.919 ' CE2' ' HB3' ' A' ' 49' ' ' ASP . 16.6 m-85 -76.74 -19.79 57.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.074 -0.512 . . . . 0.92000000000000004 110.229 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.96 -44.65 80.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.894 -0.78 . . . . 1.8600000000000001 108.894 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -61.91 -45.51 93.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.382 -0.826 . . . . 2.0 110.536 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.11 -39.48 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.153 0.501 . . . . 0.53000000000000003 110.58 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.59 -37.23 75.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.625 -0.716 . . . . 0.42999999999999999 110.619 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 7.4 m-85 -75.82 -24.69 55.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 3.0800000000000001 112.11 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.1 p -81.63 -14.95 56.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.575 -0.45 . . . . 0.75 111.393 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.7 mt -90.88 3.92 53.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.444 -0.344 . . . . 1.26 110.75 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.1 t 68.76 84.86 0.14 Allowed Pre-proline 0 C--O 1.232 0.151 0 O-C-N 123.949 0.78 . . . . 1.1100000000000001 111.246 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 56.1 Cg_endo -75.67 110.84 3.17 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.368 2.045 . . . . 0.68999999999999995 112.27 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.22 116.07 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.258 0.552 . . . . 1.4299999999999999 110.195 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 60.31 23.18 12.64 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.608 -0.724 . . . . 2.1499999999999999 111.257 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.26 18.53 60.53 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.959 -0.564 . . . . 0.62 113.645 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 100' ' ' LEU . 37.3 tttt -153.84 125.19 7.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.301 0.551 . . . . 2.2400000000000002 109.765 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.4 pt -85.32 155.46 3.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.159 0.504 . . . . 0.31 110.874 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.49 ' HA ' HD22 ' A' ' 100' ' ' LEU . 73.5 p -87.37 176.19 7.63 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.375 -0.83 . . . . 0.52000000000000002 110.995 -176.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.466 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -66.24 -26.91 72.65 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.847 -0.692 . . . . 0.38 112.468 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.497 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -69.84 -43.62 71.6 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.922 0.391 . . . . 0.40000000000000002 111.145 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -60.92 -51.89 67.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.714 0.769 . . . . 1.73 109.996 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.473 ' HB3' ' HZ3' ' A' ' 90' ' ' TRP . . . -73.54 -24.29 60.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.481 -0.781 . . . . 0.35999999999999999 110.985 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.661 ' HD3' ' HB2' ' B' ' 150' ' ' PRO . 34.0 ttpt -64.1 -46.84 82.47 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.586 -0.446 . . . . 0.60999999999999999 110.278 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.703 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 5.4 ptpp? -71.09 -27.32 63.53 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 120.232 -0.587 . . . . 2.2400000000000002 110.728 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.452 ' HA ' ' NZ ' ' A' ' 78' ' ' LYS . 17.7 tp10 -67.3 -44.12 80.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.228 0.537 . . . . 0.81999999999999995 109.851 174.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.425 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -61.45 -39.57 91.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.427 -0.806 . . . . 1.04 111.674 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 74' ' ' LYS . 19.2 m -73.72 -23.03 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.366 -0.534 . . . . 1.02 110.71 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.703 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 32.6 mtmm -73.17 -24.14 60.52 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.981 0.419 . . . . 3.04 110.147 174.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.2 m -68.84 -16.04 63.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.85999999999999999 111.089 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? 67.59 31.08 6.31 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.441 0.534 . . . . 2.0499999999999998 112.441 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 81' ' ' LEU . 3.6 mm? -97.66 152.92 38.41 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.486 -0.325 . . . . 1.3400000000000001 110.16 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.527 ' O ' HD13 ' A' ' 86' ' ' LEU . 35.5 Cg_exo -57.64 143.12 95.67 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.552 2.168 . . . . 0.62 111.616 174.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -57.38 -34.77 69.19 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.85 0.357 . . . . 0.93999999999999995 111.436 -173.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.0 m -58.6 -38.86 78.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.872 -0.604 . . . . 0.58999999999999997 110.948 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.609 ' O ' HG12 ' A' ' 89' ' ' ILE . 98.6 t -70.21 -39.24 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.81 -0.632 . . . . 0.40000000000000002 109.426 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.527 HD13 ' O ' ' A' ' 82' ' ' PRO . 6.5 mp -57.67 -47.02 83.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.462 -0.79 . . . . 1.25 110.527 178.01 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.564 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -60.67 -39.92 97.28 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.033 -0.603 . . . . 0.34000000000000002 112.401 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -69.96 -45.34 67.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.664 0.269 . . . . 1.1599999999999999 110.604 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 85' ' ' VAL . 46.0 mm -56.64 -47.09 82.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.89000000000000001 110.266 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.473 ' HZ3' ' HB3' ' A' ' 72' ' ' ALA . 22.9 t-105 -64.46 -46.62 82.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.855 -0.611 . . . . 0.34999999999999998 110.906 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -66.32 -24.1 66.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 1.3799999999999999 111.38 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.472 ' O ' HD11 ' A' ' 126' ' ' LEU . 4.3 mm? -86.72 -47.44 9.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.349 -0.387 . . . . 1.53 110.841 173.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.48 -38.16 83.96 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.95 0.722 . . . . 0.42999999999999999 112.95 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -76.59 86.28 3.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.274 0.559 . . . . 0.58999999999999997 109.719 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.0 t -76.62 -25.01 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.648 -0.706 . . . . 1.49 110.786 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.564 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 67.1 m-20 -70.49 -24.82 62.92 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.606 -0.438 . . . . 1.45 110.871 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 97' ' ' LYS . 41.2 mmtm 56.27 35.78 26.36 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.776 0.798 . . . . 2.6699999999999999 108.997 -170.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.564 ' OD1' ' HB2' ' A' ' 96' ' ' ASP . 9.0 p-10 -99.6 -18.72 17.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.486 -1.234 . . . . 1.1299999999999999 110.692 -173.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.72 -6.85 77.34 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.613 -0.803 . . . . 0.42999999999999999 112.777 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . 67.8 mt -117.67 160.15 21.79 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.458 -0.571 . . . . 0.45000000000000001 109.458 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 105' ' ' GLU . 65.0 mt -121.54 113.96 20.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.977 0.417 . . . . 0.70999999999999996 110.321 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.746 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 3.4 p30 -84.29 -176.28 6.18 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.56 -0.904 . . . . 1.4199999999999999 108.56 171.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -63.7 -28.16 69.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.623 0.601 . . . . 1.73 112.623 -170.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.746 ' HG2' ' OD1' ' A' ' 102' ' ' ASP . 13.3 pt-20 -85.42 -39.07 17.95 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 119.841 -0.744 . . . . 1.53 110.704 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.498 ' HB3' HD22 ' A' ' 101' ' ' LEU . 46.0 mt-10 -63.61 -45.84 88.52 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.361 0.601 . . . . 0.81999999999999995 110.27 175.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -64.44 -39.33 93.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.197 -0.91 . . . . 0.37 110.657 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.79 79.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.143 -0.481 . . . . 0.5 110.734 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.2 mt -68.98 -41.42 77.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.623 -0.262 . . . . 1.3200000000000001 110.462 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -54.01 -52.07 61.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.26000000000000001 110.509 174.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -65.6 -39.78 91.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.273 -0.421 . . . . 1.3600000000000001 110.95 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.646 ' O ' HG23 ' A' ' 115' ' ' VAL . 79.1 t60 -57.87 -47.29 83.17 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.534 -0.303 . . . . 0.67000000000000004 110.428 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.469 HD13 HD13 ' A' ' 122' ' ' LEU . 92.5 mt -65.18 -43.3 92.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.526 -0.306 . . . . 0.89000000000000001 111.018 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 109' ' ' ALA . 73.9 mt -56.63 -44.24 80.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 120.989 0.423 . . . . 0.46000000000000002 110.304 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.655 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 62.9 tttp -61.35 -42.87 99.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.898 -0.592 . . . . 2.0699999999999998 110.833 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 111' ' ' HIS . 29.8 t -55.92 -42.02 69.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.889 0.376 . . . . 0.5 110.062 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.603 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 29.1 mmmt -62.61 -43.77 97.98 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.748 -0.66 . . . . 1.25 110.802 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.96 -29.59 70.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.36 -0.382 . . . . 0.93999999999999995 111.494 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 53.9 mm-40 -72.18 -4.77 31.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.24 -0.436 . . . . 1.6499999999999999 110.753 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.34 2.24 56.71 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.851 -0.69 . . . . 0.80000000000000004 112.295 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.603 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 72.3 m-70 -112.33 -178.36 3.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.755 0.312 . . . . 1.0600000000000001 110.177 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.43 156.45 46.96 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.967 0.413 . . . . 3.6000000000000001 110.649 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.469 HD13 HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -80.81 140.25 50.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.691 -0.686 . . . . 1.51 109.271 177.583 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.53 8.09 2.02 Favored 'Trans proline' 0 N--CA 1.476 0.483 0 C-N-CA 122.997 2.465 . . . . 1.01 113.655 -174.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.7 19.15 11.58 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.242 0.544 . . . . 0.87 111.027 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.498 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 39.6 m-20 -120.48 127.38 52.16 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.862 -0.608 . . . . 1.9399999999999999 110.088 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 92' ' ' LEU . 86.6 mt -94.18 97.34 2.17 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.317 -0.401 . . . . 0.67000000000000004 110.284 167.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.695 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 86.0 Cg_endo -83.02 173.03 10.41 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.666 2.244 . . . . 0.75 111.542 175.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.96 -31.32 52.47 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.811 2.34 . . . . 0.70999999999999996 113.225 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -90.8 14.16 14.36 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.759 0.314 . . . . 0.93999999999999995 111.627 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.695 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 31.2 mt -131.06 -28.91 1.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.413 -0.358 . . . . 0.82999999999999996 110.504 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 85.8 t . . . . . 0 C--N 1.33 -0.274 0 N-CA-C 110.062 -0.347 . . . . 1.4399999999999999 110.062 174.317 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 . . . . . 0 CA--C 1.518 -0.273 0 CA-C-O 121.253 0.549 . . . . 0.89000000000000001 109.813 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.576 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 53.7 t-20 -114.97 117.76 41.35 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.202 -0.908 . . . . 0.42999999999999999 109.772 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.661 ' HB2' ' HD3' ' A' ' 73' ' ' LYS . 59.1 Cg_endo -72.11 -2.76 12.09 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.955 2.437 . . . . 0.51000000000000001 112.596 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 29.7 m-85 -107.87 5.96 26.93 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.287 -0.634 . . . . 0.5 109.287 175.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 29.0 tt0 . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 114.851 -1.068 . . . . 1.4199999999999999 108.508 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.9 t90 . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 121.534 0.683 . . . . 0.84999999999999998 109.212 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.87 5.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.148 -0.933 . . . . 1.24 112.827 -173.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.521 HG13 ' HE2' ' A' ' 53' ' ' TYR . 24.6 t -93.95 -17.04 7.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.935 0.398 . . . . 1.3 110.091 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.18 -18.87 71.6 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.506 -0.854 . . . . 0.62 112.67 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -87.18 -26.83 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.917 0.389 . . . . 2.9900000000000002 111.759 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 22.9 m-20 -101.1 -2.71 30.79 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.324 0.583 . . . . 1.8200000000000001 109.878 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.569 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 2.8 tmtp? -55.17 -50.06 88.75 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 114.932 -1.031 . . . . 0.93000000000000005 112.635 -175.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.9 Cg_endo -51.45 -38.63 64.15 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.546 2.164 . . . . 0.56999999999999995 112.095 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 m -69.24 -40.08 78.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.829 -0.623 . . . . 0.67000000000000004 110.716 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.521 ' HE2' HG13 ' A' ' 46' ' ' VAL . 14.5 m-85 -70.33 -24.29 62.97 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.127 0.489 . . . . 0.92000000000000004 109.763 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.67 -44.74 61.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.478 -0.783 . . . . 1.8600000000000001 109.989 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.09 -45.77 90.0 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.6 -0.727 . . . . 2.0 110.388 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.9 mt -64.33 -44.58 97.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 121.207 0.527 . . . . 0.53000000000000003 110.73 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -52.06 -45.19 64.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.495 -0.775 . . . . 0.42999999999999999 111.476 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -81.78 -23.71 36.41 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.36 0.504 . . . . 3.0800000000000001 112.36 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.3 p -75.33 -16.79 60.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.136 0.493 . . . . 0.75 110.627 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 72.4 mt -84.46 -10.0 57.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.893 -0.594 . . . . 1.26 110.307 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.0 m 70.07 93.09 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.314 0 O-C-N 124.161 0.913 . . . . 1.1100000000000001 111.311 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.411 ' HA ' HG22 ' A' ' 67' ' ' ILE . 1.0 OUTLIER -84.23 140.67 8.79 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.654 2.903 . . . . 0.68999999999999995 111.653 178.641 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.2 m -97.37 107.62 20.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.443 0.64 . . . . 1.4299999999999999 110.326 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 63.55 31.22 14.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.194 -0.912 . . . . 2.1499999999999999 111.014 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.15 -0.01 66.09 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.726 -0.75 . . . . 0.62 114.37 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.524 ' HE2' ' HB2' ' A' ' 100' ' ' LEU . 71.8 tttt -137.47 138.21 39.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.755 0.778 . . . . 2.2400000000000002 109.371 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 62' ' ' PRO . 46.2 pt -93.14 156.71 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.632 -0.427 . . . . 0.31 111.102 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.409 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 50.0 p -88.24 -179.65 6.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.512 -0.767 . . . . 0.52000000000000002 110.322 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.81 -14.46 81.48 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.554 -0.831 . . . . 0.38 111.808 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.03 -39.88 28.94 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.947 0.403 . . . . 0.40000000000000002 110.745 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.718 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 5.4 m120 -63.44 -52.22 62.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.981 0.896 . . . . 1.73 109.653 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.458 ' HB3' ' HZ3' ' A' ' 90' ' ' TRP . . . -67.66 -26.45 66.21 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.267 -0.879 . . . . 0.35999999999999999 110.732 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 35.7 ttmt -65.42 -47.79 75.02 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.743 -0.383 . . . . 0.60999999999999999 110.739 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.718 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 19.8 ptmt -64.74 -31.0 72.02 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.928 0.394 . . . . 2.2400000000000002 110.477 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HA ' ' HZ2' ' A' ' 78' ' ' LYS . 17.1 tp10 -71.11 -48.38 52.59 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.251 0.548 . . . . 0.81999999999999995 110.21 175.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.469 ' HB3' HD22 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -58.13 -47.3 83.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.532 -0.758 . . . . 1.04 111.604 -178.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.8 m -67.47 -34.74 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.671 0.272 . . . . 1.02 110.804 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HZ2' ' HA ' ' A' ' 75' ' ' GLU . 3.2 mtpm? -64.38 -18.7 64.92 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 112.282 0.475 . . . . 3.04 112.282 174.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.4 m -84.18 2.32 40.26 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.744 0.307 . . . . 0.85999999999999999 111.127 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? 54.92 50.36 15.74 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.76 0.652 . . . . 2.0499999999999998 112.76 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.632 ' HB2' HD21 ' A' ' 86' ' ' LEU . 96.3 mt -120.49 141.44 32.1 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 110.092 -0.336 . . . . 1.3400000000000001 110.092 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.525 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 37.1 Cg_exo -59.62 151.41 69.93 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.061 2.507 . . . . 0.62 112.82 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -51.41 -45.27 62.5 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.822 -0.627 . . . . 0.93999999999999995 111.77 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.0 m -58.25 -41.39 84.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.01 0.434 . . . . 0.58999999999999997 111.285 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 89' ' ' ILE . 46.2 t -68.88 -42.08 82.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.981 0.42 . . . . 0.40000000000000002 109.881 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' A' ' 81' ' ' LEU . 67.3 mt -62.31 -38.94 91.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.652 -0.704 . . . . 1.25 110.033 177.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.409 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -61.96 -37.22 94.04 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.792 -0.64 . . . . 0.34000000000000002 112.251 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -66.6 -47.06 73.9 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.894 0.378 . . . . 1.1599999999999999 110.034 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 85' ' ' VAL . 38.2 mm -55.08 -50.05 66.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.355 -0.839 . . . . 0.89000000000000001 109.962 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.458 ' HZ3' ' HB3' ' A' ' 72' ' ' ALA . 34.9 t-105 -65.81 -44.5 85.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.919 -0.582 . . . . 0.34999999999999998 111.545 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ttpt -67.46 -21.37 65.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.079 0.466 . . . . 1.3799999999999999 110.738 -174.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.602 HD12 HD12 ' A' ' 122' ' ' LEU . 24.7 mt -91.92 -38.37 12.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.767 -0.651 . . . . 1.53 111.139 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.77 -35.36 67.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.42999999999999999 111.781 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -85.09 82.28 8.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.744 0.783 . . . . 0.58999999999999997 109.289 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.2 t -74.1 -27.68 22.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.072 -0.967 . . . . 1.49 110.951 -173.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 55.3 p30 -86.81 -10.14 54.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.565 -0.289 . . . . 1.45 111.191 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 53.51 51.52 15.1 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.493 0.495 . . . . 2.6699999999999999 110.808 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -111.98 -8.68 14.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.061 -0.518 . . . . 1.1299999999999999 111.089 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.1 4.84 86.42 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.97 -0.633 . . . . 0.42999999999999999 112.529 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.524 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 52.3 mt -129.68 162.53 28.14 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.828 -0.434 . . . . 0.45000000000000001 109.828 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.4 mt -122.66 117.52 25.97 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.801 -0.359 . . . . 0.70999999999999996 110.946 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.05 -178.04 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.419 -0.956 . . . . 1.4199999999999999 108.419 169.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -60.51 -29.23 68.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.892 0.331 . . . . 1.73 111.892 -173.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.78 -42.23 18.18 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.811 -0.356 . . . . 1.53 110.464 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -65.72 -40.44 92.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.22 0.534 . . . . 0.81999999999999995 110.265 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -69.4 -34.48 74.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.678 -0.692 . . . . 0.37 109.998 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.33 -42.25 98.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.329 -0.396 . . . . 0.5 110.284 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 1.8 mm? -59.5 -44.16 93.17 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.713 -0.477 . . . . 1.3200000000000001 109.713 173.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.445 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.58 -54.24 48.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.651 -0.704 . . . . 0.26000000000000001 110.978 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -66.33 -34.88 78.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.736 0.303 . . . . 1.3600000000000001 110.855 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.601 ' O ' HG23 ' A' ' 115' ' ' VAL . 85.4 t60 -63.7 -43.1 97.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.403 -0.362 . . . . 0.67000000000000004 110.282 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 108' ' ' LEU . 96.1 mt -66.62 -39.83 88.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.305 -0.407 . . . . 0.89000000000000001 110.624 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 109' ' ' ALA . 77.9 mt -61.39 -40.35 85.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.499 . . . . 0.46000000000000002 109.951 174.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -59.6 -47.35 85.91 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.74 -0.664 . . . . 2.0699999999999998 110.391 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 111' ' ' HIS . 21.1 t -56.54 -43.93 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.353 0.597 . . . . 0.5 110.263 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.68 -46.97 83.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.04 -0.982 . . . . 1.25 111.041 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.65 -17.24 51.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.93999999999999995 111.384 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -70.01 -8.01 45.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.179 -0.464 . . . . 1.6499999999999999 111.183 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.87 23.06 34.01 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.51 -0.853 . . . . 0.80000000000000004 111.402 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -129.67 -173.3 2.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.004 0.43 . . . . 1.0600000000000001 110.123 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -134.18 160.08 38.92 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.618 -0.719 . . . . 3.6000000000000001 110.441 -171.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.602 HD12 HD12 ' A' ' 92' ' ' LEU . 0.1 OUTLIER -106.8 115.32 60.6 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 115.039 -0.982 . . . . 1.51 108.806 173.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.07 24.3 0.3 Allowed 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.664 2.909 . . . . 1.01 114.445 -167.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 59.16 25.58 14.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.113 0.482 . . . . 0.87 111.036 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -131.28 138.78 49.43 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.03 -0.532 . . . . 1.9399999999999999 110.047 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.47 ' HB3' ' CG1' ' A' ' 131' ' ' VAL . 96.7 mt -106.14 90.22 4.44 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.623 -0.262 . . . . 0.67000000000000004 110.677 172.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -73.59 158.97 46.85 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.844 2.363 . . . . 0.75 112.33 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.414 ' HA ' HG22 ' A' ' 131' ' ' VAL . 14.7 Cg_endo -57.55 -28.55 81.49 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.47 2.78 . . . . 0.70999999999999996 114.177 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -85.94 6.68 27.42 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.736 -0.385 . . . . 0.93999999999999995 111.605 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 62.0 mt -122.92 -22.97 5.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.519 0.199 . . . . 0.82999999999999996 111.397 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 126' ' ' LEU . 29.3 m . . . . . 0 C--N 1.324 -0.514 0 CA-C-O 120.741 0.305 . . . . 1.4399999999999999 111.318 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.63 0.252 . . . . 0.89000000000000001 110.352 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.438 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 53.2 t-20 -115.96 108.62 46.11 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.42999999999999999 109.795 -175.149 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 12.9 Cg_exo -70.23 -5.95 17.7 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.191 2.594 . . . . 0.51000000000000001 112.65 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 29.6 m-85 -107.01 -4.43 19.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.918 0.39 . . . . 0.5 110.221 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.438 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 30.6 tt0 . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 121.879 0.847 . . . . 1.4199999999999999 108.926 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.2 t90 . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 108.013 -1.106 . . . . 0.84999999999999998 108.013 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.537 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 90.6 t -56.51 -29.56 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.843 -0.617 . . . . 1.24 112.229 -171.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' A' ' 111' ' ' HIS . 18.9 m -77.69 -13.36 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 122.179 -0.326 . . . . 1.3 111.109 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.821 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -65.09 -24.46 70.34 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.063 -0.589 . . . . 0.62 112.255 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 18.5 ptpt -87.17 0.34 55.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.746 0.307 . . . . 2.9900000000000002 111.234 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -138.71 21.24 2.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.694 0.759 . . . . 1.8200000000000001 109.767 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.821 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 5.0 mmmp? -57.86 -40.15 81.56 Favored Pre-proline 0 C--O 1.22 -0.484 0 CA-C-N 115.353 -0.84 . . . . 0.93000000000000005 112.491 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 8.9 Cg_endo -50.35 -42.26 48.52 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 122.308 2.005 . . . . 0.56999999999999995 112.527 176.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.7 m -69.59 -44.05 71.55 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.12 -0.491 . . . . 0.67000000000000004 110.295 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -71.18 -22.65 62.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.953 -0.567 . . . . 0.92000000000000004 110.416 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.71 -45.53 29.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.893 -0.781 . . . . 1.8600000000000001 108.893 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.69 -54.07 43.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.3 -0.864 . . . . 2.0 110.629 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.2 mt -64.88 -44.52 96.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.234 -0.439 . . . . 0.53000000000000003 111.435 -176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.43 ' HE1' HG12 ' A' ' 67' ' ' ILE . 51.2 t80 -58.56 -44.18 89.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.42999999999999999 110.79 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 13.1 m-85 -76.34 -24.33 54.25 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.122 0.416 . . . . 3.0800000000000001 112.122 -177.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 p -76.3 -15.97 59.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.025 0.44 . . . . 0.75 111.035 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mp -88.29 -4.25 58.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.979 -0.555 . . . . 1.26 110.516 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m 69.29 89.32 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.314 0 CA-C-N 115.232 -0.895 . . . . 1.1100000000000001 111.735 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 58.7 Cg_endo -86.65 117.01 1.4 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.705 2.27 . . . . 0.68999999999999995 112.747 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.1 t -91.45 132.79 34.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.258 -0.645 . . . . 1.4299999999999999 109.258 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 49.48 23.71 0.96 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.726 0.81 . . . . 2.1499999999999999 112.108 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.78 6.75 61.95 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.073 -0.584 . . . . 0.62 113.403 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -135.74 155.58 50.15 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.673 0.749 . . . . 2.2400000000000002 112.316 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.43 HG12 ' HE1' ' A' ' 57' ' ' PHE . 41.3 pt -114.13 152.82 15.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.749 -1.114 . . . . 0.31 108.775 171.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -88.0 175.65 7.67 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 120.449 -0.501 . . . . 0.52000000000000002 110.23 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.94 -27.25 71.0 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.641 -0.79 . . . . 0.38 112.528 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.63 -48.36 82.13 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.954 0.407 . . . . 0.40000000000000002 111.915 -176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -71.8 -40.78 68.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.282 0.563 . . . . 1.73 110.571 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -72.07 -28.79 63.55 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.465 -0.494 . . . . 0.35999999999999999 110.095 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.416 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 40.7 ttmt -64.79 -50.15 67.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.725 -0.216 . . . . 0.60999999999999999 110.533 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -62.18 -38.22 88.27 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.508 -0.315 . . . . 2.2400000000000002 110.58 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.93 -50.64 72.96 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.423 0.63 . . . . 0.81999999999999995 110.22 174.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.828 ' HB3' HD22 ' A' ' 86' ' ' LEU . 22.8 mmt -58.52 -45.24 89.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.528 -0.76 . . . . 1.04 112.197 -177.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.87 -16.6 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.946 0.403 . . . . 1.02 110.796 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -91.19 -5.76 54.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.169 -0.469 . . . . 3.04 111.063 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 7.1 t -89.54 -1.18 57.95 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.271 0.558 . . . . 0.85999999999999999 110.135 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 79' ' ' SER . 9.1 mptt 70.82 16.61 6.61 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.236 0.828 . . . . 2.0499999999999998 113.236 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.537 ' HB2' HD21 ' A' ' 86' ' ' LEU . 2.6 mm? -91.29 142.85 27.49 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.574 -0.45 . . . . 1.3400000000000001 111.124 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.588 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 21.3 Cg_exo -65.49 154.87 71.77 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.263 2.642 . . . . 0.62 112.474 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -56.12 -41.23 74.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.223 -0.444 . . . . 0.93999999999999995 111.55 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 7.9 m -58.21 -48.25 80.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.218 0.532 . . . . 0.58999999999999997 110.938 178.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.576 ' O ' HG12 ' A' ' 89' ' ' ILE . 96.4 t -63.57 -42.06 94.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.731 -0.668 . . . . 0.40000000000000002 110.479 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.828 HD22 ' HB3' ' A' ' 76' ' ' MET . 79.0 mt -61.92 -44.06 97.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.062 -0.517 . . . . 1.25 110.762 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.413 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -59.7 -31.63 71.85 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 121.027 -0.606 . . . . 0.34000000000000002 112.308 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 84' ' ' THR . 55.4 mtpt -72.66 -46.56 53.26 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.747 0.308 . . . . 1.1599999999999999 110.479 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 85' ' ' VAL . 43.5 mm -55.53 -52.08 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.66 -0.7 . . . . 0.89000000000000001 109.899 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -63.78 -39.49 94.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.983 -0.553 . . . . 0.34999999999999998 110.841 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -59.72 -35.62 74.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.773 0.32 . . . . 1.3799999999999999 111.194 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.444 ' O ' HD11 ' A' ' 126' ' ' LEU . 6.3 mp -88.75 -34.6 17.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.146 -0.479 . . . . 1.53 111.343 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.21 -42.71 65.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.967 0.413 . . . . 0.42999999999999999 111.757 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.565 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 24.9 t70 -89.33 91.11 8.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.385 0.612 . . . . 0.58999999999999997 109.545 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.0 m -82.48 -29.78 9.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.118 -0.946 . . . . 1.49 112.204 -171.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -86.99 -13.11 45.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.665 -0.243 . . . . 1.45 111.151 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.565 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 17.0 mmmt 57.84 45.07 19.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.847 -0.615 . . . . 2.6699999999999999 110.718 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.54 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 11.4 p-10 -93.29 -13.22 28.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.612 -0.722 . . . . 1.1299999999999999 110.965 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.63 5.47 74.76 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.797 -0.716 . . . . 0.42999999999999999 111.993 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.54 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 30.9 mt -128.27 166.27 18.91 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.241 -0.281 . . . . 0.45000000000000001 110.241 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.0 mt -122.35 119.85 32.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.322 -0.399 . . . . 0.70999999999999996 110.157 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -95.79 -175.86 3.55 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.168 -0.678 . . . . 1.4199999999999999 109.168 171.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.34 -33.64 67.95 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.835 0.35 . . . . 1.73 111.495 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.96 -56.56 4.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.278 -0.419 . . . . 1.53 110.28 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.453 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 25.6 mt-10 -59.27 -37.0 76.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.732 -0.667 . . . . 0.81999999999999995 111.096 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -71.23 -35.28 71.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.417 -0.356 . . . . 0.37 110.865 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.63 -38.32 90.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.735 0.302 . . . . 0.5 110.436 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.39 -41.03 96.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 1.3200000000000001 110.12 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.06 -52.48 64.1 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.765 -0.652 . . . . 0.26000000000000001 110.941 177.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -68.07 -30.1 69.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.452 . . . . 1.3600000000000001 111.355 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.561 ' HB2' HG12 ' A' ' 46' ' ' VAL . 83.9 t60 -62.02 -45.86 91.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.776 0.322 . . . . 0.67000000000000004 110.377 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.6 mt -68.87 -41.55 78.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.872 -0.604 . . . . 0.89000000000000001 110.856 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 109' ' ' ALA . 78.1 mt -61.17 -39.97 84.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.951 -0.568 . . . . 0.46000000000000002 110.034 176.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.606 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 32.3 tttm -56.26 -50.4 71.45 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.93 -0.577 . . . . 2.0699999999999998 110.606 175.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 111' ' ' HIS . 46.0 t -51.34 -39.11 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.101 -0.5 . . . . 0.5 111.145 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -68.58 -30.39 69.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.722 0.296 . . . . 1.25 111.469 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 86.1 mt -72.4 -34.55 67.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.97 0.414 . . . . 0.93999999999999995 110.07 174.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 41.7 mm-40 -68.4 -25.96 65.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.884 -0.598 . . . . 1.6499999999999999 109.611 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.52 35.08 4.5 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.604 -0.726 . . . . 0.80000000000000004 112.802 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -132.99 173.55 11.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.066 0.433 . . . . 1.0600000000000001 110.638 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.88 156.14 20.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.862 -0.608 . . . . 3.6000000000000001 109.985 -177.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.26 135.18 24.65 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.546 -0.538 . . . . 1.51 109.546 176.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.36 4.66 4.22 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.013 2.476 . . . . 1.01 113.726 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 65.33 19.65 11.69 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.488 0.492 . . . . 0.87 111.425 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -131.27 148.63 52.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.048 -0.524 . . . . 1.9399999999999999 110.126 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 92' ' ' LEU . 79.1 mt -109.05 108.81 60.78 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.867 -0.606 . . . . 0.67000000000000004 110.38 173.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.647 ' HD2' HD12 ' A' ' 130' ' ' LEU . 26.4 Cg_exo -61.03 154.06 59.67 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.592 2.195 . . . . 0.75 111.662 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.461 ' HA ' HG22 ' A' ' 131' ' ' VAL . 32.5 Cg_endo -64.49 -4.93 9.04 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.811 2.341 . . . . 0.70999999999999996 113.116 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -100.94 4.03 42.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.981 0.419 . . . . 0.93999999999999995 110.38 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.647 HD12 ' HD2' ' A' ' 127' ' ' PRO . 35.5 mt -116.21 -8.3 11.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.82999999999999996 111.095 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 128' ' ' PRO . 27.0 m . . . . . 0 C--N 1.326 -0.423 0 CA-C-O 121.433 0.635 . . . . 1.4399999999999999 110.267 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 . . . . . 0 CA--C 1.514 -0.429 0 CA-C-O 121.104 0.478 . . . . 0.89000000000000001 110.27 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.698 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 55.9 t-20 -138.52 116.17 9.17 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.474 -0.785 . . . . 0.42999999999999999 109.39 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 23.1 Cg_exo -66.1 -14.48 44.59 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 123.442 2.761 . . . . 0.51000000000000001 113.362 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.672 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 17.9 m-85 -107.33 -1.62 21.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.498 0.666 . . . . 0.5 110.133 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.698 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 42.4 tt0 . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 114.673 -1.149 . . . . 1.4199999999999999 108.39 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.9 t90 . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 108.587 -0.894 . . . . 0.84999999999999998 108.587 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.1 t -54.82 -32.25 25.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.951 -0.568 . . . . 1.24 111.164 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 45.2 t -79.04 -15.21 13.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.93 -0.577 . . . . 1.3 111.321 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.83 -23.88 71.11 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.798 -0.715 . . . . 0.62 111.813 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -87.09 -16.02 36.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 122.304 1.049 . . . . 2.9900000000000002 109.881 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.461 ' HB2' ' HA ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -104.84 -11.74 16.61 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.433 -1.712 . . . . 1.8200000000000001 110.893 -163.691 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 3.6 mmmp? -57.79 -55.81 41.09 Favored Pre-proline 0 C--O 1.224 -0.281 0 N-CA-C 114.521 1.304 . . . . 0.93000000000000005 114.521 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 10.5 Cg_endo -48.8 -37.88 36.62 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.73 2.287 . . . . 0.56999999999999995 113.44 -168.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.547 ' O ' HG13 ' A' ' 56' ' ' ILE . 16.8 m -71.29 -44.39 65.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.059 -0.519 . . . . 0.67000000000000004 110.88 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.44 ' HE2' ' HB3' ' A' ' 49' ' ' ASP . 12.2 m-85 -78.26 -22.32 48.49 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.085 -0.507 . . . . 0.92000000000000004 109.992 -176.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -71.96 -42.07 66.98 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.108 -0.701 . . . . 1.8600000000000001 109.108 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -53.41 -52.83 58.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.125 -0.943 . . . . 2.0 109.898 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 52' ' ' THR . 15.8 mt -67.84 -31.33 51.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.109 -0.95 . . . . 0.53000000000000003 110.637 -178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -59.91 -37.38 79.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.765 -0.652 . . . . 0.42999999999999999 110.774 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -70.83 -24.94 62.64 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.771 0.285 . . . . 3.0800000000000001 111.771 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 p -86.23 -5.68 59.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.848 0.356 . . . . 0.75 111.399 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.486 HD11 ' OE1' ' A' ' 75' ' ' GLU . 8.8 mp -96.19 5.19 51.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.978 0.418 . . . . 1.26 110.086 175.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m 64.71 86.15 0.14 Allowed Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 115.074 -0.966 . . . . 1.1100000000000001 111.567 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.28 115.24 4.19 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.103 2.535 . . . . 0.68999999999999995 112.192 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.5 t -89.28 113.48 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.601 -0.518 . . . . 1.4299999999999999 109.601 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 65.09 22.65 12.35 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.012 -0.54 . . . . 2.1499999999999999 110.296 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.02 19.12 59.81 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.903 -0.59 . . . . 0.62 112.408 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 100' ' ' LEU . 32.4 tttp -144.2 131.79 21.13 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.652 -0.499 . . . . 2.2400000000000002 109.652 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 101' ' ' LEU . 38.9 pt -92.71 152.54 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.36 -0.536 . . . . 0.31 111.078 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.454 ' HA ' HD22 ' A' ' 100' ' ' LEU . 37.6 p -85.07 160.46 19.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.721 -0.672 . . . . 0.52000000000000002 110.982 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.416 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -61.18 -29.71 71.89 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.153 -0.546 . . . . 0.38 112.596 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.9 -50.57 72.12 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.029 0.442 . . . . 0.40000000000000002 111.634 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.47 ' HA ' ' HG2' ' A' ' 74' ' ' LYS . 40.1 m-80 -74.69 -37.01 62.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.897 -0.592 . . . . 1.73 110.954 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.39 -27.5 65.35 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.378 -0.374 . . . . 0.35999999999999999 110.458 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.561 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 38.8 ttpt -72.6 -49.54 31.43 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.537 -0.301 . . . . 0.60999999999999999 111.094 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 71' ' ' ASN . 20.2 ptmt -59.82 -36.86 77.65 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 121.132 -0.227 . . . . 2.2400000000000002 110.481 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.486 ' OE1' HD11 ' A' ' 60' ' ' LEU . 17.3 tp10 -61.46 -52.46 64.44 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.492 0.663 . . . . 0.81999999999999995 110.142 175.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.756 ' HG2' ' HG ' ' A' ' 86' ' ' LEU . 17.5 ttm -67.64 -27.47 66.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.426 -0.806 . . . . 1.04 111.376 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.55 -40.46 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 116.432 -0.349 . . . . 1.02 110.231 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -73.36 -8.89 57.78 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.226 -0.443 . . . . 3.04 110.742 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 7.4 t -73.31 -12.63 60.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.191 -0.459 . . . . 0.85999999999999999 110.447 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 79' ' ' SER . 45.3 mmtm 73.5 26.67 1.94 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.411 0.685 . . . . 2.0499999999999998 112.608 178.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.81 144.27 27.86 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.518 -0.549 . . . . 1.3400000000000001 109.518 172.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.587 ' O ' HD13 ' A' ' 86' ' ' LEU . 12.6 Cg_endo -60.23 139.06 85.15 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.814 2.343 . . . . 0.62 112.563 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.456 ' HA ' HD22 ' A' ' 86' ' ' LEU . 15.9 m120 -51.83 -35.03 43.05 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.031 0.532 . . . . 0.93999999999999995 112.164 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.497 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 2.7 m -57.64 -40.73 79.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.383 0.611 . . . . 0.58999999999999997 110.634 177.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.588 ' O ' HG12 ' A' ' 89' ' ' ILE . 66.8 t -74.19 -38.71 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.041 -0.726 . . . . 0.40000000000000002 109.041 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.756 ' HG ' ' HG2' ' A' ' 76' ' ' MET . 5.1 mp -58.77 -45.72 89.14 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.992 -1.003 . . . . 1.25 110.321 176.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.54 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -59.46 -39.68 95.21 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.528 -0.76 . . . . 0.34000000000000002 112.001 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 84' ' ' THR . 55.4 mtpt -71.09 -43.95 66.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.751 0.31 . . . . 1.1599999999999999 110.349 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 85' ' ' VAL . 45.0 mm -57.3 -47.44 84.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.89000000000000001 110.201 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.416 ' CH2' ' HA2' ' A' ' 69' ' ' GLY . 15.3 t-105 -66.7 -41.42 88.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 0.34999999999999998 110.398 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -64.86 -22.49 67.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.164 -0.471 . . . . 1.3799999999999999 111.101 -175.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.519 HD12 ' HG ' ' A' ' 126' ' ' LEU . 4.0 mm? -93.29 -41.63 9.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 1.53 111.018 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.14 88.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.563 -0.29 . . . . 0.42999999999999999 111.648 -176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -83.51 75.52 10.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.371 -0.603 . . . . 0.58999999999999997 109.371 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.4 t -67.93 -34.72 68.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.369 -0.832 . . . . 1.49 110.987 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.81 -15.37 51.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.407 -0.815 . . . . 1.45 111.866 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 60.66 72.48 0.52 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.515 0.509 . . . . 2.6699999999999999 111.63 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p30 -129.26 -14.43 4.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.007 -0.542 . . . . 1.1299999999999999 111.328 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.13 4.34 84.22 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.347 -0.93 . . . . 0.42999999999999999 112.234 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 68' ' ' THR . 67.7 mt -127.88 160.48 31.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.447 -0.575 . . . . 0.45000000000000001 109.447 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 105' ' ' GLU . 51.6 mt -124.28 118.32 26.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.804 0.335 . . . . 0.70999999999999996 110.565 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -82.84 -175.25 5.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.062 -0.718 . . . . 1.4199999999999999 109.062 167.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -61.67 -31.23 71.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.643 0.259 . . . . 1.73 111.115 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -72.11 -57.43 4.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.446 -0.343 . . . . 1.53 110.183 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.494 ' HB3' HD22 ' A' ' 101' ' ' LEU . 32.0 mt-10 -56.06 -44.63 79.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.075 -0.512 . . . . 0.81999999999999995 111.04 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -66.9 -38.24 85.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.898 -0.592 . . . . 0.37 110.954 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.28 85.14 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.943 -0.303 . . . . 0.5 110.632 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.12 -43.83 95.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.99 -0.374 . . . . 1.3200000000000001 109.99 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.33 -58.03 8.51 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.041 -0.527 . . . . 0.26000000000000001 111.069 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -67.29 -33.23 74.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.436 . . . . 1.3600000000000001 111.319 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.657 ' O ' HG23 ' A' ' 115' ' ' VAL . 77.3 t60 -64.17 -45.89 86.42 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 120.699 -0.4 . . . . 0.67000000000000004 109.991 176.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.428 ' HB3' HD12 ' A' ' 89' ' ' ILE . 75.0 mt -60.95 -41.46 96.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.59 0.233 . . . . 0.89000000000000001 111.063 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.96 -45.28 95.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.339 -0.391 . . . . 0.46000000000000002 110.196 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.475 ' HE2' ' OE2' ' A' ' 118' ' ' GLU . 86.8 tttt -64.86 -35.85 82.47 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.897 -0.321 . . . . 2.0699999999999998 110.795 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 111' ' ' HIS . 95.9 t -53.77 -44.27 58.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.359 -0.608 . . . . 0.5 109.359 173.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -66.83 -42.85 85.11 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.403 -0.817 . . . . 1.25 111.405 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.44 -27.27 64.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.334 -0.394 . . . . 0.93999999999999995 111.605 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.475 ' OE2' ' HE2' ' A' ' 114' ' ' LYS . 34.1 mt-10 -75.84 -6.98 53.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.306 -0.406 . . . . 1.6499999999999999 111.469 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.39 17.8 35.44 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.407 -0.901 . . . . 0.80000000000000004 112.327 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.462 ' HB2' ' CG1' ' A' ' 115' ' ' VAL . 11.5 m-70 -109.86 176.32 5.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.459 -0.571 . . . . 1.0600000000000001 109.459 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -139.63 130.77 26.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.876 0.369 . . . . 3.6000000000000001 111.275 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.72 126.32 88.63 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.296 -0.631 . . . . 1.51 109.296 173.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.67 13.87 1.57 Allowed 'Trans proline' 0 N--CA 1.474 0.343 0 C-N-CA 123.202 2.601 . . . . 1.01 113.748 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 66.38 19.52 10.96 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.403 0.62 . . . . 0.87 110.719 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -111.7 137.2 49.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.566 -0.743 . . . . 1.9399999999999999 109.433 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.519 ' HG ' HD12 ' A' ' 92' ' ' LEU . 92.3 mt -100.94 90.07 1.44 Allowed Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 110.193 -0.299 . . . . 0.67000000000000004 110.193 168.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 130' ' ' LEU . 43.9 Cg_endo -71.17 155.02 61.74 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.298 1.999 . . . . 0.75 111.713 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.25 -10.15 20.08 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 123.275 2.65 . . . . 0.70999999999999996 113.583 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -92.8 1.06 57.48 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.134 0.492 . . . . 0.93999999999999995 110.386 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.475 HD12 ' HD2' ' A' ' 127' ' ' PRO . 66.2 mt -117.34 -35.31 4.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.82999999999999996 110.571 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 126' ' ' LEU . 92.6 t . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.088 -0.505 . . . . 1.4399999999999999 111.478 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 . . . . . 0 CA--C 1.519 -0.237 0 CA-C-O 121.208 0.528 . . . . 0.89000000000000001 110.571 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.591 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 47.5 t-20 -96.86 112.88 61.79 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.591 -0.731 . . . . 0.42999999999999999 110.055 -174.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.479 ' HB2' ' HD3' ' A' ' 73' ' ' LYS . 56.7 Cg_endo -70.47 -9.17 25.3 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.008 2.472 . . . . 0.51000000000000001 112.616 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 31.4 m-85 -96.84 -7.99 32.12 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.129 -0.693 . . . . 0.5 109.129 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.591 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 28.3 tt0 . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 115.002 -0.999 . . . . 1.4199999999999999 109.508 -175.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 108.969 -0.752 . . . . 0.84999999999999998 108.969 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.6 t -55.63 -47.25 79.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.023 -0.535 . . . . 1.24 112.434 -172.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.582 HG23 ' HE2' ' A' ' 53' ' ' TYR . 2.7 p -69.31 -22.04 25.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.392 0.615 . . . . 1.3 110.77 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.822 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -67.65 -11.96 60.95 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.422 -0.808 . . . . 0.62 112.082 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -80.59 -27.7 37.31 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.943 -0.391 . . . . 2.9900000000000002 109.943 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.412 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 63.2 m-20 -100.4 10.55 41.05 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.839 -0.619 . . . . 1.8200000000000001 110.0 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.822 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 15.8 mmmt -52.58 -55.46 32.21 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 114.371 1.248 . . . . 0.93000000000000005 114.371 -171.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 10.6 Cg_endo -51.3 -37.36 59.95 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.532 2.155 . . . . 0.56999999999999995 112.808 -174.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.447 ' O ' HG13 ' A' ' 56' ' ' ILE . 8.6 m -69.99 -43.1 72.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.82 -0.627 . . . . 0.67000000000000004 110.34 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.582 ' HE2' HG23 ' A' ' 46' ' ' VAL . 13.9 m-30 -73.92 -23.21 59.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.365 -0.38 . . . . 0.92000000000000004 110.436 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.482 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 22.4 m-20 -69.29 -45.48 69.5 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.237 0.541 . . . . 1.8600000000000001 109.586 176.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -60.82 -38.91 87.06 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.121 -0.945 . . . . 2.0 110.892 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 52' ' ' THR . 62.7 mt -68.95 -40.96 81.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.53000000000000003 110.568 176.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -55.82 -39.68 71.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.42999999999999999 111.243 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.482 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 48.9 m-85 -75.92 -13.58 60.25 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.763 0.653 . . . . 3.0800000000000001 112.763 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 64.1 p -73.93 -18.55 60.88 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.179 -0.608 . . . . 0.75 110.824 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 2.0 mm? -87.12 -9.34 55.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.418 -0.356 . . . . 1.26 110.895 175.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.6 t 67.91 94.05 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.25 0 O-C-N 123.905 0.753 . . . . 1.1100000000000001 110.758 -176.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.37 134.51 42.18 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 123.009 2.473 . . . . 0.68999999999999995 112.992 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.2 t -107.96 123.54 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 108.881 -0.785 . . . . 1.4299999999999999 108.881 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 45.33 33.72 1.31 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.452 0.701 . . . . 2.1499999999999999 112.499 -175.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.98 -3.4 67.09 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.053 -0.594 . . . . 0.62 114.448 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -137.87 170.25 16.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.812 0.806 . . . . 2.2400000000000002 110.692 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.7 pt -114.7 155.24 15.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.79 -0.364 . . . . 0.31 110.177 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.598 ' HA ' HD22 ' A' ' 100' ' ' LEU . 76.0 p -87.25 167.58 13.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.239 -0.437 . . . . 0.52000000000000002 110.897 -176.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.47 -24.44 63.83 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.768 -0.73 . . . . 0.38 112.315 176.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.4 -35.92 76.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.204 0.526 . . . . 0.40000000000000002 110.76 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 13.5 m120 -70.58 -49.05 51.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.575 -0.739 . . . . 1.73 110.529 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.471 ' HB3' ' HZ3' ' A' ' 90' ' ' TRP . . . -73.49 -20.1 60.76 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.47 -0.492 . . . . 0.35999999999999999 110.411 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.596 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 39.5 ttmt -67.3 -50.35 60.63 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.558 -0.534 . . . . 0.60999999999999999 109.558 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 22.2 ptmt -64.79 -35.68 81.87 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.237 -0.438 . . . . 2.2400000000000002 110.793 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.83 -51.97 62.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.362 0.601 . . . . 0.81999999999999995 110.279 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.855 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -65.12 -36.51 84.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.464 -0.789 . . . . 1.04 112.384 -174.794 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -75.37 -26.07 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.294 -0.562 . . . . 1.02 110.339 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -85.43 -1.77 57.39 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.06 -0.518 . . . . 3.04 110.413 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 33.5 m -79.66 -7.76 58.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.85999999999999999 109.992 171.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 79' ' ' SER . 0.1 OUTLIER 69.97 27.36 4.43 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.631 -0.713 . . . . 2.0499999999999998 111.603 178.209 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.547 ' HB2' HD11 ' A' ' 86' ' ' LEU . 95.3 mt -110.31 157.93 36.72 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.424 . . . . 1.3400000000000001 110.368 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.667 ' O ' HD13 ' A' ' 86' ' ' LEU . 60.6 Cg_endo -74.16 147.43 37.86 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.704 2.269 . . . . 0.62 113.323 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.404 ' HA ' HD22 ' A' ' 86' ' ' LEU . 4.5 m-20 -51.46 -38.5 54.07 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.979 -0.555 . . . . 0.93999999999999995 112.029 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 35.0 m -56.69 -43.23 80.29 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.107 0.48 . . . . 0.58999999999999997 111.092 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.58 ' O ' HG12 ' A' ' 89' ' ' ILE . 53.5 t -73.93 -36.59 45.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.135 -0.691 . . . . 0.40000000000000002 109.135 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.855 ' HG ' ' HB3' ' A' ' 76' ' ' MET . 1.7 mp -62.62 -45.3 93.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.076 -0.966 . . . . 1.25 110.546 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.521 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -58.72 -37.22 89.37 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.892 -0.595 . . . . 0.34000000000000002 112.308 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 84' ' ' THR . 52.4 mtpt -71.76 -42.3 67.38 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.208 -0.293 . . . . 1.1599999999999999 110.208 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 85' ' ' VAL . 32.7 mm -53.15 -52.54 29.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.942 -0.572 . . . . 0.89000000000000001 110.132 173.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.471 ' HZ3' ' HB3' ' A' ' 72' ' ' ALA . 27.3 t-105 -64.38 -43.03 95.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.78 -0.645 . . . . 0.34999999999999998 111.159 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -63.83 -25.05 68.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.081 0.467 . . . . 1.3799999999999999 111.318 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.424 ' HA ' HD13 ' A' ' 92' ' ' LEU . 3.7 mm? -89.36 -31.23 17.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.132 -0.486 . . . . 1.53 111.158 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.59 -36.45 28.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.361 -0.381 . . . . 0.42999999999999999 111.883 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -84.93 57.2 4.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.824 0.821 . . . . 0.58999999999999997 109.942 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.6 p -68.37 -16.12 20.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.849 -1.069 . . . . 1.49 111.483 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -89.71 -18.46 26.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.119 -0.492 . . . . 1.45 110.824 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.539 ' NZ ' ' HB2' ' A' ' 97' ' ' LYS . 0.1 OUTLIER 61.01 73.46 0.48 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.14 0.576 . . . . 2.6699999999999999 111.55 179.229 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.524 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 15.4 p-10 -132.96 -18.93 2.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.463 -0.335 . . . . 1.1299999999999999 111.759 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.68 4.47 72.91 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.437 -0.887 . . . . 0.42999999999999999 112.064 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.598 HD22 ' HA ' ' A' ' 68' ' ' THR . 41.4 mt -130.35 171.6 12.76 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.361 -0.607 . . . . 0.45000000000000001 109.361 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' A' ' 105' ' ' GLU . 79.9 mt -127.06 118.45 24.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.46 -0.336 . . . . 0.70999999999999996 110.702 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -83.31 -176.48 6.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.842 -0.799 . . . . 1.4199999999999999 108.842 167.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.96 -29.44 69.84 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.616 -0.434 . . . . 1.73 111.798 -173.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.49 -50.12 48.22 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.316 -0.624 . . . . 1.53 109.316 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.484 ' HB3' HD22 ' A' ' 101' ' ' LEU . 36.5 mt-10 -59.96 -52.77 63.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.352 -0.84 . . . . 0.81999999999999995 111.431 -178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -63.09 -35.86 81.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.941 -0.572 . . . . 0.37 110.703 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.84 -47.32 75.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.5 110.682 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.84 -37.85 88.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.355 -0.384 . . . . 1.3200000000000001 109.974 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.506 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.0 -49.73 72.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.86 -0.609 . . . . 0.26000000000000001 110.426 173.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -69.19 -28.46 66.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.838 -0.619 . . . . 1.3600000000000001 111.846 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 115' ' ' VAL . 82.3 t60 -67.06 -41.97 85.54 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.395 -0.522 . . . . 0.67000000000000004 109.932 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.7 mt -64.75 -38.58 91.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.994 0.426 . . . . 0.89000000000000001 110.111 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 109' ' ' ALA . 72.0 mt -63.23 -41.23 92.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.712 -0.676 . . . . 0.46000000000000002 110.505 176.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -54.77 -49.88 69.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.836 0.35 . . . . 2.0699999999999998 110.585 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 111' ' ' HIS . 29.9 t -59.68 -40.49 82.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.99 -0.55 . . . . 0.5 109.926 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.591 ' NZ ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -61.51 -42.63 99.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.492 -0.776 . . . . 1.25 111.181 175.416 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 86.4 mt -72.37 -32.11 66.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.613 0.244 . . . . 0.93999999999999995 111.569 -176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -75.36 3.41 9.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.478 -0.328 . . . . 1.6499999999999999 111.543 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.69 2.5 75.64 Favored Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 120.642 -0.789 . . . . 0.80000000000000004 112.478 175.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.46 ' HB2' HG12 ' A' ' 115' ' ' VAL . 28.3 m-70 -92.92 173.93 7.5 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.097 0.475 . . . . 1.0600000000000001 109.887 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.33 145.39 40.12 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.0 -0.545 . . . . 3.6000000000000001 110.675 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.76 125.21 56.31 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.827 -0.624 . . . . 1.51 109.634 175.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.79 -2.14 11.45 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.898 2.399 . . . . 1.01 113.165 -172.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.3 21.02 12.22 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.421 0.629 . . . . 0.87 110.25 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.463 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -115.37 131.86 56.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.048 -0.978 . . . . 1.9399999999999999 109.872 -178.251 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.612 ' HB3' ' HB ' ' A' ' 131' ' ' VAL . 92.5 mt -96.85 96.57 2.85 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.139 0.274 . . . . 0.67000000000000004 110.624 170.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.499 ' O ' HG12 ' A' ' 131' ' ' VAL . 57.8 Cg_endo -76.48 159.76 35.73 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.406 2.07 . . . . 0.75 111.265 177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.98 -25.57 28.63 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.998 2.466 . . . . 0.70999999999999996 114.023 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -86.92 9.26 19.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.823 0.344 . . . . 0.93999999999999995 111.42 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 63.1 mt -131.71 -35.37 1.28 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 0.82999999999999996 110.65 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.612 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 7.1 p . . . . . 0 CA--C 1.534 0.342 0 CA-C-O 121.497 0.665 . . . . 1.4399999999999999 110.693 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 108.625 -0.88 . . . . 0.89000000000000001 108.625 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.521 HD21 ' HA2' ' A' ' 87' ' ' GLY . 45.9 t-20 -97.36 119.39 63.07 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 114.451 -1.249 . . . . 0.42999999999999999 109.882 -173.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.56 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 9.2 Cg_exo -71.99 -10.36 25.99 Favored 'Trans proline' 0 CA--C 1.528 0.184 0 C-N-CA 123.259 2.639 . . . . 0.51000000000000001 112.948 -175.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.596 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 15.0 m-85 -106.41 -16.08 14.65 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.626 0.726 . . . . 0.5 109.475 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.401 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 41.5 tt0 . . . . . 0 C--N 1.319 -0.737 0 CA-C-N 114.557 -1.202 . . . . 1.4199999999999999 108.595 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 109.221 -0.659 . . . . 0.84999999999999998 109.221 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.9 m -57.77 -33.66 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.667 -0.697 . . . . 1.24 112.315 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.421 HG23 ' HB2' ' A' ' 111' ' ' HIS . 7.4 p -69.87 -16.07 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.589 0.709 . . . . 1.3 110.745 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.522 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -72.81 -6.38 67.1 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.397 -0.819 . . . . 0.62 111.941 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -91.94 -25.44 18.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.185 0.517 . . . . 2.9900000000000002 110.221 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.453 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 20.7 m-20 -91.94 1.88 56.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.708 -0.678 . . . . 1.8200000000000001 110.701 -176.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HZ1' ' CG ' ' A' ' 103' ' ' ASP . 3.5 mmmp? -53.96 -49.66 88.42 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 114.062 1.134 . . . . 0.93000000000000005 114.062 -172.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 11.7 Cg_endo -52.69 -39.72 75.58 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.107 1.871 . . . . 0.56999999999999995 112.891 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.506 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . 58.5 m -82.62 -31.92 28.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.902 0.382 . . . . 0.67000000000000004 111.414 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.453 ' CE2' ' HB2' ' A' ' 49' ' ' ASP . 16.4 m-30 -71.11 -22.38 62.09 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.09 -0.708 . . . . 0.92000000000000004 109.09 175.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 16.5 t70 -71.22 -42.5 68.85 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.15 -0.932 . . . . 1.8600000000000001 109.365 172.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.506 ' OE2' ' HA ' ' A' ' 52' ' ' THR . 40.3 mt-10 -58.53 -34.35 70.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.33 -0.85 . . . . 2.0 110.837 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.7 mt -78.59 -52.44 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.075 0.464 . . . . 0.53000000000000003 110.512 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.421 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 74.2 t80 -50.01 -41.37 47.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.393 -0.821 . . . . 0.42999999999999999 111.855 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -74.75 -22.58 58.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.742 0.645 . . . . 3.0800000000000001 112.742 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.5 p -79.47 -20.82 46.44 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.018 -0.673 . . . . 0.75 110.944 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.06 -5.05 59.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 1.26 110.647 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.0 t 68.0 92.03 0.07 OUTLIER Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 115.588 -0.733 . . . . 1.1100000000000001 111.0 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.67 134.08 34.03 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.988 2.459 . . . . 0.68999999999999995 111.941 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.2 t -110.8 107.52 23.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.09 -0.505 . . . . 1.4299999999999999 110.124 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 64.1 41.47 6.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.547 -0.751 . . . . 2.1499999999999999 111.607 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.32 -3.38 72.36 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.984 -0.627 . . . . 0.62 113.94 172.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -160.3 170.53 20.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.412 0.606 . . . . 2.2400000000000002 110.476 178.646 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.48 HD11 ' CD1' ' A' ' 106' ' ' PHE . 25.6 pt -104.94 159.4 5.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.828 0.346 . . . . 0.31 111.227 -177.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.479 ' HA ' HD22 ' A' ' 100' ' ' LEU . 73.5 p -89.27 170.66 10.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.856 -0.611 . . . . 0.52000000000000002 110.972 -177.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.93 -27.98 72.06 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.688 -0.687 . . . . 0.38 112.546 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.96 -45.15 68.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.076 0.465 . . . . 0.40000000000000002 111.295 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.465 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 8.9 m120 -63.73 -46.24 86.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.509 0.671 . . . . 1.73 110.127 -177.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.533 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -75.77 -23.89 55.98 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.729 -0.669 . . . . 0.35999999999999999 110.489 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.799 ' HA ' ' HZ ' ' B' ' 151' ' ' PHE . 35.1 ttmt -61.32 -50.62 72.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.893 0.377 . . . . 0.60999999999999999 110.033 174.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 19.4 ptmt -70.13 -27.71 64.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.312 -0.404 . . . . 2.2400000000000002 110.395 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 13.2 tp10 -68.36 -40.39 81.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.612 0.72 . . . . 0.81999999999999995 109.98 174.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.647 ' HB3' HD22 ' A' ' 86' ' ' LEU . 22.3 mmt -59.8 -42.81 94.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.67 -0.695 . . . . 1.04 111.24 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 74' ' ' LYS . 15.0 m -72.0 -24.07 22.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.459 -0.496 . . . . 1.02 110.441 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 10.1 mtpm? -71.67 -20.87 61.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 3.04 110.644 175.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.9 m -84.88 1.35 47.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.08 -0.509 . . . . 0.85999999999999999 111.263 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.1 mptt 62.01 25.19 15.09 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.862 0.69 . . . . 2.0499999999999998 112.862 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.603 ' HB2' HD21 ' A' ' 86' ' ' LEU . 98.8 mt -98.79 140.61 21.89 Favored Pre-proline 0 C--N 1.326 -0.45 0 C-N-CA 121.06 -0.256 . . . . 1.3400000000000001 110.908 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.607 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 19.3 Cg_exo -64.92 159.49 45.88 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.189 2.592 . . . . 0.62 112.614 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -56.74 -43.71 80.96 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.823 -0.626 . . . . 0.93999999999999995 111.611 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.2 m -56.34 -45.92 80.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.16 0.505 . . . . 0.58999999999999997 110.905 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 89' ' ' ILE . 96.3 t -64.27 -45.24 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.763 -0.653 . . . . 0.40000000000000002 110.618 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.647 HD22 ' HB3' ' A' ' 76' ' ' MET . 31.3 mt -62.62 -38.48 90.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.088 -0.506 . . . . 1.25 110.271 177.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.729 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -56.56 -37.42 75.54 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.289 -0.869 . . . . 0.34000000000000002 111.783 176.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -77.63 -47.69 18.68 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.927 0.394 . . . . 1.1599999999999999 110.561 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.648 HD13 HG12 ' A' ' 113' ' ' ILE . 67.8 mt -57.84 -49.57 80.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.01 -0.541 . . . . 0.89000000000000001 111.105 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.588 ' HB3' ' ND2' ' B' ' 149' ' ' ASN . 13.4 t-105 -66.04 -38.48 88.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.215 0.531 . . . . 0.34999999999999998 110.197 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 87' ' ' GLY . 24.4 ttmm -56.91 -33.33 66.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.521 -0.763 . . . . 1.3799999999999999 111.05 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.416 ' HA ' HD13 ' A' ' 92' ' ' LEU . 3.8 mm? -90.72 -43.1 10.33 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.587 0.588 . . . . 1.53 112.587 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.63 -42.45 98.15 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.5 0.556 . . . . 0.42999999999999999 112.5 -171.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.635 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 36.0 t0 -90.22 99.72 12.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.327 -0.62 . . . . 0.58999999999999997 109.327 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.8 m -82.83 -30.31 8.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.767 -0.651 . . . . 1.49 111.839 -170.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -102.28 -9.29 20.53 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.131 0.419 . . . . 1.45 112.131 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.635 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 67.9 mmtt 66.15 74.48 0.35 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.187 0.517 . . . . 2.6699999999999999 112.326 175.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.425 ' HB2' ' H ' ' A' ' 100' ' ' LEU . 5.5 m-20 -91.82 -29.08 16.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.748 -0.66 . . . . 1.1299999999999999 109.525 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.49 2.39 79.56 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 109.58 -1.408 . . . . 0.42999999999999999 109.58 -167.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' A' ' 68' ' ' THR . 23.1 mt -133.93 175.8 9.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.195 -1.003 . . . . 0.45000000000000001 108.435 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.565 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 96.6 mt -131.88 118.12 19.41 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.972 -0.291 . . . . 0.70999999999999996 110.413 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.536 ' HA ' ' CB ' ' A' ' 66' ' ' LYS . 1.3 p-10 -81.08 -175.82 5.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.047 -0.723 . . . . 1.4199999999999999 109.047 175.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.553 ' CG ' ' HZ1' ' A' ' 50' ' ' LYS . 17.9 t70 -61.4 -35.48 77.63 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 111.865 0.32 . . . . 1.73 111.865 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -68.36 -55.45 11.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.986 0.422 . . . . 1.53 110.542 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.491 ' HG3' ' OD1' ' A' ' 102' ' ' ASP . 36.0 mt-10 -72.22 -32.25 66.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.885 -0.598 . . . . 0.81999999999999995 112.383 -173.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CD1' HD11 ' A' ' 67' ' ' ILE . 49.5 t80 -69.29 -39.0 78.6 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.091 -0.644 . . . . 0.37 109.625 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.28 96.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.41 -0.516 . . . . 0.5 110.074 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.5 mt -65.55 -36.52 84.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.492 -0.322 . . . . 1.3200000000000001 111.057 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.48 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -58.51 -52.16 66.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.801 0.334 . . . . 0.26000000000000001 110.305 174.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -63.64 -36.47 83.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.043 -0.526 . . . . 1.3600000000000001 110.627 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.622 ' O ' HG23 ' A' ' 115' ' ' VAL . 77.1 t60 -63.72 -46.19 86.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.28 -0.418 . . . . 0.67000000000000004 111.008 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.581 ' HB3' HD23 ' A' ' 122' ' ' LEU . 96.1 mt -63.66 -41.02 98.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.887 0.375 . . . . 0.89000000000000001 110.731 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.648 HG12 HD13 ' A' ' 89' ' ' ILE . 73.9 mt -59.72 -44.15 93.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.46000000000000002 109.986 175.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 22.5 ttmm -60.51 -42.15 95.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.814 -0.63 . . . . 2.0699999999999998 111.203 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 111' ' ' HIS . 59.5 t -58.11 -46.35 88.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.816 0.341 . . . . 0.5 110.351 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 16.5 mtpp -62.13 -42.24 99.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.033 0.383 . . . . 1.25 112.033 175.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 97.2 mt -64.51 -28.47 69.67 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.185 0.516 . . . . 0.93999999999999995 110.723 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 58.2 mm-40 -73.04 -2.74 22.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.651 -0.704 . . . . 1.6499999999999999 111.471 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.48 32.43 9.44 Favored Glycine 0 CA--C 1.505 -0.588 0 C-N-CA 120.647 -0.787 . . . . 0.80000000000000004 112.099 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 95.4 m-70 -131.14 179.72 5.84 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.389 0.614 . . . . 1.0600000000000001 111.406 -176.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.85 149.79 49.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.11 -0.95 . . . . 3.6000000000000001 109.404 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.581 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -79.9 144.51 59.82 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.505 -0.554 . . . . 1.51 109.505 175.44 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.33 -5.91 15.06 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.998 2.465 . . . . 1.01 113.315 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.42 17.83 9.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.329 0.585 . . . . 0.87 110.599 -175.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -134.78 156.58 48.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.222 -0.899 . . . . 1.9399999999999999 109.496 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.83 93.87 9.56 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.399 -0.364 . . . . 0.67000000000000004 110.721 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -78.2 160.19 29.7 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.39 2.06 . . . . 0.75 112.084 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PRO . . . . . 0.465 ' HA ' HG22 ' A' ' 131' ' ' VAL . 78.4 Cg_exo -51.63 -27.42 25.77 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.422 2.748 . . . . 0.70999999999999996 113.805 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -88.37 9.07 24.67 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.649 -0.42 . . . . 0.93999999999999995 111.776 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.8 mt -128.25 -32.87 2.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.508 0.194 . . . . 0.82999999999999996 111.028 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 128' ' ' PRO . 28.1 m . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 1.4399999999999999 110.56 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 . . . . . 0 CA--C 1.517 -0.325 0 CA-C-O 120.919 0.39 . . . . 0.89000000000000001 110.705 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.729 HD21 ' HA2' ' A' ' 87' ' ' GLY . 54.9 t-20 -93.16 122.11 64.05 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.904 -0.589 . . . . 0.42999999999999999 109.741 -176.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 23.7 Cg_exo -64.92 -5.68 11.17 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.171 2.581 . . . . 0.51000000000000001 113.394 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.799 ' HZ ' ' HA ' ' A' ' 73' ' ' LYS . 43.4 m-85 -108.09 -3.52 18.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.368 0.604 . . . . 0.5 110.108 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.601 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 46.9 tt0 . . . . . 0 C--N 1.324 -0.511 0 N-CA-C 108.329 -0.989 . . . . 1.4199999999999999 108.329 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.2 t90 . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 108.374 -0.972 . . . . 0.84999999999999998 108.374 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.1 m -58.56 -15.01 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.876 0.695 . . . . 1.24 112.876 -172.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.486 HG21 HD23 ' A' ' 108' ' ' LEU . 61.2 t -80.6 -26.96 11.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.996 0.427 . . . . 1.3 110.714 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.471 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -73.85 -1.64 59.45 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.694 -0.765 . . . . 0.62 111.712 177.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -97.35 -17.13 19.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.166 0.508 . . . . 2.9900000000000002 110.307 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.08 20.62 5.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.773 -0.649 . . . . 1.8200000000000001 110.244 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.642 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 8.3 mmmm -58.25 -43.74 98.55 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 114.751 1.389 . . . . 0.93000000000000005 114.751 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.9 Cg_endo -46.47 -41.98 23.15 Favored 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 122.906 2.404 . . . . 0.56999999999999995 113.654 -172.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.3 m -70.54 -40.34 73.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.101 0.477 . . . . 0.67000000000000004 110.679 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 110' ' ' ASN . 7.4 m-85 -71.11 -23.41 62.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.92000000000000004 109.67 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -75.22 -45.69 38.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.329 -0.85 . . . . 1.8600000000000001 110.102 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -58.99 -50.44 74.1 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.449 -0.796 . . . . 2.0 110.39 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.68 -41.79 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.164 -0.471 . . . . 0.53000000000000003 111.259 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.417 ' HB2' ' CD2' ' A' ' 106' ' ' PHE . 90.5 t80 -58.55 -47.83 82.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.287 -0.415 . . . . 0.42999999999999999 110.927 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -76.37 -20.86 56.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.225 0.454 . . . . 3.0800000000000001 112.225 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.7 p -78.43 -13.0 60.04 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.214 -0.594 . . . . 0.75 111.463 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.3 mt -92.24 2.76 56.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.496 -0.32 . . . . 1.26 111.003 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.0 m 66.51 90.1 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 O-C-N 123.785 0.678 . . . . 1.1100000000000001 111.468 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.9 137.16 13.75 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.064 2.51 . . . . 0.68999999999999995 112.436 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.507 HG12 ' OD1' ' A' ' 64' ' ' ASN . 22.4 t -108.81 115.36 49.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.191 -0.458 . . . . 1.4299999999999999 110.195 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.507 ' OD1' HG12 ' A' ' 63' ' ' VAL . 3.0 p-10 40.94 51.61 3.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.621 0.768 . . . . 2.1499999999999999 112.859 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.59 -3.77 71.97 Favored Glycine 0 CA--C 1.518 0.233 0 N-CA-C 114.754 0.662 . . . . 0.62 114.754 170.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.464 ' HG2' ' CA ' ' A' ' 102' ' ' ASP . 14.0 mtmm -147.95 149.79 32.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.951 0.875 . . . . 2.2400000000000002 111.173 177.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.9 pt -92.09 147.57 5.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.807 -0.442 . . . . 0.31 109.807 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.2 p -77.77 155.11 31.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.363 -0.38 . . . . 0.52000000000000002 110.688 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.38 -15.37 45.36 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 121.285 -0.483 . . . . 0.38 113.387 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -63.77 -56.96 11.57 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.254 0.55 . . . . 0.40000000000000002 111.081 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.65 -37.93 83.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.644 -0.707 . . . . 1.73 110.25 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.46 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -69.64 -32.55 71.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.809 -0.632 . . . . 0.35999999999999999 110.551 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.577 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 39.9 ttmt -64.05 -42.71 96.93 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.4 0.619 . . . . 0.60999999999999999 109.561 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.8 mtpp -67.76 -38.27 83.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.281 -0.872 . . . . 2.2400000000000002 110.982 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.92 -45.39 93.91 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.481 0.658 . . . . 0.81999999999999995 110.263 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.938 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 25.0 mmt -57.48 -48.11 80.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.354 -0.839 . . . . 1.04 111.274 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.12 -21.57 19.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.849 -0.34 . . . . 1.02 111.074 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 92.5 mttt -70.31 -25.12 63.17 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.545 -0.298 . . . . 3.04 110.82 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 42.5 m -81.99 -1.69 49.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.255 -0.43 . . . . 0.85999999999999999 111.124 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 79' ' ' SER . 10.1 mptt 70.15 14.95 7.65 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.984 0.735 . . . . 2.0499999999999998 112.984 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.99 143.62 43.24 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.57 -0.452 . . . . 1.3400000000000001 110.672 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.544 ' O ' HD13 ' A' ' 86' ' ' LEU . 39.7 Cg_exo -62.27 152.07 78.59 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.292 2.661 . . . . 0.62 112.803 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.534 ' HA ' HD22 ' A' ' 86' ' ' LEU . 16.5 m120 -57.79 -38.45 75.52 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.226 -0.443 . . . . 0.93999999999999995 111.33 -177.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.3 m -57.8 -37.42 73.71 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.197 0.522 . . . . 0.58999999999999997 111.161 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 89' ' ' ILE . 70.7 t -77.08 -37.25 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.029 -0.73 . . . . 0.40000000000000002 109.029 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.938 ' HG ' ' HB3' ' A' ' 76' ' ' MET . 0.4 OUTLIER -61.42 -44.85 96.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.143 -0.935 . . . . 1.25 110.715 176.023 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.608 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -61.31 -37.2 93.65 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.87 -0.681 . . . . 0.34000000000000002 111.634 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -68.03 -48.31 66.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.819 0.342 . . . . 1.1599999999999999 110.754 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 85' ' ' VAL . 39.8 mm -56.89 -48.82 80.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.916 -0.584 . . . . 0.89000000000000001 110.253 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TRP . . . . . 0.504 ' CH2' HD23 ' A' ' 101' ' ' LEU . 16.6 t-105 -61.94 -51.31 68.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.055 -0.521 . . . . 0.34999999999999998 111.161 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -60.65 -27.64 67.96 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.122 -0.49 . . . . 1.3799999999999999 111.823 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.487 HD12 HD22 ' A' ' 122' ' ' LEU . 66.3 mt -85.51 -49.97 7.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.502 -0.317 . . . . 1.53 111.214 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.89 82.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.504 -0.316 . . . . 0.42999999999999999 111.834 -175.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.731 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 18.7 t70 -78.66 83.94 4.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.831 -0.803 . . . . 0.58999999999999997 108.831 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.62 -25.99 13.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.91 -1.041 . . . . 1.49 110.887 -173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.53 -15.55 30.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.901 -0.59 . . . . 1.45 111.949 -176.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.698 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 4.2 mptp? 54.74 72.07 0.49 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.31 0.576 . . . . 2.6699999999999999 110.983 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -117.25 -33.16 4.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.767 -0.652 . . . . 1.1299999999999999 111.932 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.12 -23.09 14.65 Favored Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 120.476 -0.869 . . . . 0.42999999999999999 112.357 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -102.01 -171.74 2.02 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.881 -0.785 . . . . 0.45000000000000001 108.881 174.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.552 HD13 ' HG2' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -132.66 111.69 11.39 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.754 -0.462 . . . . 0.70999999999999996 109.754 178.288 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.464 ' CA ' ' HG2' ' A' ' 66' ' ' LYS . 7.0 t70 -87.55 -177.13 5.81 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.701 -0.681 . . . . 1.4199999999999999 110.843 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.34 -37.02 57.91 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.246 0.461 . . . . 1.73 112.246 -173.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -69.56 -41.92 75.24 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 122.782 1.277 . . . . 1.53 107.91 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.731 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 5.9 tt0 -65.4 -40.88 93.98 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 112.375 -2.193 . . . . 0.81999999999999995 110.899 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.536 ' HB2' HD12 ' A' ' 101' ' ' LEU . 52.9 t80 -72.75 -35.41 67.48 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.608 0.718 . . . . 0.37 109.77 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . 0.412 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -66.28 -39.82 89.67 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.733 -1.121 . . . . 0.5 110.629 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.486 HD23 HG21 ' A' ' 46' ' ' VAL . 15.7 mt -70.05 -35.42 74.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.165 -0.47 . . . . 1.3200000000000001 110.47 175.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.44 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.74 -55.47 33.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 0.26000000000000001 110.561 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 94.8 m-20 -70.63 -25.72 63.16 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.32 -0.4 . . . . 1.3600000000000001 110.932 -177.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.593 ' O ' HG23 ' A' ' 115' ' ' VAL . 72.6 t60 -69.83 -43.82 71.19 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.408 -0.36 . . . . 0.67000000000000004 110.051 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.83 -41.1 97.92 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.95 0.405 . . . . 0.89000000000000001 110.077 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 80.3 mt -59.81 -43.73 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.437 -0.801 . . . . 0.46000000000000002 110.437 174.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -59.72 -46.64 88.5 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.187 -0.461 . . . . 2.0699999999999998 111.196 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 111' ' ' HIS . 38.4 t -60.38 -42.83 92.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.114 0.483 . . . . 0.5 110.325 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -56.16 -43.86 78.74 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.847 -0.615 . . . . 1.25 110.998 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 91.5 mt -74.04 -16.97 61.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.398 -0.365 . . . . 0.93999999999999995 111.316 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.3 0.41 25.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.735 0.302 . . . . 1.6499999999999999 110.421 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.52 -1.48 84.03 Favored Glycine 0 CA--C 1.503 -0.705 0 N-CA-C 111.42 -0.672 . . . . 0.80000000000000004 111.42 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -97.05 -179.14 4.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.115 0.483 . . . . 1.0600000000000001 111.11 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.15 144.45 50.75 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.465 -0.789 . . . . 3.6000000000000001 110.179 -176.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.487 HD22 HD12 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -77.96 138.97 61.21 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 109.711 -0.477 . . . . 1.51 109.711 173.656 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.45 -3.43 12.45 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.537 2.158 . . . . 1.01 113.699 -170.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.22 21.55 12.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.309 0.576 . . . . 0.87 110.739 -177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.702 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 0.8 OUTLIER -127.93 142.23 51.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.099 -0.955 . . . . 1.9399999999999999 108.999 178.287 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.2 mt -97.32 92.49 1.25 Allowed Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 121.166 0.508 . . . . 0.67000000000000004 110.551 169.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.758 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 17.8 Cg_endo -94.35 165.95 1.93 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.749 2.966 . . . . 0.75 112.254 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.6 -25.04 24.52 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.523 2.815 . . . . 0.70999999999999996 113.948 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -86.79 5.54 35.99 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.458 -0.497 . . . . 0.93999999999999995 111.476 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.758 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 72.9 mt -129.23 -35.56 1.78 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.585 -0.28 . . . . 0.82999999999999996 111.182 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--N 1.325 -0.479 0 CA-C-O 121.342 0.591 . . . . 1.4399999999999999 111.352 178.945 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 CA--C 1.519 -0.215 0 N-CA-C 108.851 -0.796 . . . . 0.89000000000000001 108.851 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.608 HD21 ' HA2' ' A' ' 87' ' ' GLY . 45.2 t-20 -87.91 114.51 59.51 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.822 -1.081 . . . . 0.42999999999999999 109.641 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 11.0 Cg_exo -72.22 -6.55 19.31 Favored 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 123.09 2.526 . . . . 0.51000000000000001 112.8 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 40.7 m-85 -105.55 0.19 26.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.452 0.644 . . . . 0.5 109.676 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 23.2 tt0 . . . . . 0 C--N 1.318 -0.803 0 CA-C-N 115.018 -0.992 . . . . 1.4199999999999999 109.255 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.419 ' HH2' ' HA ' ' A' ' 104' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.631 0 N-CA-C 109.355 -0.609 . . . . 0.84999999999999998 109.355 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.5 m -56.65 -31.5 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.761 0.652 . . . . 1.24 112.761 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.658 ' HB ' ' HE2' ' A' ' 53' ' ' TYR . 22.7 m -77.1 -6.42 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.623 -0.431 . . . . 1.3 110.795 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.89 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -72.97 -20.25 79.88 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.86 -0.896 . . . . 0.62 110.86 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -84.51 -10.86 57.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.021 -0.59 . . . . 2.9900000000000002 110.011 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -118.89 9.26 11.91 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.447 -0.797 . . . . 1.8200000000000001 110.882 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.89 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 28.8 mmmt -53.11 -49.75 85.88 Favored Pre-proline 0 N--CA 1.471 0.582 0 N-CA-C 113.252 0.834 . . . . 0.93000000000000005 113.252 -175.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 10.1 Cg_endo -51.74 -38.67 67.2 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.585 2.19 . . . . 0.56999999999999995 112.432 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -70.82 -42.73 69.85 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.625 0.726 . . . . 0.67000000000000004 110.102 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.658 ' HE2' ' HB ' ' A' ' 46' ' ' VAL . 15.9 m-30 -70.36 -22.63 62.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.39 -0.823 . . . . 0.92000000000000004 109.86 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -73.84 -43.94 57.14 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.687 -0.688 . . . . 1.8600000000000001 110.1 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.609 ' HA ' ' CE2' ' A' ' 58' ' ' TYR . 39.8 mt-10 -58.14 -33.38 69.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.728 -0.669 . . . . 2.0 111.259 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.0 mt -85.19 -22.44 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.241 0.544 . . . . 0.53000000000000003 110.569 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -77.83 -55.53 5.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.315 -0.402 . . . . 0.42999999999999999 112.009 -175.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.609 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 23.1 p90 -70.43 -17.14 63.0 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 120.679 -0.408 . . . . 3.0800000000000001 111.509 -172.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 p -71.54 -12.61 61.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.106 0.479 . . . . 0.75 111.074 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 87.7 mt -99.92 14.62 29.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.75 -0.659 . . . . 1.26 110.648 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.9 m 65.06 88.69 0.11 Allowed Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 115.509 -0.769 . . . . 1.1100000000000001 111.136 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 38.2 Cg_endo -74.54 98.74 1.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.478 2.119 . . . . 0.68999999999999995 112.385 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.3 t -89.9 117.28 32.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.725 -0.472 . . . . 1.4299999999999999 109.725 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 60.6 22.82 12.6 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.223 0.535 . . . . 2.1499999999999999 110.856 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.95 14.35 69.83 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.706 -0.759 . . . . 0.62 113.259 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.735 ' HE3' ' HB2' ' A' ' 100' ' ' LEU . 39.5 tttp -147.26 126.36 12.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.385 0.593 . . . . 2.2400000000000002 109.459 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 101' ' ' LEU . 35.3 pt -83.87 146.11 7.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 120.94 0.4 . . . . 0.31 110.552 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.639 ' HA ' HD22 ' A' ' 100' ' ' LEU . 68.6 p -80.48 159.53 25.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.795 -0.639 . . . . 0.52000000000000002 111.314 -177.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.41 -22.3 67.41 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.957 -0.565 . . . . 0.38 112.845 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.04 -49.75 74.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.372 0.606 . . . . 0.40000000000000002 111.332 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 39.5 m-80 -73.36 -38.05 65.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.515 -0.766 . . . . 1.73 111.18 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.51 -30.93 69.85 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.496 -0.482 . . . . 0.35999999999999999 109.862 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -62.64 -48.96 77.05 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.537 -0.301 . . . . 0.60999999999999999 110.704 176.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.658 ' HD3' ' N ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -64.91 -31.96 73.44 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 120.482 -0.487 . . . . 2.2400000000000002 111.123 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.658 ' N ' ' HD3' ' A' ' 74' ' ' LYS . 7.5 tp10 -67.57 -45.12 76.5 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.32 0.581 . . . . 0.81999999999999995 109.914 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.469 ' HB3' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -64.99 -46.55 80.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.381 -0.827 . . . . 1.04 111.547 -178.17 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.04 -30.38 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.946 -0.302 . . . . 1.02 111.558 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -80.48 -11.31 59.69 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.101 -0.374 . . . . 3.04 110.602 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.9 t -74.22 -11.44 60.29 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.893 -0.78 . . . . 0.85999999999999999 108.893 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 72.4 mmtt 66.4 35.11 5.87 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.249 -0.887 . . . . 2.0499999999999998 112.208 175.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.597 ' HB2' HD21 ' A' ' 86' ' ' LEU . 89.7 mt -100.7 144.85 29.31 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.867 -0.79 . . . . 1.3400000000000001 108.867 171.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.402 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 52.1 Cg_exo -55.35 142.65 79.21 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.587 2.191 . . . . 0.62 112.241 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -56.23 -34.14 66.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.149 -0.478 . . . . 0.93999999999999995 111.28 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' THR . . . . . 0.502 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 6.2 m -59.62 -48.52 81.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.198 0.523 . . . . 0.58999999999999997 110.496 177.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.632 ' O ' HG12 ' A' ' 89' ' ' ILE . 58.7 t -63.05 -43.29 98.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.716 -0.674 . . . . 0.40000000000000002 109.968 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' A' ' 81' ' ' LEU . 78.9 mt -59.36 -43.94 92.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.746 -0.661 . . . . 1.25 110.685 178.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.04 -34.38 83.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.982 -0.627 . . . . 0.34000000000000002 112.069 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 84' ' ' THR . 27.9 mtpp -72.62 -45.32 59.64 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.83 0.348 . . . . 1.1599999999999999 110.23 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 85' ' ' VAL . 42.7 mm -56.37 -49.39 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.725 -0.671 . . . . 0.89000000000000001 110.107 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -66.79 -41.16 88.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.086 -0.506 . . . . 0.34999999999999998 110.524 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -55.81 -29.23 59.42 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.696 -0.683 . . . . 1.3799999999999999 110.695 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.488 HD12 HD22 ' A' ' 122' ' ' LEU . 82.8 mt -91.86 -42.95 9.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 1.53 112.056 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.09 -40.29 95.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.42999999999999999 111.779 -171.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -92.05 94.23 9.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.983 -0.747 . . . . 0.58999999999999997 108.983 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.5 -48.94 28.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.267 -0.879 . . . . 1.49 111.24 -172.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -83.93 -9.97 58.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.599 -0.728 . . . . 1.45 112.051 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt 73.45 76.4 0.13 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.641 0.608 . . . . 2.6699999999999999 112.641 171.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.537 ' HB2' ' H ' ' A' ' 100' ' ' LEU . 3.8 m-20 -104.31 -44.85 4.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.456 0.646 . . . . 1.1299999999999999 110.226 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.69 2.35 57.43 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.34 -1.104 . . . . 0.42999999999999999 110.34 -167.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.735 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 36.7 mt -131.22 165.02 24.28 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.549 -0.908 . . . . 0.45000000000000001 108.549 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.422 ' O ' HG12 ' A' ' 67' ' ' ILE . 96.2 mt -125.56 122.68 37.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.267 0.555 . . . . 0.70999999999999996 111.573 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.419 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 2.1 p30 -87.16 -176.29 5.63 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.74 -0.837 . . . . 1.4199999999999999 108.74 167.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.02 -22.79 63.07 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.712 -0.395 . . . . 1.73 111.444 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HA ' ' HH2' ' A' ' 44' ' ' TRP . 52.2 mt-10 -72.01 -56.77 5.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.14 0.495 . . . . 1.53 109.818 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -68.28 -32.13 72.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.384 -0.826 . . . . 0.81999999999999995 111.086 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -71.49 -29.79 65.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.751 -0.463 . . . . 0.37 109.751 176.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.52 -39.11 88.47 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.285 -0.416 . . . . 0.5 110.152 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.47 -42.57 99.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.035 -0.529 . . . . 1.3200000000000001 110.347 172.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.12 -55.46 30.85 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 123.553 0.533 . . . . 0.26000000000000001 110.672 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -63.01 -41.49 99.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.78 -0.646 . . . . 1.3600000000000001 111.046 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.618 ' O ' HG23 ' A' ' 115' ' ' VAL . 81.5 t60 -61.52 -45.84 92.48 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.908 -0.317 . . . . 0.67000000000000004 111.187 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.0 -40.66 87.37 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.752 0.311 . . . . 0.89000000000000001 111.233 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.437 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 80.7 mt -61.41 -42.69 94.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.46000000000000002 109.837 175.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 52.9 tttp -55.45 -46.2 76.78 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.754 -0.657 . . . . 2.0699999999999998 110.683 174.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 111' ' ' HIS . 60.4 t -58.2 -44.71 88.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 120.716 0.293 . . . . 0.5 110.702 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -65.58 -39.85 92.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.153 -0.476 . . . . 1.25 111.465 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 93.6 mt -70.68 -26.03 63.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.938 0.399 . . . . 0.93999999999999995 110.8 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 68.8 mm-40 -71.02 -18.2 62.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.201 -0.454 . . . . 1.6499999999999999 110.559 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.23 -13.16 48.44 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.859 -0.686 . . . . 0.80000000000000004 112.007 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -85.17 172.8 10.91 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.885 -0.413 . . . . 1.0600000000000001 109.885 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -121.41 134.39 55.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.899 0.38 . . . . 3.6000000000000001 110.906 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.537 HD21 HD13 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -74.97 139.9 73.5 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.96 -0.564 . . . . 1.51 109.747 175.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 3.7 Cg_exo -76.85 1.32 8.72 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.911 2.407 . . . . 1.01 113.236 -173.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.75 20.38 11.34 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.549 0.69 . . . . 0.87 110.36 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.512 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 12.2 t70 -130.53 131.91 45.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.08 -0.964 . . . . 1.9399999999999999 109.399 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -91.99 103.22 7.63 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.244 -0.435 . . . . 0.67000000000000004 110.439 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 125' ' ' ASP . 2.5 Cg_endo -81.45 158.56 19.57 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.937 2.425 . . . . 0.75 111.897 -178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.44 -20.62 33.88 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.992 2.461 . . . . 0.70999999999999996 113.426 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -91.27 11.93 21.93 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.923 -0.311 . . . . 0.93999999999999995 111.29 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.43 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 37.8 mt -128.43 -21.41 3.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.555 -0.293 . . . . 0.82999999999999996 110.878 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--N 1.327 -0.398 0 CA-C-O 120.825 0.345 . . . . 1.4399999999999999 110.762 178.35 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 . . . . . 0 CA--C 1.52 -0.192 0 CA-C-O 120.963 0.411 . . . . 0.89000000000000001 110.365 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.595 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 52.2 t-20 -97.62 113.7 63.87 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 0.42999999999999999 110.081 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 10.0 Cg_exo -72.66 -7.34 20.65 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.421 2.747 . . . . 0.51000000000000001 112.862 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -107.15 5.65 28.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.317 0.579 . . . . 0.5 109.861 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.595 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 23.0 tt0 . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.188 -0.915 . . . . 1.4199999999999999 108.643 -175.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TRP . . . . . 0.468 ' HZ2' ' HG ' ' A' ' 108' ' ' LEU . 13.9 t90 . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 108.512 -0.921 . . . . 0.84999999999999998 108.512 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.4 t -48.56 -33.35 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 115.497 -0.774 . . . . 1.24 112.848 -171.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.59 HG21 HD23 ' A' ' 108' ' ' LEU . 58.8 t -67.6 -22.71 28.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.252 -0.431 . . . . 1.3 111.722 -175.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.61 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -66.28 -22.37 70.95 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.455 -0.878 . . . . 0.62 111.503 176.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -78.54 -21.32 48.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.235 0.54 . . . . 2.9900000000000002 110.889 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -119.72 15.13 12.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.73 0.776 . . . . 1.8200000000000001 109.761 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.61 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 2.4 mmmm -54.04 -45.03 99.17 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.1 -0.955 . . . . 0.93000000000000005 113.343 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.6 Cg_endo -48.42 -40.72 36.53 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.739 2.292 . . . . 0.56999999999999995 113.15 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 m -69.66 -43.99 71.43 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-O 121.611 0.72 . . . . 0.67000000000000004 110.276 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.481 ' CE2' HG13 ' A' ' 46' ' ' VAL . 12.0 m-85 -71.01 -22.51 62.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.342 -0.844 . . . . 0.92000000000000004 109.878 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.25 -45.17 66.99 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.189 -0.671 . . . . 1.8600000000000001 109.189 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -56.3 -47.5 78.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.758 -1.11 . . . . 2.0 111.379 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.3 mt -75.31 -37.86 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.728 0.299 . . . . 0.53000000000000003 111.282 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -59.65 -52.28 66.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.327 -0.397 . . . . 0.42999999999999999 111.431 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -71.15 -21.03 62.24 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.299 0.481 . . . . 3.0800000000000001 112.299 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.4 p -78.92 -3.32 44.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.425 -0.51 . . . . 0.75 111.679 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.0 mt -100.96 7.58 43.5 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.941 0.401 . . . . 1.26 110.469 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.0 m 59.18 84.7 0.2 Allowed Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 115.475 -0.784 . . . . 1.1100000000000001 112.12 176.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.91 142.69 20.08 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.09 2.527 . . . . 0.68999999999999995 112.309 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.3 t -114.07 118.98 60.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.609 -0.515 . . . . 1.4299999999999999 109.609 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 59.98 27.21 16.58 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.088 -0.505 . . . . 2.1499999999999999 111.49 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.17 -3.42 69.69 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.001 -0.619 . . . . 0.62 114.003 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.63 ' HE3' ' N ' ' A' ' 102' ' ' ASP . 30.5 mtpt -131.1 149.21 52.7 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 117.901 0.85 . . . . 2.2400000000000002 110.776 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.421 HD11 ' CD1' ' A' ' 106' ' ' PHE . 43.2 pt -101.95 157.89 4.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.002 -0.545 . . . . 0.31 110.079 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.9 p -86.78 161.96 18.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.526 -0.761 . . . . 0.52000000000000002 110.915 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.88 -27.39 72.07 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.645 -0.707 . . . . 0.38 112.883 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.34 -53.59 55.53 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.097 0.475 . . . . 0.40000000000000002 111.866 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.466 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 45.0 m-80 -73.6 -34.32 65.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.021 -0.536 . . . . 1.73 111.094 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 76' ' ' MET . . . -73.44 -29.17 62.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.346 -0.388 . . . . 0.35999999999999999 110.275 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.559 ' HA ' ' HZ ' ' B' ' 151' ' ' PHE . 39.3 ttmt -66.4 -51.16 59.95 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.702 0.287 . . . . 0.60999999999999999 110.263 176.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 ptmt -63.26 -35.75 81.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.365 -0.379 . . . . 2.2400000000000002 111.731 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -67.4 -45.9 74.81 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.521 0.677 . . . . 0.81999999999999995 109.815 175.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.716 ' SD ' HD11 ' A' ' 113' ' ' ILE . 7.7 tpp -59.62 -42.4 92.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.392 -0.822 . . . . 1.04 111.077 -177.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.3 m -74.2 -30.39 26.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.819 0.342 . . . . 1.02 110.663 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -69.47 -17.9 63.66 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.913 -0.315 . . . . 3.04 110.983 176.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.4 m -73.83 -8.56 56.53 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.429 -0.35 . . . . 0.85999999999999999 111.053 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm 73.17 21.36 3.13 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.658 0.985 . . . . 2.0499999999999998 113.658 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.413 ' HB2' HD11 ' A' ' 86' ' ' LEU . 2.7 mm? -95.3 148.82 35.25 Favored Pre-proline 0 C--N 1.32 -0.682 0 C-N-CA 120.602 -0.439 . . . . 1.3400000000000001 109.822 174.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.592 ' O ' HD13 ' A' ' 86' ' ' LEU . 32.9 Cg_exo -60.1 151.95 69.04 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.982 2.454 . . . . 0.62 112.432 176.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -57.67 -33.14 68.02 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.424 -0.353 . . . . 0.93999999999999995 111.244 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.34 -38.68 80.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.437 0.637 . . . . 0.58999999999999997 110.514 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 89' ' ' ILE . 57.3 t -75.83 -39.6 38.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.754 -0.832 . . . . 0.40000000000000002 108.754 -177.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.652 ' HG ' ' CG ' ' A' ' 76' ' ' MET . 3.6 mp -60.76 -44.82 96.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.997 -1.001 . . . . 1.25 111.16 176.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.623 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -61.92 -35.35 91.24 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.888 -0.672 . . . . 0.34000000000000002 111.784 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.715 ' HD3' ' HB2' ' A' ' 122' ' ' LEU . 38.6 ttmt -71.48 -45.39 62.64 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.188 0.518 . . . . 1.1599999999999999 110.063 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.691 HG23 ' HB2' ' A' ' 112' ' ' LEU . 72.0 mt -61.44 -50.77 79.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.539 -0.755 . . . . 0.89000000000000001 110.692 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -60.32 -43.04 96.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.89 -0.595 . . . . 0.34999999999999998 110.67 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.13 -25.2 64.27 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.92 -0.312 . . . . 1.3799999999999999 111.244 -175.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.34 -43.78 55.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.344 0.592 . . . . 1.53 110.026 172.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -66.97 -42.63 84.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.196 -0.911 . . . . 0.42999999999999999 111.411 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.547 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 27.9 t0 -95.89 62.14 2.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.8 0.809 . . . . 0.58999999999999997 109.348 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.0 p -64.66 -28.09 44.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 114.543 -1.208 . . . . 1.49 111.575 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -86.99 -10.94 51.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.997 -0.547 . . . . 1.45 111.795 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HD2' ' O ' ' A' ' 94' ' ' ASP . 1.3 mptm? 56.17 73.64 0.43 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.715 0.406 . . . . 2.6699999999999999 112.062 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -120.32 -20.94 7.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.478 -0.328 . . . . 1.1299999999999999 110.753 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 100.5 -18.99 54.44 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.706 -0.759 . . . . 0.42999999999999999 113.444 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.424 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 86.6 mt -110.21 169.03 9.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.013 0.406 . . . . 0.45000000000000001 109.985 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 106' ' ' PHE . 76.3 mt -124.52 114.93 20.07 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.565 -0.454 . . . . 0.70999999999999996 110.952 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.63 ' N ' ' HE3' ' A' ' 66' ' ' LYS . 1.0 OUTLIER -84.85 -175.78 5.93 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.119 -0.697 . . . . 1.4199999999999999 109.119 171.473 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -62.27 -32.93 73.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.882 -0.327 . . . . 1.73 110.713 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.88 -52.29 11.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.766 0.317 . . . . 1.53 110.637 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.547 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 31.5 mt-10 -62.18 -47.36 84.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.345 -0.389 . . . . 0.81999999999999995 111.606 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 92.4 t80 -63.78 -37.1 86.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.987 0.422 . . . . 0.37 110.469 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.05 90.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.843 -0.617 . . . . 0.5 110.778 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.59 HD23 HG21 ' A' ' 46' ' ' VAL . 26.1 mt -64.08 -41.52 97.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 1.3200000000000001 110.632 174.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -54.94 -52.4 63.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.257 0.551 . . . . 0.26000000000000001 110.281 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . 0.415 HD22 ' N ' ' A' ' 110' ' ' ASN . 0.9 OUTLIER -69.0 -21.78 64.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.614 . . . . 1.3600000000000001 110.912 -177.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.609 ' O ' HG23 ' A' ' 115' ' ' VAL . 9.5 t60 -60.52 -61.2 2.77 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.18 0.514 . . . . 0.67000000000000004 109.626 174.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.691 ' HB2' HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -60.17 -34.9 74.23 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.73 -1.123 . . . . 0.89000000000000001 110.76 -176.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.716 HD11 ' SD ' ' A' ' 76' ' ' MET . 86.7 mt -60.75 -46.88 95.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.242 -0.436 . . . . 0.46000000000000002 110.484 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.414 ' HA ' HD12 ' A' ' 117' ' ' LEU . 36.6 ttmt -63.06 -36.41 83.49 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.429 -0.351 . . . . 2.0699999999999998 111.162 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 111' ' ' HIS . 14.1 t -62.74 -36.97 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.063 0.459 . . . . 0.5 109.793 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.7 mmtt -72.14 -28.11 63.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 1.25 111.135 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 95.4 mt -68.98 -20.59 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.125 0.488 . . . . 0.93999999999999995 110.326 176.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -87.75 -1.12 57.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.185 0.516 . . . . 1.6499999999999999 110.396 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.74 35.44 54.89 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.783 -0.644 . . . . 0.80000000000000004 112.203 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.482 ' HB2' HG12 ' A' ' 115' ' ' VAL . 20.4 m-70 -99.49 -171.84 2.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.196 0.522 . . . . 1.0600000000000001 111.99 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -118.59 152.06 36.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.376 -0.829 . . . . 3.6000000000000001 110.638 -174.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.715 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 5.1 mt -118.74 122.04 30.19 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.852 -0.425 . . . . 1.51 109.852 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.45 -11.79 12.91 Favored 'Trans proline' 0 C--N 1.334 -0.22 0 C-N-CA 123.458 2.772 . . . . 1.01 112.698 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.584 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . 65.98 19.29 11.22 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.838 -0.619 . . . . 0.87 110.896 -176.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . 0.425 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 10.7 m-20 -107.0 137.34 45.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.849 -0.614 . . . . 1.9399999999999999 110.573 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.4 mt -95.89 109.53 46.96 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.934 -0.575 . . . . 0.67000000000000004 111.21 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.791 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -83.72 160.62 14.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.504 2.803 . . . . 0.75 111.61 176.131 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.84 -25.38 76.31 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.709 2.272 . . . . 0.70999999999999996 113.057 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -89.46 8.6 30.14 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.943 -0.303 . . . . 0.93999999999999995 111.586 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.791 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 30.0 mt -123.45 -19.54 5.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.734 -0.212 . . . . 0.82999999999999996 111.204 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.4 t . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.983 0.42 . . . . 1.4399999999999999 110.198 176.912 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 121.551 0.691 . . . . 0.89000000000000001 109.404 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.623 HD21 ' HA2' ' A' ' 87' ' ' GLY . 51.7 t-20 -102.34 118.9 57.83 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.021 -0.99 . . . . 0.42999999999999999 109.814 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 18.9 Cg_exo -67.45 -7.45 19.19 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.504 2.803 . . . . 0.51000000000000001 112.951 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.559 ' HZ ' ' HA ' ' A' ' 73' ' ' LYS . 40.6 m-85 -107.68 4.21 25.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.295 0.569 . . . . 0.5 110.081 176.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.604 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 32.8 tt0 . . . . . 0 C--N 1.321 -0.652 0 CA-C-N 115.05 -0.977 . . . . 1.4199999999999999 109.393 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.3 t90 . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 108.83 -0.804 . . . . 0.84999999999999998 108.83 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.7 t -57.5 -40.66 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 113.614 0.968 . . . . 1.24 113.614 -167.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.5 HG12 ' CG ' ' A' ' 111' ' ' HIS . 5.3 m -69.87 -10.76 14.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.893 -0.323 . . . . 1.3 111.723 -171.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.767 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -69.53 -15.94 71.22 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.745 -0.741 . . . . 0.62 111.895 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -78.33 -28.2 47.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 2.9900000000000002 110.628 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -121.16 23.4 10.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.538 0.685 . . . . 1.8200000000000001 109.959 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.767 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 4.4 mmmp? -52.61 -41.98 86.17 Favored Pre-proline 0 C--O 1.218 -0.556 0 CA-C-N 115.342 -0.845 . . . . 0.93000000000000005 112.942 177.032 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 7.8 Cg_endo -48.8 -43.31 35.14 Favored 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 122.582 2.188 . . . . 0.56999999999999995 112.671 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.583 ' O ' HG13 ' A' ' 56' ' ' ILE . 14.3 m -70.18 -44.58 68.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.035 0.445 . . . . 0.67000000000000004 110.889 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -71.07 -22.74 62.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.352 0.596 . . . . 0.92000000000000004 109.809 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.414 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 9.3 t70 -73.67 -44.3 57.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.031 -0.986 . . . . 1.8600000000000001 108.85 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -55.31 -53.44 56.16 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 114.916 -1.038 . . . . 2.0 110.318 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.583 HG13 ' O ' ' A' ' 52' ' ' THR . 17.3 mt -64.56 -40.0 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 114.962 -1.017 . . . . 0.53000000000000003 110.668 -175.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 62' ' ' PRO . 79.9 t80 -59.03 -38.13 78.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.066 -0.516 . . . . 0.42999999999999999 110.783 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.493 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 17.5 m-85 -82.07 -22.99 36.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.445 -0.343 . . . . 3.0800000000000001 111.892 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.3 p -77.62 -18.71 56.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.14 0.495 . . . . 0.75 111.006 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.0 mp -91.08 4.1 53.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.972 -0.558 . . . . 1.26 110.465 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.7 m 68.01 91.43 0.07 OUTLIER Pre-proline 0 CA--C 1.529 0.165 0 O-C-N 124.047 0.842 . . . . 1.1100000000000001 111.726 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.493 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 1.9 Cg_endo -81.14 96.36 0.96 Allowed 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.599 2.2 . . . . 0.68999999999999995 111.299 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.5 m -86.87 117.44 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.34 0.591 . . . . 1.4299999999999999 110.205 -175.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 64.2 23.87 13.25 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.231 -0.895 . . . . 2.1499999999999999 110.819 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.48 33.42 19.61 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.931 -0.652 . . . . 0.62 113.36 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HG2' ' HB2' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -165.08 145.58 7.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.079 -0.711 . . . . 2.2400000000000002 109.079 175.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.4 pt -102.69 145.92 11.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.492 -0.483 . . . . 0.31 110.13 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.803 ' HA ' HD22 ' A' ' 100' ' ' LEU . 44.3 p -84.91 165.91 17.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.11 0.481 . . . . 0.52000000000000002 111.108 -176.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.2 -17.75 64.13 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.67 -0.695 . . . . 0.38 112.663 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.03 -54.34 22.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.113 0.482 . . . . 0.40000000000000002 110.656 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.547 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 1.0 OUTLIER -69.97 -41.29 74.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.769 -0.651 . . . . 1.73 110.593 -174.153 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.523 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -68.19 -29.34 68.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.012 -0.54 . . . . 0.35999999999999999 110.831 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.542 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 40.8 ttmt -65.38 -40.22 93.24 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.645 -0.502 . . . . 0.60999999999999999 109.645 174.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.596 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.2 mtpp -60.1 -43.28 95.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.51 -0.768 . . . . 2.2400000000000002 110.669 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.438 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 4.2 tp10 -65.74 -44.94 84.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.344 0.592 . . . . 0.81999999999999995 110.692 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.697 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 25.6 mmt -56.35 -46.48 79.97 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.769 -0.651 . . . . 1.04 111.243 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.7 m -75.3 -17.69 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.393 -0.367 . . . . 1.02 110.944 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 93.4 mttt -70.4 -30.33 67.19 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 120.402 -0.519 . . . . 3.04 109.831 172.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.0 m -76.3 -9.07 58.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.596 -0.729 . . . . 0.85999999999999999 110.999 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm 62.46 26.95 16.04 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.64 0.734 . . . . 2.0499999999999998 110.665 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.482 ' HB3' HD11 ' A' ' 86' ' ' LEU . 7.9 tp -89.75 137.44 28.5 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.039 -0.982 . . . . 1.3400000000000001 109.893 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.522 ' O ' HD13 ' A' ' 86' ' ' LEU . 45.1 Cg_exo -55.52 145.46 68.99 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 123.23 2.62 . . . . 0.62 113.406 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.409 ' HA ' HD22 ' A' ' 86' ' ' LEU . 13.2 m120 -52.75 -39.96 62.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.98 -0.555 . . . . 0.93999999999999995 112.145 -178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.5 m -58.08 -35.09 70.89 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.3 0.572 . . . . 0.58999999999999997 110.93 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.625 ' O ' HG12 ' A' ' 89' ' ' ILE . 57.4 t -76.11 -40.96 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 108.867 -0.79 . . . . 0.40000000000000002 108.867 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.697 ' HG ' ' HB3' ' A' ' 76' ' ' MET . 2.2 mp -57.17 -45.37 83.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.309 -0.859 . . . . 1.25 110.05 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.576 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -56.35 -41.68 87.89 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.746 -0.661 . . . . 0.34000000000000002 112.572 175.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -71.16 -46.41 61.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.979 0.39 . . . . 1.1599999999999999 110.664 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 85' ' ' VAL . 49.0 mm -55.89 -50.86 66.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.76 -0.655 . . . . 0.89000000000000001 110.122 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -65.11 -41.98 94.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 0.34999999999999998 110.658 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -65.2 -32.62 74.39 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.207 -0.451 . . . . 1.3799999999999999 111.45 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.513 HD22 HD12 ' A' ' 122' ' ' LEU . 8.3 mp -86.75 -41.98 13.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.42 -0.354 . . . . 1.53 111.367 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -64.9 -43.22 93.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.464 -0.335 . . . . 0.42999999999999999 111.797 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . 0.508 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 34.4 t70 -84.7 88.59 7.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.536 0.684 . . . . 0.58999999999999997 109.831 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.0 t -83.16 -38.0 14.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.984 -1.007 . . . . 1.49 111.141 -176.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -76.82 -17.25 59.13 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.91 -0.586 . . . . 1.45 110.741 -173.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.505 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 71.8 mmtt 63.16 50.86 2.91 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.571 -0.741 . . . . 2.6699999999999999 111.154 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.401 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 6.8 p-10 -92.91 -16.48 25.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.583 -0.735 . . . . 1.1299999999999999 109.796 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.71 -1.87 66.4 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.745 -0.662 . . . . 0.42999999999999999 112.464 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.803 HD22 ' HA ' ' A' ' 68' ' ' THR . 56.6 mt -128.06 177.75 6.68 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.331 -0.618 . . . . 0.45000000000000001 109.331 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.2 mt -114.56 113.86 24.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.201 0.524 . . . . 0.70999999999999996 110.832 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.478 ' CA ' ' HD3' ' A' ' 66' ' ' LYS . 12.7 t70 -84.81 -177.8 6.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.342 -0.845 . . . . 1.4199999999999999 109.21 173.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -66.62 -35.89 81.28 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.186 0.448 . . . . 1.73 111.719 -170.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -71.92 -42.61 66.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.225 0.536 . . . . 1.53 110.361 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.508 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 19.2 mt-10 -68.05 -45.15 74.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.325 -0.852 . . . . 0.81999999999999995 110.794 -175.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -68.84 -36.51 78.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.032 -0.531 . . . . 0.37 110.908 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.8 -40.81 98.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.903 0.382 . . . . 0.5 110.413 176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.2 mt -66.99 -36.29 81.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.021 -0.536 . . . . 1.3200000000000001 110.545 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.85 -52.34 65.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.26000000000000001 110.455 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -61.42 -39.65 91.53 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.691 0.281 . . . . 1.3600000000000001 110.661 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' HIS . . . . . 0.609 ' O ' HG23 ' A' ' 115' ' ' VAL . 83.5 t60 -59.74 -47.79 84.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.472 . . . . 0.67000000000000004 110.807 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.756 HD13 HD13 ' A' ' 122' ' ' LEU . 96.3 mt -64.53 -41.81 96.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.367 -0.379 . . . . 0.89000000000000001 111.116 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.4 mt -60.75 -40.68 85.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.133 0.492 . . . . 0.46000000000000002 109.713 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.651 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 59.7 tttp -59.31 -42.11 90.61 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.715 -0.675 . . . . 2.0699999999999998 110.428 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 111' ' ' HIS . 25.5 t -56.79 -40.15 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.816 0.341 . . . . 0.5 110.116 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 2.3 mmmp? -60.68 -45.49 93.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 1.25 109.912 175.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.9 -25.2 65.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.555 -0.748 . . . . 0.93999999999999995 111.07 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 45.0 mm-40 -70.85 -21.71 62.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.348 -0.387 . . . . 1.6499999999999999 110.461 176.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 111.62 12.54 14.57 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.0 -0.619 . . . . 0.80000000000000004 112.38 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.563 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 29.6 m-70 -121.4 -179.35 4.04 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.553 -0.536 . . . . 1.0600000000000001 109.553 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.469 ' HA ' ' HD2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -140.44 160.18 40.56 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 110.048 -0.353 . . . . 3.6000000000000001 110.048 174.732 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.756 HD13 HD13 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -92.69 123.94 60.26 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.46 -0.336 . . . . 1.51 110.238 -177.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.38 15.42 0.27 Allowed 'Trans proline' 0 N--CA 1.48 0.695 0 C-N-CA 123.934 3.089 . . . . 1.01 114.229 -169.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 67.01 18.34 10.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.386 0.612 . . . . 0.87 110.489 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.57 147.59 43.55 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.375 -0.829 . . . . 1.9399999999999999 109.506 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.676 ' HB3' ' HB ' ' A' ' 131' ' ' VAL . 96.2 mt -101.31 97.81 8.0 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.574 -0.285 . . . . 0.67000000000000004 110.432 172.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.5 147.97 87.26 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.217 1.945 . . . . 0.75 111.416 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.53 -27.45 25.18 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 123.295 2.663 . . . . 0.70999999999999996 114.173 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -85.01 7.58 20.85 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.061 0.458 . . . . 0.93999999999999995 111.247 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.8 mt -132.39 -31.46 1.41 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.215 -0.448 . . . . 0.82999999999999996 111.327 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.676 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 7.7 p . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 121.117 0.484 . . . . 1.4399999999999999 110.923 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 CA--C 1.52 -0.191 0 CA-C-O 121.208 0.528 . . . . 0.89000000000000001 110.288 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 149' ' ' ASN . . . . . 0.665 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 34.1 t-20 -96.2 114.92 65.19 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.412 -0.813 . . . . 0.42999999999999999 111.101 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 150' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 10.4 Cg_exo -72.08 -2.65 11.9 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.351 2.701 . . . . 0.51000000000000001 113.007 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 151' ' ' PHE . . . . . 0.542 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 68.8 m-85 -107.02 -23.34 12.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.511 0.672 . . . . 0.5 110.333 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 152' ' ' GLU . . . . . 0.665 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 41.7 tt0 . . . . . 0 C--N 1.316 -0.87 0 CA-C-N 114.975 -1.011 . . . . 1.4199999999999999 109.397 -173.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.404 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.48 1.568 0 N-CA-C 112.337 -0.305 . . . . 11.68 112.337 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 4.9 Cg_exo -74.65 102.13 1.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.79 2.327 . . . . 11.24 111.401 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.67 145.3 31.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.955 -0.566 . . . . 8.6199999999999992 110.294 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.86 170.49 54.97 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.159 -0.544 . . . . 6.6399999999999997 113.044 -176.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 p -88.72 125.28 34.79 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.163 -0.31 . . . . 5.8499999999999996 110.163 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -86.71 97.11 10.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.081 0.467 . . . . 4.0099999999999998 110.205 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -101.51 97.46 7.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.858 -0.61 . . . . 3.8599999999999999 109.964 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.0 p -89.19 154.06 3.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.407 -0.815 . . . . 1.8400000000000001 109.879 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.3 pm0 -79.19 87.2 4.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.552 0.691 . . . . 3.02 111.159 -178.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.407 ' HH2' ' HB2' ' A' ' 104' ' ' GLU . 6.2 t90 -82.22 95.32 7.51 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.526 -0.916 . . . . 0.84999999999999998 108.526 174.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.2 m -56.79 -26.06 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.911 -0.586 . . . . 1.24 112.28 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.637 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 40.8 t -62.77 -19.42 23.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.898 0.38 . . . . 1.3 110.829 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.34 -23.38 64.4 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.789 -0.72 . . . . 0.62 111.982 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -84.11 -28.13 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.794 0.807 . . . . 2.9900000000000002 109.314 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.919 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.1 m-20 -84.29 -28.08 27.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.288 -1.324 . . . . 1.8200000000000001 111.455 -175.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 4.2 mmmp? -47.06 -54.73 18.64 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 115.342 1.608 . . . . 0.93000000000000005 115.342 -168.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.5 Cg_endo -50.21 -41.77 49.0 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.279 1.986 . . . . 0.56999999999999995 112.792 -173.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.4 m -70.63 -43.98 68.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.759 -0.655 . . . . 0.67000000000000004 111.026 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.919 ' CE2' ' HB3' ' A' ' 49' ' ' ASP . 16.6 m-85 -76.74 -19.79 57.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.074 -0.512 . . . . 0.92000000000000004 110.229 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.96 -44.65 80.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.894 -0.78 . . . . 1.8600000000000001 108.894 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -61.91 -45.51 93.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.382 -0.826 . . . . 2.0 110.536 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.11 -39.48 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.153 0.501 . . . . 0.53000000000000003 110.58 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.59 -37.23 75.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.625 -0.716 . . . . 0.42999999999999999 110.619 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 7.4 m-85 -75.82 -24.69 55.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 3.0800000000000001 112.11 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.1 p -81.63 -14.95 56.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.575 -0.45 . . . . 0.75 111.393 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.7 mt -90.88 3.92 53.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.444 -0.344 . . . . 1.26 110.75 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.1 t 68.76 84.86 0.14 Allowed Pre-proline 0 C--O 1.232 0.151 0 O-C-N 123.949 0.78 . . . . 1.1100000000000001 111.246 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 56.1 Cg_endo -75.67 110.84 3.17 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.368 2.045 . . . . 0.68999999999999995 112.27 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.22 116.07 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.258 0.552 . . . . 1.4299999999999999 110.195 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 60.31 23.18 12.64 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.608 -0.724 . . . . 2.1499999999999999 111.257 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.26 18.53 60.53 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.959 -0.564 . . . . 0.62 113.645 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 100' ' ' LEU . 37.3 tttt -153.84 125.19 7.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.301 0.551 . . . . 2.2400000000000002 109.765 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.4 pt -85.32 155.46 3.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.159 0.504 . . . . 0.31 110.874 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.49 ' HA ' HD22 ' A' ' 100' ' ' LEU . 73.5 p -87.37 176.19 7.63 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.375 -0.83 . . . . 0.52000000000000002 110.995 -176.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.466 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -66.24 -26.91 72.65 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.847 -0.692 . . . . 0.38 112.468 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.497 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -69.84 -43.62 71.6 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.922 0.391 . . . . 0.40000000000000002 111.145 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -60.92 -51.89 67.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.714 0.769 . . . . 1.73 109.996 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.473 ' HB3' ' HZ3' ' A' ' 90' ' ' TRP . . . -73.54 -24.29 60.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.481 -0.781 . . . . 0.35999999999999999 110.985 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.661 ' HD3' ' HB2' ' B' ' 150' ' ' PRO . 34.0 ttpt -64.1 -46.84 82.47 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.586 -0.446 . . . . 0.60999999999999999 110.278 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.703 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 5.4 ptpp? -71.09 -27.32 63.53 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 120.232 -0.587 . . . . 2.2400000000000002 110.728 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.452 ' HA ' ' NZ ' ' A' ' 78' ' ' LYS . 17.7 tp10 -67.3 -44.12 80.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.228 0.537 . . . . 0.81999999999999995 109.851 174.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.425 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -61.45 -39.57 91.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.427 -0.806 . . . . 1.04 111.674 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 74' ' ' LYS . 19.2 m -73.72 -23.03 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.366 -0.534 . . . . 1.02 110.71 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.703 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 32.6 mtmm -73.17 -24.14 60.52 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.981 0.419 . . . . 3.04 110.147 174.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.2 m -68.84 -16.04 63.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.85999999999999999 111.089 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? 67.59 31.08 6.31 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.441 0.534 . . . . 2.0499999999999998 112.441 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 81' ' ' LEU . 3.6 mm? -97.66 152.92 38.41 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.486 -0.325 . . . . 1.3400000000000001 110.16 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.527 ' O ' HD13 ' A' ' 86' ' ' LEU . 35.5 Cg_exo -57.64 143.12 95.67 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.552 2.168 . . . . 0.62 111.616 174.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -57.38 -34.77 69.19 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.85 0.357 . . . . 0.93999999999999995 111.436 -173.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.0 m -58.6 -38.86 78.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.872 -0.604 . . . . 0.58999999999999997 110.948 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.609 ' O ' HG12 ' A' ' 89' ' ' ILE . 98.6 t -70.21 -39.24 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.81 -0.632 . . . . 0.40000000000000002 109.426 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.527 HD13 ' O ' ' A' ' 82' ' ' PRO . 6.5 mp -57.67 -47.02 83.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.462 -0.79 . . . . 1.25 110.527 178.01 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.564 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -60.67 -39.92 97.28 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.033 -0.603 . . . . 0.34000000000000002 112.401 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -69.96 -45.34 67.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.664 0.269 . . . . 1.1599999999999999 110.604 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 85' ' ' VAL . 46.0 mm -56.64 -47.09 82.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.89000000000000001 110.266 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.473 ' HZ3' ' HB3' ' A' ' 72' ' ' ALA . 22.9 t-105 -64.46 -46.62 82.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.855 -0.611 . . . . 0.34999999999999998 110.906 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -66.32 -24.1 66.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 1.3799999999999999 111.38 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.472 ' O ' HD11 ' A' ' 126' ' ' LEU . 4.3 mm? -86.72 -47.44 9.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.349 -0.387 . . . . 1.53 110.841 173.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.48 -38.16 83.96 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.95 0.722 . . . . 0.42999999999999999 112.95 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.645 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 35.2 t70 -76.59 86.28 3.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.274 0.559 . . . . 0.58999999999999997 109.719 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.0 t -76.62 -25.01 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.648 -0.706 . . . . 1.49 110.786 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.687 ' OD1' ' HE2' ' A' ' 135' ' ' LYS . 67.1 m-20 -70.49 -24.82 62.92 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.606 -0.438 . . . . 1.45 110.871 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 97' ' ' LYS . 41.2 mmtm 56.27 35.78 26.36 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.776 0.798 . . . . 2.6699999999999999 108.997 -170.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.633 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 9.0 p-10 -99.6 -18.72 17.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.486 -1.234 . . . . 1.1299999999999999 110.692 -173.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.72 -6.85 77.34 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.613 -0.803 . . . . 0.42999999999999999 112.777 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . 67.8 mt -117.67 160.15 21.79 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.458 -0.571 . . . . 0.45000000000000001 109.458 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 105' ' ' GLU . 65.0 mt -121.54 113.96 20.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.977 0.417 . . . . 0.70999999999999996 110.321 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.746 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 3.4 p30 -84.29 -176.28 6.18 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.56 -0.904 . . . . 1.4199999999999999 108.56 171.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -63.7 -28.16 69.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.623 0.601 . . . . 1.73 112.623 -170.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.746 ' HG2' ' OD1' ' A' ' 102' ' ' ASP . 13.3 pt-20 -85.42 -39.07 17.95 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 119.841 -0.744 . . . . 1.53 110.704 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.498 ' HB3' HD22 ' A' ' 101' ' ' LEU . 46.0 mt-10 -63.61 -45.84 88.52 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.361 0.601 . . . . 0.81999999999999995 110.27 175.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -64.44 -39.33 93.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.197 -0.91 . . . . 0.37 110.657 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.79 79.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.143 -0.481 . . . . 0.5 110.734 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.2 mt -68.98 -41.42 77.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.623 -0.262 . . . . 1.3200000000000001 110.462 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -54.01 -52.07 61.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.26000000000000001 110.509 174.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -65.6 -39.78 91.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.273 -0.421 . . . . 1.3600000000000001 110.95 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.646 ' O ' HG23 ' A' ' 115' ' ' VAL . 79.1 t60 -57.87 -47.29 83.17 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.534 -0.303 . . . . 0.67000000000000004 110.428 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.469 HD13 HD13 ' A' ' 122' ' ' LEU . 92.5 mt -65.18 -43.3 92.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.526 -0.306 . . . . 0.89000000000000001 111.018 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 109' ' ' ALA . 73.9 mt -56.63 -44.24 80.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 120.989 0.423 . . . . 0.46000000000000002 110.304 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.655 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 62.9 tttp -61.35 -42.87 99.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.898 -0.592 . . . . 2.0699999999999998 110.833 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 111' ' ' HIS . 29.8 t -55.92 -42.02 69.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.889 0.376 . . . . 0.5 110.062 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.603 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 29.1 mmmt -62.61 -43.77 97.98 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.748 -0.66 . . . . 1.25 110.802 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.96 -29.59 70.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.36 -0.382 . . . . 0.93999999999999995 111.494 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 53.9 mm-40 -72.18 -4.77 31.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.24 -0.436 . . . . 1.6499999999999999 110.753 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.34 2.24 56.71 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.851 -0.69 . . . . 0.80000000000000004 112.295 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.603 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 72.3 m-70 -112.33 -178.36 3.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.755 0.312 . . . . 1.0600000000000001 110.177 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.43 156.45 46.96 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.967 0.413 . . . . 3.6000000000000001 110.649 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.469 HD13 HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -80.81 140.25 50.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.691 -0.686 . . . . 1.51 109.271 177.583 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.53 8.09 2.02 Favored 'Trans proline' 0 N--CA 1.476 0.483 0 C-N-CA 122.997 2.465 . . . . 1.01 113.655 -174.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.7 19.15 11.58 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.242 0.544 . . . . 0.87 111.027 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.498 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 39.6 m-20 -120.48 127.38 52.16 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.862 -0.608 . . . . 1.9399999999999999 110.088 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 92' ' ' LEU . 86.6 mt -94.18 97.34 2.17 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.317 -0.401 . . . . 0.67000000000000004 110.284 167.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.695 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 86.0 Cg_endo -83.02 173.03 10.41 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.666 2.244 . . . . 0.75 111.542 175.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.96 -31.32 52.47 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.811 2.34 . . . . 0.70999999999999996 113.225 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -90.8 14.16 14.36 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.759 0.314 . . . . 0.93999999999999995 111.627 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.695 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 31.2 mt -131.06 -28.91 1.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.413 -0.358 . . . . 0.82999999999999996 110.504 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 85.8 t -74.61 120.5 81.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 110.062 -0.347 . . . . 1.4399999999999999 110.062 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -61.81 147.05 96.11 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.381 2.054 . . . . 1.22 111.704 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.427 ' HA ' ' HG2' ' A' ' 136' ' ' ARG . 41.4 Cg_exo -57.85 -24.7 65.61 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.047 2.498 . . . . 1.8600000000000001 112.417 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.8 t -66.91 -20.51 65.92 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.281 -0.418 . . . . 2.0699999999999998 110.912 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.687 ' HE2' ' OD1' ' A' ' 96' ' ' ASP . 3.0 mptt -120.3 26.23 9.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.46 -0.336 . . . . 1.27 111.554 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.427 ' HG2' ' HA ' ' A' ' 133' ' ' PRO . 30.7 mmm180 -92.02 110.18 21.54 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.988 0.423 . . . . 3.0699999999999998 110.65 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -75.14 119.8 19.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.721 -0.672 . . . . 5.46 111.612 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -102.87 126.82 50.17 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.408 -0.59 . . . . 5.7999999999999998 109.408 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 . . . . . 0 C--O 1.251 1.169 0 O-C-N 123.8 0.687 . . . . 6.9299999999999997 110.693 -179.352 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.545 0.212 . . . . 10.57 111.284 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -84.97 -31.84 23.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.636 -0.426 . . . . 8.0399999999999991 111.432 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 14.7 m -72.61 105.41 4.23 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.26 -1.015 . . . . 5.1100000000000003 108.26 172.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 0.462 ' HA ' ' HD3' ' B' ' 147' ' ' PRO . 49.5 mmtm -86.16 107.28 12.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.169 0.509 . . . . 6.7000000000000002 111.041 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 147' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' B' ' 146' ' ' LYS . 6.2 Cg_endo -85.35 15.68 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.382 2.721 . . . . 1.96 112.986 -173.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -98.93 2.32 46.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.253 0.549 . . . . 0.89000000000000001 109.813 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.576 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 53.7 t-20 -114.97 117.76 41.35 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.202 -0.908 . . . . 0.42999999999999999 109.772 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.661 ' HB2' ' HD3' ' A' ' 73' ' ' LYS . 59.1 Cg_endo -72.11 -2.76 12.09 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.955 2.437 . . . . 0.51000000000000001 112.596 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 29.7 m-85 -107.87 5.96 26.93 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.287 -0.634 . . . . 0.5 109.287 175.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 29.0 tt0 -129.51 17.44 5.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.851 -1.068 . . . . 1.4199999999999999 108.508 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.62 86.87 3.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.096 -0.956 . . . . 1.71 111.414 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 72.22 148.93 0.09 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.823 -1.081 . . . . 4.8099999999999996 111.696 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -105.47 -73.07 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 5.9800000000000004 111.362 -173.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -117.8 -25.79 6.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.231 0.539 . . . . 7.1900000000000004 110.301 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.246 0.882 0 CA-C-N 114.828 -1.078 . . . . 7.3200000000000003 108.742 179.653 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.645 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 N-CA-C 112.091 -0.404 . . . . 11.68 112.091 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.32 127.23 11.0 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.577 2.185 . . . . 11.24 111.669 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 89.9 mt -94.0 120.07 33.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.98 0.419 . . . . 8.6199999999999992 111.222 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -105.66 136.62 13.31 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.997 -0.841 . . . . 6.6399999999999997 110.997 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.3 p -79.46 115.48 19.12 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.162 0.506 . . . . 5.8499999999999996 111.717 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -88.15 93.88 9.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.866 -0.606 . . . . 4.0099999999999998 109.484 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -144.81 107.94 4.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.419 -0.809 . . . . 3.8599999999999999 109.582 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.524 HG13 ' HA ' ' A' ' 129' ' ' HIS . 62.5 t -103.06 124.46 57.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.963 -0.562 . . . . 1.8400000000000001 110.776 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.76 105.99 16.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.336 0.589 . . . . 3.02 109.835 174.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -87.59 93.72 9.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.534 0.683 . . . . 0.84999999999999998 109.212 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.87 5.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.148 -0.933 . . . . 1.24 112.827 -173.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.521 HG13 ' HE2' ' A' ' 53' ' ' TYR . 24.6 t -93.95 -17.04 7.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.935 0.398 . . . . 1.3 110.091 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.18 -18.87 71.6 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.506 -0.854 . . . . 0.62 112.67 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -87.18 -26.83 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.917 0.389 . . . . 2.9900000000000002 111.759 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 22.9 m-20 -101.1 -2.71 30.79 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.324 0.583 . . . . 1.8200000000000001 109.878 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.569 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 2.8 tmtp? -55.17 -50.06 88.75 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 114.932 -1.031 . . . . 0.93000000000000005 112.635 -175.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.9 Cg_endo -51.45 -38.63 64.15 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.546 2.164 . . . . 0.56999999999999995 112.095 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 m -69.24 -40.08 78.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.829 -0.623 . . . . 0.67000000000000004 110.716 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.521 ' HE2' HG13 ' A' ' 46' ' ' VAL . 14.5 m-85 -70.33 -24.29 62.97 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.127 0.489 . . . . 0.92000000000000004 109.763 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.67 -44.74 61.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.478 -0.783 . . . . 1.8600000000000001 109.989 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.09 -45.77 90.0 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.6 -0.727 . . . . 2.0 110.388 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.9 mt -64.33 -44.58 97.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 121.207 0.527 . . . . 0.53000000000000003 110.73 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -52.06 -45.19 64.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.495 -0.775 . . . . 0.42999999999999999 111.476 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -81.78 -23.71 36.41 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.36 0.504 . . . . 3.0800000000000001 112.36 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.3 p -75.33 -16.79 60.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.136 0.493 . . . . 0.75 110.627 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 72.4 mt -84.46 -10.0 57.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.893 -0.594 . . . . 1.26 110.307 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.0 m 70.07 93.09 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.314 0 O-C-N 124.161 0.913 . . . . 1.1100000000000001 111.311 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.411 ' HA ' HG22 ' A' ' 67' ' ' ILE . 1.0 OUTLIER -84.23 140.67 8.79 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.654 2.903 . . . . 0.68999999999999995 111.653 178.641 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.2 m -97.37 107.62 20.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.443 0.64 . . . . 1.4299999999999999 110.326 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 63.55 31.22 14.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.194 -0.912 . . . . 2.1499999999999999 111.014 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.15 -0.01 66.09 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.726 -0.75 . . . . 0.62 114.37 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.524 ' HE2' ' HB2' ' A' ' 100' ' ' LEU . 71.8 tttt -137.47 138.21 39.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.755 0.778 . . . . 2.2400000000000002 109.371 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 62' ' ' PRO . 46.2 pt -93.14 156.71 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.632 -0.427 . . . . 0.31 111.102 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.409 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 50.0 p -88.24 -179.65 6.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.512 -0.767 . . . . 0.52000000000000002 110.322 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.81 -14.46 81.48 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.554 -0.831 . . . . 0.38 111.808 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.03 -39.88 28.94 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.947 0.403 . . . . 0.40000000000000002 110.745 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.718 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 5.4 m120 -63.44 -52.22 62.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.981 0.896 . . . . 1.73 109.653 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.458 ' HB3' ' HZ3' ' A' ' 90' ' ' TRP . . . -67.66 -26.45 66.21 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.267 -0.879 . . . . 0.35999999999999999 110.732 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 35.7 ttmt -65.42 -47.79 75.02 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.743 -0.383 . . . . 0.60999999999999999 110.739 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.718 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 19.8 ptmt -64.74 -31.0 72.02 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.928 0.394 . . . . 2.2400000000000002 110.477 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HA ' ' HZ2' ' A' ' 78' ' ' LYS . 17.1 tp10 -71.11 -48.38 52.59 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.251 0.548 . . . . 0.81999999999999995 110.21 175.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.469 ' HB3' HD22 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -58.13 -47.3 83.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.532 -0.758 . . . . 1.04 111.604 -178.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.8 m -67.47 -34.74 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.671 0.272 . . . . 1.02 110.804 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HZ2' ' HA ' ' A' ' 75' ' ' GLU . 3.2 mtpm? -64.38 -18.7 64.92 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 112.282 0.475 . . . . 3.04 112.282 174.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.4 m -84.18 2.32 40.26 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.744 0.307 . . . . 0.85999999999999999 111.127 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? 54.92 50.36 15.74 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.76 0.652 . . . . 2.0499999999999998 112.76 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.632 ' HB2' HD21 ' A' ' 86' ' ' LEU . 96.3 mt -120.49 141.44 32.1 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 110.092 -0.336 . . . . 1.3400000000000001 110.092 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.525 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 37.1 Cg_exo -59.62 151.41 69.93 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.061 2.507 . . . . 0.62 112.82 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -51.41 -45.27 62.5 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.822 -0.627 . . . . 0.93999999999999995 111.77 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.0 m -58.25 -41.39 84.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.01 0.434 . . . . 0.58999999999999997 111.285 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 89' ' ' ILE . 46.2 t -68.88 -42.08 82.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.981 0.42 . . . . 0.40000000000000002 109.881 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' A' ' 81' ' ' LEU . 67.3 mt -62.31 -38.94 91.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.652 -0.704 . . . . 1.25 110.033 177.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.409 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -61.96 -37.22 94.04 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.792 -0.64 . . . . 0.34000000000000002 112.251 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -66.6 -47.06 73.9 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.894 0.378 . . . . 1.1599999999999999 110.034 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 85' ' ' VAL . 38.2 mm -55.08 -50.05 66.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.355 -0.839 . . . . 0.89000000000000001 109.962 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.458 ' HZ3' ' HB3' ' A' ' 72' ' ' ALA . 34.9 t-105 -65.81 -44.5 85.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.919 -0.582 . . . . 0.34999999999999998 111.545 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ttpt -67.46 -21.37 65.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.079 0.466 . . . . 1.3799999999999999 110.738 -174.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.602 HD12 HD12 ' A' ' 122' ' ' LEU . 24.7 mt -91.92 -38.37 12.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.767 -0.651 . . . . 1.53 111.139 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.77 -35.36 67.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.42999999999999999 111.781 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.66 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 22.0 t0 -85.09 82.28 8.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.744 0.783 . . . . 0.58999999999999997 109.289 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.2 t -74.1 -27.68 22.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.072 -0.967 . . . . 1.49 110.951 -173.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 55.3 p30 -86.81 -10.14 54.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.565 -0.289 . . . . 1.45 111.191 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 53.51 51.52 15.1 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.493 0.495 . . . . 2.6699999999999999 110.808 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -111.98 -8.68 14.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.061 -0.518 . . . . 1.1299999999999999 111.089 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.1 4.84 86.42 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.97 -0.633 . . . . 0.42999999999999999 112.529 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.524 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 52.3 mt -129.68 162.53 28.14 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.828 -0.434 . . . . 0.45000000000000001 109.828 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.4 mt -122.66 117.52 25.97 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.801 -0.359 . . . . 0.70999999999999996 110.946 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.05 -178.04 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.419 -0.956 . . . . 1.4199999999999999 108.419 169.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -60.51 -29.23 68.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.892 0.331 . . . . 1.73 111.892 -173.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.78 -42.23 18.18 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.811 -0.356 . . . . 1.53 110.464 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -65.72 -40.44 92.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.22 0.534 . . . . 0.81999999999999995 110.265 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -69.4 -34.48 74.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.678 -0.692 . . . . 0.37 109.998 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.33 -42.25 98.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.329 -0.396 . . . . 0.5 110.284 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 1.8 mm? -59.5 -44.16 93.17 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.713 -0.477 . . . . 1.3200000000000001 109.713 173.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.445 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.58 -54.24 48.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.651 -0.704 . . . . 0.26000000000000001 110.978 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -66.33 -34.88 78.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.736 0.303 . . . . 1.3600000000000001 110.855 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.601 ' O ' HG23 ' A' ' 115' ' ' VAL . 85.4 t60 -63.7 -43.1 97.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.403 -0.362 . . . . 0.67000000000000004 110.282 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 108' ' ' LEU . 96.1 mt -66.62 -39.83 88.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.305 -0.407 . . . . 0.89000000000000001 110.624 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 109' ' ' ALA . 77.9 mt -61.39 -40.35 85.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.499 . . . . 0.46000000000000002 109.951 174.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -59.6 -47.35 85.91 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.74 -0.664 . . . . 2.0699999999999998 110.391 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 111' ' ' HIS . 21.1 t -56.54 -43.93 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.353 0.597 . . . . 0.5 110.263 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.68 -46.97 83.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.04 -0.982 . . . . 1.25 111.041 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.65 -17.24 51.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.93999999999999995 111.384 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -70.01 -8.01 45.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.179 -0.464 . . . . 1.6499999999999999 111.183 175.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.87 23.06 34.01 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.51 -0.853 . . . . 0.80000000000000004 111.402 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 46.9 m80 -129.67 -173.3 2.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.004 0.43 . . . . 1.0600000000000001 110.123 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -134.18 160.08 38.92 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.618 -0.719 . . . . 3.6000000000000001 110.441 -171.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.602 HD12 HD12 ' A' ' 92' ' ' LEU . 0.1 OUTLIER -106.8 115.32 60.6 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 115.039 -0.982 . . . . 1.51 108.806 173.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.07 24.3 0.3 Allowed 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.664 2.909 . . . . 1.01 114.445 -167.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 59.16 25.58 14.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.113 0.482 . . . . 0.87 111.036 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -131.28 138.78 49.43 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.03 -0.532 . . . . 1.9399999999999999 110.047 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.47 ' HB3' ' CG1' ' A' ' 131' ' ' VAL . 96.7 mt -106.14 90.22 4.44 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.623 -0.262 . . . . 0.67000000000000004 110.677 172.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -73.59 158.97 46.85 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.844 2.363 . . . . 0.75 112.33 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.414 ' HA ' HG22 ' A' ' 131' ' ' VAL . 14.7 Cg_endo -57.55 -28.55 81.49 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.47 2.78 . . . . 0.70999999999999996 114.177 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.524 ' HA ' HG13 ' A' ' 42' ' ' VAL . 36.2 p-80 -85.94 6.68 27.42 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.736 -0.385 . . . . 0.93999999999999995 111.605 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 62.0 mt -122.92 -22.97 5.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.519 0.199 . . . . 0.82999999999999996 111.397 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 126' ' ' LEU . 29.3 m -83.68 142.08 42.22 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.741 0.305 . . . . 1.4399999999999999 111.318 -178.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.729 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 24.6 Cg_exo -63.42 136.05 52.93 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.768 2.312 . . . . 1.22 111.627 175.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -59.12 -31.45 95.49 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.746 2.297 . . . . 1.8600000000000001 112.406 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.8 p -66.58 -30.25 70.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.915 -0.584 . . . . 2.0699999999999998 111.309 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.729 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 13.8 mptt -85.99 9.42 17.1 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.973 -0.558 . . . . 1.27 112.041 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -85.47 105.22 15.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.042 0.448 . . . . 3.0699999999999998 111.226 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -108.83 149.05 29.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.784 -0.644 . . . . 5.46 109.731 176.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.558 ' O ' ' HB2' ' A' ' 139' ' ' GLU . 28.8 t60 -94.66 98.2 10.63 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.958 0.355 . . . . 5.7999999999999998 111.958 -174.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 138' ' ' HIS . 21.7 tt0 . . . . . 0 C--O 1.248 0.997 0 O-C-N 124.396 1.06 . . . . 6.9299999999999997 109.12 170.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 109.586 -0.524 . . . . 10.57 109.586 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -143.64 162.95 34.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.504 -0.771 . . . . 8.0399999999999991 109.661 -171.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 47.5 m -66.7 98.58 0.53 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.82 -0.808 . . . . 5.1100000000000003 108.82 171.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' B' ' 148' ' ' TYR . 10.2 tptm -64.23 115.26 18.18 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.629 -0.714 . . . . 6.7000000000000002 111.133 -172.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.29 23.58 0.31 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.079 2.519 . . . . 1.96 112.851 -176.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 148' ' ' TYR . . . . . 0.405 ' H ' ' C ' ' B' ' 146' ' ' LYS . 85.5 m-85 -129.53 -16.25 3.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.975 -0.557 . . . . 0.89000000000000001 110.352 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.438 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 53.2 t-20 -115.96 108.62 46.11 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.42999999999999999 109.795 -175.149 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 12.9 Cg_exo -70.23 -5.95 17.7 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.191 2.594 . . . . 0.51000000000000001 112.65 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 29.6 m-85 -107.01 -4.43 19.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.918 0.39 . . . . 0.5 110.221 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.438 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 30.6 tt0 -108.88 22.9 15.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.879 0.847 . . . . 1.4199999999999999 108.926 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -75.22 -72.86 0.28 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.891 -1.05 . . . . 1.71 110.402 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 45.82 -100.41 0.05 OUTLIER 'General case' 0 C--O 1.235 0.297 0 O-C-N 124.125 0.891 . . . . 4.8099999999999996 112.579 -177.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -167.29 -171.87 1.84 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.058 -0.349 . . . . 5.9800000000000004 110.058 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -79.72 84.82 5.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.224 0.535 . . . . 7.1900000000000004 110.228 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 27.7 t70 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.434 -0.793 . . . . 7.3200000000000003 109.975 -179.079 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.66 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.484 1.84 0 N-CA-C 112.349 -0.3 . . . . 11.68 112.349 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.456 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 9.3 Cg_exo -73.8 107.47 2.42 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.625 2.217 . . . . 11.24 111.452 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.63 149.55 27.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.301 -0.409 . . . . 8.6199999999999992 110.91 -177.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.79 71.2 2.76 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.564 -0.827 . . . . 6.6399999999999997 112.099 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.9 m -132.95 113.89 13.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.831 -0.433 . . . . 5.8499999999999996 109.831 175.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -105.17 102.9 12.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.606 0.717 . . . . 4.0099999999999998 111.486 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -87.43 135.5 33.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.285 -0.87 . . . . 3.8599999999999999 108.82 171.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 52.6 t -76.54 113.1 15.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.025 0.44 . . . . 1.8400000000000001 110.821 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -115.33 136.62 52.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.858 -0.61 . . . . 3.02 109.716 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -81.83 104.58 12.31 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.013 -1.106 . . . . 0.84999999999999998 108.013 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.537 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 90.6 t -56.51 -29.56 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.843 -0.617 . . . . 1.24 112.229 -171.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' A' ' 111' ' ' HIS . 18.9 m -77.69 -13.36 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 122.179 -0.326 . . . . 1.3 111.109 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.821 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -65.09 -24.46 70.34 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.063 -0.589 . . . . 0.62 112.255 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 18.5 ptpt -87.17 0.34 55.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.746 0.307 . . . . 2.9900000000000002 111.234 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -138.71 21.24 2.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.694 0.759 . . . . 1.8200000000000001 109.767 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.821 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 5.0 mmmp? -57.86 -40.15 81.56 Favored Pre-proline 0 C--O 1.22 -0.484 0 CA-C-N 115.353 -0.84 . . . . 0.93000000000000005 112.491 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 8.9 Cg_endo -50.35 -42.26 48.52 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 122.308 2.005 . . . . 0.56999999999999995 112.527 176.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.7 m -69.59 -44.05 71.55 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.12 -0.491 . . . . 0.67000000000000004 110.295 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -71.18 -22.65 62.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.953 -0.567 . . . . 0.92000000000000004 110.416 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.71 -45.53 29.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.893 -0.781 . . . . 1.8600000000000001 108.893 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.69 -54.07 43.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.3 -0.864 . . . . 2.0 110.629 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.2 mt -64.88 -44.52 96.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.234 -0.439 . . . . 0.53000000000000003 111.435 -176.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.43 ' HE1' HG12 ' A' ' 67' ' ' ILE . 51.2 t80 -58.56 -44.18 89.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.42999999999999999 110.79 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 13.1 m-85 -76.34 -24.33 54.25 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.122 0.416 . . . . 3.0800000000000001 112.122 -177.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 p -76.3 -15.97 59.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.025 0.44 . . . . 0.75 111.035 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mp -88.29 -4.25 58.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.979 -0.555 . . . . 1.26 110.516 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m 69.29 89.32 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.314 0 CA-C-N 115.232 -0.895 . . . . 1.1100000000000001 111.735 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 58.7 Cg_endo -86.65 117.01 1.4 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.705 2.27 . . . . 0.68999999999999995 112.747 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.1 t -91.45 132.79 34.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.258 -0.645 . . . . 1.4299999999999999 109.258 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 49.48 23.71 0.96 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.726 0.81 . . . . 2.1499999999999999 112.108 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.78 6.75 61.95 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.073 -0.584 . . . . 0.62 113.403 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -135.74 155.58 50.15 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.673 0.749 . . . . 2.2400000000000002 112.316 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.43 HG12 ' HE1' ' A' ' 57' ' ' PHE . 41.3 pt -114.13 152.82 15.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.749 -1.114 . . . . 0.31 108.775 171.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -88.0 175.65 7.67 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 120.449 -0.501 . . . . 0.52000000000000002 110.23 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.94 -27.25 71.0 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.641 -0.79 . . . . 0.38 112.528 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.63 -48.36 82.13 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.954 0.407 . . . . 0.40000000000000002 111.915 -176.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -71.8 -40.78 68.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.282 0.563 . . . . 1.73 110.571 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -72.07 -28.79 63.55 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.465 -0.494 . . . . 0.35999999999999999 110.095 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.416 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 40.7 ttmt -64.79 -50.15 67.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.725 -0.216 . . . . 0.60999999999999999 110.533 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -62.18 -38.22 88.27 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.508 -0.315 . . . . 2.2400000000000002 110.58 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.93 -50.64 72.96 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.423 0.63 . . . . 0.81999999999999995 110.22 174.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.828 ' HB3' HD22 ' A' ' 86' ' ' LEU . 22.8 mmt -58.52 -45.24 89.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.528 -0.76 . . . . 1.04 112.197 -177.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.87 -16.6 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.946 0.403 . . . . 1.02 110.796 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -91.19 -5.76 54.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.169 -0.469 . . . . 3.04 111.063 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 7.1 t -89.54 -1.18 57.95 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.271 0.558 . . . . 0.85999999999999999 110.135 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 79' ' ' SER . 9.1 mptt 70.82 16.61 6.61 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.236 0.828 . . . . 2.0499999999999998 113.236 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.537 ' HB2' HD21 ' A' ' 86' ' ' LEU . 2.6 mm? -91.29 142.85 27.49 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.574 -0.45 . . . . 1.3400000000000001 111.124 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.588 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 21.3 Cg_exo -65.49 154.87 71.77 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.263 2.642 . . . . 0.62 112.474 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -56.12 -41.23 74.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.223 -0.444 . . . . 0.93999999999999995 111.55 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 7.9 m -58.21 -48.25 80.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.218 0.532 . . . . 0.58999999999999997 110.938 178.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.576 ' O ' HG12 ' A' ' 89' ' ' ILE . 96.4 t -63.57 -42.06 94.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.731 -0.668 . . . . 0.40000000000000002 110.479 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.828 HD22 ' HB3' ' A' ' 76' ' ' MET . 79.0 mt -61.92 -44.06 97.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.062 -0.517 . . . . 1.25 110.762 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.413 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -59.7 -31.63 71.85 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 121.027 -0.606 . . . . 0.34000000000000002 112.308 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 84' ' ' THR . 55.4 mtpt -72.66 -46.56 53.26 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.747 0.308 . . . . 1.1599999999999999 110.479 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 85' ' ' VAL . 43.5 mm -55.53 -52.08 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.66 -0.7 . . . . 0.89000000000000001 109.899 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -63.78 -39.49 94.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.983 -0.553 . . . . 0.34999999999999998 110.841 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -59.72 -35.62 74.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.773 0.32 . . . . 1.3799999999999999 111.194 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.444 ' O ' HD11 ' A' ' 126' ' ' LEU . 6.3 mp -88.75 -34.6 17.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.146 -0.479 . . . . 1.53 111.343 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.21 -42.71 65.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.967 0.413 . . . . 0.42999999999999999 111.757 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.628 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 24.9 t70 -89.33 91.11 8.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.385 0.612 . . . . 0.58999999999999997 109.545 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.474 HG21 ' HG2' ' A' ' 135' ' ' LYS . 34.0 m -82.48 -29.78 9.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.118 -0.946 . . . . 1.49 112.204 -171.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -86.99 -13.11 45.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.665 -0.243 . . . . 1.45 111.151 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.565 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 17.0 mmmt 57.84 45.07 19.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.847 -0.615 . . . . 2.6699999999999999 110.718 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.54 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 11.4 p-10 -93.29 -13.22 28.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.612 -0.722 . . . . 1.1299999999999999 110.965 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.63 5.47 74.76 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.797 -0.716 . . . . 0.42999999999999999 111.993 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.54 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 30.9 mt -128.27 166.27 18.91 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.241 -0.281 . . . . 0.45000000000000001 110.241 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.0 mt -122.35 119.85 32.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.322 -0.399 . . . . 0.70999999999999996 110.157 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -95.79 -175.86 3.55 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.168 -0.678 . . . . 1.4199999999999999 109.168 171.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.34 -33.64 67.95 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.835 0.35 . . . . 1.73 111.495 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.96 -56.56 4.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.278 -0.419 . . . . 1.53 110.28 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.453 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 25.6 mt-10 -59.27 -37.0 76.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.732 -0.667 . . . . 0.81999999999999995 111.096 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -71.23 -35.28 71.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.417 -0.356 . . . . 0.37 110.865 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.63 -38.32 90.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.735 0.302 . . . . 0.5 110.436 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.39 -41.03 96.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 1.3200000000000001 110.12 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.06 -52.48 64.1 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.765 -0.652 . . . . 0.26000000000000001 110.941 177.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -68.07 -30.1 69.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.452 . . . . 1.3600000000000001 111.355 -176.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.561 ' HB2' HG12 ' A' ' 46' ' ' VAL . 83.9 t60 -62.02 -45.86 91.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.776 0.322 . . . . 0.67000000000000004 110.377 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.6 mt -68.87 -41.55 78.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.872 -0.604 . . . . 0.89000000000000001 110.856 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 109' ' ' ALA . 78.1 mt -61.17 -39.97 84.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.951 -0.568 . . . . 0.46000000000000002 110.034 176.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.606 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 32.3 tttm -56.26 -50.4 71.45 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.93 -0.577 . . . . 2.0699999999999998 110.606 175.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 111' ' ' HIS . 46.0 t -51.34 -39.11 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.101 -0.5 . . . . 0.5 111.145 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -68.58 -30.39 69.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.722 0.296 . . . . 1.25 111.469 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 86.1 mt -72.4 -34.55 67.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.97 0.414 . . . . 0.93999999999999995 110.07 174.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 41.7 mm-40 -68.4 -25.96 65.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.884 -0.598 . . . . 1.6499999999999999 109.611 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.52 35.08 4.5 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.604 -0.726 . . . . 0.80000000000000004 112.802 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -132.99 173.55 11.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.066 0.433 . . . . 1.0600000000000001 110.638 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.88 156.14 20.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.862 -0.608 . . . . 3.6000000000000001 109.985 -177.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.26 135.18 24.65 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.546 -0.538 . . . . 1.51 109.546 176.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.36 4.66 4.22 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.013 2.476 . . . . 1.01 113.726 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 65.33 19.65 11.69 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.488 0.492 . . . . 0.87 111.425 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -131.27 148.63 52.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.048 -0.524 . . . . 1.9399999999999999 110.126 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 92' ' ' LEU . 79.1 mt -109.05 108.81 60.78 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.867 -0.606 . . . . 0.67000000000000004 110.38 173.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.647 ' HD2' HD12 ' A' ' 130' ' ' LEU . 26.4 Cg_exo -61.03 154.06 59.67 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.592 2.195 . . . . 0.75 111.662 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.461 ' HA ' HG22 ' A' ' 131' ' ' VAL . 32.5 Cg_endo -64.49 -4.93 9.04 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.811 2.341 . . . . 0.70999999999999996 113.116 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -100.94 4.03 42.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.981 0.419 . . . . 0.93999999999999995 110.38 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.647 HD12 ' HD2' ' A' ' 127' ' ' PRO . 35.5 mt -116.21 -8.3 11.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.82999999999999996 111.095 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 128' ' ' PRO . 27.0 m -103.92 123.14 42.03 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.433 0.635 . . . . 1.4399999999999999 110.267 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.18 156.85 63.61 Favored 'Trans proline' 0 C--N 1.33 -0.399 0 C-N-CA 122.926 2.417 . . . . 1.22 111.453 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.509 ' HA ' ' HB2' ' A' ' 136' ' ' ARG . 32.1 Cg_exo -58.66 -21.38 55.38 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.96 2.44 . . . . 1.8600000000000001 112.112 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.6 t -60.21 -26.95 66.79 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.666 -0.697 . . . . 2.0699999999999998 110.799 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.474 ' HG2' HG21 ' A' ' 95' ' ' VAL . 10.4 mptt -112.46 14.22 20.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.998 0.427 . . . . 1.27 110.785 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 133' ' ' PRO . 50.9 mtp180 -111.47 151.61 28.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.099 0.476 . . . . 3.0699999999999998 111.772 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.83 130.13 41.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.728 -0.669 . . . . 5.46 110.021 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -101.71 131.66 47.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.885 0.374 . . . . 5.7999999999999998 110.79 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--O 1.25 1.085 0 N-CA-C 109.07 -0.715 . . . . 6.9299999999999997 109.07 171.84 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 51.4 tp . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.704 0.288 . . . . 10.57 110.759 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 144' ' ' GLU . . . . . 0.428 ' HB3' ' HG3' ' B' ' 146' ' ' LYS . 42.8 mt-10 -99.9 134.89 42.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.666 0.27 . . . . 8.0399999999999991 110.881 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 5.6 p -75.72 -55.75 5.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.969 -0.56 . . . . 5.1100000000000003 109.992 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 0.428 ' HG3' ' HB3' ' B' ' 144' ' ' GLU . 67.3 mttm 58.58 79.54 0.31 Allowed Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.331 -0.85 . . . . 6.7000000000000002 111.627 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 147' ' ' PRO . . . . . 0.428 ' CG ' ' HA ' ' B' ' 153' ' ' GLU . 81.1 Cg_endo -77.75 170.89 18.3 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.498 2.132 . . . . 1.96 112.351 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -120.7 33.1 5.7 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.109 -0.496 . . . . 0.89000000000000001 110.27 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.698 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 55.9 t-20 -138.52 116.17 9.17 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.474 -0.785 . . . . 0.42999999999999999 109.39 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.462 ' HA ' ' OE1' ' B' ' 153' ' ' GLU . 23.1 Cg_exo -66.1 -14.48 44.59 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 123.442 2.761 . . . . 0.51000000000000001 113.362 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.672 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 17.9 m-85 -107.33 -1.62 21.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.498 0.666 . . . . 0.5 110.133 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.698 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 42.4 tt0 -133.92 23.64 3.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.673 -1.149 . . . . 1.4199999999999999 108.39 -175.721 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 153' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' B' ' 150' ' ' PRO . 8.5 pt-20 -80.46 -13.51 59.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.9 -1.045 . . . . 1.71 111.12 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 57.37 -154.3 0.35 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.013 -0.539 . . . . 4.8099999999999996 111.643 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -116.07 -68.35 0.93 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.558 -0.292 . . . . 5.9800000000000004 110.598 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -141.16 58.79 1.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.852 -0.796 . . . . 7.1900000000000004 108.852 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 C--O 1.246 0.881 0 CA-C-N 115.182 -0.917 . . . . 7.3200000000000003 110.977 -172.718 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.628 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 111.533 -0.627 . . . . 11.68 111.533 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.69 141.73 13.86 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.465 2.11 . . . . 11.24 111.827 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.8 mp -115.0 147.88 39.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.245 -0.434 . . . . 8.6199999999999992 110.383 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -131.34 136.95 9.11 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.471 -0.652 . . . . 6.6399999999999997 111.471 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.7 m -77.91 134.52 37.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.852 0.358 . . . . 5.8499999999999996 110.171 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -77.0 134.48 38.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.096 -0.502 . . . . 4.0099999999999998 111.07 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -119.8 107.6 13.38 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.181 -0.463 . . . . 3.8599999999999999 109.921 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.0 t -101.34 118.93 48.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.277 -0.419 . . . . 1.8400000000000001 110.676 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -89.97 125.77 35.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.195 -0.457 . . . . 3.02 109.981 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -75.02 104.52 5.63 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.587 -0.894 . . . . 0.84999999999999998 108.587 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.1 t -54.82 -32.25 25.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.951 -0.568 . . . . 1.24 111.164 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 45.2 t -79.04 -15.21 13.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.93 -0.577 . . . . 1.3 111.321 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.83 -23.88 71.11 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.798 -0.715 . . . . 0.62 111.813 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -87.09 -16.02 36.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 122.304 1.049 . . . . 2.9900000000000002 109.881 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.461 ' HB2' ' HA ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -104.84 -11.74 16.61 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.433 -1.712 . . . . 1.8200000000000001 110.893 -163.691 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 3.6 mmmp? -57.79 -55.81 41.09 Favored Pre-proline 0 C--O 1.224 -0.281 0 N-CA-C 114.521 1.304 . . . . 0.93000000000000005 114.521 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 10.5 Cg_endo -48.8 -37.88 36.62 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.73 2.287 . . . . 0.56999999999999995 113.44 -168.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.547 ' O ' HG13 ' A' ' 56' ' ' ILE . 16.8 m -71.29 -44.39 65.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.059 -0.519 . . . . 0.67000000000000004 110.88 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.44 ' HE2' ' HB3' ' A' ' 49' ' ' ASP . 12.2 m-85 -78.26 -22.32 48.49 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.085 -0.507 . . . . 0.92000000000000004 109.992 -176.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -71.96 -42.07 66.98 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.108 -0.701 . . . . 1.8600000000000001 109.108 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -53.41 -52.83 58.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.125 -0.943 . . . . 2.0 109.898 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 52' ' ' THR . 15.8 mt -67.84 -31.33 51.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.109 -0.95 . . . . 0.53000000000000003 110.637 -178.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -59.91 -37.38 79.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.765 -0.652 . . . . 0.42999999999999999 110.774 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -70.83 -24.94 62.64 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.771 0.285 . . . . 3.0800000000000001 111.771 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 p -86.23 -5.68 59.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.848 0.356 . . . . 0.75 111.399 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.486 HD11 ' OE1' ' A' ' 75' ' ' GLU . 8.8 mp -96.19 5.19 51.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.978 0.418 . . . . 1.26 110.086 175.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m 64.71 86.15 0.14 Allowed Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 115.074 -0.966 . . . . 1.1100000000000001 111.567 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.28 115.24 4.19 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.103 2.535 . . . . 0.68999999999999995 112.192 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.5 t -89.28 113.48 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.601 -0.518 . . . . 1.4299999999999999 109.601 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 65.09 22.65 12.35 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.012 -0.54 . . . . 2.1499999999999999 110.296 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.02 19.12 59.81 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.903 -0.59 . . . . 0.62 112.408 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 100' ' ' LEU . 32.4 tttp -144.2 131.79 21.13 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.652 -0.499 . . . . 2.2400000000000002 109.652 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 101' ' ' LEU . 38.9 pt -92.71 152.54 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.36 -0.536 . . . . 0.31 111.078 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.454 ' HA ' HD22 ' A' ' 100' ' ' LEU . 37.6 p -85.07 160.46 19.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.721 -0.672 . . . . 0.52000000000000002 110.982 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.416 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -61.18 -29.71 71.89 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.153 -0.546 . . . . 0.38 112.596 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.9 -50.57 72.12 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.029 0.442 . . . . 0.40000000000000002 111.634 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.47 ' HA ' ' HG2' ' A' ' 74' ' ' LYS . 40.1 m-80 -74.69 -37.01 62.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.897 -0.592 . . . . 1.73 110.954 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.39 -27.5 65.35 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.378 -0.374 . . . . 0.35999999999999999 110.458 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.561 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 38.8 ttpt -72.6 -49.54 31.43 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.537 -0.301 . . . . 0.60999999999999999 111.094 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 71' ' ' ASN . 20.2 ptmt -59.82 -36.86 77.65 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 121.132 -0.227 . . . . 2.2400000000000002 110.481 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.486 ' OE1' HD11 ' A' ' 60' ' ' LEU . 17.3 tp10 -61.46 -52.46 64.44 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.492 0.663 . . . . 0.81999999999999995 110.142 175.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.756 ' HG2' ' HG ' ' A' ' 86' ' ' LEU . 17.5 ttm -67.64 -27.47 66.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.426 -0.806 . . . . 1.04 111.376 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.55 -40.46 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 116.432 -0.349 . . . . 1.02 110.231 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -73.36 -8.89 57.78 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.226 -0.443 . . . . 3.04 110.742 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 7.4 t -73.31 -12.63 60.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.191 -0.459 . . . . 0.85999999999999999 110.447 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 79' ' ' SER . 45.3 mmtm 73.5 26.67 1.94 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.411 0.685 . . . . 2.0499999999999998 112.608 178.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.81 144.27 27.86 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.518 -0.549 . . . . 1.3400000000000001 109.518 172.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.587 ' O ' HD13 ' A' ' 86' ' ' LEU . 12.6 Cg_endo -60.23 139.06 85.15 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.814 2.343 . . . . 0.62 112.563 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.456 ' HA ' HD22 ' A' ' 86' ' ' LEU . 15.9 m120 -51.83 -35.03 43.05 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.031 0.532 . . . . 0.93999999999999995 112.164 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.497 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 2.7 m -57.64 -40.73 79.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.383 0.611 . . . . 0.58999999999999997 110.634 177.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.588 ' O ' HG12 ' A' ' 89' ' ' ILE . 66.8 t -74.19 -38.71 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.041 -0.726 . . . . 0.40000000000000002 109.041 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.756 ' HG ' ' HG2' ' A' ' 76' ' ' MET . 5.1 mp -58.77 -45.72 89.14 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.992 -1.003 . . . . 1.25 110.321 176.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.54 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -59.46 -39.68 95.21 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.528 -0.76 . . . . 0.34000000000000002 112.001 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 84' ' ' THR . 55.4 mtpt -71.09 -43.95 66.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.751 0.31 . . . . 1.1599999999999999 110.349 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 85' ' ' VAL . 45.0 mm -57.3 -47.44 84.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.89000000000000001 110.201 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.416 ' CH2' ' HA2' ' A' ' 69' ' ' GLY . 15.3 t-105 -66.7 -41.42 88.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 0.34999999999999998 110.398 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -64.86 -22.49 67.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.164 -0.471 . . . . 1.3799999999999999 111.101 -175.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.519 HD12 ' HG ' ' A' ' 126' ' ' LEU . 4.0 mm? -93.29 -41.63 9.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 1.53 111.018 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.14 88.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.563 -0.29 . . . . 0.42999999999999999 111.648 -176.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.62 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 41.6 t0 -83.51 75.52 10.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.371 -0.603 . . . . 0.58999999999999997 109.371 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.4 t -67.93 -34.72 68.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.369 -0.832 . . . . 1.49 110.987 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.627 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.7 OUTLIER -82.81 -15.37 51.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.407 -0.815 . . . . 1.45 111.866 -175.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 60.66 72.48 0.52 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.515 0.509 . . . . 2.6699999999999999 111.63 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p30 -129.26 -14.43 4.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.007 -0.542 . . . . 1.1299999999999999 111.328 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.13 4.34 84.22 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.347 -0.93 . . . . 0.42999999999999999 112.234 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 68' ' ' THR . 67.7 mt -127.88 160.48 31.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.447 -0.575 . . . . 0.45000000000000001 109.447 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 105' ' ' GLU . 51.6 mt -124.28 118.32 26.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.804 0.335 . . . . 0.70999999999999996 110.565 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -82.84 -175.25 5.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.062 -0.718 . . . . 1.4199999999999999 109.062 167.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -61.67 -31.23 71.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.643 0.259 . . . . 1.73 111.115 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.435 ' CD ' ' HG2' ' A' ' 132' ' ' PRO . 11.1 tt0 -72.11 -57.43 4.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.446 -0.343 . . . . 1.53 110.183 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.67 ' OE1' 'CA ' ' A' ' 141' ' ' ' CA' . 32.0 mt-10 -56.06 -44.63 79.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.075 -0.512 . . . . 0.81999999999999995 111.04 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -66.9 -38.24 85.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.898 -0.592 . . . . 0.37 110.954 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.28 85.14 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.943 -0.303 . . . . 0.5 110.632 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.12 -43.83 95.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.99 -0.374 . . . . 1.3200000000000001 109.99 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.33 -58.03 8.51 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.041 -0.527 . . . . 0.26000000000000001 111.069 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -67.29 -33.23 74.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.436 . . . . 1.3600000000000001 111.319 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.657 ' O ' HG23 ' A' ' 115' ' ' VAL . 77.3 t60 -64.17 -45.89 86.42 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 120.699 -0.4 . . . . 0.67000000000000004 109.991 176.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.428 ' HB3' HD12 ' A' ' 89' ' ' ILE . 75.0 mt -60.95 -41.46 96.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.59 0.233 . . . . 0.89000000000000001 111.063 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.96 -45.28 95.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.339 -0.391 . . . . 0.46000000000000002 110.196 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.475 ' HE2' ' OE2' ' A' ' 118' ' ' GLU . 86.8 tttt -64.86 -35.85 82.47 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.897 -0.321 . . . . 2.0699999999999998 110.795 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 111' ' ' HIS . 95.9 t -53.77 -44.27 58.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.359 -0.608 . . . . 0.5 109.359 173.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -66.83 -42.85 85.11 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.403 -0.817 . . . . 1.25 111.405 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.44 -27.27 64.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.334 -0.394 . . . . 0.93999999999999995 111.605 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.475 ' OE2' ' HE2' ' A' ' 114' ' ' LYS . 34.1 mt-10 -75.84 -6.98 53.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.306 -0.406 . . . . 1.6499999999999999 111.469 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.39 17.8 35.44 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.407 -0.901 . . . . 0.80000000000000004 112.327 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.462 ' HB2' ' CG1' ' A' ' 115' ' ' VAL . 11.5 m-70 -109.86 176.32 5.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.459 -0.571 . . . . 1.0600000000000001 109.459 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -139.63 130.77 26.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.876 0.369 . . . . 3.6000000000000001 111.275 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.72 126.32 88.63 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.296 -0.631 . . . . 1.51 109.296 173.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.67 13.87 1.57 Allowed 'Trans proline' 0 N--CA 1.474 0.343 0 C-N-CA 123.202 2.601 . . . . 1.01 113.748 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 66.38 19.52 10.96 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.403 0.62 . . . . 0.87 110.719 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -111.7 137.2 49.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.566 -0.743 . . . . 1.9399999999999999 109.433 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.519 ' HG ' HD12 ' A' ' 92' ' ' LEU . 92.3 mt -100.94 90.07 1.44 Allowed Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 110.193 -0.299 . . . . 0.67000000000000004 110.193 168.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 130' ' ' LEU . 43.9 Cg_endo -71.17 155.02 61.74 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.298 1.999 . . . . 0.75 111.713 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.25 -10.15 20.08 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 123.275 2.65 . . . . 0.70999999999999996 113.583 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -92.8 1.06 57.48 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.134 0.492 . . . . 0.93999999999999995 110.386 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.475 HD12 ' HD2' ' A' ' 127' ' ' PRO . 66.2 mt -117.34 -35.31 4.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.82999999999999996 110.571 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 92.6 t -88.75 124.03 66.46 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.088 -0.505 . . . . 1.4399999999999999 111.478 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.435 ' HG2' ' CD ' ' A' ' 104' ' ' GLU . 18.5 Cg_exo -67.86 153.85 74.48 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.885 2.39 . . . . 1.22 111.43 172.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.683 ' HA ' ' HB2' ' A' ' 136' ' ' ARG . 61.3 Cg_endo -67.85 11.28 0.25 Allowed 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 123.594 2.862 . . . . 1.8600000000000001 113.51 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.7 p -75.85 -33.94 60.04 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.96 0.409 . . . . 2.0699999999999998 110.709 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.91 20.89 12.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.251 0.548 . . . . 1.27 110.706 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.683 ' HB2' ' HA ' ' A' ' 133' ' ' PRO . 78.8 mtp180 -104.07 149.99 24.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.581 -0.736 . . . . 3.0699999999999998 109.612 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -87.74 160.98 17.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.934 0.397 . . . . 5.46 110.608 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -109.01 114.87 28.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.961 -0.563 . . . . 5.7999999999999998 110.635 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.274 -0.87 . . . . 6.9299999999999997 109.805 175.995 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 143' ' ' LEU . . . . . 0.435 ' N ' HD22 ' B' ' 143' ' ' LEU . 1.3 mm? . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.24 -0.652 . . . . 10.57 109.24 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -119.84 156.58 30.4 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.517 -0.765 . . . . 8.0399999999999991 110.331 -168.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 13.6 p -108.81 127.28 53.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.103 -0.499 . . . . 5.1100000000000003 110.88 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' B' ' 147' ' ' PRO . 16.5 ttmm -108.25 111.46 61.72 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.459 -0.571 . . . . 6.7000000000000002 109.459 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 147' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 146' ' ' LYS . 4.0 Cg_exo -78.11 -167.21 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.248 2.632 . . . . 1.96 113.454 -176.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -83.74 -3.99 58.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.216 -0.902 . . . . 0.89000000000000001 110.571 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.591 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 47.5 t-20 -96.86 112.88 61.79 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.591 -0.731 . . . . 0.42999999999999999 110.055 -174.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.479 ' HB2' ' HD3' ' A' ' 73' ' ' LYS . 56.7 Cg_endo -70.47 -9.17 25.3 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.008 2.472 . . . . 0.51000000000000001 112.616 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 31.4 m-85 -96.84 -7.99 32.12 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.129 -0.693 . . . . 0.5 109.129 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.591 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 28.3 tt0 -115.2 28.06 8.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.002 -0.999 . . . . 1.4199999999999999 109.508 -175.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -72.49 82.56 1.09 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.426 -0.806 . . . . 1.71 110.674 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 154' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' B' ' 155' ' ' GLU . 15.8 mt-10 73.17 174.46 0.28 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.608 -0.724 . . . . 4.8099999999999996 111.959 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 155' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' B' ' 154' ' ' GLU . 47.9 mm-40 72.2 151.18 0.11 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.14 -0.936 . . . . 5.9800000000000004 113.189 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 69.3 107.14 0.06 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.328 -1.305 . . . . 7.1900000000000004 112.158 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 114.933 -1.03 . . . . 7.3200000000000003 109.169 175.942 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.67 'CA ' ' OE1' ' A' ' 105' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 112.054 -0.418 . . . . 11.68 112.054 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.36 142.92 30.69 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.865 2.377 . . . . 11.24 112.29 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.2 mp -96.69 121.51 38.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.044 -0.526 . . . . 8.6199999999999992 109.999 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.57 159.58 27.18 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.756 -0.735 . . . . 6.6399999999999997 112.187 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.4 m -106.77 143.31 35.05 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.245 -0.28 . . . . 5.8499999999999996 110.245 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.86 118.7 19.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.209 -0.451 . . . . 4.0099999999999998 109.982 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -88.06 117.99 27.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.519 0.676 . . . . 3.8599999999999999 111.324 -175.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.03 114.93 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.499 -0.773 . . . . 1.8400000000000001 110.23 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -85.42 137.92 32.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.86 0.362 . . . . 3.02 110.603 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -75.19 104.88 5.94 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.969 -0.752 . . . . 0.84999999999999998 108.969 175.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.6 t -55.63 -47.25 79.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.023 -0.535 . . . . 1.24 112.434 -172.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.582 HG23 ' HE2' ' A' ' 53' ' ' TYR . 2.7 p -69.31 -22.04 25.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.392 0.615 . . . . 1.3 110.77 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.822 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -67.65 -11.96 60.95 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.422 -0.808 . . . . 0.62 112.082 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -80.59 -27.7 37.31 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.943 -0.391 . . . . 2.9900000000000002 109.943 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.412 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 63.2 m-20 -100.4 10.55 41.05 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.839 -0.619 . . . . 1.8200000000000001 110.0 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.822 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 15.8 mmmt -52.58 -55.46 32.21 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 114.371 1.248 . . . . 0.93000000000000005 114.371 -171.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 10.6 Cg_endo -51.3 -37.36 59.95 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.532 2.155 . . . . 0.56999999999999995 112.808 -174.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.447 ' O ' HG13 ' A' ' 56' ' ' ILE . 8.6 m -69.99 -43.1 72.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.82 -0.627 . . . . 0.67000000000000004 110.34 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.582 ' HE2' HG23 ' A' ' 46' ' ' VAL . 13.9 m-30 -73.92 -23.21 59.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.365 -0.38 . . . . 0.92000000000000004 110.436 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.482 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 22.4 m-20 -69.29 -45.48 69.5 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.237 0.541 . . . . 1.8600000000000001 109.586 176.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -60.82 -38.91 87.06 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.121 -0.945 . . . . 2.0 110.892 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 52' ' ' THR . 62.7 mt -68.95 -40.96 81.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.53000000000000003 110.568 176.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -55.82 -39.68 71.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.42999999999999999 111.243 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.482 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 48.9 m-85 -75.92 -13.58 60.25 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.763 0.653 . . . . 3.0800000000000001 112.763 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 64.1 p -73.93 -18.55 60.88 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.179 -0.608 . . . . 0.75 110.824 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 2.0 mm? -87.12 -9.34 55.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.418 -0.356 . . . . 1.26 110.895 175.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.6 t 67.91 94.05 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.25 0 O-C-N 123.905 0.753 . . . . 1.1100000000000001 110.758 -176.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.37 134.51 42.18 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 123.009 2.473 . . . . 0.68999999999999995 112.992 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.2 t -107.96 123.54 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 108.881 -0.785 . . . . 1.4299999999999999 108.881 177.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 45.33 33.72 1.31 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.452 0.701 . . . . 2.1499999999999999 112.499 -175.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.98 -3.4 67.09 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.053 -0.594 . . . . 0.62 114.448 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -137.87 170.25 16.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.812 0.806 . . . . 2.2400000000000002 110.692 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.7 pt -114.7 155.24 15.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.79 -0.364 . . . . 0.31 110.177 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.598 ' HA ' HD22 ' A' ' 100' ' ' LEU . 76.0 p -87.25 167.58 13.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.239 -0.437 . . . . 0.52000000000000002 110.897 -176.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.47 -24.44 63.83 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.768 -0.73 . . . . 0.38 112.315 176.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.4 -35.92 76.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.204 0.526 . . . . 0.40000000000000002 110.76 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 13.5 m120 -70.58 -49.05 51.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.575 -0.739 . . . . 1.73 110.529 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.471 ' HB3' ' HZ3' ' A' ' 90' ' ' TRP . . . -73.49 -20.1 60.76 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.47 -0.492 . . . . 0.35999999999999999 110.411 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.596 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 39.5 ttmt -67.3 -50.35 60.63 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.558 -0.534 . . . . 0.60999999999999999 109.558 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 22.2 ptmt -64.79 -35.68 81.87 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.237 -0.438 . . . . 2.2400000000000002 110.793 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.83 -51.97 62.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.362 0.601 . . . . 0.81999999999999995 110.279 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.855 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -65.12 -36.51 84.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.464 -0.789 . . . . 1.04 112.384 -174.794 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -75.37 -26.07 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.294 -0.562 . . . . 1.02 110.339 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -85.43 -1.77 57.39 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.06 -0.518 . . . . 3.04 110.413 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 33.5 m -79.66 -7.76 58.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.85999999999999999 109.992 171.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 79' ' ' SER . 0.1 OUTLIER 69.97 27.36 4.43 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.631 -0.713 . . . . 2.0499999999999998 111.603 178.209 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.547 ' HB2' HD11 ' A' ' 86' ' ' LEU . 95.3 mt -110.31 157.93 36.72 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.424 . . . . 1.3400000000000001 110.368 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.667 ' O ' HD13 ' A' ' 86' ' ' LEU . 60.6 Cg_endo -74.16 147.43 37.86 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.704 2.269 . . . . 0.62 113.323 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.404 ' HA ' HD22 ' A' ' 86' ' ' LEU . 4.5 m-20 -51.46 -38.5 54.07 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.979 -0.555 . . . . 0.93999999999999995 112.029 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 35.0 m -56.69 -43.23 80.29 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.107 0.48 . . . . 0.58999999999999997 111.092 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.58 ' O ' HG12 ' A' ' 89' ' ' ILE . 53.5 t -73.93 -36.59 45.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.135 -0.691 . . . . 0.40000000000000002 109.135 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.855 ' HG ' ' HB3' ' A' ' 76' ' ' MET . 1.7 mp -62.62 -45.3 93.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.076 -0.966 . . . . 1.25 110.546 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.521 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -58.72 -37.22 89.37 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.892 -0.595 . . . . 0.34000000000000002 112.308 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 84' ' ' THR . 52.4 mtpt -71.76 -42.3 67.38 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.208 -0.293 . . . . 1.1599999999999999 110.208 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 85' ' ' VAL . 32.7 mm -53.15 -52.54 29.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.942 -0.572 . . . . 0.89000000000000001 110.132 173.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.471 ' HZ3' ' HB3' ' A' ' 72' ' ' ALA . 27.3 t-105 -64.38 -43.03 95.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.78 -0.645 . . . . 0.34999999999999998 111.159 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -63.83 -25.05 68.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.081 0.467 . . . . 1.3799999999999999 111.318 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.424 ' HA ' HD13 ' A' ' 92' ' ' LEU . 3.7 mm? -89.36 -31.23 17.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.132 -0.486 . . . . 1.53 111.158 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.59 -36.45 28.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.361 -0.381 . . . . 0.42999999999999999 111.883 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.62 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 24.7 t0 -84.93 57.2 4.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.824 0.821 . . . . 0.58999999999999997 109.942 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.476 HG13 ' HG2' ' A' ' 135' ' ' LYS . 13.6 p -68.37 -16.12 20.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.849 -1.069 . . . . 1.49 111.483 -177.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -89.71 -18.46 26.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.119 -0.492 . . . . 1.45 110.824 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.539 ' NZ ' ' HB2' ' A' ' 97' ' ' LYS . 0.1 OUTLIER 61.01 73.46 0.48 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.14 0.576 . . . . 2.6699999999999999 111.55 179.229 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.647 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 15.4 p-10 -132.96 -18.93 2.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.463 -0.335 . . . . 1.1299999999999999 111.759 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.68 4.47 72.91 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.437 -0.887 . . . . 0.42999999999999999 112.064 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.598 HD22 ' HA ' ' A' ' 68' ' ' THR . 41.4 mt -130.35 171.6 12.76 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.361 -0.607 . . . . 0.45000000000000001 109.361 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' A' ' 105' ' ' GLU . 79.9 mt -127.06 118.45 24.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.46 -0.336 . . . . 0.70999999999999996 110.702 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -83.31 -176.48 6.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.842 -0.799 . . . . 1.4199999999999999 108.842 167.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.96 -29.44 69.84 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.616 -0.434 . . . . 1.73 111.798 -173.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.49 -50.12 48.22 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.316 -0.624 . . . . 1.53 109.316 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.484 ' HB3' HD22 ' A' ' 101' ' ' LEU . 36.5 mt-10 -59.96 -52.77 63.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.352 -0.84 . . . . 0.81999999999999995 111.431 -178.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -63.09 -35.86 81.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.941 -0.572 . . . . 0.37 110.703 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.84 -47.32 75.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.5 110.682 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.84 -37.85 88.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.355 -0.384 . . . . 1.3200000000000001 109.974 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.506 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.0 -49.73 72.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.86 -0.609 . . . . 0.26000000000000001 110.426 173.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -69.19 -28.46 66.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.838 -0.619 . . . . 1.3600000000000001 111.846 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 115' ' ' VAL . 82.3 t60 -67.06 -41.97 85.54 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.395 -0.522 . . . . 0.67000000000000004 109.932 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.7 mt -64.75 -38.58 91.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.994 0.426 . . . . 0.89000000000000001 110.111 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 109' ' ' ALA . 72.0 mt -63.23 -41.23 92.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.712 -0.676 . . . . 0.46000000000000002 110.505 176.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -54.77 -49.88 69.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.836 0.35 . . . . 2.0699999999999998 110.585 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 111' ' ' HIS . 29.9 t -59.68 -40.49 82.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.99 -0.55 . . . . 0.5 109.926 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.591 ' NZ ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -61.51 -42.63 99.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.492 -0.776 . . . . 1.25 111.181 175.416 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 86.4 mt -72.37 -32.11 66.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.613 0.244 . . . . 0.93999999999999995 111.569 -176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -75.36 3.41 9.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.478 -0.328 . . . . 1.6499999999999999 111.543 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.69 2.5 75.64 Favored Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 120.642 -0.789 . . . . 0.80000000000000004 112.478 175.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.46 ' HB2' HG12 ' A' ' 115' ' ' VAL . 28.3 m-70 -92.92 173.93 7.5 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.097 0.475 . . . . 1.0600000000000001 109.887 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.33 145.39 40.12 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.0 -0.545 . . . . 3.6000000000000001 110.675 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.76 125.21 56.31 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.827 -0.624 . . . . 1.51 109.634 175.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.79 -2.14 11.45 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.898 2.399 . . . . 1.01 113.165 -172.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.3 21.02 12.22 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.421 0.629 . . . . 0.87 110.25 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.463 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -115.37 131.86 56.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.048 -0.978 . . . . 1.9399999999999999 109.872 -178.251 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.612 ' HB3' ' HB ' ' A' ' 131' ' ' VAL . 92.5 mt -96.85 96.57 2.85 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.139 0.274 . . . . 0.67000000000000004 110.624 170.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.499 ' O ' HG12 ' A' ' 131' ' ' VAL . 57.8 Cg_endo -76.48 159.76 35.73 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.406 2.07 . . . . 0.75 111.265 177.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.98 -25.57 28.63 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.998 2.466 . . . . 0.70999999999999996 114.023 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 27.8 p80 -86.92 9.26 19.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.823 0.344 . . . . 0.93999999999999995 111.42 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.447 ' O ' ' HD3' ' A' ' 132' ' ' PRO . 63.1 mt -131.71 -35.37 1.28 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 0.82999999999999996 110.65 174.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.612 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 7.1 p -91.14 108.45 28.5 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 121.497 0.665 . . . . 1.4399999999999999 110.693 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.462 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 16.8 Cg_exo -67.86 151.29 78.49 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.661 2.24 . . . . 1.22 111.48 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 41.6 Cg_exo -56.38 -27.3 66.95 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.969 2.446 . . . . 1.8600000000000001 112.837 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.8 t -69.4 -17.7 63.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.886 -0.597 . . . . 2.0699999999999998 111.041 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.476 ' HG2' HG13 ' A' ' 95' ' ' VAL . 1.0 OUTLIER -114.09 12.72 17.95 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.845 0.355 . . . . 1.27 110.926 179.547 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 98.8 mtt180 -95.77 116.35 28.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.629 0.252 . . . . 3.0699999999999998 110.815 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -109.4 133.52 52.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.996 0.427 . . . . 5.46 110.575 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -94.8 115.93 28.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.053 -0.721 . . . . 5.7999999999999998 109.053 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 C--O 1.247 0.969 0 O-C-N 123.949 0.78 . . . . 6.9299999999999997 109.842 -175.256 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 110.29 -0.263 . . . . 10.57 110.29 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -90.44 -75.88 0.45 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.493 -0.558 . . . . 8.0399999999999991 109.493 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 45.7 m -118.6 -97.66 0.46 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.961 -0.563 . . . . 5.1100000000000003 110.088 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 68.1 mttm 52.16 72.4 1.2 Allowed Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 122.756 0.422 . . . . 6.7000000000000002 111.13 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.02 171.55 13.99 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.458 2.105 . . . . 1.96 113.032 -176.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -99.75 21.34 12.6 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.625 -0.88 . . . . 0.89000000000000001 108.625 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.521 HD21 ' HA2' ' A' ' 87' ' ' GLY . 45.9 t-20 -97.36 119.39 63.07 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 114.451 -1.249 . . . . 0.42999999999999999 109.882 -173.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.56 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 9.2 Cg_exo -71.99 -10.36 25.99 Favored 'Trans proline' 0 CA--C 1.528 0.184 0 C-N-CA 123.259 2.639 . . . . 0.51000000000000001 112.948 -175.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.596 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 15.0 m-85 -106.41 -16.08 14.65 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.626 0.726 . . . . 0.5 109.475 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.401 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 41.5 tt0 -123.33 54.6 1.26 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.557 -1.202 . . . . 1.4199999999999999 108.595 177.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -74.61 -15.43 60.83 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 114.756 -1.111 . . . . 1.71 110.651 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 68.85 151.43 0.09 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.191 -0.913 . . . . 4.8099999999999996 110.996 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -99.34 -68.21 0.81 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.623 0.601 . . . . 5.9800000000000004 112.623 -170.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -110.2 109.36 19.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.974 0.416 . . . . 7.1900000000000004 111.608 -172.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.802 -0.618 . . . . 7.3200000000000003 109.615 172.912 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.647 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 112.06 -0.416 . . . . 11.68 112.06 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.69 113.42 3.79 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.625 2.217 . . . . 11.24 111.619 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.416 ' HG ' ' H ' ' A' ' 37' ' ' LEU . 3.6 pp -85.9 159.09 19.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.859 -0.609 . . . . 8.6199999999999992 110.882 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -106.83 133.62 11.74 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.645 -0.788 . . . . 6.6399999999999997 111.488 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.9 p -91.19 136.73 32.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.019 0.438 . . . . 5.8499999999999996 110.896 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.91 92.69 6.18 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.168 0.509 . . . . 4.0099999999999998 110.013 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -123.45 69.37 1.02 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.741 -0.663 . . . . 3.8599999999999999 109.461 176.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.735 HG23 ' HA ' ' A' ' 129' ' ' HIS . 4.3 p -124.15 126.04 71.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.042 -0.527 . . . . 1.8400000000000001 112.178 -177.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -122.53 124.88 44.57 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.614 -0.721 . . . . 3.02 109.094 169.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.56 90.36 4.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.221 -0.659 . . . . 0.84999999999999998 109.221 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.9 m -57.77 -33.66 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.667 -0.697 . . . . 1.24 112.315 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.421 HG23 ' HB2' ' A' ' 111' ' ' HIS . 7.4 p -69.87 -16.07 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.589 0.709 . . . . 1.3 110.745 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.522 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -72.81 -6.38 67.1 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.397 -0.819 . . . . 0.62 111.941 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -91.94 -25.44 18.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.185 0.517 . . . . 2.9900000000000002 110.221 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.453 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 20.7 m-20 -91.94 1.88 56.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.708 -0.678 . . . . 1.8200000000000001 110.701 -176.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HZ1' ' CG ' ' A' ' 103' ' ' ASP . 3.5 mmmp? -53.96 -49.66 88.42 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 114.062 1.134 . . . . 0.93000000000000005 114.062 -172.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 11.7 Cg_endo -52.69 -39.72 75.58 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.107 1.871 . . . . 0.56999999999999995 112.891 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.506 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . 58.5 m -82.62 -31.92 28.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.902 0.382 . . . . 0.67000000000000004 111.414 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.453 ' CE2' ' HB2' ' A' ' 49' ' ' ASP . 16.4 m-30 -71.11 -22.38 62.09 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.09 -0.708 . . . . 0.92000000000000004 109.09 175.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 16.5 t70 -71.22 -42.5 68.85 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.15 -0.932 . . . . 1.8600000000000001 109.365 172.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.506 ' OE2' ' HA ' ' A' ' 52' ' ' THR . 40.3 mt-10 -58.53 -34.35 70.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.33 -0.85 . . . . 2.0 110.837 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.7 mt -78.59 -52.44 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.075 0.464 . . . . 0.53000000000000003 110.512 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.421 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 74.2 t80 -50.01 -41.37 47.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.393 -0.821 . . . . 0.42999999999999999 111.855 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -74.75 -22.58 58.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.742 0.645 . . . . 3.0800000000000001 112.742 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.5 p -79.47 -20.82 46.44 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.018 -0.673 . . . . 0.75 110.944 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.06 -5.05 59.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 1.26 110.647 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.0 t 68.0 92.03 0.07 OUTLIER Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 115.588 -0.733 . . . . 1.1100000000000001 111.0 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.67 134.08 34.03 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.988 2.459 . . . . 0.68999999999999995 111.941 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.2 t -110.8 107.52 23.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.09 -0.505 . . . . 1.4299999999999999 110.124 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.4 m-20 64.1 41.47 6.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.547 -0.751 . . . . 2.1499999999999999 111.607 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.32 -3.38 72.36 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.984 -0.627 . . . . 0.62 113.94 172.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -160.3 170.53 20.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.412 0.606 . . . . 2.2400000000000002 110.476 178.646 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.48 HD11 ' CD1' ' A' ' 106' ' ' PHE . 25.6 pt -104.94 159.4 5.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.828 0.346 . . . . 0.31 111.227 -177.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.479 ' HA ' HD22 ' A' ' 100' ' ' LEU . 73.5 p -89.27 170.66 10.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.856 -0.611 . . . . 0.52000000000000002 110.972 -177.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.93 -27.98 72.06 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.688 -0.687 . . . . 0.38 112.546 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.96 -45.15 68.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.076 0.465 . . . . 0.40000000000000002 111.295 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.465 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 8.9 m120 -63.73 -46.24 86.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.509 0.671 . . . . 1.73 110.127 -177.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.533 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -75.77 -23.89 55.98 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.729 -0.669 . . . . 0.35999999999999999 110.489 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.799 ' HA ' ' HZ ' ' B' ' 151' ' ' PHE . 35.1 ttmt -61.32 -50.62 72.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.893 0.377 . . . . 0.60999999999999999 110.033 174.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 19.4 ptmt -70.13 -27.71 64.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.312 -0.404 . . . . 2.2400000000000002 110.395 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 13.2 tp10 -68.36 -40.39 81.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.612 0.72 . . . . 0.81999999999999995 109.98 174.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.647 ' HB3' HD22 ' A' ' 86' ' ' LEU . 22.3 mmt -59.8 -42.81 94.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.67 -0.695 . . . . 1.04 111.24 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 74' ' ' LYS . 15.0 m -72.0 -24.07 22.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.459 -0.496 . . . . 1.02 110.441 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 10.1 mtpm? -71.67 -20.87 61.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 3.04 110.644 175.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.9 m -84.88 1.35 47.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.08 -0.509 . . . . 0.85999999999999999 111.263 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.1 mptt 62.01 25.19 15.09 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.862 0.69 . . . . 2.0499999999999998 112.862 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.603 ' HB2' HD21 ' A' ' 86' ' ' LEU . 98.8 mt -98.79 140.61 21.89 Favored Pre-proline 0 C--N 1.326 -0.45 0 C-N-CA 121.06 -0.256 . . . . 1.3400000000000001 110.908 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.607 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 19.3 Cg_exo -64.92 159.49 45.88 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.189 2.592 . . . . 0.62 112.614 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -56.74 -43.71 80.96 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.823 -0.626 . . . . 0.93999999999999995 111.611 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.2 m -56.34 -45.92 80.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.16 0.505 . . . . 0.58999999999999997 110.905 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 89' ' ' ILE . 96.3 t -64.27 -45.24 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.763 -0.653 . . . . 0.40000000000000002 110.618 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.647 HD22 ' HB3' ' A' ' 76' ' ' MET . 31.3 mt -62.62 -38.48 90.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.088 -0.506 . . . . 1.25 110.271 177.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.729 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -56.56 -37.42 75.54 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.289 -0.869 . . . . 0.34000000000000002 111.783 176.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -77.63 -47.69 18.68 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.927 0.394 . . . . 1.1599999999999999 110.561 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.648 HD13 HG12 ' A' ' 113' ' ' ILE . 67.8 mt -57.84 -49.57 80.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.01 -0.541 . . . . 0.89000000000000001 111.105 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.588 ' HB3' ' ND2' ' B' ' 149' ' ' ASN . 13.4 t-105 -66.04 -38.48 88.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.215 0.531 . . . . 0.34999999999999998 110.197 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 87' ' ' GLY . 24.4 ttmm -56.91 -33.33 66.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.521 -0.763 . . . . 1.3799999999999999 111.05 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.416 ' HA ' HD13 ' A' ' 92' ' ' LEU . 3.8 mm? -90.72 -43.1 10.33 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.587 0.588 . . . . 1.53 112.587 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.63 -42.45 98.15 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.5 0.556 . . . . 0.42999999999999999 112.5 -171.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.635 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 36.0 t0 -90.22 99.72 12.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.327 -0.62 . . . . 0.58999999999999997 109.327 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.8 m -82.83 -30.31 8.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.767 -0.651 . . . . 1.49 111.839 -170.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.646 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 1.2 p30 -102.28 -9.29 20.53 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.131 0.419 . . . . 1.45 112.131 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.635 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 67.9 mmtt 66.15 74.48 0.35 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.187 0.517 . . . . 2.6699999999999999 112.326 175.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.652 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 5.5 m-20 -91.82 -29.08 16.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.748 -0.66 . . . . 1.1299999999999999 109.525 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.49 2.39 79.56 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 109.58 -1.408 . . . . 0.42999999999999999 109.58 -167.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' A' ' 68' ' ' THR . 23.1 mt -133.93 175.8 9.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.195 -1.003 . . . . 0.45000000000000001 108.435 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.565 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 96.6 mt -131.88 118.12 19.41 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.972 -0.291 . . . . 0.70999999999999996 110.413 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.536 ' HA ' ' CB ' ' A' ' 66' ' ' LYS . 1.3 p-10 -81.08 -175.82 5.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.047 -0.723 . . . . 1.4199999999999999 109.047 175.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.553 ' CG ' ' HZ1' ' A' ' 50' ' ' LYS . 17.9 t70 -61.4 -35.48 77.63 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 111.865 0.32 . . . . 1.73 111.865 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.431 ' OE2' ' HB3' ' A' ' 132' ' ' PRO . 48.4 mt-10 -68.36 -55.45 11.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.986 0.422 . . . . 1.53 110.542 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.491 ' HG3' ' OD1' ' A' ' 102' ' ' ASP . 36.0 mt-10 -72.22 -32.25 66.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.885 -0.598 . . . . 0.81999999999999995 112.383 -173.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CD1' HD11 ' A' ' 67' ' ' ILE . 49.5 t80 -69.29 -39.0 78.6 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.091 -0.644 . . . . 0.37 109.625 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.28 96.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.41 -0.516 . . . . 0.5 110.074 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.5 mt -65.55 -36.52 84.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.492 -0.322 . . . . 1.3200000000000001 111.057 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.48 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -58.51 -52.16 66.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.801 0.334 . . . . 0.26000000000000001 110.305 174.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -63.64 -36.47 83.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.043 -0.526 . . . . 1.3600000000000001 110.627 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.622 ' O ' HG23 ' A' ' 115' ' ' VAL . 77.1 t60 -63.72 -46.19 86.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.28 -0.418 . . . . 0.67000000000000004 111.008 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.581 ' HB3' HD23 ' A' ' 122' ' ' LEU . 96.1 mt -63.66 -41.02 98.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.887 0.375 . . . . 0.89000000000000001 110.731 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.648 HG12 HD13 ' A' ' 89' ' ' ILE . 73.9 mt -59.72 -44.15 93.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.46000000000000002 109.986 175.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 22.5 ttmm -60.51 -42.15 95.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.814 -0.63 . . . . 2.0699999999999998 111.203 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 111' ' ' HIS . 59.5 t -58.11 -46.35 88.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.816 0.341 . . . . 0.5 110.351 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 16.5 mtpp -62.13 -42.24 99.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.033 0.383 . . . . 1.25 112.033 175.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 97.2 mt -64.51 -28.47 69.67 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.185 0.516 . . . . 0.93999999999999995 110.723 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 58.2 mm-40 -73.04 -2.74 22.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.651 -0.704 . . . . 1.6499999999999999 111.471 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.48 32.43 9.44 Favored Glycine 0 CA--C 1.505 -0.588 0 C-N-CA 120.647 -0.787 . . . . 0.80000000000000004 112.099 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 95.4 m-70 -131.14 179.72 5.84 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.389 0.614 . . . . 1.0600000000000001 111.406 -176.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.85 149.79 49.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.11 -0.95 . . . . 3.6000000000000001 109.404 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.581 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -79.9 144.51 59.82 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.505 -0.554 . . . . 1.51 109.505 175.44 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.33 -5.91 15.06 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.998 2.465 . . . . 1.01 113.315 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.42 17.83 9.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.329 0.585 . . . . 0.87 110.599 -175.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -134.78 156.58 48.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.222 -0.899 . . . . 1.9399999999999999 109.496 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.83 93.87 9.56 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.399 -0.364 . . . . 0.67000000000000004 110.721 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -78.2 160.19 29.7 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.39 2.06 . . . . 0.75 112.084 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.465 ' HA ' HG22 ' A' ' 131' ' ' VAL . 78.4 Cg_exo -51.63 -27.42 25.77 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.422 2.748 . . . . 0.70999999999999996 113.805 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.735 ' HA ' HG23 ' A' ' 42' ' ' VAL . 28.0 p-80 -88.37 9.07 24.67 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.649 -0.42 . . . . 0.93999999999999995 111.776 -177.374 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.8 mt -128.25 -32.87 2.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.508 0.194 . . . . 0.82999999999999996 111.028 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 128' ' ' PRO . 28.1 m -61.93 133.07 93.75 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 1.4399999999999999 110.56 176.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.431 ' HB3' ' OE2' ' A' ' 104' ' ' GLU . 37.9 Cg_exo -58.2 142.73 97.44 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.281 1.987 . . . . 1.22 110.829 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 136' ' ' ARG . 31.3 Cg_exo -56.99 -22.53 47.11 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.643 2.229 . . . . 1.8600000000000001 112.15 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.7 t -77.84 -16.9 57.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.742 -0.663 . . . . 2.0699999999999998 111.279 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.464 ' HE2' ' OD2' ' A' ' 96' ' ' ASP . 6.1 mptt -120.29 23.5 10.88 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.318 0.488 . . . . 1.27 112.318 -174.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 133' ' ' PRO . 31.3 ptt180 -110.32 151.85 26.91 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.638 -0.425 . . . . 3.0699999999999998 111.664 -177.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -64.17 174.02 1.74 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.415 0.626 . . . . 5.46 112.238 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -133.79 128.62 35.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.385 -0.825 . . . . 5.7999999999999998 109.091 167.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 . . . . . 0 C--O 1.253 1.286 0 O-C-N 123.801 0.688 . . . . 6.9299999999999997 111.808 -179.381 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.006 -0.738 . . . . 10.57 109.006 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -154.84 111.82 3.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.233 -0.44 . . . . 8.0399999999999991 110.456 -170.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 8.1 t -162.27 158.48 24.36 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.55 -0.537 . . . . 5.1100000000000003 109.55 -178.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -105.6 154.19 39.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.559 -0.291 . . . . 6.7000000000000002 110.811 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -82.88 -176.67 2.98 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.137 2.558 . . . . 1.96 112.386 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -130.46 1.45 4.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.057 -0.52 . . . . 0.89000000000000001 110.705 -175.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.729 HD21 ' HA2' ' A' ' 87' ' ' GLY . 54.9 t-20 -93.16 122.11 64.05 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.904 -0.589 . . . . 0.42999999999999999 109.741 -176.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 23.7 Cg_exo -64.92 -5.68 11.17 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.171 2.581 . . . . 0.51000000000000001 113.394 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.799 ' HZ ' ' HA ' ' A' ' 73' ' ' LYS . 43.4 m-85 -108.09 -3.52 18.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.368 0.604 . . . . 0.5 110.108 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.601 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 46.9 tt0 -123.19 29.36 6.74 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.329 -0.989 . . . . 1.4199999999999999 108.329 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -62.03 -40.3 95.24 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.185 -0.916 . . . . 1.71 111.352 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 65.05 -79.69 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 122.987 0.515 . . . . 4.8099999999999996 112.168 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -94.94 106.84 18.85 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.068 -0.345 . . . . 5.9800000000000004 110.068 -175.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -95.54 -55.93 2.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.917 -0.583 . . . . 7.1900000000000004 109.803 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 C--O 1.251 1.152 0 CA-C-N 115.024 -0.989 . . . . 7.3200000000000003 108.91 175.959 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.652 'CA ' ' OD2' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 111.694 -0.562 . . . . 11.68 111.694 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.89 136.4 25.07 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.82 2.347 . . . . 11.24 111.75 -176.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.758 HD23 ' H ' ' A' ' 37' ' ' LEU . 2.2 pt? -84.44 134.14 34.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.935 -0.575 . . . . 8.6199999999999992 110.812 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.08 143.06 16.54 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.376 -0.69 . . . . 6.6399999999999997 111.376 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.9 m -131.22 124.13 29.92 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.889 0.344 . . . . 5.8499999999999996 111.226 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.33 93.11 7.66 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.672 -0.492 . . . . 4.0099999999999998 109.672 173.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -125.2 78.76 1.74 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.548 0.69 . . . . 3.8599999999999999 110.873 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.61 138.28 54.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.204 -0.907 . . . . 1.8400000000000001 110.402 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -105.71 136.25 45.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.468 -0.333 . . . . 3.02 110.392 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -76.13 96.7 3.92 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.374 -0.972 . . . . 0.84999999999999998 108.374 173.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.1 m -58.56 -15.01 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.876 0.695 . . . . 1.24 112.876 -172.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.486 HG21 HD23 ' A' ' 108' ' ' LEU . 61.2 t -80.6 -26.96 11.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.996 0.427 . . . . 1.3 110.714 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.471 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -73.85 -1.64 59.45 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.694 -0.765 . . . . 0.62 111.712 177.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -97.35 -17.13 19.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.166 0.508 . . . . 2.9900000000000002 110.307 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.08 20.62 5.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.773 -0.649 . . . . 1.8200000000000001 110.244 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.642 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 8.3 mmmm -58.25 -43.74 98.55 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 114.751 1.389 . . . . 0.93000000000000005 114.751 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.9 Cg_endo -46.47 -41.98 23.15 Favored 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 122.906 2.404 . . . . 0.56999999999999995 113.654 -172.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.3 m -70.54 -40.34 73.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.101 0.477 . . . . 0.67000000000000004 110.679 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 110' ' ' ASN . 7.4 m-85 -71.11 -23.41 62.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.92000000000000004 109.67 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -75.22 -45.69 38.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.329 -0.85 . . . . 1.8600000000000001 110.102 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -58.99 -50.44 74.1 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.449 -0.796 . . . . 2.0 110.39 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.68 -41.79 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.164 -0.471 . . . . 0.53000000000000003 111.259 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.417 ' HB2' ' CD2' ' A' ' 106' ' ' PHE . 90.5 t80 -58.55 -47.83 82.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.287 -0.415 . . . . 0.42999999999999999 110.927 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -76.37 -20.86 56.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.225 0.454 . . . . 3.0800000000000001 112.225 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.7 p -78.43 -13.0 60.04 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.214 -0.594 . . . . 0.75 111.463 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.3 mt -92.24 2.76 56.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.496 -0.32 . . . . 1.26 111.003 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.0 m 66.51 90.1 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 O-C-N 123.785 0.678 . . . . 1.1100000000000001 111.468 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.9 137.16 13.75 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.064 2.51 . . . . 0.68999999999999995 112.436 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.507 HG12 ' OD1' ' A' ' 64' ' ' ASN . 22.4 t -108.81 115.36 49.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.191 -0.458 . . . . 1.4299999999999999 110.195 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.507 ' OD1' HG12 ' A' ' 63' ' ' VAL . 3.0 p-10 40.94 51.61 3.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.621 0.768 . . . . 2.1499999999999999 112.859 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.59 -3.77 71.97 Favored Glycine 0 CA--C 1.518 0.233 0 N-CA-C 114.754 0.662 . . . . 0.62 114.754 170.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.464 ' HG2' ' CA ' ' A' ' 102' ' ' ASP . 14.0 mtmm -147.95 149.79 32.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.951 0.875 . . . . 2.2400000000000002 111.173 177.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.9 pt -92.09 147.57 5.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.807 -0.442 . . . . 0.31 109.807 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.2 p -77.77 155.11 31.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.363 -0.38 . . . . 0.52000000000000002 110.688 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.38 -15.37 45.36 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 121.285 -0.483 . . . . 0.38 113.387 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -63.77 -56.96 11.57 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.254 0.55 . . . . 0.40000000000000002 111.081 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.65 -37.93 83.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.644 -0.707 . . . . 1.73 110.25 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.46 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -69.64 -32.55 71.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.809 -0.632 . . . . 0.35999999999999999 110.551 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.577 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 39.9 ttmt -64.05 -42.71 96.93 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.4 0.619 . . . . 0.60999999999999999 109.561 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.8 mtpp -67.76 -38.27 83.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.281 -0.872 . . . . 2.2400000000000002 110.982 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.92 -45.39 93.91 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.481 0.658 . . . . 0.81999999999999995 110.263 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.938 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 25.0 mmt -57.48 -48.11 80.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.354 -0.839 . . . . 1.04 111.274 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.12 -21.57 19.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.849 -0.34 . . . . 1.02 111.074 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 92.5 mttt -70.31 -25.12 63.17 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.545 -0.298 . . . . 3.04 110.82 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 42.5 m -81.99 -1.69 49.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.255 -0.43 . . . . 0.85999999999999999 111.124 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 79' ' ' SER . 10.1 mptt 70.15 14.95 7.65 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.984 0.735 . . . . 2.0499999999999998 112.984 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.99 143.62 43.24 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.57 -0.452 . . . . 1.3400000000000001 110.672 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.544 ' O ' HD13 ' A' ' 86' ' ' LEU . 39.7 Cg_exo -62.27 152.07 78.59 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.292 2.661 . . . . 0.62 112.803 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.534 ' HA ' HD22 ' A' ' 86' ' ' LEU . 16.5 m120 -57.79 -38.45 75.52 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.226 -0.443 . . . . 0.93999999999999995 111.33 -177.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.3 m -57.8 -37.42 73.71 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.197 0.522 . . . . 0.58999999999999997 111.161 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 89' ' ' ILE . 70.7 t -77.08 -37.25 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.029 -0.73 . . . . 0.40000000000000002 109.029 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.938 ' HG ' ' HB3' ' A' ' 76' ' ' MET . 0.4 OUTLIER -61.42 -44.85 96.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.143 -0.935 . . . . 1.25 110.715 176.023 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.608 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -61.31 -37.2 93.65 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.87 -0.681 . . . . 0.34000000000000002 111.634 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -68.03 -48.31 66.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.819 0.342 . . . . 1.1599999999999999 110.754 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 85' ' ' VAL . 39.8 mm -56.89 -48.82 80.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.916 -0.584 . . . . 0.89000000000000001 110.253 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TRP . . . . . 0.504 ' CH2' HD23 ' A' ' 101' ' ' LEU . 16.6 t-105 -61.94 -51.31 68.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.055 -0.521 . . . . 0.34999999999999998 111.161 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -60.65 -27.64 67.96 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.122 -0.49 . . . . 1.3799999999999999 111.823 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.487 HD12 HD22 ' A' ' 122' ' ' LEU . 66.3 mt -85.51 -49.97 7.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.502 -0.317 . . . . 1.53 111.214 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.89 82.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.504 -0.316 . . . . 0.42999999999999999 111.834 -175.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.731 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 18.7 t70 -78.66 83.94 4.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.831 -0.803 . . . . 0.58999999999999997 108.831 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.62 -25.99 13.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.91 -1.041 . . . . 1.49 110.887 -173.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.611 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.7 OUTLIER -90.53 -15.55 30.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.901 -0.59 . . . . 1.45 111.949 -176.176 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.698 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 4.2 mptp? 54.74 72.07 0.49 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.31 0.576 . . . . 2.6699999999999999 110.983 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.62 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 7.3 p-10 -117.25 -33.16 4.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.767 -0.652 . . . . 1.1299999999999999 111.932 -173.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.12 -23.09 14.65 Favored Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 120.476 -0.869 . . . . 0.42999999999999999 112.357 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -102.01 -171.74 2.02 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.881 -0.785 . . . . 0.45000000000000001 108.881 174.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.552 HD13 ' HG2' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -132.66 111.69 11.39 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.754 -0.462 . . . . 0.70999999999999996 109.754 178.288 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.464 ' CA ' ' HG2' ' A' ' 66' ' ' LYS . 7.0 t70 -87.55 -177.13 5.81 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.701 -0.681 . . . . 1.4199999999999999 110.843 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.34 -37.02 57.91 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.246 0.461 . . . . 1.73 112.246 -173.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -69.56 -41.92 75.24 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 122.782 1.277 . . . . 1.53 107.91 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.731 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 5.9 tt0 -65.4 -40.88 93.98 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 112.375 -2.193 . . . . 0.81999999999999995 110.899 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.536 ' HB2' HD12 ' A' ' 101' ' ' LEU . 52.9 t80 -72.75 -35.41 67.48 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.608 0.718 . . . . 0.37 109.77 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . 0.412 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -66.28 -39.82 89.67 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.733 -1.121 . . . . 0.5 110.629 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.486 HD23 HG21 ' A' ' 46' ' ' VAL . 15.7 mt -70.05 -35.42 74.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.165 -0.47 . . . . 1.3200000000000001 110.47 175.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.44 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.74 -55.47 33.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 0.26000000000000001 110.561 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 94.8 m-20 -70.63 -25.72 63.16 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.32 -0.4 . . . . 1.3600000000000001 110.932 -177.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.593 ' O ' HG23 ' A' ' 115' ' ' VAL . 72.6 t60 -69.83 -43.82 71.19 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.408 -0.36 . . . . 0.67000000000000004 110.051 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.83 -41.1 97.92 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.95 0.405 . . . . 0.89000000000000001 110.077 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 80.3 mt -59.81 -43.73 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.437 -0.801 . . . . 0.46000000000000002 110.437 174.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -59.72 -46.64 88.5 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.187 -0.461 . . . . 2.0699999999999998 111.196 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 111' ' ' HIS . 38.4 t -60.38 -42.83 92.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.114 0.483 . . . . 0.5 110.325 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -56.16 -43.86 78.74 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.847 -0.615 . . . . 1.25 110.998 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 91.5 mt -74.04 -16.97 61.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.398 -0.365 . . . . 0.93999999999999995 111.316 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.3 0.41 25.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.735 0.302 . . . . 1.6499999999999999 110.421 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.52 -1.48 84.03 Favored Glycine 0 CA--C 1.503 -0.705 0 N-CA-C 111.42 -0.672 . . . . 0.80000000000000004 111.42 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -97.05 -179.14 4.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.115 0.483 . . . . 1.0600000000000001 111.11 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.15 144.45 50.75 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.465 -0.789 . . . . 3.6000000000000001 110.179 -176.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.487 HD22 HD12 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -77.96 138.97 61.21 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 109.711 -0.477 . . . . 1.51 109.711 173.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.45 -3.43 12.45 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.537 2.158 . . . . 1.01 113.699 -170.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.22 21.55 12.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.309 0.576 . . . . 0.87 110.739 -177.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.702 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 0.8 OUTLIER -127.93 142.23 51.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.099 -0.955 . . . . 1.9399999999999999 108.999 178.287 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.2 mt -97.32 92.49 1.25 Allowed Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 121.166 0.508 . . . . 0.67000000000000004 110.551 169.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.758 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 17.8 Cg_endo -94.35 165.95 1.93 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.749 2.966 . . . . 0.75 112.254 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.6 -25.04 24.52 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.523 2.815 . . . . 0.70999999999999996 113.948 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 30.1 p80 -86.79 5.54 35.99 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.458 -0.497 . . . . 0.93999999999999995 111.476 -178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.758 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 72.9 mt -129.23 -35.56 1.78 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.585 -0.28 . . . . 0.82999999999999996 111.182 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 31.0 m -75.99 122.01 86.11 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 121.342 0.591 . . . . 1.4399999999999999 111.352 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.472 ' HG2' ' HE2' ' A' ' 135' ' ' LYS . 24.5 Cg_exo -63.25 140.97 80.25 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.581 2.187 . . . . 1.22 111.88 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 37.9 Cg_exo -59.04 -19.82 50.54 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.936 2.424 . . . . 1.8600000000000001 112.663 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.3 p -67.45 -22.12 65.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.045 -0.525 . . . . 2.0699999999999998 111.601 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.472 ' HE2' ' HG2' ' A' ' 132' ' ' PRO . 0.7 OUTLIER -99.37 -6.91 26.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.789 0.328 . . . . 1.27 110.744 179.56 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -77.88 132.78 38.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.109 0.48 . . . . 3.0699999999999998 111.181 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -117.68 132.73 56.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.875 -0.602 . . . . 5.46 110.626 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -103.61 141.79 35.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.297 -0.411 . . . . 5.7999999999999998 110.784 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.428 -0.796 . . . . 6.9299999999999997 109.601 175.793 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 57.0 tp . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.642 0.258 . . . . 10.57 110.808 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -136.43 -8.88 1.95 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.22 0.533 . . . . 8.0399999999999991 110.611 177.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 4.0 p -102.18 156.76 17.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.438 -0.801 . . . . 5.1100000000000003 110.264 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' B' ' 147' ' ' PRO . 23.9 pttm -145.89 128.79 8.13 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.779 0.324 . . . . 6.7000000000000002 110.409 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 147' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 146' ' ' LYS . 1.7 Cg_endo -84.34 -79.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.687 2.258 . . . . 1.96 111.191 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -139.13 -36.83 0.52 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.851 -0.796 . . . . 0.89000000000000001 108.851 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.608 HD21 ' HA2' ' A' ' 87' ' ' GLY . 45.2 t-20 -87.91 114.51 59.51 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.822 -1.081 . . . . 0.42999999999999999 109.641 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 11.0 Cg_exo -72.22 -6.55 19.31 Favored 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 123.09 2.526 . . . . 0.51000000000000001 112.8 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 40.7 m-85 -105.55 0.19 26.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.452 0.644 . . . . 0.5 109.676 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 23.2 tt0 -117.68 35.25 4.77 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.018 -0.992 . . . . 1.4199999999999999 109.255 -174.387 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -82.79 -7.36 59.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.05 -0.977 . . . . 1.71 111.775 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 68.92 149.66 0.07 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.705 0.764 . . . . 4.8099999999999996 112.873 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -113.73 -165.04 0.97 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.299 -0.864 . . . . 5.9800000000000004 110.29 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.75 143.24 42.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.328 0.585 . . . . 7.1900000000000004 111.314 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 21.9 t70 . . . . . 0 C--O 1.247 0.974 0 CA-C-N 115.258 -0.883 . . . . 7.3200000000000003 108.992 174.884 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.62 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.47 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 111.67 -0.572 . . . . 11.68 111.67 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 7.0 Cg_exo -73.87 109.41 2.86 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.623 2.215 . . . . 11.24 111.932 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' ' 37' ' ' LEU . 1.9 tm? -102.2 120.02 39.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.015 -0.539 . . . . 8.6199999999999992 109.592 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.28 137.52 13.66 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.713 -0.756 . . . . 6.6399999999999997 112.102 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.5 m -131.67 134.07 45.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.687 0.28 . . . . 5.8499999999999996 110.919 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -85.65 93.21 8.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.866 -0.79 . . . . 4.0099999999999998 108.866 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -107.85 130.64 54.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.085 -0.507 . . . . 3.8599999999999999 110.608 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.458 ' CG1' ' HA ' ' A' ' 129' ' ' HIS . 90.3 t -123.19 121.12 62.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.463 -0.79 . . . . 1.8400000000000001 110.087 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.22 120.33 24.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.534 0.683 . . . . 3.02 109.576 174.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.419 ' HH2' ' HA ' ' A' ' 104' ' ' GLU . 0.6 OUTLIER -79.81 98.75 7.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.82 -0.627 . . . . 0.84999999999999998 109.355 -178.647 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.5 m -56.65 -31.5 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.761 0.652 . . . . 1.24 112.761 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.658 ' HB ' ' HE2' ' A' ' 53' ' ' TYR . 22.7 m -77.1 -6.42 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.623 -0.431 . . . . 1.3 110.795 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.89 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -72.97 -20.25 79.88 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.86 -0.896 . . . . 0.62 110.86 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -84.51 -10.86 57.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.021 -0.59 . . . . 2.9900000000000002 110.011 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -118.89 9.26 11.91 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.447 -0.797 . . . . 1.8200000000000001 110.882 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.89 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 28.8 mmmt -53.11 -49.75 85.88 Favored Pre-proline 0 N--CA 1.471 0.582 0 N-CA-C 113.252 0.834 . . . . 0.93000000000000005 113.252 -175.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 10.1 Cg_endo -51.74 -38.67 67.2 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.585 2.19 . . . . 0.56999999999999995 112.432 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -70.82 -42.73 69.85 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.625 0.726 . . . . 0.67000000000000004 110.102 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.658 ' HE2' ' HB ' ' A' ' 46' ' ' VAL . 15.9 m-30 -70.36 -22.63 62.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.39 -0.823 . . . . 0.92000000000000004 109.86 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -73.84 -43.94 57.14 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.687 -0.688 . . . . 1.8600000000000001 110.1 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.609 ' HA ' ' CE2' ' A' ' 58' ' ' TYR . 39.8 mt-10 -58.14 -33.38 69.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.728 -0.669 . . . . 2.0 111.259 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.0 mt -85.19 -22.44 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.241 0.544 . . . . 0.53000000000000003 110.569 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -77.83 -55.53 5.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.315 -0.402 . . . . 0.42999999999999999 112.009 -175.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.609 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 23.1 p90 -70.43 -17.14 63.0 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 120.679 -0.408 . . . . 3.0800000000000001 111.509 -172.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 p -71.54 -12.61 61.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.106 0.479 . . . . 0.75 111.074 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 87.7 mt -99.92 14.62 29.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.75 -0.659 . . . . 1.26 110.648 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.9 m 65.06 88.69 0.11 Allowed Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 115.509 -0.769 . . . . 1.1100000000000001 111.136 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 38.2 Cg_endo -74.54 98.74 1.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.478 2.119 . . . . 0.68999999999999995 112.385 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.3 t -89.9 117.28 32.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.725 -0.472 . . . . 1.4299999999999999 109.725 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 60.6 22.82 12.6 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.223 0.535 . . . . 2.1499999999999999 110.856 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.95 14.35 69.83 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.706 -0.759 . . . . 0.62 113.259 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.735 ' HE3' ' HB2' ' A' ' 100' ' ' LEU . 39.5 tttp -147.26 126.36 12.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.385 0.593 . . . . 2.2400000000000002 109.459 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 101' ' ' LEU . 35.3 pt -83.87 146.11 7.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 120.94 0.4 . . . . 0.31 110.552 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.639 ' HA ' HD22 ' A' ' 100' ' ' LEU . 68.6 p -80.48 159.53 25.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.795 -0.639 . . . . 0.52000000000000002 111.314 -177.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.41 -22.3 67.41 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.957 -0.565 . . . . 0.38 112.845 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.04 -49.75 74.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.372 0.606 . . . . 0.40000000000000002 111.332 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 39.5 m-80 -73.36 -38.05 65.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.515 -0.766 . . . . 1.73 111.18 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.51 -30.93 69.85 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.496 -0.482 . . . . 0.35999999999999999 109.862 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -62.64 -48.96 77.05 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.537 -0.301 . . . . 0.60999999999999999 110.704 176.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.658 ' HD3' ' N ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -64.91 -31.96 73.44 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 120.482 -0.487 . . . . 2.2400000000000002 111.123 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.658 ' N ' ' HD3' ' A' ' 74' ' ' LYS . 7.5 tp10 -67.57 -45.12 76.5 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.32 0.581 . . . . 0.81999999999999995 109.914 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.469 ' HB3' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -64.99 -46.55 80.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.381 -0.827 . . . . 1.04 111.547 -178.17 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.04 -30.38 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.946 -0.302 . . . . 1.02 111.558 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -80.48 -11.31 59.69 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.101 -0.374 . . . . 3.04 110.602 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.9 t -74.22 -11.44 60.29 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.893 -0.78 . . . . 0.85999999999999999 108.893 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 72.4 mmtt 66.4 35.11 5.87 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.249 -0.887 . . . . 2.0499999999999998 112.208 175.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.597 ' HB2' HD21 ' A' ' 86' ' ' LEU . 89.7 mt -100.7 144.85 29.31 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.867 -0.79 . . . . 1.3400000000000001 108.867 171.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.402 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 52.1 Cg_exo -55.35 142.65 79.21 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.587 2.191 . . . . 0.62 112.241 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -56.23 -34.14 66.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.149 -0.478 . . . . 0.93999999999999995 111.28 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' THR . . . . . 0.502 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 6.2 m -59.62 -48.52 81.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.198 0.523 . . . . 0.58999999999999997 110.496 177.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.632 ' O ' HG12 ' A' ' 89' ' ' ILE . 58.7 t -63.05 -43.29 98.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.716 -0.674 . . . . 0.40000000000000002 109.968 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' A' ' 81' ' ' LEU . 78.9 mt -59.36 -43.94 92.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.746 -0.661 . . . . 1.25 110.685 178.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.04 -34.38 83.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.982 -0.627 . . . . 0.34000000000000002 112.069 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 84' ' ' THR . 27.9 mtpp -72.62 -45.32 59.64 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.83 0.348 . . . . 1.1599999999999999 110.23 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 85' ' ' VAL . 42.7 mm -56.37 -49.39 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.725 -0.671 . . . . 0.89000000000000001 110.107 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -66.79 -41.16 88.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.086 -0.506 . . . . 0.34999999999999998 110.524 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -55.81 -29.23 59.42 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.696 -0.683 . . . . 1.3799999999999999 110.695 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.488 HD12 HD22 ' A' ' 122' ' ' LEU . 82.8 mt -91.86 -42.95 9.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 1.53 112.056 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.09 -40.29 95.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.42999999999999999 111.779 -171.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -92.05 94.23 9.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.983 -0.747 . . . . 0.58999999999999997 108.983 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.5 -48.94 28.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.267 -0.879 . . . . 1.49 111.24 -172.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.624 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 4.4 p30 -83.93 -9.97 58.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.599 -0.728 . . . . 1.45 112.051 -174.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt 73.45 76.4 0.13 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.641 0.608 . . . . 2.6699999999999999 112.641 171.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.652 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 3.8 m-20 -104.31 -44.85 4.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.456 0.646 . . . . 1.1299999999999999 110.226 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.69 2.35 57.43 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.34 -1.104 . . . . 0.42999999999999999 110.34 -167.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.735 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 36.7 mt -131.22 165.02 24.28 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.549 -0.908 . . . . 0.45000000000000001 108.549 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.422 ' O ' HG12 ' A' ' 67' ' ' ILE . 96.2 mt -125.56 122.68 37.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.267 0.555 . . . . 0.70999999999999996 111.573 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.419 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 2.1 p30 -87.16 -176.29 5.63 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.74 -0.837 . . . . 1.4199999999999999 108.74 167.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.02 -22.79 63.07 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.712 -0.395 . . . . 1.73 111.444 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HA ' ' HH2' ' A' ' 44' ' ' TRP . 52.2 mt-10 -72.01 -56.77 5.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.14 0.495 . . . . 1.53 109.818 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -68.28 -32.13 72.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.384 -0.826 . . . . 0.81999999999999995 111.086 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -71.49 -29.79 65.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.751 -0.463 . . . . 0.37 109.751 176.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.52 -39.11 88.47 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.285 -0.416 . . . . 0.5 110.152 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.47 -42.57 99.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.035 -0.529 . . . . 1.3200000000000001 110.347 172.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.12 -55.46 30.85 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 123.553 0.533 . . . . 0.26000000000000001 110.672 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -63.01 -41.49 99.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.78 -0.646 . . . . 1.3600000000000001 111.046 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.618 ' O ' HG23 ' A' ' 115' ' ' VAL . 81.5 t60 -61.52 -45.84 92.48 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.908 -0.317 . . . . 0.67000000000000004 111.187 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.0 -40.66 87.37 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.752 0.311 . . . . 0.89000000000000001 111.233 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.437 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 80.7 mt -61.41 -42.69 94.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.46000000000000002 109.837 175.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 52.9 tttp -55.45 -46.2 76.78 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.754 -0.657 . . . . 2.0699999999999998 110.683 174.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 111' ' ' HIS . 60.4 t -58.2 -44.71 88.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 120.716 0.293 . . . . 0.5 110.702 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -65.58 -39.85 92.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.153 -0.476 . . . . 1.25 111.465 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 93.6 mt -70.68 -26.03 63.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.938 0.399 . . . . 0.93999999999999995 110.8 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 68.8 mm-40 -71.02 -18.2 62.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.201 -0.454 . . . . 1.6499999999999999 110.559 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.23 -13.16 48.44 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.859 -0.686 . . . . 0.80000000000000004 112.007 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 31.1 m80 -85.17 172.8 10.91 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.885 -0.413 . . . . 1.0600000000000001 109.885 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -121.41 134.39 55.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.899 0.38 . . . . 3.6000000000000001 110.906 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.537 HD21 HD13 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -74.97 139.9 73.5 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.96 -0.564 . . . . 1.51 109.747 175.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 3.7 Cg_exo -76.85 1.32 8.72 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.911 2.407 . . . . 1.01 113.236 -173.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.75 20.38 11.34 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.549 0.69 . . . . 0.87 110.36 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.512 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 12.2 t70 -130.53 131.91 45.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.08 -0.964 . . . . 1.9399999999999999 109.399 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -91.99 103.22 7.63 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.244 -0.435 . . . . 0.67000000000000004 110.439 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 125' ' ' ASP . 2.5 Cg_endo -81.45 158.56 19.57 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.937 2.425 . . . . 0.75 111.897 -178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.44 -20.62 33.88 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.992 2.461 . . . . 0.70999999999999996 113.426 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.458 ' HA ' ' CG1' ' A' ' 42' ' ' VAL . 10.5 p-80 -91.27 11.93 21.93 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.923 -0.311 . . . . 0.93999999999999995 111.29 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.43 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 37.8 mt -128.43 -21.41 3.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.555 -0.293 . . . . 0.82999999999999996 110.878 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.4 m -100.48 128.49 30.1 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.825 0.345 . . . . 1.4399999999999999 110.762 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 32.6 Cg_exo -62.16 154.09 65.13 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.624 2.216 . . . . 1.22 111.349 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 52.5 Cg_exo -55.02 -29.53 65.4 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.819 2.346 . . . . 1.8600000000000001 112.37 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.4 m -58.83 -32.47 69.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.017 -0.538 . . . . 2.0699999999999998 111.029 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -97.46 7.08 47.19 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.438 -0.346 . . . . 1.27 111.218 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -100.1 151.69 21.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 3.0699999999999998 111.301 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -100.63 158.98 15.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.941 -0.572 . . . . 5.46 110.221 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -133.76 129.16 36.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.397 -0.365 . . . . 5.7999999999999998 110.231 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.823 -0.608 . . . . 6.9299999999999997 109.876 174.499 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 121.26 0.552 . . . . 10.57 110.479 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -111.05 162.72 14.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.589 -0.732 . . . . 8.0399999999999991 110.396 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 96.9 p 54.19 -166.04 0.09 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.029 0.831 . . . . 5.1100000000000003 111.547 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 43.9 mttp 63.27 92.79 0.06 OUTLIER Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.017 -0.538 . . . . 6.7000000000000002 111.373 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -73.85 -173.66 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.925 2.417 . . . . 1.96 112.543 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -87.54 -11.25 49.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.908 -0.587 . . . . 0.89000000000000001 110.365 -177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.595 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 52.2 t-20 -97.62 113.7 63.87 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 0.42999999999999999 110.081 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 10.0 Cg_exo -72.66 -7.34 20.65 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.421 2.747 . . . . 0.51000000000000001 112.862 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -107.15 5.65 28.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.317 0.579 . . . . 0.5 109.861 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.595 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 23.0 tt0 -130.36 26.65 5.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.188 -0.915 . . . . 1.4199999999999999 108.643 -175.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -91.46 138.81 31.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.002 -0.999 . . . . 1.71 111.274 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 67.25 -175.56 0.2 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.371 -0.831 . . . . 4.8099999999999996 112.32 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -119.58 -62.21 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.741 -0.663 . . . . 5.9800000000000004 111.259 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 55.64 41.48 30.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.57 0.7 . . . . 7.1900000000000004 111.051 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.25 1.103 0 CA-C-N 115.002 -0.999 . . . . 7.3200000000000003 110.169 178.827 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.652 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 112.162 -0.375 . . . . 11.68 112.162 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.39 102.31 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.619 2.212 . . . . 11.24 111.726 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.5 mt -66.41 121.46 15.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.896 -0.593 . . . . 8.6199999999999992 111.642 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -98.32 117.98 6.0 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.759 -0.734 . . . . 6.6399999999999997 111.785 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.7 t -129.48 115.85 18.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.801 0.334 . . . . 5.8499999999999996 110.392 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.07 95.04 9.55 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.256 -0.646 . . . . 4.0099999999999998 109.256 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -77.31 121.8 24.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.451 0.643 . . . . 3.8599999999999999 109.815 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 129' ' ' HIS . 24.7 t -98.17 133.59 39.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.673 -0.694 . . . . 1.8400000000000001 110.66 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -72.56 139.65 47.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.06 -0.518 . . . . 3.02 110.427 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TRP . . . . . 0.468 ' HZ2' ' HG ' ' A' ' 108' ' ' LEU . 13.9 t90 -70.32 101.95 2.03 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.512 -0.921 . . . . 0.84999999999999998 108.512 175.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.4 t -48.56 -33.35 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 115.497 -0.774 . . . . 1.24 112.848 -171.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.59 HG21 HD23 ' A' ' 108' ' ' LEU . 58.8 t -67.6 -22.71 28.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.252 -0.431 . . . . 1.3 111.722 -175.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.61 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -66.28 -22.37 70.95 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.455 -0.878 . . . . 0.62 111.503 176.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -78.54 -21.32 48.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.235 0.54 . . . . 2.9900000000000002 110.889 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -119.72 15.13 12.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.73 0.776 . . . . 1.8200000000000001 109.761 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.61 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 2.4 mmmm -54.04 -45.03 99.17 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.1 -0.955 . . . . 0.93000000000000005 113.343 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.6 Cg_endo -48.42 -40.72 36.53 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.739 2.292 . . . . 0.56999999999999995 113.15 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 m -69.66 -43.99 71.43 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-O 121.611 0.72 . . . . 0.67000000000000004 110.276 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.481 ' CE2' HG13 ' A' ' 46' ' ' VAL . 12.0 m-85 -71.01 -22.51 62.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.342 -0.844 . . . . 0.92000000000000004 109.878 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.25 -45.17 66.99 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.189 -0.671 . . . . 1.8600000000000001 109.189 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -56.3 -47.5 78.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.758 -1.11 . . . . 2.0 111.379 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.3 mt -75.31 -37.86 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.728 0.299 . . . . 0.53000000000000003 111.282 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -59.65 -52.28 66.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.327 -0.397 . . . . 0.42999999999999999 111.431 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -71.15 -21.03 62.24 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.299 0.481 . . . . 3.0800000000000001 112.299 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.4 p -78.92 -3.32 44.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.425 -0.51 . . . . 0.75 111.679 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.0 mt -100.96 7.58 43.5 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.941 0.401 . . . . 1.26 110.469 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.0 m 59.18 84.7 0.2 Allowed Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 115.475 -0.784 . . . . 1.1100000000000001 112.12 176.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.91 142.69 20.08 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.09 2.527 . . . . 0.68999999999999995 112.309 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.3 t -114.07 118.98 60.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.609 -0.515 . . . . 1.4299999999999999 109.609 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 59.98 27.21 16.58 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.088 -0.505 . . . . 2.1499999999999999 111.49 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.17 -3.42 69.69 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.001 -0.619 . . . . 0.62 114.003 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.63 ' HE3' ' N ' ' A' ' 102' ' ' ASP . 30.5 mtpt -131.1 149.21 52.7 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 117.901 0.85 . . . . 2.2400000000000002 110.776 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.421 HD11 ' CD1' ' A' ' 106' ' ' PHE . 43.2 pt -101.95 157.89 4.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.002 -0.545 . . . . 0.31 110.079 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.9 p -86.78 161.96 18.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.526 -0.761 . . . . 0.52000000000000002 110.915 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.88 -27.39 72.07 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.645 -0.707 . . . . 0.38 112.883 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.34 -53.59 55.53 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.097 0.475 . . . . 0.40000000000000002 111.866 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.466 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 45.0 m-80 -73.6 -34.32 65.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.021 -0.536 . . . . 1.73 111.094 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 76' ' ' MET . . . -73.44 -29.17 62.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.346 -0.388 . . . . 0.35999999999999999 110.275 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.559 ' HA ' ' HZ ' ' B' ' 151' ' ' PHE . 39.3 ttmt -66.4 -51.16 59.95 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.702 0.287 . . . . 0.60999999999999999 110.263 176.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 ptmt -63.26 -35.75 81.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.365 -0.379 . . . . 2.2400000000000002 111.731 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -67.4 -45.9 74.81 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.521 0.677 . . . . 0.81999999999999995 109.815 175.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.716 ' SD ' HD11 ' A' ' 113' ' ' ILE . 7.7 tpp -59.62 -42.4 92.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.392 -0.822 . . . . 1.04 111.077 -177.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.3 m -74.2 -30.39 26.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.819 0.342 . . . . 1.02 110.663 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -69.47 -17.9 63.66 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.913 -0.315 . . . . 3.04 110.983 176.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.4 m -73.83 -8.56 56.53 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.429 -0.35 . . . . 0.85999999999999999 111.053 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm 73.17 21.36 3.13 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.658 0.985 . . . . 2.0499999999999998 113.658 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.413 ' HB2' HD11 ' A' ' 86' ' ' LEU . 2.7 mm? -95.3 148.82 35.25 Favored Pre-proline 0 C--N 1.32 -0.682 0 C-N-CA 120.602 -0.439 . . . . 1.3400000000000001 109.822 174.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.592 ' O ' HD13 ' A' ' 86' ' ' LEU . 32.9 Cg_exo -60.1 151.95 69.04 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.982 2.454 . . . . 0.62 112.432 176.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -57.67 -33.14 68.02 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.424 -0.353 . . . . 0.93999999999999995 111.244 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.34 -38.68 80.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.437 0.637 . . . . 0.58999999999999997 110.514 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 89' ' ' ILE . 57.3 t -75.83 -39.6 38.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.754 -0.832 . . . . 0.40000000000000002 108.754 -177.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.652 ' HG ' ' CG ' ' A' ' 76' ' ' MET . 3.6 mp -60.76 -44.82 96.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.997 -1.001 . . . . 1.25 111.16 176.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.623 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -61.92 -35.35 91.24 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.888 -0.672 . . . . 0.34000000000000002 111.784 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.715 ' HD3' ' HB2' ' A' ' 122' ' ' LEU . 38.6 ttmt -71.48 -45.39 62.64 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.188 0.518 . . . . 1.1599999999999999 110.063 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.691 HG23 ' HB2' ' A' ' 112' ' ' LEU . 72.0 mt -61.44 -50.77 79.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.539 -0.755 . . . . 0.89000000000000001 110.692 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -60.32 -43.04 96.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.89 -0.595 . . . . 0.34999999999999998 110.67 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.13 -25.2 64.27 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.92 -0.312 . . . . 1.3799999999999999 111.244 -175.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.34 -43.78 55.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.344 0.592 . . . . 1.53 110.026 172.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -66.97 -42.63 84.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.196 -0.911 . . . . 0.42999999999999999 111.411 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.647 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 27.9 t0 -95.89 62.14 2.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.8 0.809 . . . . 0.58999999999999997 109.348 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.569 HG13 ' HG2' ' A' ' 135' ' ' LYS . 3.0 p -64.66 -28.09 44.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 114.543 -1.208 . . . . 1.49 111.575 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.618 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 3.9 p30 -86.99 -10.94 51.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.997 -0.547 . . . . 1.45 111.795 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HD2' ' O ' ' A' ' 94' ' ' ASP . 1.3 mptm? 56.17 73.64 0.43 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.715 0.406 . . . . 2.6699999999999999 112.062 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.634 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 5.4 p-10 -120.32 -20.94 7.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.478 -0.328 . . . . 1.1299999999999999 110.753 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 100.5 -18.99 54.44 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.706 -0.759 . . . . 0.42999999999999999 113.444 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.424 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 86.6 mt -110.21 169.03 9.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.013 0.406 . . . . 0.45000000000000001 109.985 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 106' ' ' PHE . 76.3 mt -124.52 114.93 20.07 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.565 -0.454 . . . . 0.70999999999999996 110.952 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.63 ' N ' ' HE3' ' A' ' 66' ' ' LYS . 1.0 OUTLIER -84.85 -175.78 5.93 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.119 -0.697 . . . . 1.4199999999999999 109.119 171.473 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -62.27 -32.93 73.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.882 -0.327 . . . . 1.73 110.713 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.88 -52.29 11.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.766 0.317 . . . . 1.53 110.637 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.547 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 31.5 mt-10 -62.18 -47.36 84.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.345 -0.389 . . . . 0.81999999999999995 111.606 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 92.4 t80 -63.78 -37.1 86.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.987 0.422 . . . . 0.37 110.469 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.05 90.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.843 -0.617 . . . . 0.5 110.778 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.59 HD23 HG21 ' A' ' 46' ' ' VAL . 26.1 mt -64.08 -41.52 97.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 1.3200000000000001 110.632 174.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -54.94 -52.4 63.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.257 0.551 . . . . 0.26000000000000001 110.281 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . 0.415 HD22 ' N ' ' A' ' 110' ' ' ASN . 0.9 OUTLIER -69.0 -21.78 64.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.614 . . . . 1.3600000000000001 110.912 -177.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.609 ' O ' HG23 ' A' ' 115' ' ' VAL . 9.5 t60 -60.52 -61.2 2.77 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.18 0.514 . . . . 0.67000000000000004 109.626 174.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.691 ' HB2' HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -60.17 -34.9 74.23 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.73 -1.123 . . . . 0.89000000000000001 110.76 -176.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.716 HD11 ' SD ' ' A' ' 76' ' ' MET . 86.7 mt -60.75 -46.88 95.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.242 -0.436 . . . . 0.46000000000000002 110.484 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.414 ' HA ' HD12 ' A' ' 117' ' ' LEU . 36.6 ttmt -63.06 -36.41 83.49 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.429 -0.351 . . . . 2.0699999999999998 111.162 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 111' ' ' HIS . 14.1 t -62.74 -36.97 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.063 0.459 . . . . 0.5 109.793 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.7 mmtt -72.14 -28.11 63.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 1.25 111.135 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 95.4 mt -68.98 -20.59 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.125 0.488 . . . . 0.93999999999999995 110.326 176.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -87.75 -1.12 57.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.185 0.516 . . . . 1.6499999999999999 110.396 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.74 35.44 54.89 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.783 -0.644 . . . . 0.80000000000000004 112.203 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.482 ' HB2' HG12 ' A' ' 115' ' ' VAL . 20.4 m-70 -99.49 -171.84 2.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.196 0.522 . . . . 1.0600000000000001 111.99 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -118.59 152.06 36.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.376 -0.829 . . . . 3.6000000000000001 110.638 -174.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.715 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 5.1 mt -118.74 122.04 30.19 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.852 -0.425 . . . . 1.51 109.852 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.45 -11.79 12.91 Favored 'Trans proline' 0 C--N 1.334 -0.22 0 C-N-CA 123.458 2.772 . . . . 1.01 112.698 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.584 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . 65.98 19.29 11.22 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.838 -0.619 . . . . 0.87 110.896 -176.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . 0.425 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 10.7 m-20 -107.0 137.34 45.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.849 -0.614 . . . . 1.9399999999999999 110.573 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.4 mt -95.89 109.53 46.96 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.934 -0.575 . . . . 0.67000000000000004 111.21 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.791 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -83.72 160.62 14.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.504 2.803 . . . . 0.75 111.61 176.131 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.84 -25.38 76.31 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.709 2.272 . . . . 0.70999999999999996 113.057 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' HIS . . . . . 0.464 ' HB3' HG11 ' A' ' 42' ' ' VAL . 12.1 p-80 -89.46 8.6 30.14 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.943 -0.303 . . . . 0.93999999999999995 111.586 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.791 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 30.0 mt -123.45 -19.54 5.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.734 -0.212 . . . . 0.82999999999999996 111.204 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.4 t -87.5 108.96 22.52 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.983 0.42 . . . . 1.4399999999999999 110.198 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 10.2 Cg_exo -69.81 146.75 60.84 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.789 2.326 . . . . 1.22 111.933 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 36.2 Cg_exo -59.85 -22.45 68.38 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.016 2.477 . . . . 1.8600000000000001 111.965 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.2 t -64.93 -19.91 66.18 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.856 -0.611 . . . . 2.0699999999999998 110.801 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.569 ' HG2' HG13 ' A' ' 95' ' ' VAL . 2.5 mptp? -110.35 18.74 19.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.904 0.383 . . . . 1.27 110.621 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -95.33 123.63 38.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.855 0.36 . . . . 3.0699999999999998 111.148 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -82.18 106.05 13.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.078 0.465 . . . . 5.46 111.453 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -110.67 107.26 16.77 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.648 -0.871 . . . . 5.7999999999999998 108.648 172.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.332 -0.842 . . . . 6.9299999999999997 110.208 -177.061 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 120.974 0.416 . . . . 10.57 109.908 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -91.52 143.26 26.77 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.159 0.504 . . . . 8.0399999999999991 111.101 -171.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 19.6 t -145.74 80.61 1.59 Allowed 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.357 -0.979 . . . . 5.1100000000000003 108.357 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 0.473 ' HA ' ' HD3' ' B' ' 147' ' ' PRO . 21.4 pttp -91.38 146.64 33.75 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 6.7000000000000002 109.777 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 147' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' B' ' 146' ' ' LYS . 12.1 Cg_exo -69.56 -179.74 3.03 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.793 2.328 . . . . 1.96 112.824 -175.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -107.08 2.72 25.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.499 -0.773 . . . . 0.89000000000000001 109.404 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.623 HD21 ' HA2' ' A' ' 87' ' ' GLY . 51.7 t-20 -102.34 118.9 57.83 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.021 -0.99 . . . . 0.42999999999999999 109.814 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 18.9 Cg_exo -67.45 -7.45 19.19 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.504 2.803 . . . . 0.51000000000000001 112.951 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.559 ' HZ ' ' HA ' ' A' ' 73' ' ' LYS . 40.6 m-85 -107.68 4.21 25.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.295 0.569 . . . . 0.5 110.081 176.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.604 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 32.8 tt0 -118.5 13.77 13.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.05 -0.977 . . . . 1.4199999999999999 109.393 -174.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -82.97 105.55 14.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.584 -0.735 . . . . 1.71 111.846 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 75.3 111.4 0.07 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.906 -1.043 . . . . 4.8099999999999996 112.023 173.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -147.45 -72.56 0.21 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.391 -0.822 . . . . 5.9800000000000004 109.987 173.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 156' ' ' GLU . . . . . 0.807 ' HG3' ' H ' ' B' ' 157' ' ' ASP . 4.5 pt-20 -112.84 -74.69 0.62 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.713 -0.676 . . . . 7.1900000000000004 110.509 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 157' ' ' ASP . . . . . 0.807 ' H ' ' HG3' ' B' ' 156' ' ' GLU . 28.2 t70 . . . . . 0 C--O 1.244 0.811 0 CA-C-O 118.155 -0.926 . . . . 7.3200000000000003 109.193 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.647 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.48 1.573 0 N-CA-C 111.781 -0.528 . . . . 11.68 111.781 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 4.4 Cg_exo -74.85 126.49 10.09 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.008 2.472 . . . . 11.24 112.208 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.2 mp -96.2 148.74 22.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.9 0.381 . . . . 8.6199999999999992 110.577 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.63 130.91 10.42 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.97 -0.852 . . . . 6.6399999999999997 110.97 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.8 m -71.29 111.78 6.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.872 0.367 . . . . 5.8499999999999996 110.538 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -94.61 92.24 6.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.864 0.364 . . . . 4.0099999999999998 110.765 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -144.56 120.62 10.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.287 0.565 . . . . 3.8599999999999999 109.69 172.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 p -124.08 156.63 31.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.472 -0.785 . . . . 1.8400000000000001 110.046 -173.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 1.3 pm0 -74.58 105.25 5.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.252 0.549 . . . . 3.02 110.954 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -82.35 99.31 9.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.83 -0.804 . . . . 0.84999999999999998 108.83 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.7 t -57.5 -40.66 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 113.614 0.968 . . . . 1.24 113.614 -167.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.5 HG12 ' CG ' ' A' ' 111' ' ' HIS . 5.3 m -69.87 -10.76 14.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.893 -0.323 . . . . 1.3 111.723 -171.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.767 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -69.53 -15.94 71.22 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.745 -0.741 . . . . 0.62 111.895 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -78.33 -28.2 47.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 2.9900000000000002 110.628 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -121.16 23.4 10.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.538 0.685 . . . . 1.8200000000000001 109.959 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.767 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 4.4 mmmp? -52.61 -41.98 86.17 Favored Pre-proline 0 C--O 1.218 -0.556 0 CA-C-N 115.342 -0.845 . . . . 0.93000000000000005 112.942 177.032 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 7.8 Cg_endo -48.8 -43.31 35.14 Favored 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 122.582 2.188 . . . . 0.56999999999999995 112.671 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.583 ' O ' HG13 ' A' ' 56' ' ' ILE . 14.3 m -70.18 -44.58 68.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.035 0.445 . . . . 0.67000000000000004 110.889 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -71.07 -22.74 62.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.352 0.596 . . . . 0.92000000000000004 109.809 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.414 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 9.3 t70 -73.67 -44.3 57.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.031 -0.986 . . . . 1.8600000000000001 108.85 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -55.31 -53.44 56.16 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 114.916 -1.038 . . . . 2.0 110.318 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.583 HG13 ' O ' ' A' ' 52' ' ' THR . 17.3 mt -64.56 -40.0 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 114.962 -1.017 . . . . 0.53000000000000003 110.668 -175.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 62' ' ' PRO . 79.9 t80 -59.03 -38.13 78.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.066 -0.516 . . . . 0.42999999999999999 110.783 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.493 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 17.5 m-85 -82.07 -22.99 36.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.445 -0.343 . . . . 3.0800000000000001 111.892 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.3 p -77.62 -18.71 56.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.14 0.495 . . . . 0.75 111.006 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.0 mp -91.08 4.1 53.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.972 -0.558 . . . . 1.26 110.465 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.7 m 68.01 91.43 0.07 OUTLIER Pre-proline 0 CA--C 1.529 0.165 0 O-C-N 124.047 0.842 . . . . 1.1100000000000001 111.726 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.493 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 1.9 Cg_endo -81.14 96.36 0.96 Allowed 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.599 2.2 . . . . 0.68999999999999995 111.299 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.5 m -86.87 117.44 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.34 0.591 . . . . 1.4299999999999999 110.205 -175.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 64.2 23.87 13.25 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.231 -0.895 . . . . 2.1499999999999999 110.819 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.48 33.42 19.61 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.931 -0.652 . . . . 0.62 113.36 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HG2' ' HB2' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -165.08 145.58 7.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.079 -0.711 . . . . 2.2400000000000002 109.079 175.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.4 pt -102.69 145.92 11.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.492 -0.483 . . . . 0.31 110.13 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.803 ' HA ' HD22 ' A' ' 100' ' ' LEU . 44.3 p -84.91 165.91 17.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.11 0.481 . . . . 0.52000000000000002 111.108 -176.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.2 -17.75 64.13 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.67 -0.695 . . . . 0.38 112.663 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.03 -54.34 22.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.113 0.482 . . . . 0.40000000000000002 110.656 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.547 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 1.0 OUTLIER -69.97 -41.29 74.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.769 -0.651 . . . . 1.73 110.593 -174.153 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.523 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -68.19 -29.34 68.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.012 -0.54 . . . . 0.35999999999999999 110.831 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.542 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 40.8 ttmt -65.38 -40.22 93.24 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.645 -0.502 . . . . 0.60999999999999999 109.645 174.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.596 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.2 mtpp -60.1 -43.28 95.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.51 -0.768 . . . . 2.2400000000000002 110.669 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.438 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 4.2 tp10 -65.74 -44.94 84.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.344 0.592 . . . . 0.81999999999999995 110.692 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.697 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 25.6 mmt -56.35 -46.48 79.97 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.769 -0.651 . . . . 1.04 111.243 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.7 m -75.3 -17.69 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.393 -0.367 . . . . 1.02 110.944 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 93.4 mttt -70.4 -30.33 67.19 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 120.402 -0.519 . . . . 3.04 109.831 172.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.0 m -76.3 -9.07 58.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.596 -0.729 . . . . 0.85999999999999999 110.999 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm 62.46 26.95 16.04 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.64 0.734 . . . . 2.0499999999999998 110.665 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.482 ' HB3' HD11 ' A' ' 86' ' ' LEU . 7.9 tp -89.75 137.44 28.5 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.039 -0.982 . . . . 1.3400000000000001 109.893 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.522 ' O ' HD13 ' A' ' 86' ' ' LEU . 45.1 Cg_exo -55.52 145.46 68.99 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 123.23 2.62 . . . . 0.62 113.406 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.409 ' HA ' HD22 ' A' ' 86' ' ' LEU . 13.2 m120 -52.75 -39.96 62.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.98 -0.555 . . . . 0.93999999999999995 112.145 -178.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.5 m -58.08 -35.09 70.89 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.3 0.572 . . . . 0.58999999999999997 110.93 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.625 ' O ' HG12 ' A' ' 89' ' ' ILE . 57.4 t -76.11 -40.96 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 108.867 -0.79 . . . . 0.40000000000000002 108.867 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.697 ' HG ' ' HB3' ' A' ' 76' ' ' MET . 2.2 mp -57.17 -45.37 83.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.309 -0.859 . . . . 1.25 110.05 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.576 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -56.35 -41.68 87.89 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.746 -0.661 . . . . 0.34000000000000002 112.572 175.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -71.16 -46.41 61.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.979 0.39 . . . . 1.1599999999999999 110.664 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 85' ' ' VAL . 49.0 mm -55.89 -50.86 66.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.76 -0.655 . . . . 0.89000000000000001 110.122 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -65.11 -41.98 94.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 0.34999999999999998 110.658 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -65.2 -32.62 74.39 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.207 -0.451 . . . . 1.3799999999999999 111.45 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.513 HD22 HD12 ' A' ' 122' ' ' LEU . 8.3 mp -86.75 -41.98 13.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.42 -0.354 . . . . 1.53 111.367 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -64.9 -43.22 93.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.464 -0.335 . . . . 0.42999999999999999 111.797 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . 0.634 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 34.4 t70 -84.7 88.59 7.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.536 0.684 . . . . 0.58999999999999997 109.831 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.0 t -83.16 -38.0 14.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.984 -1.007 . . . . 1.49 111.141 -176.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.581 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 18.5 p-10 -76.82 -17.25 59.13 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.91 -0.586 . . . . 1.45 110.741 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.505 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 71.8 mmtt 63.16 50.86 2.91 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.571 -0.741 . . . . 2.6699999999999999 111.154 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.623 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 6.8 p-10 -92.91 -16.48 25.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.583 -0.735 . . . . 1.1299999999999999 109.796 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.71 -1.87 66.4 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.745 -0.662 . . . . 0.42999999999999999 112.464 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.803 HD22 ' HA ' ' A' ' 68' ' ' THR . 56.6 mt -128.06 177.75 6.68 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.331 -0.618 . . . . 0.45000000000000001 109.331 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.2 mt -114.56 113.86 24.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.201 0.524 . . . . 0.70999999999999996 110.832 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.478 ' CA ' ' HD3' ' A' ' 66' ' ' LYS . 12.7 t70 -84.81 -177.8 6.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.342 -0.845 . . . . 1.4199999999999999 109.21 173.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -66.62 -35.89 81.28 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.186 0.448 . . . . 1.73 111.719 -170.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -71.92 -42.61 66.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.225 0.536 . . . . 1.53 110.361 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.508 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 19.2 mt-10 -68.05 -45.15 74.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.325 -0.852 . . . . 0.81999999999999995 110.794 -175.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -68.84 -36.51 78.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.032 -0.531 . . . . 0.37 110.908 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.8 -40.81 98.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.903 0.382 . . . . 0.5 110.413 176.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.2 mt -66.99 -36.29 81.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.021 -0.536 . . . . 1.3200000000000001 110.545 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.85 -52.34 65.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.26000000000000001 110.455 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -61.42 -39.65 91.53 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.691 0.281 . . . . 1.3600000000000001 110.661 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.609 ' O ' HG23 ' A' ' 115' ' ' VAL . 83.5 t60 -59.74 -47.79 84.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.472 . . . . 0.67000000000000004 110.807 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.756 HD13 HD13 ' A' ' 122' ' ' LEU . 96.3 mt -64.53 -41.81 96.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.367 -0.379 . . . . 0.89000000000000001 111.116 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.4 mt -60.75 -40.68 85.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.133 0.492 . . . . 0.46000000000000002 109.713 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.651 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 59.7 tttp -59.31 -42.11 90.61 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.715 -0.675 . . . . 2.0699999999999998 110.428 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 111' ' ' HIS . 25.5 t -56.79 -40.15 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.816 0.341 . . . . 0.5 110.116 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 2.3 mmmp? -60.68 -45.49 93.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 1.25 109.912 175.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.9 -25.2 65.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.555 -0.748 . . . . 0.93999999999999995 111.07 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 45.0 mm-40 -70.85 -21.71 62.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.348 -0.387 . . . . 1.6499999999999999 110.461 176.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 111.62 12.54 14.57 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.0 -0.619 . . . . 0.80000000000000004 112.38 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.563 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 29.6 m-70 -121.4 -179.35 4.04 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.553 -0.536 . . . . 1.0600000000000001 109.553 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.469 ' HA ' ' HD2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -140.44 160.18 40.56 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 110.048 -0.353 . . . . 3.6000000000000001 110.048 174.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.756 HD13 HD13 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -92.69 123.94 60.26 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.46 -0.336 . . . . 1.51 110.238 -177.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.38 15.42 0.27 Allowed 'Trans proline' 0 N--CA 1.48 0.695 0 C-N-CA 123.934 3.089 . . . . 1.01 114.229 -169.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 67.01 18.34 10.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.386 0.612 . . . . 0.87 110.489 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.57 147.59 43.55 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.375 -0.829 . . . . 1.9399999999999999 109.506 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.676 ' HB3' ' HB ' ' A' ' 131' ' ' VAL . 96.2 mt -101.31 97.81 8.0 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.574 -0.285 . . . . 0.67000000000000004 110.432 172.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.5 147.97 87.26 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.217 1.945 . . . . 0.75 111.416 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.53 -27.45 25.18 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 123.295 2.663 . . . . 0.70999999999999996 114.173 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -85.01 7.58 20.85 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.061 0.458 . . . . 0.93999999999999995 111.247 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.8 mt -132.39 -31.46 1.41 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.215 -0.448 . . . . 0.82999999999999996 111.327 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.676 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 7.7 p -82.95 123.42 77.77 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 121.117 0.484 . . . . 1.4399999999999999 110.923 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' PRO . . . . . 0.728 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 44.4 Cg_exo -57.02 130.0 37.47 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.934 2.423 . . . . 1.22 112.123 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 33.3 Cg_exo -58.61 -27.53 83.08 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.613 2.875 . . . . 1.8600000000000001 112.933 -175.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.7 t -67.11 -27.14 67.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 2.0699999999999998 111.137 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.728 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 12.8 mptt -96.29 29.69 2.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.089 -0.505 . . . . 1.27 111.021 -175.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -101.6 112.0 24.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.161 0.505 . . . . 3.0699999999999998 111.409 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -112.02 158.56 19.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.651 -0.704 . . . . 5.46 109.87 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -99.97 114.64 28.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.85 0.357 . . . . 5.7999999999999998 111.672 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--O 1.25 1.082 0 CA-C-N 115.284 -0.871 . . . . 6.9299999999999997 109.683 174.461 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.734 -0.469 . . . . 10.57 109.734 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -119.46 166.51 13.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.016 -0.538 . . . . 8.0399999999999991 110.592 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 16.3 m -106.88 -165.27 1.06 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 5.1100000000000003 110.936 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 146' ' ' LYS . . . . . 0.418 ' HB3' ' HE2' ' B' ' 146' ' ' LYS . 49.8 mtpt -117.73 157.98 46.65 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.115 -0.493 . . . . 6.7000000000000002 110.426 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.62 169.67 18.19 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.518 2.145 . . . . 1.96 112.374 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -89.13 -13.66 37.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.018 -0.537 . . . . 0.89000000000000001 110.288 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 149' ' ' ASN . . . . . 0.665 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 34.1 t-20 -96.2 114.92 65.19 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.412 -0.813 . . . . 0.42999999999999999 111.101 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 150' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 10.4 Cg_exo -72.08 -2.65 11.9 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.351 2.701 . . . . 0.51000000000000001 113.007 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 151' ' ' PHE . . . . . 0.542 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 68.8 m-85 -107.02 -23.34 12.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.511 0.672 . . . . 0.5 110.333 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 152' ' ' GLU . . . . . 0.665 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 41.7 tt0 -109.46 22.38 15.85 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.975 -1.011 . . . . 1.4199999999999999 109.397 -173.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.0 142.96 56.2 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.401 -0.818 . . . . 1.71 110.731 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 74.3 79.28 0.12 Allowed 'General case' 0 C--O 1.234 0.287 0 O-C-N 124.046 0.841 . . . . 4.8099999999999996 110.654 175.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -106.57 161.32 14.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.439 -0.8 . . . . 5.9800000000000004 110.284 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -119.3 -66.87 1.03 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.393 -0.595 . . . . 7.1900000000000004 109.393 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.359 -0.837 . . . . 7.3200000000000003 109.477 173.33 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ' CA' . . . . . 0.634 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.407 ' HH2' ' HB2' ' A' ' 104' ' ' GLU . 6.2 t90 . . . . . 0 N--CA 1.451 -0.401 0 N-CA-C 108.526 -0.916 . . . . 0.84999999999999998 108.526 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.2 m -56.79 -26.06 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.911 -0.586 . . . . 1.24 112.28 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.637 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 40.8 t -62.77 -19.42 23.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.898 0.38 . . . . 1.3 110.829 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.34 -23.38 64.4 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.789 -0.72 . . . . 0.62 111.982 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -84.11 -28.13 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.794 0.807 . . . . 2.9900000000000002 109.314 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.919 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.1 m-20 -84.29 -28.08 27.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.288 -1.324 . . . . 1.8200000000000001 111.455 -175.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 4.2 mmmp? -47.06 -54.73 18.64 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 115.342 1.608 . . . . 0.93000000000000005 115.342 -168.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.5 Cg_endo -50.21 -41.77 49.0 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.279 1.986 . . . . 0.56999999999999995 112.792 -173.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.4 m -70.63 -43.98 68.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.759 -0.655 . . . . 0.67000000000000004 111.026 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.919 ' CE2' ' HB3' ' A' ' 49' ' ' ASP . 16.6 m-85 -76.74 -19.79 57.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.074 -0.512 . . . . 0.92000000000000004 110.229 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.96 -44.65 80.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.894 -0.78 . . . . 1.8600000000000001 108.894 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -61.91 -45.51 93.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.382 -0.826 . . . . 2.0 110.536 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.11 -39.48 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.153 0.501 . . . . 0.53000000000000003 110.58 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.59 -37.23 75.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.625 -0.716 . . . . 0.42999999999999999 110.619 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 7.4 m-85 -75.82 -24.69 55.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 3.0800000000000001 112.11 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.1 p -81.63 -14.95 56.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.575 -0.45 . . . . 0.75 111.393 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.7 mt -90.88 3.92 53.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.444 -0.344 . . . . 1.26 110.75 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.1 t 68.76 84.86 0.14 Allowed Pre-proline 0 C--O 1.232 0.151 0 O-C-N 123.949 0.78 . . . . 1.1100000000000001 111.246 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 56.1 Cg_endo -75.67 110.84 3.17 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.368 2.045 . . . . 0.68999999999999995 112.27 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.22 116.07 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.258 0.552 . . . . 1.4299999999999999 110.195 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 60.31 23.18 12.64 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.608 -0.724 . . . . 2.1499999999999999 111.257 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.26 18.53 60.53 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.959 -0.564 . . . . 0.62 113.645 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 100' ' ' LEU . 37.3 tttt -153.84 125.19 7.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.301 0.551 . . . . 2.2400000000000002 109.765 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.4 pt -85.32 155.46 3.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.159 0.504 . . . . 0.31 110.874 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.49 ' HA ' HD22 ' A' ' 100' ' ' LEU . 73.5 p -87.37 176.19 7.63 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.375 -0.83 . . . . 0.52000000000000002 110.995 -176.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.466 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -66.24 -26.91 72.65 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.847 -0.692 . . . . 0.38 112.468 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.497 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -69.84 -43.62 71.6 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.922 0.391 . . . . 0.40000000000000002 111.145 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -60.92 -51.89 67.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.714 0.769 . . . . 1.73 109.996 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.473 ' HB3' ' HZ3' ' A' ' 90' ' ' TRP . . . -73.54 -24.29 60.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.481 -0.781 . . . . 0.35999999999999999 110.985 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.661 ' HD3' ' HB2' ' B' ' 150' ' ' PRO . 34.0 ttpt -64.1 -46.84 82.47 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.586 -0.446 . . . . 0.60999999999999999 110.278 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.703 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 5.4 ptpp? -71.09 -27.32 63.53 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 120.232 -0.587 . . . . 2.2400000000000002 110.728 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.452 ' HA ' ' NZ ' ' A' ' 78' ' ' LYS . 17.7 tp10 -67.3 -44.12 80.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.228 0.537 . . . . 0.81999999999999995 109.851 174.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.425 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -61.45 -39.57 91.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.427 -0.806 . . . . 1.04 111.674 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 74' ' ' LYS . 19.2 m -73.72 -23.03 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.366 -0.534 . . . . 1.02 110.71 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.703 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 32.6 mtmm -73.17 -24.14 60.52 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.981 0.419 . . . . 3.04 110.147 174.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.2 m -68.84 -16.04 63.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.85999999999999999 111.089 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? 67.59 31.08 6.31 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.441 0.534 . . . . 2.0499999999999998 112.441 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 81' ' ' LEU . 3.6 mm? -97.66 152.92 38.41 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.486 -0.325 . . . . 1.3400000000000001 110.16 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.527 ' O ' HD13 ' A' ' 86' ' ' LEU . 35.5 Cg_exo -57.64 143.12 95.67 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.552 2.168 . . . . 0.62 111.616 174.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -57.38 -34.77 69.19 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.85 0.357 . . . . 0.93999999999999995 111.436 -173.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.0 m -58.6 -38.86 78.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.872 -0.604 . . . . 0.58999999999999997 110.948 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.609 ' O ' HG12 ' A' ' 89' ' ' ILE . 98.6 t -70.21 -39.24 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.81 -0.632 . . . . 0.40000000000000002 109.426 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.527 HD13 ' O ' ' A' ' 82' ' ' PRO . 6.5 mp -57.67 -47.02 83.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.462 -0.79 . . . . 1.25 110.527 178.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.564 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -60.67 -39.92 97.28 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.033 -0.603 . . . . 0.34000000000000002 112.401 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -69.96 -45.34 67.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.664 0.269 . . . . 1.1599999999999999 110.604 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 85' ' ' VAL . 46.0 mm -56.64 -47.09 82.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.89000000000000001 110.266 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.473 ' HZ3' ' HB3' ' A' ' 72' ' ' ALA . 22.9 t-105 -64.46 -46.62 82.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.855 -0.611 . . . . 0.34999999999999998 110.906 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -66.32 -24.1 66.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 1.3799999999999999 111.38 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.472 ' O ' HD11 ' A' ' 126' ' ' LEU . 4.3 mm? -86.72 -47.44 9.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.349 -0.387 . . . . 1.53 110.841 173.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.48 -38.16 83.96 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.95 0.722 . . . . 0.42999999999999999 112.95 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -76.59 86.28 3.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.274 0.559 . . . . 0.58999999999999997 109.719 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.0 t -76.62 -25.01 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.648 -0.706 . . . . 1.49 110.786 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.564 ' HB2' ' OD1' ' A' ' 98' ' ' ASP . 67.1 m-20 -70.49 -24.82 62.92 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.606 -0.438 . . . . 1.45 110.871 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 97' ' ' LYS . 41.2 mmtm 56.27 35.78 26.36 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.776 0.798 . . . . 2.6699999999999999 108.997 -170.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.564 ' OD1' ' HB2' ' A' ' 96' ' ' ASP . 9.0 p-10 -99.6 -18.72 17.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.486 -1.234 . . . . 1.1299999999999999 110.692 -173.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.72 -6.85 77.34 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.613 -0.803 . . . . 0.42999999999999999 112.777 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . 67.8 mt -117.67 160.15 21.79 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.458 -0.571 . . . . 0.45000000000000001 109.458 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 105' ' ' GLU . 65.0 mt -121.54 113.96 20.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.977 0.417 . . . . 0.70999999999999996 110.321 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.746 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 3.4 p30 -84.29 -176.28 6.18 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.56 -0.904 . . . . 1.4199999999999999 108.56 171.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -63.7 -28.16 69.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.623 0.601 . . . . 1.73 112.623 -170.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.746 ' HG2' ' OD1' ' A' ' 102' ' ' ASP . 13.3 pt-20 -85.42 -39.07 17.95 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 119.841 -0.744 . . . . 1.53 110.704 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.498 ' HB3' HD22 ' A' ' 101' ' ' LEU . 46.0 mt-10 -63.61 -45.84 88.52 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.361 0.601 . . . . 0.81999999999999995 110.27 175.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -64.44 -39.33 93.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.197 -0.91 . . . . 0.37 110.657 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.79 79.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.143 -0.481 . . . . 0.5 110.734 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.2 mt -68.98 -41.42 77.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.623 -0.262 . . . . 1.3200000000000001 110.462 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -54.01 -52.07 61.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.26000000000000001 110.509 174.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -65.6 -39.78 91.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.273 -0.421 . . . . 1.3600000000000001 110.95 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.646 ' O ' HG23 ' A' ' 115' ' ' VAL . 79.1 t60 -57.87 -47.29 83.17 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.534 -0.303 . . . . 0.67000000000000004 110.428 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.469 HD13 HD13 ' A' ' 122' ' ' LEU . 92.5 mt -65.18 -43.3 92.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.526 -0.306 . . . . 0.89000000000000001 111.018 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 109' ' ' ALA . 73.9 mt -56.63 -44.24 80.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 120.989 0.423 . . . . 0.46000000000000002 110.304 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.655 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 62.9 tttp -61.35 -42.87 99.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.898 -0.592 . . . . 2.0699999999999998 110.833 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 111' ' ' HIS . 29.8 t -55.92 -42.02 69.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.889 0.376 . . . . 0.5 110.062 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.603 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 29.1 mmmt -62.61 -43.77 97.98 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.748 -0.66 . . . . 1.25 110.802 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.96 -29.59 70.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.36 -0.382 . . . . 0.93999999999999995 111.494 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 53.9 mm-40 -72.18 -4.77 31.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.24 -0.436 . . . . 1.6499999999999999 110.753 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.34 2.24 56.71 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.851 -0.69 . . . . 0.80000000000000004 112.295 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.603 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 72.3 m-70 -112.33 -178.36 3.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.755 0.312 . . . . 1.0600000000000001 110.177 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.43 156.45 46.96 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.967 0.413 . . . . 3.6000000000000001 110.649 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.469 HD13 HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -80.81 140.25 50.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.691 -0.686 . . . . 1.51 109.271 177.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.53 8.09 2.02 Favored 'Trans proline' 0 N--CA 1.476 0.483 0 C-N-CA 122.997 2.465 . . . . 1.01 113.655 -174.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.7 19.15 11.58 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.242 0.544 . . . . 0.87 111.027 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.498 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 39.6 m-20 -120.48 127.38 52.16 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.862 -0.608 . . . . 1.9399999999999999 110.088 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 92' ' ' LEU . 86.6 mt -94.18 97.34 2.17 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.317 -0.401 . . . . 0.67000000000000004 110.284 167.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.695 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 86.0 Cg_endo -83.02 173.03 10.41 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.666 2.244 . . . . 0.75 111.542 175.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.96 -31.32 52.47 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.811 2.34 . . . . 0.70999999999999996 113.225 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -90.8 14.16 14.36 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.759 0.314 . . . . 0.93999999999999995 111.627 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.695 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 31.2 mt -131.06 -28.91 1.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.413 -0.358 . . . . 0.82999999999999996 110.504 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 85.8 t . . . . . 0 C--N 1.33 -0.274 0 N-CA-C 110.062 -0.347 . . . . 1.4399999999999999 110.062 174.317 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 . . . . . 0 CA--C 1.518 -0.273 0 CA-C-O 121.253 0.549 . . . . 0.89000000000000001 109.813 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.576 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 53.7 t-20 -114.97 117.76 41.35 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.202 -0.908 . . . . 0.42999999999999999 109.772 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.661 ' HB2' ' HD3' ' A' ' 73' ' ' LYS . 59.1 Cg_endo -72.11 -2.76 12.09 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.955 2.437 . . . . 0.51000000000000001 112.596 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 29.7 m-85 -107.87 5.96 26.93 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.287 -0.634 . . . . 0.5 109.287 175.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 29.0 tt0 . . . . . 0 C--N 1.322 -0.601 0 CA-C-N 114.851 -1.068 . . . . 1.4199999999999999 108.508 -177.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.9 t90 . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 121.534 0.683 . . . . 0.84999999999999998 109.212 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.87 5.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.148 -0.933 . . . . 1.24 112.827 -173.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.521 HG13 ' HE2' ' A' ' 53' ' ' TYR . 24.6 t -93.95 -17.04 7.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.935 0.398 . . . . 1.3 110.091 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.18 -18.87 71.6 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.506 -0.854 . . . . 0.62 112.67 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -87.18 -26.83 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.917 0.389 . . . . 2.9900000000000002 111.759 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 22.9 m-20 -101.1 -2.71 30.79 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.324 0.583 . . . . 1.8200000000000001 109.878 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.569 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 2.8 tmtp? -55.17 -50.06 88.75 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 114.932 -1.031 . . . . 0.93000000000000005 112.635 -175.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.9 Cg_endo -51.45 -38.63 64.15 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.546 2.164 . . . . 0.56999999999999995 112.095 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 m -69.24 -40.08 78.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.829 -0.623 . . . . 0.67000000000000004 110.716 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.521 ' HE2' HG13 ' A' ' 46' ' ' VAL . 14.5 m-85 -70.33 -24.29 62.97 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.127 0.489 . . . . 0.92000000000000004 109.763 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.67 -44.74 61.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.478 -0.783 . . . . 1.8600000000000001 109.989 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.09 -45.77 90.0 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.6 -0.727 . . . . 2.0 110.388 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.9 mt -64.33 -44.58 97.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 121.207 0.527 . . . . 0.53000000000000003 110.73 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -52.06 -45.19 64.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.495 -0.775 . . . . 0.42999999999999999 111.476 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -81.78 -23.71 36.41 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.36 0.504 . . . . 3.0800000000000001 112.36 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.3 p -75.33 -16.79 60.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.136 0.493 . . . . 0.75 110.627 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 72.4 mt -84.46 -10.0 57.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.893 -0.594 . . . . 1.26 110.307 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.0 m 70.07 93.09 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.314 0 O-C-N 124.161 0.913 . . . . 1.1100000000000001 111.311 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.411 ' HA ' HG22 ' A' ' 67' ' ' ILE . 1.0 OUTLIER -84.23 140.67 8.79 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.654 2.903 . . . . 0.68999999999999995 111.653 178.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.2 m -97.37 107.62 20.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.443 0.64 . . . . 1.4299999999999999 110.326 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 m120 63.55 31.22 14.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.194 -0.912 . . . . 2.1499999999999999 111.014 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.15 -0.01 66.09 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.726 -0.75 . . . . 0.62 114.37 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.524 ' HE2' ' HB2' ' A' ' 100' ' ' LEU . 71.8 tttt -137.47 138.21 39.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.755 0.778 . . . . 2.2400000000000002 109.371 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 62' ' ' PRO . 46.2 pt -93.14 156.71 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.632 -0.427 . . . . 0.31 111.102 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.409 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 50.0 p -88.24 -179.65 6.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.512 -0.767 . . . . 0.52000000000000002 110.322 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.81 -14.46 81.48 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.554 -0.831 . . . . 0.38 111.808 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.03 -39.88 28.94 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.947 0.403 . . . . 0.40000000000000002 110.745 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.718 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 5.4 m120 -63.44 -52.22 62.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.981 0.896 . . . . 1.73 109.653 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.458 ' HB3' ' HZ3' ' A' ' 90' ' ' TRP . . . -67.66 -26.45 66.21 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.267 -0.879 . . . . 0.35999999999999999 110.732 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 35.7 ttmt -65.42 -47.79 75.02 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.743 -0.383 . . . . 0.60999999999999999 110.739 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.718 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 19.8 ptmt -64.74 -31.0 72.02 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.928 0.394 . . . . 2.2400000000000002 110.477 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HA ' ' HZ2' ' A' ' 78' ' ' LYS . 17.1 tp10 -71.11 -48.38 52.59 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.251 0.548 . . . . 0.81999999999999995 110.21 175.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.469 ' HB3' HD22 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -58.13 -47.3 83.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.532 -0.758 . . . . 1.04 111.604 -178.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.8 m -67.47 -34.74 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.671 0.272 . . . . 1.02 110.804 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HZ2' ' HA ' ' A' ' 75' ' ' GLU . 3.2 mtpm? -64.38 -18.7 64.92 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 112.282 0.475 . . . . 3.04 112.282 174.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.4 m -84.18 2.32 40.26 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.744 0.307 . . . . 0.85999999999999999 111.127 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? 54.92 50.36 15.74 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.76 0.652 . . . . 2.0499999999999998 112.76 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.632 ' HB2' HD21 ' A' ' 86' ' ' LEU . 96.3 mt -120.49 141.44 32.1 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 110.092 -0.336 . . . . 1.3400000000000001 110.092 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.525 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 37.1 Cg_exo -59.62 151.41 69.93 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.061 2.507 . . . . 0.62 112.82 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -51.41 -45.27 62.5 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.822 -0.627 . . . . 0.93999999999999995 111.77 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.0 m -58.25 -41.39 84.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.01 0.434 . . . . 0.58999999999999997 111.285 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 89' ' ' ILE . 46.2 t -68.88 -42.08 82.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.981 0.42 . . . . 0.40000000000000002 109.881 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' A' ' 81' ' ' LEU . 67.3 mt -62.31 -38.94 91.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.652 -0.704 . . . . 1.25 110.033 177.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.409 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -61.96 -37.22 94.04 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.792 -0.64 . . . . 0.34000000000000002 112.251 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -66.6 -47.06 73.9 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.894 0.378 . . . . 1.1599999999999999 110.034 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 85' ' ' VAL . 38.2 mm -55.08 -50.05 66.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.355 -0.839 . . . . 0.89000000000000001 109.962 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.458 ' HZ3' ' HB3' ' A' ' 72' ' ' ALA . 34.9 t-105 -65.81 -44.5 85.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.919 -0.582 . . . . 0.34999999999999998 111.545 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ttpt -67.46 -21.37 65.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.079 0.466 . . . . 1.3799999999999999 110.738 -174.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.602 HD12 HD12 ' A' ' 122' ' ' LEU . 24.7 mt -91.92 -38.37 12.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.767 -0.651 . . . . 1.53 111.139 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.77 -35.36 67.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.42999999999999999 111.781 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -85.09 82.28 8.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.744 0.783 . . . . 0.58999999999999997 109.289 -179.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.2 t -74.1 -27.68 22.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.072 -0.967 . . . . 1.49 110.951 -173.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 55.3 p30 -86.81 -10.14 54.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.565 -0.289 . . . . 1.45 111.191 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 53.51 51.52 15.1 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.493 0.495 . . . . 2.6699999999999999 110.808 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -111.98 -8.68 14.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.061 -0.518 . . . . 1.1299999999999999 111.089 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.1 4.84 86.42 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.97 -0.633 . . . . 0.42999999999999999 112.529 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.524 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 52.3 mt -129.68 162.53 28.14 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.828 -0.434 . . . . 0.45000000000000001 109.828 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.4 mt -122.66 117.52 25.97 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.801 -0.359 . . . . 0.70999999999999996 110.946 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.05 -178.04 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.419 -0.956 . . . . 1.4199999999999999 108.419 169.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -60.51 -29.23 68.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.892 0.331 . . . . 1.73 111.892 -173.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.78 -42.23 18.18 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.811 -0.356 . . . . 1.53 110.464 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -65.72 -40.44 92.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.22 0.534 . . . . 0.81999999999999995 110.265 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -69.4 -34.48 74.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.678 -0.692 . . . . 0.37 109.998 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.33 -42.25 98.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.329 -0.396 . . . . 0.5 110.284 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 1.8 mm? -59.5 -44.16 93.17 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.713 -0.477 . . . . 1.3200000000000001 109.713 173.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.445 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.58 -54.24 48.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.651 -0.704 . . . . 0.26000000000000001 110.978 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -66.33 -34.88 78.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.736 0.303 . . . . 1.3600000000000001 110.855 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.601 ' O ' HG23 ' A' ' 115' ' ' VAL . 85.4 t60 -63.7 -43.1 97.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.403 -0.362 . . . . 0.67000000000000004 110.282 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 108' ' ' LEU . 96.1 mt -66.62 -39.83 88.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.305 -0.407 . . . . 0.89000000000000001 110.624 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 109' ' ' ALA . 77.9 mt -61.39 -40.35 85.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.499 . . . . 0.46000000000000002 109.951 174.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -59.6 -47.35 85.91 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.74 -0.664 . . . . 2.0699999999999998 110.391 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 111' ' ' HIS . 21.1 t -56.54 -43.93 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.353 0.597 . . . . 0.5 110.263 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.68 -46.97 83.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.04 -0.982 . . . . 1.25 111.041 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.65 -17.24 51.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.93999999999999995 111.384 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.521 ' HB3' ' HD2' ' A' ' 120' ' ' HIS . 11.7 mm-40 -70.01 -8.01 45.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.179 -0.464 . . . . 1.6499999999999999 111.183 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.87 23.06 34.01 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.51 -0.853 . . . . 0.80000000000000004 111.402 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.521 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 85.0 m-70 -129.67 -173.3 2.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.004 0.43 . . . . 1.0600000000000001 110.123 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -134.18 160.08 38.92 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.618 -0.719 . . . . 3.6000000000000001 110.441 -171.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.602 HD12 HD12 ' A' ' 92' ' ' LEU . 0.1 OUTLIER -106.8 115.32 60.6 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 115.039 -0.982 . . . . 1.51 108.806 173.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.07 24.3 0.3 Allowed 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.664 2.909 . . . . 1.01 114.445 -167.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 59.16 25.58 14.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.113 0.482 . . . . 0.87 111.036 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -131.28 138.78 49.43 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.03 -0.532 . . . . 1.9399999999999999 110.047 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.47 ' HB3' ' CG1' ' A' ' 131' ' ' VAL . 96.7 mt -106.14 90.22 4.44 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.623 -0.262 . . . . 0.67000000000000004 110.677 172.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -73.59 158.97 46.85 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.844 2.363 . . . . 0.75 112.33 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.414 ' HA ' HG22 ' A' ' 131' ' ' VAL . 14.7 Cg_endo -57.55 -28.55 81.49 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.47 2.78 . . . . 0.70999999999999996 114.177 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -85.94 6.68 27.42 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.736 -0.385 . . . . 0.93999999999999995 111.605 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 62.0 mt -122.92 -22.97 5.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.519 0.199 . . . . 0.82999999999999996 111.397 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 126' ' ' LEU . 29.3 m . . . . . 0 C--N 1.324 -0.514 0 CA-C-O 120.741 0.305 . . . . 1.4399999999999999 111.318 -178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 85.5 m-85 . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.63 0.252 . . . . 0.89000000000000001 110.352 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.438 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 53.2 t-20 -115.96 108.62 46.11 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.42999999999999999 109.795 -175.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 12.9 Cg_exo -70.23 -5.95 17.7 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.191 2.594 . . . . 0.51000000000000001 112.65 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 29.6 m-85 -107.01 -4.43 19.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.918 0.39 . . . . 0.5 110.221 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.438 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 30.6 tt0 . . . . . 0 C--N 1.326 -0.454 0 CA-C-O 121.879 0.847 . . . . 1.4199999999999999 108.926 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.2 t90 . . . . . 0 N--CA 1.443 -0.79 0 N-CA-C 108.013 -1.106 . . . . 0.84999999999999998 108.013 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.537 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 90.6 t -56.51 -29.56 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.843 -0.617 . . . . 1.24 112.229 -171.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' A' ' 111' ' ' HIS . 18.9 m -77.69 -13.36 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 122.179 -0.326 . . . . 1.3 111.109 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.821 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -65.09 -24.46 70.34 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.063 -0.589 . . . . 0.62 112.255 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 18.5 ptpt -87.17 0.34 55.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.746 0.307 . . . . 2.9900000000000002 111.234 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -138.71 21.24 2.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.694 0.759 . . . . 1.8200000000000001 109.767 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.821 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 5.0 mmmp? -57.86 -40.15 81.56 Favored Pre-proline 0 C--O 1.22 -0.484 0 CA-C-N 115.353 -0.84 . . . . 0.93000000000000005 112.491 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 8.9 Cg_endo -50.35 -42.26 48.52 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 122.308 2.005 . . . . 0.56999999999999995 112.527 176.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.7 m -69.59 -44.05 71.55 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.12 -0.491 . . . . 0.67000000000000004 110.295 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -71.18 -22.65 62.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.953 -0.567 . . . . 0.92000000000000004 110.416 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.71 -45.53 29.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.893 -0.781 . . . . 1.8600000000000001 108.893 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.69 -54.07 43.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.3 -0.864 . . . . 2.0 110.629 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.2 mt -64.88 -44.52 96.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.234 -0.439 . . . . 0.53000000000000003 111.435 -176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.43 ' HE1' HG12 ' A' ' 67' ' ' ILE . 51.2 t80 -58.56 -44.18 89.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.42999999999999999 110.79 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 13.1 m-85 -76.34 -24.33 54.25 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.122 0.416 . . . . 3.0800000000000001 112.122 -177.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 p -76.3 -15.97 59.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.025 0.44 . . . . 0.75 111.035 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mp -88.29 -4.25 58.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.979 -0.555 . . . . 1.26 110.516 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m 69.29 89.32 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.314 0 CA-C-N 115.232 -0.895 . . . . 1.1100000000000001 111.735 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 58.7 Cg_endo -86.65 117.01 1.4 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.705 2.27 . . . . 0.68999999999999995 112.747 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.1 t -91.45 132.79 34.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.258 -0.645 . . . . 1.4299999999999999 109.258 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.8 p30 49.48 23.71 0.96 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.726 0.81 . . . . 2.1499999999999999 112.108 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.78 6.75 61.95 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.073 -0.584 . . . . 0.62 113.403 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -135.74 155.58 50.15 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.673 0.749 . . . . 2.2400000000000002 112.316 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.43 HG12 ' HE1' ' A' ' 57' ' ' PHE . 41.3 pt -114.13 152.82 15.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.749 -1.114 . . . . 0.31 108.775 171.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -88.0 175.65 7.67 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 120.449 -0.501 . . . . 0.52000000000000002 110.23 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.94 -27.25 71.0 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.641 -0.79 . . . . 0.38 112.528 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.63 -48.36 82.13 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.954 0.407 . . . . 0.40000000000000002 111.915 -176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -71.8 -40.78 68.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.282 0.563 . . . . 1.73 110.571 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -72.07 -28.79 63.55 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.465 -0.494 . . . . 0.35999999999999999 110.095 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.416 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 40.7 ttmt -64.79 -50.15 67.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.725 -0.216 . . . . 0.60999999999999999 110.533 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -62.18 -38.22 88.27 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.508 -0.315 . . . . 2.2400000000000002 110.58 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.93 -50.64 72.96 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.423 0.63 . . . . 0.81999999999999995 110.22 174.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.828 ' HB3' HD22 ' A' ' 86' ' ' LEU . 22.8 mmt -58.52 -45.24 89.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.528 -0.76 . . . . 1.04 112.197 -177.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.87 -16.6 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.946 0.403 . . . . 1.02 110.796 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -91.19 -5.76 54.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.169 -0.469 . . . . 3.04 111.063 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 7.1 t -89.54 -1.18 57.95 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.271 0.558 . . . . 0.85999999999999999 110.135 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 79' ' ' SER . 9.1 mptt 70.82 16.61 6.61 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.236 0.828 . . . . 2.0499999999999998 113.236 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.537 ' HB2' HD21 ' A' ' 86' ' ' LEU . 2.6 mm? -91.29 142.85 27.49 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.574 -0.45 . . . . 1.3400000000000001 111.124 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.588 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 21.3 Cg_exo -65.49 154.87 71.77 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.263 2.642 . . . . 0.62 112.474 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -56.12 -41.23 74.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.223 -0.444 . . . . 0.93999999999999995 111.55 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 7.9 m -58.21 -48.25 80.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.218 0.532 . . . . 0.58999999999999997 110.938 178.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.576 ' O ' HG12 ' A' ' 89' ' ' ILE . 96.4 t -63.57 -42.06 94.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.731 -0.668 . . . . 0.40000000000000002 110.479 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.828 HD22 ' HB3' ' A' ' 76' ' ' MET . 79.0 mt -61.92 -44.06 97.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.062 -0.517 . . . . 1.25 110.762 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.413 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -59.7 -31.63 71.85 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 121.027 -0.606 . . . . 0.34000000000000002 112.308 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 84' ' ' THR . 55.4 mtpt -72.66 -46.56 53.26 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.747 0.308 . . . . 1.1599999999999999 110.479 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 85' ' ' VAL . 43.5 mm -55.53 -52.08 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.66 -0.7 . . . . 0.89000000000000001 109.899 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -63.78 -39.49 94.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.983 -0.553 . . . . 0.34999999999999998 110.841 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -59.72 -35.62 74.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.773 0.32 . . . . 1.3799999999999999 111.194 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.444 ' O ' HD11 ' A' ' 126' ' ' LEU . 6.3 mp -88.75 -34.6 17.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.146 -0.479 . . . . 1.53 111.343 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.21 -42.71 65.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.967 0.413 . . . . 0.42999999999999999 111.757 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.565 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 24.9 t70 -89.33 91.11 8.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.385 0.612 . . . . 0.58999999999999997 109.545 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.0 m -82.48 -29.78 9.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.118 -0.946 . . . . 1.49 112.204 -171.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -86.99 -13.11 45.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.665 -0.243 . . . . 1.45 111.151 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.565 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 17.0 mmmt 57.84 45.07 19.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.847 -0.615 . . . . 2.6699999999999999 110.718 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.54 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 11.4 p-10 -93.29 -13.22 28.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.612 -0.722 . . . . 1.1299999999999999 110.965 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.63 5.47 74.76 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.797 -0.716 . . . . 0.42999999999999999 111.993 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.54 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 30.9 mt -128.27 166.27 18.91 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.241 -0.281 . . . . 0.45000000000000001 110.241 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.0 mt -122.35 119.85 32.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.322 -0.399 . . . . 0.70999999999999996 110.157 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -95.79 -175.86 3.55 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.168 -0.678 . . . . 1.4199999999999999 109.168 171.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.34 -33.64 67.95 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.835 0.35 . . . . 1.73 111.495 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.96 -56.56 4.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.278 -0.419 . . . . 1.53 110.28 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.453 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 25.6 mt-10 -59.27 -37.0 76.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.732 -0.667 . . . . 0.81999999999999995 111.096 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -71.23 -35.28 71.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.417 -0.356 . . . . 0.37 110.865 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.63 -38.32 90.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.735 0.302 . . . . 0.5 110.436 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.39 -41.03 96.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 1.3200000000000001 110.12 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.06 -52.48 64.1 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.765 -0.652 . . . . 0.26000000000000001 110.941 177.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.07 -30.1 69.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.452 . . . . 1.3600000000000001 111.355 -176.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.561 ' HB2' HG12 ' A' ' 46' ' ' VAL . 83.9 t60 -62.02 -45.86 91.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.776 0.322 . . . . 0.67000000000000004 110.377 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.6 mt -68.87 -41.55 78.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.872 -0.604 . . . . 0.89000000000000001 110.856 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 109' ' ' ALA . 78.1 mt -61.17 -39.97 84.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.951 -0.568 . . . . 0.46000000000000002 110.034 176.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.606 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 32.3 tttm -56.26 -50.4 71.45 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.93 -0.577 . . . . 2.0699999999999998 110.606 175.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 111' ' ' HIS . 46.0 t -51.34 -39.11 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.101 -0.5 . . . . 0.5 111.145 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -68.58 -30.39 69.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.722 0.296 . . . . 1.25 111.469 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 86.1 mt -72.4 -34.55 67.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.97 0.414 . . . . 0.93999999999999995 110.07 174.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 41.7 mm-40 -68.4 -25.96 65.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.884 -0.598 . . . . 1.6499999999999999 109.611 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.52 35.08 4.5 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.604 -0.726 . . . . 0.80000000000000004 112.802 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -132.99 173.55 11.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.066 0.433 . . . . 1.0600000000000001 110.638 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.88 156.14 20.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.862 -0.608 . . . . 3.6000000000000001 109.985 -177.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.26 135.18 24.65 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.546 -0.538 . . . . 1.51 109.546 176.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.36 4.66 4.22 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.013 2.476 . . . . 1.01 113.726 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 65.33 19.65 11.69 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.488 0.492 . . . . 0.87 111.425 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -131.27 148.63 52.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.048 -0.524 . . . . 1.9399999999999999 110.126 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 92' ' ' LEU . 79.1 mt -109.05 108.81 60.78 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.867 -0.606 . . . . 0.67000000000000004 110.38 173.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.647 ' HD2' HD12 ' A' ' 130' ' ' LEU . 26.4 Cg_exo -61.03 154.06 59.67 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.592 2.195 . . . . 0.75 111.662 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.461 ' HA ' HG22 ' A' ' 131' ' ' VAL . 32.5 Cg_endo -64.49 -4.93 9.04 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.811 2.341 . . . . 0.70999999999999996 113.116 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -100.94 4.03 42.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.981 0.419 . . . . 0.93999999999999995 110.38 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.647 HD12 ' HD2' ' A' ' 127' ' ' PRO . 35.5 mt -116.21 -8.3 11.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.82999999999999996 111.095 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 128' ' ' PRO . 27.0 m . . . . . 0 C--N 1.326 -0.423 0 CA-C-O 121.433 0.635 . . . . 1.4399999999999999 110.267 177.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 . . . . . 0 CA--C 1.514 -0.429 0 CA-C-O 121.104 0.478 . . . . 0.89000000000000001 110.27 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.698 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 55.9 t-20 -138.52 116.17 9.17 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.474 -0.785 . . . . 0.42999999999999999 109.39 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 23.1 Cg_exo -66.1 -14.48 44.59 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 123.442 2.761 . . . . 0.51000000000000001 113.362 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.672 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 17.9 m-85 -107.33 -1.62 21.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.498 0.666 . . . . 0.5 110.133 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.698 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 42.4 tt0 . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 114.673 -1.149 . . . . 1.4199999999999999 108.39 -175.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.9 t90 . . . . . 0 N--CA 1.447 -0.603 0 N-CA-C 108.587 -0.894 . . . . 0.84999999999999998 108.587 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.1 t -54.82 -32.25 25.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.951 -0.568 . . . . 1.24 111.164 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 45.2 t -79.04 -15.21 13.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.93 -0.577 . . . . 1.3 111.321 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.83 -23.88 71.11 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.798 -0.715 . . . . 0.62 111.813 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -87.09 -16.02 36.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 122.304 1.049 . . . . 2.9900000000000002 109.881 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.461 ' HB2' ' HA ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -104.84 -11.74 16.61 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.433 -1.712 . . . . 1.8200000000000001 110.893 -163.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 3.6 mmmp? -57.79 -55.81 41.09 Favored Pre-proline 0 C--O 1.224 -0.281 0 N-CA-C 114.521 1.304 . . . . 0.93000000000000005 114.521 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 10.5 Cg_endo -48.8 -37.88 36.62 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.73 2.287 . . . . 0.56999999999999995 113.44 -168.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.547 ' O ' HG13 ' A' ' 56' ' ' ILE . 16.8 m -71.29 -44.39 65.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.059 -0.519 . . . . 0.67000000000000004 110.88 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.44 ' HE2' ' HB3' ' A' ' 49' ' ' ASP . 12.2 m-85 -78.26 -22.32 48.49 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.085 -0.507 . . . . 0.92000000000000004 109.992 -176.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -71.96 -42.07 66.98 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.108 -0.701 . . . . 1.8600000000000001 109.108 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -53.41 -52.83 58.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.125 -0.943 . . . . 2.0 109.898 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 52' ' ' THR . 15.8 mt -67.84 -31.33 51.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.109 -0.95 . . . . 0.53000000000000003 110.637 -178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -59.91 -37.38 79.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.765 -0.652 . . . . 0.42999999999999999 110.774 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -70.83 -24.94 62.64 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.771 0.285 . . . . 3.0800000000000001 111.771 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 p -86.23 -5.68 59.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.848 0.356 . . . . 0.75 111.399 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.486 HD11 ' OE1' ' A' ' 75' ' ' GLU . 8.8 mp -96.19 5.19 51.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.978 0.418 . . . . 1.26 110.086 175.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m 64.71 86.15 0.14 Allowed Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 115.074 -0.966 . . . . 1.1100000000000001 111.567 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.28 115.24 4.19 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.103 2.535 . . . . 0.68999999999999995 112.192 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.5 t -89.28 113.48 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.601 -0.518 . . . . 1.4299999999999999 109.601 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 65.09 22.65 12.35 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.012 -0.54 . . . . 2.1499999999999999 110.296 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.02 19.12 59.81 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.903 -0.59 . . . . 0.62 112.408 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 100' ' ' LEU . 32.4 tttp -144.2 131.79 21.13 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.652 -0.499 . . . . 2.2400000000000002 109.652 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 101' ' ' LEU . 38.9 pt -92.71 152.54 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.36 -0.536 . . . . 0.31 111.078 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.454 ' HA ' HD22 ' A' ' 100' ' ' LEU . 37.6 p -85.07 160.46 19.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.721 -0.672 . . . . 0.52000000000000002 110.982 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.416 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -61.18 -29.71 71.89 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.153 -0.546 . . . . 0.38 112.596 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.9 -50.57 72.12 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.029 0.442 . . . . 0.40000000000000002 111.634 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.47 ' HA ' ' HG2' ' A' ' 74' ' ' LYS . 40.1 m-80 -74.69 -37.01 62.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.897 -0.592 . . . . 1.73 110.954 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.39 -27.5 65.35 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.378 -0.374 . . . . 0.35999999999999999 110.458 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.561 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 38.8 ttpt -72.6 -49.54 31.43 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.537 -0.301 . . . . 0.60999999999999999 111.094 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 71' ' ' ASN . 20.2 ptmt -59.82 -36.86 77.65 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 121.132 -0.227 . . . . 2.2400000000000002 110.481 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.486 ' OE1' HD11 ' A' ' 60' ' ' LEU . 17.3 tp10 -61.46 -52.46 64.44 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.492 0.663 . . . . 0.81999999999999995 110.142 175.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.756 ' HG2' ' HG ' ' A' ' 86' ' ' LEU . 17.5 ttm -67.64 -27.47 66.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.426 -0.806 . . . . 1.04 111.376 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.55 -40.46 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 116.432 -0.349 . . . . 1.02 110.231 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -73.36 -8.89 57.78 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.226 -0.443 . . . . 3.04 110.742 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 7.4 t -73.31 -12.63 60.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.191 -0.459 . . . . 0.85999999999999999 110.447 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 79' ' ' SER . 45.3 mmtm 73.5 26.67 1.94 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.411 0.685 . . . . 2.0499999999999998 112.608 178.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.81 144.27 27.86 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.518 -0.549 . . . . 1.3400000000000001 109.518 172.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.587 ' O ' HD13 ' A' ' 86' ' ' LEU . 12.6 Cg_endo -60.23 139.06 85.15 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.814 2.343 . . . . 0.62 112.563 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.456 ' HA ' HD22 ' A' ' 86' ' ' LEU . 15.9 m120 -51.83 -35.03 43.05 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.031 0.532 . . . . 0.93999999999999995 112.164 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.497 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 2.7 m -57.64 -40.73 79.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.383 0.611 . . . . 0.58999999999999997 110.634 177.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.588 ' O ' HG12 ' A' ' 89' ' ' ILE . 66.8 t -74.19 -38.71 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.041 -0.726 . . . . 0.40000000000000002 109.041 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.756 ' HG ' ' HG2' ' A' ' 76' ' ' MET . 5.1 mp -58.77 -45.72 89.14 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.992 -1.003 . . . . 1.25 110.321 176.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.54 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -59.46 -39.68 95.21 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.528 -0.76 . . . . 0.34000000000000002 112.001 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 84' ' ' THR . 55.4 mtpt -71.09 -43.95 66.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.751 0.31 . . . . 1.1599999999999999 110.349 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 85' ' ' VAL . 45.0 mm -57.3 -47.44 84.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.89000000000000001 110.201 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.416 ' CH2' ' HA2' ' A' ' 69' ' ' GLY . 15.3 t-105 -66.7 -41.42 88.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 0.34999999999999998 110.398 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -64.86 -22.49 67.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.164 -0.471 . . . . 1.3799999999999999 111.101 -175.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.519 HD12 ' HG ' ' A' ' 126' ' ' LEU . 4.0 mm? -93.29 -41.63 9.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 1.53 111.018 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.14 88.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.563 -0.29 . . . . 0.42999999999999999 111.648 -176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 41.6 t0 -83.51 75.52 10.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.371 -0.603 . . . . 0.58999999999999997 109.371 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.4 t -67.93 -34.72 68.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.369 -0.832 . . . . 1.49 110.987 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -82.81 -15.37 51.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.407 -0.815 . . . . 1.45 111.866 -175.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 60.66 72.48 0.52 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.515 0.509 . . . . 2.6699999999999999 111.63 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p30 -129.26 -14.43 4.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.007 -0.542 . . . . 1.1299999999999999 111.328 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.13 4.34 84.22 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.347 -0.93 . . . . 0.42999999999999999 112.234 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 68' ' ' THR . 67.7 mt -127.88 160.48 31.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.447 -0.575 . . . . 0.45000000000000001 109.447 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 105' ' ' GLU . 51.6 mt -124.28 118.32 26.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.804 0.335 . . . . 0.70999999999999996 110.565 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -82.84 -175.25 5.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.062 -0.718 . . . . 1.4199999999999999 109.062 167.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -61.67 -31.23 71.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.643 0.259 . . . . 1.73 111.115 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -72.11 -57.43 4.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.446 -0.343 . . . . 1.53 110.183 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.494 ' HB3' HD22 ' A' ' 101' ' ' LEU . 32.0 mt-10 -56.06 -44.63 79.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.075 -0.512 . . . . 0.81999999999999995 111.04 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -66.9 -38.24 85.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.898 -0.592 . . . . 0.37 110.954 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.28 85.14 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.943 -0.303 . . . . 0.5 110.632 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.12 -43.83 95.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.99 -0.374 . . . . 1.3200000000000001 109.99 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.33 -58.03 8.51 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.041 -0.527 . . . . 0.26000000000000001 111.069 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -67.29 -33.23 74.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.436 . . . . 1.3600000000000001 111.319 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.657 ' O ' HG23 ' A' ' 115' ' ' VAL . 77.3 t60 -64.17 -45.89 86.42 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 120.699 -0.4 . . . . 0.67000000000000004 109.991 176.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.428 ' HB3' HD12 ' A' ' 89' ' ' ILE . 75.0 mt -60.95 -41.46 96.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.59 0.233 . . . . 0.89000000000000001 111.063 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.96 -45.28 95.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.339 -0.391 . . . . 0.46000000000000002 110.196 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.475 ' HE2' ' OE2' ' A' ' 118' ' ' GLU . 86.8 tttt -64.86 -35.85 82.47 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.897 -0.321 . . . . 2.0699999999999998 110.795 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 111' ' ' HIS . 95.9 t -53.77 -44.27 58.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.359 -0.608 . . . . 0.5 109.359 173.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -66.83 -42.85 85.11 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.403 -0.817 . . . . 1.25 111.405 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.44 -27.27 64.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.334 -0.394 . . . . 0.93999999999999995 111.605 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.475 ' OE2' ' HE2' ' A' ' 114' ' ' LYS . 34.1 mt-10 -75.84 -6.98 53.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.306 -0.406 . . . . 1.6499999999999999 111.469 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.39 17.8 35.44 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.407 -0.901 . . . . 0.80000000000000004 112.327 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.462 ' HB2' ' CG1' ' A' ' 115' ' ' VAL . 11.5 m-70 -109.86 176.32 5.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.459 -0.571 . . . . 1.0600000000000001 109.459 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -139.63 130.77 26.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.876 0.369 . . . . 3.6000000000000001 111.275 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.72 126.32 88.63 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.296 -0.631 . . . . 1.51 109.296 173.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.67 13.87 1.57 Allowed 'Trans proline' 0 N--CA 1.474 0.343 0 C-N-CA 123.202 2.601 . . . . 1.01 113.748 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 66.38 19.52 10.96 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.403 0.62 . . . . 0.87 110.719 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -111.7 137.2 49.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.566 -0.743 . . . . 1.9399999999999999 109.433 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.519 ' HG ' HD12 ' A' ' 92' ' ' LEU . 92.3 mt -100.94 90.07 1.44 Allowed Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 110.193 -0.299 . . . . 0.67000000000000004 110.193 168.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 130' ' ' LEU . 43.9 Cg_endo -71.17 155.02 61.74 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.298 1.999 . . . . 0.75 111.713 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.25 -10.15 20.08 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 123.275 2.65 . . . . 0.70999999999999996 113.583 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -92.8 1.06 57.48 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.134 0.492 . . . . 0.93999999999999995 110.386 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.475 HD12 ' HD2' ' A' ' 127' ' ' PRO . 66.2 mt -117.34 -35.31 4.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.82999999999999996 110.571 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.416 ' CG2' ' HB3' ' A' ' 126' ' ' LEU . 92.6 t . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.088 -0.505 . . . . 1.4399999999999999 111.478 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 . . . . . 0 CA--C 1.519 -0.237 0 CA-C-O 121.208 0.528 . . . . 0.89000000000000001 110.571 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.591 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 47.5 t-20 -96.86 112.88 61.79 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.591 -0.731 . . . . 0.42999999999999999 110.055 -174.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.479 ' HB2' ' HD3' ' A' ' 73' ' ' LYS . 56.7 Cg_endo -70.47 -9.17 25.3 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.008 2.472 . . . . 0.51000000000000001 112.616 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 31.4 m-85 -96.84 -7.99 32.12 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.129 -0.693 . . . . 0.5 109.129 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.591 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 28.3 tt0 . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 115.002 -0.999 . . . . 1.4199999999999999 109.508 -175.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 108.969 -0.752 . . . . 0.84999999999999998 108.969 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.6 t -55.63 -47.25 79.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.023 -0.535 . . . . 1.24 112.434 -172.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.582 HG23 ' HE2' ' A' ' 53' ' ' TYR . 2.7 p -69.31 -22.04 25.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.392 0.615 . . . . 1.3 110.77 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.822 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -67.65 -11.96 60.95 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.422 -0.808 . . . . 0.62 112.082 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -80.59 -27.7 37.31 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.943 -0.391 . . . . 2.9900000000000002 109.943 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.412 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 63.2 m-20 -100.4 10.55 41.05 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.839 -0.619 . . . . 1.8200000000000001 110.0 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.822 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 15.8 mmmt -52.58 -55.46 32.21 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 114.371 1.248 . . . . 0.93000000000000005 114.371 -171.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 10.6 Cg_endo -51.3 -37.36 59.95 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.532 2.155 . . . . 0.56999999999999995 112.808 -174.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.447 ' O ' HG13 ' A' ' 56' ' ' ILE . 8.6 m -69.99 -43.1 72.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.82 -0.627 . . . . 0.67000000000000004 110.34 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.582 ' HE2' HG23 ' A' ' 46' ' ' VAL . 13.9 m-30 -73.92 -23.21 59.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.365 -0.38 . . . . 0.92000000000000004 110.436 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.482 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 22.4 m-20 -69.29 -45.48 69.5 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.237 0.541 . . . . 1.8600000000000001 109.586 176.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -60.82 -38.91 87.06 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.121 -0.945 . . . . 2.0 110.892 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 52' ' ' THR . 62.7 mt -68.95 -40.96 81.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.53000000000000003 110.568 176.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -55.82 -39.68 71.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.42999999999999999 111.243 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.482 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 48.9 m-85 -75.92 -13.58 60.25 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.763 0.653 . . . . 3.0800000000000001 112.763 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 64.1 p -73.93 -18.55 60.88 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.179 -0.608 . . . . 0.75 110.824 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 2.0 mm? -87.12 -9.34 55.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.418 -0.356 . . . . 1.26 110.895 175.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.6 t 67.91 94.05 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.25 0 O-C-N 123.905 0.753 . . . . 1.1100000000000001 110.758 -176.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.37 134.51 42.18 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 123.009 2.473 . . . . 0.68999999999999995 112.992 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.403 HG12 HD22 ' A' ' 64' ' ' ASN . 36.2 t -107.96 123.54 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 108.881 -0.785 . . . . 1.4299999999999999 108.881 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.403 HD22 HG12 ' A' ' 63' ' ' VAL . 9.8 p30 45.33 33.72 1.31 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.452 0.701 . . . . 2.1499999999999999 112.499 -175.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.98 -3.4 67.09 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.053 -0.594 . . . . 0.62 114.448 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -137.87 170.25 16.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.812 0.806 . . . . 2.2400000000000002 110.692 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.7 pt -114.7 155.24 15.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.79 -0.364 . . . . 0.31 110.177 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.598 ' HA ' HD22 ' A' ' 100' ' ' LEU . 76.0 p -87.25 167.58 13.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.239 -0.437 . . . . 0.52000000000000002 110.897 -176.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.47 -24.44 63.83 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.768 -0.73 . . . . 0.38 112.315 176.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.4 -35.92 76.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.204 0.526 . . . . 0.40000000000000002 110.76 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 13.5 m120 -70.58 -49.05 51.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.575 -0.739 . . . . 1.73 110.529 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.471 ' HB3' ' HZ3' ' A' ' 90' ' ' TRP . . . -73.49 -20.1 60.76 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.47 -0.492 . . . . 0.35999999999999999 110.411 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.596 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 39.5 ttmt -67.3 -50.35 60.63 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.558 -0.534 . . . . 0.60999999999999999 109.558 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 22.2 ptmt -64.79 -35.68 81.87 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.237 -0.438 . . . . 2.2400000000000002 110.793 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.83 -51.97 62.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.362 0.601 . . . . 0.81999999999999995 110.279 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.855 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -65.12 -36.51 84.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.464 -0.789 . . . . 1.04 112.384 -174.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -75.37 -26.07 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.294 -0.562 . . . . 1.02 110.339 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -85.43 -1.77 57.39 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.06 -0.518 . . . . 3.04 110.413 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 33.5 m -79.66 -7.76 58.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.85999999999999999 109.992 171.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 79' ' ' SER . 0.1 OUTLIER 69.97 27.36 4.43 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.631 -0.713 . . . . 2.0499999999999998 111.603 178.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.547 ' HB2' HD11 ' A' ' 86' ' ' LEU . 95.3 mt -110.31 157.93 36.72 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.424 . . . . 1.3400000000000001 110.368 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.667 ' O ' HD13 ' A' ' 86' ' ' LEU . 60.6 Cg_endo -74.16 147.43 37.86 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.704 2.269 . . . . 0.62 113.323 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.404 ' HA ' HD22 ' A' ' 86' ' ' LEU . 4.5 m-20 -51.46 -38.5 54.07 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.979 -0.555 . . . . 0.93999999999999995 112.029 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 35.0 m -56.69 -43.23 80.29 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.107 0.48 . . . . 0.58999999999999997 111.092 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.58 ' O ' HG12 ' A' ' 89' ' ' ILE . 53.5 t -73.93 -36.59 45.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.135 -0.691 . . . . 0.40000000000000002 109.135 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.855 ' HG ' ' HB3' ' A' ' 76' ' ' MET . 1.7 mp -62.62 -45.3 93.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.076 -0.966 . . . . 1.25 110.546 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.521 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -58.72 -37.22 89.37 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.892 -0.595 . . . . 0.34000000000000002 112.308 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 84' ' ' THR . 52.4 mtpt -71.76 -42.3 67.38 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.208 -0.293 . . . . 1.1599999999999999 110.208 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 85' ' ' VAL . 32.7 mm -53.15 -52.54 29.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.942 -0.572 . . . . 0.89000000000000001 110.132 173.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.471 ' HZ3' ' HB3' ' A' ' 72' ' ' ALA . 27.3 t-105 -64.38 -43.03 95.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.78 -0.645 . . . . 0.34999999999999998 111.159 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -63.83 -25.05 68.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.081 0.467 . . . . 1.3799999999999999 111.318 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.424 ' HA ' HD13 ' A' ' 92' ' ' LEU . 3.7 mm? -89.36 -31.23 17.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.132 -0.486 . . . . 1.53 111.158 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.59 -36.45 28.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.361 -0.381 . . . . 0.42999999999999999 111.883 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 24.7 t0 -84.93 57.2 4.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.824 0.821 . . . . 0.58999999999999997 109.942 -176.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.6 p -68.37 -16.12 20.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.849 -1.069 . . . . 1.49 111.483 -177.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -89.71 -18.46 26.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.119 -0.492 . . . . 1.45 110.824 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.539 ' NZ ' ' HB2' ' A' ' 97' ' ' LYS . 0.1 OUTLIER 61.01 73.46 0.48 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.14 0.576 . . . . 2.6699999999999999 111.55 179.229 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.524 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 15.4 p-10 -132.96 -18.93 2.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.463 -0.335 . . . . 1.1299999999999999 111.759 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.68 4.47 72.91 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.437 -0.887 . . . . 0.42999999999999999 112.064 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.598 HD22 ' HA ' ' A' ' 68' ' ' THR . 41.4 mt -130.35 171.6 12.76 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.361 -0.607 . . . . 0.45000000000000001 109.361 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' A' ' 105' ' ' GLU . 79.9 mt -127.06 118.45 24.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.46 -0.336 . . . . 0.70999999999999996 110.702 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -83.31 -176.48 6.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.842 -0.799 . . . . 1.4199999999999999 108.842 167.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.96 -29.44 69.84 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.616 -0.434 . . . . 1.73 111.798 -173.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.49 -50.12 48.22 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.316 -0.624 . . . . 1.53 109.316 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.484 ' HB3' HD22 ' A' ' 101' ' ' LEU . 36.5 mt-10 -59.96 -52.77 63.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.352 -0.84 . . . . 0.81999999999999995 111.431 -178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -63.09 -35.86 81.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.941 -0.572 . . . . 0.37 110.703 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.84 -47.32 75.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.5 110.682 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.84 -37.85 88.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.355 -0.384 . . . . 1.3200000000000001 109.974 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.506 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.0 -49.73 72.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.86 -0.609 . . . . 0.26000000000000001 110.426 173.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -69.19 -28.46 66.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.838 -0.619 . . . . 1.3600000000000001 111.846 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 115' ' ' VAL . 82.3 t60 -67.06 -41.97 85.54 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.395 -0.522 . . . . 0.67000000000000004 109.932 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.7 mt -64.75 -38.58 91.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.994 0.426 . . . . 0.89000000000000001 110.111 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 109' ' ' ALA . 72.0 mt -63.23 -41.23 92.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.712 -0.676 . . . . 0.46000000000000002 110.505 176.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -54.77 -49.88 69.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.836 0.35 . . . . 2.0699999999999998 110.585 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 111' ' ' HIS . 29.9 t -59.68 -40.49 82.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.99 -0.55 . . . . 0.5 109.926 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.591 ' NZ ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -61.51 -42.63 99.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.492 -0.776 . . . . 1.25 111.181 175.416 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 86.4 mt -72.37 -32.11 66.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.613 0.244 . . . . 0.93999999999999995 111.569 -176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -75.36 3.41 9.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.478 -0.328 . . . . 1.6499999999999999 111.543 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.69 2.5 75.64 Favored Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 120.642 -0.789 . . . . 0.80000000000000004 112.478 175.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.46 ' HB2' HG12 ' A' ' 115' ' ' VAL . 28.3 m-70 -92.92 173.93 7.5 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.097 0.475 . . . . 1.0600000000000001 109.887 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.33 145.39 40.12 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.0 -0.545 . . . . 3.6000000000000001 110.675 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.76 125.21 56.31 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.827 -0.624 . . . . 1.51 109.634 175.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.79 -2.14 11.45 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.898 2.399 . . . . 1.01 113.165 -172.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.3 21.02 12.22 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.421 0.629 . . . . 0.87 110.25 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.463 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -115.37 131.86 56.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.048 -0.978 . . . . 1.9399999999999999 109.872 -178.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.612 ' HB3' ' HB ' ' A' ' 131' ' ' VAL . 92.5 mt -96.85 96.57 2.85 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.139 0.274 . . . . 0.67000000000000004 110.624 170.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.499 ' O ' HG12 ' A' ' 131' ' ' VAL . 57.8 Cg_endo -76.48 159.76 35.73 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.406 2.07 . . . . 0.75 111.265 177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.98 -25.57 28.63 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.998 2.466 . . . . 0.70999999999999996 114.023 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -86.92 9.26 19.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.823 0.344 . . . . 0.93999999999999995 111.42 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 63.1 mt -131.71 -35.37 1.28 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 0.82999999999999996 110.65 174.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.612 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 7.1 p . . . . . 0 CA--C 1.534 0.342 0 CA-C-O 121.497 0.665 . . . . 1.4399999999999999 110.693 177.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 . . . . . 0 N--CA 1.455 -0.187 0 N-CA-C 108.625 -0.88 . . . . 0.89000000000000001 108.625 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.521 HD21 ' HA2' ' A' ' 87' ' ' GLY . 45.9 t-20 -97.36 119.39 63.07 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 114.451 -1.249 . . . . 0.42999999999999999 109.882 -173.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.56 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 9.2 Cg_exo -71.99 -10.36 25.99 Favored 'Trans proline' 0 CA--C 1.528 0.184 0 C-N-CA 123.259 2.639 . . . . 0.51000000000000001 112.948 -175.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.596 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 15.0 m-85 -106.41 -16.08 14.65 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.626 0.726 . . . . 0.5 109.475 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.401 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 41.5 tt0 . . . . . 0 C--N 1.319 -0.737 0 CA-C-N 114.557 -1.202 . . . . 1.4199999999999999 108.595 177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 109.221 -0.659 . . . . 0.84999999999999998 109.221 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.9 m -57.77 -33.66 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.667 -0.697 . . . . 1.24 112.315 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.421 HG23 ' HB2' ' A' ' 111' ' ' HIS . 7.4 p -69.87 -16.07 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.589 0.709 . . . . 1.3 110.745 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.522 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -72.81 -6.38 67.1 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.397 -0.819 . . . . 0.62 111.941 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -91.94 -25.44 18.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.185 0.517 . . . . 2.9900000000000002 110.221 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.453 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 20.7 m-20 -91.94 1.88 56.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.708 -0.678 . . . . 1.8200000000000001 110.701 -176.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HZ1' ' CG ' ' A' ' 103' ' ' ASP . 3.5 mmmp? -53.96 -49.66 88.42 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 114.062 1.134 . . . . 0.93000000000000005 114.062 -172.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 11.7 Cg_endo -52.69 -39.72 75.58 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.107 1.871 . . . . 0.56999999999999995 112.891 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.506 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . 58.5 m -82.62 -31.92 28.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.902 0.382 . . . . 0.67000000000000004 111.414 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.453 ' CE2' ' HB2' ' A' ' 49' ' ' ASP . 16.4 m-30 -71.11 -22.38 62.09 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.09 -0.708 . . . . 0.92000000000000004 109.09 175.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 16.5 t70 -71.22 -42.5 68.85 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.15 -0.932 . . . . 1.8600000000000001 109.365 172.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.506 ' OE2' ' HA ' ' A' ' 52' ' ' THR . 40.3 mt-10 -58.53 -34.35 70.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.33 -0.85 . . . . 2.0 110.837 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.7 mt -78.59 -52.44 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.075 0.464 . . . . 0.53000000000000003 110.512 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.421 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 74.2 t80 -50.01 -41.37 47.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.393 -0.821 . . . . 0.42999999999999999 111.855 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -74.75 -22.58 58.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.742 0.645 . . . . 3.0800000000000001 112.742 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.5 p -79.47 -20.82 46.44 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.018 -0.673 . . . . 0.75 110.944 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.06 -5.05 59.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 1.26 110.647 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.0 t 68.0 92.03 0.07 OUTLIER Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 115.588 -0.733 . . . . 1.1100000000000001 111.0 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.67 134.08 34.03 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.988 2.459 . . . . 0.68999999999999995 111.941 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.2 t -110.8 107.52 23.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.09 -0.505 . . . . 1.4299999999999999 110.124 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.9 m120 64.1 41.47 6.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.547 -0.751 . . . . 2.1499999999999999 111.607 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.32 -3.38 72.36 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.984 -0.627 . . . . 0.62 113.94 172.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -160.3 170.53 20.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.412 0.606 . . . . 2.2400000000000002 110.476 178.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.48 HD11 ' CD1' ' A' ' 106' ' ' PHE . 25.6 pt -104.94 159.4 5.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.828 0.346 . . . . 0.31 111.227 -177.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.479 ' HA ' HD22 ' A' ' 100' ' ' LEU . 73.5 p -89.27 170.66 10.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.856 -0.611 . . . . 0.52000000000000002 110.972 -177.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.93 -27.98 72.06 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.688 -0.687 . . . . 0.38 112.546 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.96 -45.15 68.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.076 0.465 . . . . 0.40000000000000002 111.295 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.465 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 8.9 m120 -63.73 -46.24 86.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.509 0.671 . . . . 1.73 110.127 -177.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.533 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -75.77 -23.89 55.98 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.729 -0.669 . . . . 0.35999999999999999 110.489 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.799 ' HA ' ' HZ ' ' B' ' 151' ' ' PHE . 35.1 ttmt -61.32 -50.62 72.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.893 0.377 . . . . 0.60999999999999999 110.033 174.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 19.4 ptmt -70.13 -27.71 64.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.312 -0.404 . . . . 2.2400000000000002 110.395 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 13.2 tp10 -68.36 -40.39 81.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.612 0.72 . . . . 0.81999999999999995 109.98 174.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.647 ' HB3' HD22 ' A' ' 86' ' ' LEU . 22.3 mmt -59.8 -42.81 94.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.67 -0.695 . . . . 1.04 111.24 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 74' ' ' LYS . 15.0 m -72.0 -24.07 22.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.459 -0.496 . . . . 1.02 110.441 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 10.1 mtpm? -71.67 -20.87 61.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 3.04 110.644 175.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.9 m -84.88 1.35 47.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.08 -0.509 . . . . 0.85999999999999999 111.263 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.1 mptt 62.01 25.19 15.09 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.862 0.69 . . . . 2.0499999999999998 112.862 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.603 ' HB2' HD21 ' A' ' 86' ' ' LEU . 98.8 mt -98.79 140.61 21.89 Favored Pre-proline 0 C--N 1.326 -0.45 0 C-N-CA 121.06 -0.256 . . . . 1.3400000000000001 110.908 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.607 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 19.3 Cg_exo -64.92 159.49 45.88 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.189 2.592 . . . . 0.62 112.614 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -56.74 -43.71 80.96 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.823 -0.626 . . . . 0.93999999999999995 111.611 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.2 m -56.34 -45.92 80.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.16 0.505 . . . . 0.58999999999999997 110.905 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 89' ' ' ILE . 96.3 t -64.27 -45.24 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.763 -0.653 . . . . 0.40000000000000002 110.618 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.647 HD22 ' HB3' ' A' ' 76' ' ' MET . 31.3 mt -62.62 -38.48 90.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.088 -0.506 . . . . 1.25 110.271 177.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.729 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -56.56 -37.42 75.54 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.289 -0.869 . . . . 0.34000000000000002 111.783 176.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -77.63 -47.69 18.68 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.927 0.394 . . . . 1.1599999999999999 110.561 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.648 HD13 HG12 ' A' ' 113' ' ' ILE . 67.8 mt -57.84 -49.57 80.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.01 -0.541 . . . . 0.89000000000000001 111.105 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.588 ' HB3' ' ND2' ' B' ' 149' ' ' ASN . 13.4 t-105 -66.04 -38.48 88.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.215 0.531 . . . . 0.34999999999999998 110.197 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 87' ' ' GLY . 24.4 ttmm -56.91 -33.33 66.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.521 -0.763 . . . . 1.3799999999999999 111.05 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.416 ' HA ' HD13 ' A' ' 92' ' ' LEU . 3.8 mm? -90.72 -43.1 10.33 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.587 0.588 . . . . 1.53 112.587 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.63 -42.45 98.15 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.5 0.556 . . . . 0.42999999999999999 112.5 -171.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.635 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 36.0 t0 -90.22 99.72 12.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.327 -0.62 . . . . 0.58999999999999997 109.327 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.8 m -82.83 -30.31 8.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.767 -0.651 . . . . 1.49 111.839 -170.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -102.28 -9.29 20.53 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.131 0.419 . . . . 1.45 112.131 -176.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.635 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 67.9 mmtt 66.15 74.48 0.35 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.187 0.517 . . . . 2.6699999999999999 112.326 175.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.425 ' HB2' ' H ' ' A' ' 100' ' ' LEU . 5.5 m-20 -91.82 -29.08 16.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.748 -0.66 . . . . 1.1299999999999999 109.525 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.49 2.39 79.56 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 109.58 -1.408 . . . . 0.42999999999999999 109.58 -167.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' A' ' 68' ' ' THR . 23.1 mt -133.93 175.8 9.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.195 -1.003 . . . . 0.45000000000000001 108.435 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.565 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 96.6 mt -131.88 118.12 19.41 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.972 -0.291 . . . . 0.70999999999999996 110.413 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.536 ' HA ' ' CB ' ' A' ' 66' ' ' LYS . 1.3 p-10 -81.08 -175.82 5.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.047 -0.723 . . . . 1.4199999999999999 109.047 175.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.553 ' CG ' ' HZ1' ' A' ' 50' ' ' LYS . 17.9 t70 -61.4 -35.48 77.63 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 111.865 0.32 . . . . 1.73 111.865 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -68.36 -55.45 11.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.986 0.422 . . . . 1.53 110.542 -179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.491 ' HG3' ' OD1' ' A' ' 102' ' ' ASP . 36.0 mt-10 -72.22 -32.25 66.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.885 -0.598 . . . . 0.81999999999999995 112.383 -173.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CD1' HD11 ' A' ' 67' ' ' ILE . 49.5 t80 -69.29 -39.0 78.6 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.091 -0.644 . . . . 0.37 109.625 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.28 96.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.41 -0.516 . . . . 0.5 110.074 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.5 mt -65.55 -36.52 84.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.492 -0.322 . . . . 1.3200000000000001 111.057 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.48 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -58.51 -52.16 66.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.801 0.334 . . . . 0.26000000000000001 110.305 174.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -63.64 -36.47 83.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.043 -0.526 . . . . 1.3600000000000001 110.627 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.622 ' O ' HG23 ' A' ' 115' ' ' VAL . 77.1 t60 -63.72 -46.19 86.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.28 -0.418 . . . . 0.67000000000000004 111.008 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.581 ' HB3' HD23 ' A' ' 122' ' ' LEU . 96.1 mt -63.66 -41.02 98.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.887 0.375 . . . . 0.89000000000000001 110.731 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.648 HG12 HD13 ' A' ' 89' ' ' ILE . 73.9 mt -59.72 -44.15 93.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.46000000000000002 109.986 175.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 22.5 ttmm -60.51 -42.15 95.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.814 -0.63 . . . . 2.0699999999999998 111.203 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 111' ' ' HIS . 59.5 t -58.11 -46.35 88.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.816 0.341 . . . . 0.5 110.351 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 16.5 mtpp -62.13 -42.24 99.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.033 0.383 . . . . 1.25 112.033 175.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 97.2 mt -64.51 -28.47 69.67 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.185 0.516 . . . . 0.93999999999999995 110.723 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 58.2 mm-40 -73.04 -2.74 22.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.651 -0.704 . . . . 1.6499999999999999 111.471 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.48 32.43 9.44 Favored Glycine 0 CA--C 1.505 -0.588 0 C-N-CA 120.647 -0.787 . . . . 0.80000000000000004 112.099 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 95.4 m-70 -131.14 179.72 5.84 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.389 0.614 . . . . 1.0600000000000001 111.406 -176.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.85 149.79 49.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.11 -0.95 . . . . 3.6000000000000001 109.404 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.581 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -79.9 144.51 59.82 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.505 -0.554 . . . . 1.51 109.505 175.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.33 -5.91 15.06 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.998 2.465 . . . . 1.01 113.315 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.42 17.83 9.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.329 0.585 . . . . 0.87 110.599 -175.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -134.78 156.58 48.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.222 -0.899 . . . . 1.9399999999999999 109.496 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.83 93.87 9.56 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.399 -0.364 . . . . 0.67000000000000004 110.721 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -78.2 160.19 29.7 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.39 2.06 . . . . 0.75 112.084 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . 0.465 ' HA ' HG22 ' A' ' 131' ' ' VAL . 78.4 Cg_exo -51.63 -27.42 25.77 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.422 2.748 . . . . 0.70999999999999996 113.805 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 28.0 p-80 -88.37 9.07 24.67 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.649 -0.42 . . . . 0.93999999999999995 111.776 -177.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.8 mt -128.25 -32.87 2.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.508 0.194 . . . . 0.82999999999999996 111.028 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 128' ' ' PRO . 28.1 m . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 1.4399999999999999 110.56 176.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 . . . . . 0 CA--C 1.517 -0.325 0 CA-C-O 120.919 0.39 . . . . 0.89000000000000001 110.705 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.729 HD21 ' HA2' ' A' ' 87' ' ' GLY . 54.9 t-20 -93.16 122.11 64.05 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.904 -0.589 . . . . 0.42999999999999999 109.741 -176.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 23.7 Cg_exo -64.92 -5.68 11.17 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.171 2.581 . . . . 0.51000000000000001 113.394 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.799 ' HZ ' ' HA ' ' A' ' 73' ' ' LYS . 43.4 m-85 -108.09 -3.52 18.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.368 0.604 . . . . 0.5 110.108 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.601 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 46.9 tt0 . . . . . 0 C--N 1.324 -0.511 0 N-CA-C 108.329 -0.989 . . . . 1.4199999999999999 108.329 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.2 t90 . . . . . 0 N--CA 1.449 -0.511 0 N-CA-C 108.374 -0.972 . . . . 0.84999999999999998 108.374 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.1 m -58.56 -15.01 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.876 0.695 . . . . 1.24 112.876 -172.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.486 HG21 HD23 ' A' ' 108' ' ' LEU . 61.2 t -80.6 -26.96 11.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.996 0.427 . . . . 1.3 110.714 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.471 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -73.85 -1.64 59.45 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.694 -0.765 . . . . 0.62 111.712 177.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -97.35 -17.13 19.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.166 0.508 . . . . 2.9900000000000002 110.307 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.08 20.62 5.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.773 -0.649 . . . . 1.8200000000000001 110.244 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.642 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 8.3 mmmm -58.25 -43.74 98.55 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 114.751 1.389 . . . . 0.93000000000000005 114.751 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.9 Cg_endo -46.47 -41.98 23.15 Favored 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 122.906 2.404 . . . . 0.56999999999999995 113.654 -172.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.3 m -70.54 -40.34 73.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.101 0.477 . . . . 0.67000000000000004 110.679 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 110' ' ' ASN . 7.4 m-85 -71.11 -23.41 62.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.92000000000000004 109.67 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -75.22 -45.69 38.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.329 -0.85 . . . . 1.8600000000000001 110.102 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -58.99 -50.44 74.1 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.449 -0.796 . . . . 2.0 110.39 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.68 -41.79 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.164 -0.471 . . . . 0.53000000000000003 111.259 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.417 ' HB2' ' CD2' ' A' ' 106' ' ' PHE . 90.5 t80 -58.55 -47.83 82.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.287 -0.415 . . . . 0.42999999999999999 110.927 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -76.37 -20.86 56.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.225 0.454 . . . . 3.0800000000000001 112.225 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.7 p -78.43 -13.0 60.04 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.214 -0.594 . . . . 0.75 111.463 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.3 mt -92.24 2.76 56.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.496 -0.32 . . . . 1.26 111.003 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.0 m 66.51 90.1 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 O-C-N 123.785 0.678 . . . . 1.1100000000000001 111.468 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.9 137.16 13.75 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.064 2.51 . . . . 0.68999999999999995 112.436 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.507 HG12 ' OD1' ' A' ' 64' ' ' ASN . 22.4 t -108.81 115.36 49.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.191 -0.458 . . . . 1.4299999999999999 110.195 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.507 ' OD1' HG12 ' A' ' 63' ' ' VAL . 3.0 p-10 40.94 51.61 3.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.621 0.768 . . . . 2.1499999999999999 112.859 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.59 -3.77 71.97 Favored Glycine 0 CA--C 1.518 0.233 0 N-CA-C 114.754 0.662 . . . . 0.62 114.754 170.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.464 ' HG2' ' CA ' ' A' ' 102' ' ' ASP . 14.0 mtmm -147.95 149.79 32.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.951 0.875 . . . . 2.2400000000000002 111.173 177.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.9 pt -92.09 147.57 5.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.807 -0.442 . . . . 0.31 109.807 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.2 p -77.77 155.11 31.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.363 -0.38 . . . . 0.52000000000000002 110.688 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.38 -15.37 45.36 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 121.285 -0.483 . . . . 0.38 113.387 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -63.77 -56.96 11.57 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.254 0.55 . . . . 0.40000000000000002 111.081 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.65 -37.93 83.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.644 -0.707 . . . . 1.73 110.25 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.46 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -69.64 -32.55 71.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.809 -0.632 . . . . 0.35999999999999999 110.551 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.577 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 39.9 ttmt -64.05 -42.71 96.93 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.4 0.619 . . . . 0.60999999999999999 109.561 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.8 mtpp -67.76 -38.27 83.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.281 -0.872 . . . . 2.2400000000000002 110.982 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.92 -45.39 93.91 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.481 0.658 . . . . 0.81999999999999995 110.263 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.938 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 25.0 mmt -57.48 -48.11 80.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.354 -0.839 . . . . 1.04 111.274 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.12 -21.57 19.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.849 -0.34 . . . . 1.02 111.074 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 92.5 mttt -70.31 -25.12 63.17 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.545 -0.298 . . . . 3.04 110.82 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 42.5 m -81.99 -1.69 49.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.255 -0.43 . . . . 0.85999999999999999 111.124 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 79' ' ' SER . 10.1 mptt 70.15 14.95 7.65 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.984 0.735 . . . . 2.0499999999999998 112.984 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.99 143.62 43.24 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.57 -0.452 . . . . 1.3400000000000001 110.672 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.544 ' O ' HD13 ' A' ' 86' ' ' LEU . 39.7 Cg_exo -62.27 152.07 78.59 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.292 2.661 . . . . 0.62 112.803 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.534 ' HA ' HD22 ' A' ' 86' ' ' LEU . 16.5 m120 -57.79 -38.45 75.52 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.226 -0.443 . . . . 0.93999999999999995 111.33 -177.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.3 m -57.8 -37.42 73.71 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.197 0.522 . . . . 0.58999999999999997 111.161 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 89' ' ' ILE . 70.7 t -77.08 -37.25 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.029 -0.73 . . . . 0.40000000000000002 109.029 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.938 ' HG ' ' HB3' ' A' ' 76' ' ' MET . 0.4 OUTLIER -61.42 -44.85 96.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.143 -0.935 . . . . 1.25 110.715 176.023 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.608 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -61.31 -37.2 93.65 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.87 -0.681 . . . . 0.34000000000000002 111.634 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -68.03 -48.31 66.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.819 0.342 . . . . 1.1599999999999999 110.754 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 85' ' ' VAL . 39.8 mm -56.89 -48.82 80.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.916 -0.584 . . . . 0.89000000000000001 110.253 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . 0.504 ' CH2' HD23 ' A' ' 101' ' ' LEU . 16.6 t-105 -61.94 -51.31 68.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.055 -0.521 . . . . 0.34999999999999998 111.161 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -60.65 -27.64 67.96 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.122 -0.49 . . . . 1.3799999999999999 111.823 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.487 HD12 HD22 ' A' ' 122' ' ' LEU . 66.3 mt -85.51 -49.97 7.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.502 -0.317 . . . . 1.53 111.214 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.89 82.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.504 -0.316 . . . . 0.42999999999999999 111.834 -175.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.731 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 18.7 t70 -78.66 83.94 4.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.831 -0.803 . . . . 0.58999999999999997 108.831 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.62 -25.99 13.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.91 -1.041 . . . . 1.49 110.887 -173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.53 -15.55 30.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.901 -0.59 . . . . 1.45 111.949 -176.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.698 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 4.2 mptp? 54.74 72.07 0.49 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.31 0.576 . . . . 2.6699999999999999 110.983 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -117.25 -33.16 4.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.767 -0.652 . . . . 1.1299999999999999 111.932 -173.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.12 -23.09 14.65 Favored Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 120.476 -0.869 . . . . 0.42999999999999999 112.357 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -102.01 -171.74 2.02 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.881 -0.785 . . . . 0.45000000000000001 108.881 174.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.552 HD13 ' HG2' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -132.66 111.69 11.39 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.754 -0.462 . . . . 0.70999999999999996 109.754 178.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.464 ' CA ' ' HG2' ' A' ' 66' ' ' LYS . 7.0 t70 -87.55 -177.13 5.81 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.701 -0.681 . . . . 1.4199999999999999 110.843 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.34 -37.02 57.91 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.246 0.461 . . . . 1.73 112.246 -173.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -69.56 -41.92 75.24 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 122.782 1.277 . . . . 1.53 107.91 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.731 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 5.9 tt0 -65.4 -40.88 93.98 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 112.375 -2.193 . . . . 0.81999999999999995 110.899 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.536 ' HB2' HD12 ' A' ' 101' ' ' LEU . 52.9 t80 -72.75 -35.41 67.48 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.608 0.718 . . . . 0.37 109.77 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . 0.412 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -66.28 -39.82 89.67 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.733 -1.121 . . . . 0.5 110.629 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.486 HD23 HG21 ' A' ' 46' ' ' VAL . 15.7 mt -70.05 -35.42 74.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.165 -0.47 . . . . 1.3200000000000001 110.47 175.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.44 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.74 -55.47 33.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 0.26000000000000001 110.561 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 94.8 m-20 -70.63 -25.72 63.16 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.32 -0.4 . . . . 1.3600000000000001 110.932 -177.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.593 ' O ' HG23 ' A' ' 115' ' ' VAL . 72.6 t60 -69.83 -43.82 71.19 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.408 -0.36 . . . . 0.67000000000000004 110.051 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.83 -41.1 97.92 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.95 0.405 . . . . 0.89000000000000001 110.077 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 80.3 mt -59.81 -43.73 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.437 -0.801 . . . . 0.46000000000000002 110.437 174.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -59.72 -46.64 88.5 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.187 -0.461 . . . . 2.0699999999999998 111.196 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 111' ' ' HIS . 38.4 t -60.38 -42.83 92.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.114 0.483 . . . . 0.5 110.325 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -56.16 -43.86 78.74 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.847 -0.615 . . . . 1.25 110.998 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 91.5 mt -74.04 -16.97 61.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.398 -0.365 . . . . 0.93999999999999995 111.316 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.3 0.41 25.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.735 0.302 . . . . 1.6499999999999999 110.421 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.52 -1.48 84.03 Favored Glycine 0 CA--C 1.503 -0.705 0 N-CA-C 111.42 -0.672 . . . . 0.80000000000000004 111.42 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -97.05 -179.14 4.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.115 0.483 . . . . 1.0600000000000001 111.11 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.15 144.45 50.75 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.465 -0.789 . . . . 3.6000000000000001 110.179 -176.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.487 HD22 HD12 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -77.96 138.97 61.21 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 109.711 -0.477 . . . . 1.51 109.711 173.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.45 -3.43 12.45 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.537 2.158 . . . . 1.01 113.699 -170.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.22 21.55 12.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.309 0.576 . . . . 0.87 110.739 -177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.702 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 0.8 OUTLIER -127.93 142.23 51.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.099 -0.955 . . . . 1.9399999999999999 108.999 178.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.2 mt -97.32 92.49 1.25 Allowed Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 121.166 0.508 . . . . 0.67000000000000004 110.551 169.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.758 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 17.8 Cg_endo -94.35 165.95 1.93 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.749 2.966 . . . . 0.75 112.254 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.6 -25.04 24.52 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.523 2.815 . . . . 0.70999999999999996 113.948 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . 0.408 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 20.2 p-80 -86.79 5.54 35.99 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.458 -0.497 . . . . 0.93999999999999995 111.476 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.758 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 72.9 mt -129.23 -35.56 1.78 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.585 -0.28 . . . . 0.82999999999999996 111.182 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 C--N 1.325 -0.479 0 CA-C-O 121.342 0.591 . . . . 1.4399999999999999 111.352 178.945 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 . . . . . 0 CA--C 1.519 -0.215 0 N-CA-C 108.851 -0.796 . . . . 0.89000000000000001 108.851 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.608 HD21 ' HA2' ' A' ' 87' ' ' GLY . 45.2 t-20 -87.91 114.51 59.51 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.822 -1.081 . . . . 0.42999999999999999 109.641 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 11.0 Cg_exo -72.22 -6.55 19.31 Favored 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 123.09 2.526 . . . . 0.51000000000000001 112.8 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 40.7 m-85 -105.55 0.19 26.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.452 0.644 . . . . 0.5 109.676 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 23.2 tt0 . . . . . 0 C--N 1.318 -0.803 0 CA-C-N 115.018 -0.992 . . . . 1.4199999999999999 109.255 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.419 ' HH2' ' HA ' ' A' ' 104' ' ' GLU . 0.6 OUTLIER . . . . . 0 N--CA 1.446 -0.631 0 N-CA-C 109.355 -0.609 . . . . 0.84999999999999998 109.355 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.5 m -56.65 -31.5 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.761 0.652 . . . . 1.24 112.761 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.658 ' HB ' ' HE2' ' A' ' 53' ' ' TYR . 22.7 m -77.1 -6.42 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.623 -0.431 . . . . 1.3 110.795 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.89 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -72.97 -20.25 79.88 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.86 -0.896 . . . . 0.62 110.86 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -84.51 -10.86 57.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.021 -0.59 . . . . 2.9900000000000002 110.011 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -118.89 9.26 11.91 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.447 -0.797 . . . . 1.8200000000000001 110.882 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.89 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 28.8 mmmt -53.11 -49.75 85.88 Favored Pre-proline 0 N--CA 1.471 0.582 0 N-CA-C 113.252 0.834 . . . . 0.93000000000000005 113.252 -175.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 10.1 Cg_endo -51.74 -38.67 67.2 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.585 2.19 . . . . 0.56999999999999995 112.432 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -70.82 -42.73 69.85 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.625 0.726 . . . . 0.67000000000000004 110.102 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.658 ' HE2' ' HB ' ' A' ' 46' ' ' VAL . 15.9 m-30 -70.36 -22.63 62.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.39 -0.823 . . . . 0.92000000000000004 109.86 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -73.84 -43.94 57.14 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.687 -0.688 . . . . 1.8600000000000001 110.1 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.609 ' HA ' ' CE2' ' A' ' 58' ' ' TYR . 39.8 mt-10 -58.14 -33.38 69.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.728 -0.669 . . . . 2.0 111.259 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.0 mt -85.19 -22.44 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.241 0.544 . . . . 0.53000000000000003 110.569 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -77.83 -55.53 5.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.315 -0.402 . . . . 0.42999999999999999 112.009 -175.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.609 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 23.1 p90 -70.43 -17.14 63.0 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 120.679 -0.408 . . . . 3.0800000000000001 111.509 -172.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 p -71.54 -12.61 61.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.106 0.479 . . . . 0.75 111.074 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 87.7 mt -99.92 14.62 29.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.75 -0.659 . . . . 1.26 110.648 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.9 m 65.06 88.69 0.11 Allowed Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 115.509 -0.769 . . . . 1.1100000000000001 111.136 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 38.2 Cg_endo -74.54 98.74 1.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.478 2.119 . . . . 0.68999999999999995 112.385 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.3 t -89.9 117.28 32.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.725 -0.472 . . . . 1.4299999999999999 109.725 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 60.6 22.82 12.6 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.223 0.535 . . . . 2.1499999999999999 110.856 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.95 14.35 69.83 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.706 -0.759 . . . . 0.62 113.259 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.735 ' HE3' ' HB2' ' A' ' 100' ' ' LEU . 39.5 tttp -147.26 126.36 12.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.385 0.593 . . . . 2.2400000000000002 109.459 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 101' ' ' LEU . 35.3 pt -83.87 146.11 7.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 120.94 0.4 . . . . 0.31 110.552 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.639 ' HA ' HD22 ' A' ' 100' ' ' LEU . 68.6 p -80.48 159.53 25.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.795 -0.639 . . . . 0.52000000000000002 111.314 -177.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.41 -22.3 67.41 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.957 -0.565 . . . . 0.38 112.845 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.04 -49.75 74.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.372 0.606 . . . . 0.40000000000000002 111.332 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 39.5 m-80 -73.36 -38.05 65.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.515 -0.766 . . . . 1.73 111.18 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.51 -30.93 69.85 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.496 -0.482 . . . . 0.35999999999999999 109.862 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -62.64 -48.96 77.05 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.537 -0.301 . . . . 0.60999999999999999 110.704 176.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.658 ' HD3' ' N ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -64.91 -31.96 73.44 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 120.482 -0.487 . . . . 2.2400000000000002 111.123 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.658 ' N ' ' HD3' ' A' ' 74' ' ' LYS . 7.5 tp10 -67.57 -45.12 76.5 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.32 0.581 . . . . 0.81999999999999995 109.914 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.469 ' HB3' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -64.99 -46.55 80.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.381 -0.827 . . . . 1.04 111.547 -178.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.04 -30.38 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.946 -0.302 . . . . 1.02 111.558 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -80.48 -11.31 59.69 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.101 -0.374 . . . . 3.04 110.602 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.9 t -74.22 -11.44 60.29 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.893 -0.78 . . . . 0.85999999999999999 108.893 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 72.4 mmtt 66.4 35.11 5.87 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.249 -0.887 . . . . 2.0499999999999998 112.208 175.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.597 ' HB2' HD21 ' A' ' 86' ' ' LEU . 89.7 mt -100.7 144.85 29.31 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.867 -0.79 . . . . 1.3400000000000001 108.867 171.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.402 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 52.1 Cg_exo -55.35 142.65 79.21 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.587 2.191 . . . . 0.62 112.241 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -56.23 -34.14 66.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.149 -0.478 . . . . 0.93999999999999995 111.28 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . 0.502 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 6.2 m -59.62 -48.52 81.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.198 0.523 . . . . 0.58999999999999997 110.496 177.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.632 ' O ' HG12 ' A' ' 89' ' ' ILE . 58.7 t -63.05 -43.29 98.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.716 -0.674 . . . . 0.40000000000000002 109.968 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' A' ' 81' ' ' LEU . 78.9 mt -59.36 -43.94 92.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.746 -0.661 . . . . 1.25 110.685 178.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.04 -34.38 83.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.982 -0.627 . . . . 0.34000000000000002 112.069 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 84' ' ' THR . 27.9 mtpp -72.62 -45.32 59.64 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.83 0.348 . . . . 1.1599999999999999 110.23 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 85' ' ' VAL . 42.7 mm -56.37 -49.39 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.725 -0.671 . . . . 0.89000000000000001 110.107 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -66.79 -41.16 88.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.086 -0.506 . . . . 0.34999999999999998 110.524 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -55.81 -29.23 59.42 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.696 -0.683 . . . . 1.3799999999999999 110.695 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.488 HD12 HD22 ' A' ' 122' ' ' LEU . 82.8 mt -91.86 -42.95 9.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 1.53 112.056 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.09 -40.29 95.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.42999999999999999 111.779 -171.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -92.05 94.23 9.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.983 -0.747 . . . . 0.58999999999999997 108.983 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.5 -48.94 28.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.267 -0.879 . . . . 1.49 111.24 -172.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -83.93 -9.97 58.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.599 -0.728 . . . . 1.45 112.051 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt 73.45 76.4 0.13 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.641 0.608 . . . . 2.6699999999999999 112.641 171.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.537 ' HB2' ' H ' ' A' ' 100' ' ' LEU . 3.8 m-20 -104.31 -44.85 4.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.456 0.646 . . . . 1.1299999999999999 110.226 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.69 2.35 57.43 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.34 -1.104 . . . . 0.42999999999999999 110.34 -167.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.735 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 36.7 mt -131.22 165.02 24.28 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.549 -0.908 . . . . 0.45000000000000001 108.549 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.422 ' O ' HG12 ' A' ' 67' ' ' ILE . 96.2 mt -125.56 122.68 37.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.267 0.555 . . . . 0.70999999999999996 111.573 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.419 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 2.1 p30 -87.16 -176.29 5.63 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.74 -0.837 . . . . 1.4199999999999999 108.74 167.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.02 -22.79 63.07 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.712 -0.395 . . . . 1.73 111.444 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HA ' ' HH2' ' A' ' 44' ' ' TRP . 52.2 mt-10 -72.01 -56.77 5.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.14 0.495 . . . . 1.53 109.818 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -68.28 -32.13 72.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.384 -0.826 . . . . 0.81999999999999995 111.086 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -71.49 -29.79 65.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.751 -0.463 . . . . 0.37 109.751 176.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.52 -39.11 88.47 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.285 -0.416 . . . . 0.5 110.152 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.47 -42.57 99.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.035 -0.529 . . . . 1.3200000000000001 110.347 172.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.12 -55.46 30.85 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 123.553 0.533 . . . . 0.26000000000000001 110.672 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -63.01 -41.49 99.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.78 -0.646 . . . . 1.3600000000000001 111.046 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.618 ' O ' HG23 ' A' ' 115' ' ' VAL . 81.5 t60 -61.52 -45.84 92.48 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.908 -0.317 . . . . 0.67000000000000004 111.187 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.0 -40.66 87.37 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.752 0.311 . . . . 0.89000000000000001 111.233 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.437 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 80.7 mt -61.41 -42.69 94.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.46000000000000002 109.837 175.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 52.9 tttp -55.45 -46.2 76.78 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.754 -0.657 . . . . 2.0699999999999998 110.683 174.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 111' ' ' HIS . 60.4 t -58.2 -44.71 88.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 120.716 0.293 . . . . 0.5 110.702 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -65.58 -39.85 92.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.153 -0.476 . . . . 1.25 111.465 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 93.6 mt -70.68 -26.03 63.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.938 0.399 . . . . 0.93999999999999995 110.8 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 68.8 mm-40 -71.02 -18.2 62.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.201 -0.454 . . . . 1.6499999999999999 110.559 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.23 -13.16 48.44 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.859 -0.686 . . . . 0.80000000000000004 112.007 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -85.17 172.8 10.91 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.885 -0.413 . . . . 1.0600000000000001 109.885 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -121.41 134.39 55.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.899 0.38 . . . . 3.6000000000000001 110.906 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.537 HD21 HD13 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -74.97 139.9 73.5 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.96 -0.564 . . . . 1.51 109.747 175.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 3.7 Cg_exo -76.85 1.32 8.72 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.911 2.407 . . . . 1.01 113.236 -173.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.75 20.38 11.34 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.549 0.69 . . . . 0.87 110.36 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.512 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 12.2 t70 -130.53 131.91 45.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.08 -0.964 . . . . 1.9399999999999999 109.399 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -91.99 103.22 7.63 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.244 -0.435 . . . . 0.67000000000000004 110.439 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 125' ' ' ASP . 2.5 Cg_endo -81.45 158.56 19.57 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.937 2.425 . . . . 0.75 111.897 -178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.44 -20.62 33.88 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.992 2.461 . . . . 0.70999999999999996 113.426 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 10.5 p-80 -91.27 11.93 21.93 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.923 -0.311 . . . . 0.93999999999999995 111.29 -179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.43 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 37.8 mt -128.43 -21.41 3.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.555 -0.293 . . . . 0.82999999999999996 110.878 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.4 m . . . . . 0 C--N 1.327 -0.398 0 CA-C-O 120.825 0.345 . . . . 1.4399999999999999 110.762 178.35 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 . . . . . 0 CA--C 1.52 -0.192 0 CA-C-O 120.963 0.411 . . . . 0.89000000000000001 110.365 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.595 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 52.2 t-20 -97.62 113.7 63.87 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 0.42999999999999999 110.081 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 10.0 Cg_exo -72.66 -7.34 20.65 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.421 2.747 . . . . 0.51000000000000001 112.862 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -107.15 5.65 28.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.317 0.579 . . . . 0.5 109.861 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.595 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 23.0 tt0 . . . . . 0 C--N 1.325 -0.465 0 CA-C-N 115.188 -0.915 . . . . 1.4199999999999999 108.643 -175.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . 0.468 ' HZ2' ' HG ' ' A' ' 108' ' ' LEU . 13.9 t90 . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 108.512 -0.921 . . . . 0.84999999999999998 108.512 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.4 t -48.56 -33.35 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 115.497 -0.774 . . . . 1.24 112.848 -171.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.59 HG21 HD23 ' A' ' 108' ' ' LEU . 58.8 t -67.6 -22.71 28.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.252 -0.431 . . . . 1.3 111.722 -175.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.61 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -66.28 -22.37 70.95 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.455 -0.878 . . . . 0.62 111.503 176.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -78.54 -21.32 48.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.235 0.54 . . . . 2.9900000000000002 110.889 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -119.72 15.13 12.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.73 0.776 . . . . 1.8200000000000001 109.761 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.61 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 2.4 mmmm -54.04 -45.03 99.17 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.1 -0.955 . . . . 0.93000000000000005 113.343 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.6 Cg_endo -48.42 -40.72 36.53 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.739 2.292 . . . . 0.56999999999999995 113.15 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 m -69.66 -43.99 71.43 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-O 121.611 0.72 . . . . 0.67000000000000004 110.276 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.481 ' CE2' HG13 ' A' ' 46' ' ' VAL . 12.0 m-85 -71.01 -22.51 62.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.342 -0.844 . . . . 0.92000000000000004 109.878 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.25 -45.17 66.99 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.189 -0.671 . . . . 1.8600000000000001 109.189 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -56.3 -47.5 78.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.758 -1.11 . . . . 2.0 111.379 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.3 mt -75.31 -37.86 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.728 0.299 . . . . 0.53000000000000003 111.282 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -59.65 -52.28 66.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.327 -0.397 . . . . 0.42999999999999999 111.431 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -71.15 -21.03 62.24 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.299 0.481 . . . . 3.0800000000000001 112.299 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.4 p -78.92 -3.32 44.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.425 -0.51 . . . . 0.75 111.679 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.0 mt -100.96 7.58 43.5 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.941 0.401 . . . . 1.26 110.469 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.0 m 59.18 84.7 0.2 Allowed Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 115.475 -0.784 . . . . 1.1100000000000001 112.12 176.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.91 142.69 20.08 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.09 2.527 . . . . 0.68999999999999995 112.309 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.3 t -114.07 118.98 60.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.609 -0.515 . . . . 1.4299999999999999 109.609 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 59.98 27.21 16.58 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.088 -0.505 . . . . 2.1499999999999999 111.49 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.17 -3.42 69.69 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.001 -0.619 . . . . 0.62 114.003 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.63 ' HE3' ' N ' ' A' ' 102' ' ' ASP . 30.5 mtpt -131.1 149.21 52.7 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 117.901 0.85 . . . . 2.2400000000000002 110.776 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.421 HD11 ' CD1' ' A' ' 106' ' ' PHE . 43.2 pt -101.95 157.89 4.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.002 -0.545 . . . . 0.31 110.079 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.9 p -86.78 161.96 18.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.526 -0.761 . . . . 0.52000000000000002 110.915 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.88 -27.39 72.07 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.645 -0.707 . . . . 0.38 112.883 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.34 -53.59 55.53 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.097 0.475 . . . . 0.40000000000000002 111.866 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.466 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 45.0 m-80 -73.6 -34.32 65.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.021 -0.536 . . . . 1.73 111.094 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 76' ' ' MET . . . -73.44 -29.17 62.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.346 -0.388 . . . . 0.35999999999999999 110.275 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.559 ' HA ' ' HZ ' ' B' ' 151' ' ' PHE . 39.3 ttmt -66.4 -51.16 59.95 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.702 0.287 . . . . 0.60999999999999999 110.263 176.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 ptmt -63.26 -35.75 81.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.365 -0.379 . . . . 2.2400000000000002 111.731 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -67.4 -45.9 74.81 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.521 0.677 . . . . 0.81999999999999995 109.815 175.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.716 ' SD ' HD11 ' A' ' 113' ' ' ILE . 7.7 tpp -59.62 -42.4 92.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.392 -0.822 . . . . 1.04 111.077 -177.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.3 m -74.2 -30.39 26.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.819 0.342 . . . . 1.02 110.663 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -69.47 -17.9 63.66 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.913 -0.315 . . . . 3.04 110.983 176.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.4 m -73.83 -8.56 56.53 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.429 -0.35 . . . . 0.85999999999999999 111.053 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm 73.17 21.36 3.13 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.658 0.985 . . . . 2.0499999999999998 113.658 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.413 ' HB2' HD11 ' A' ' 86' ' ' LEU . 2.7 mm? -95.3 148.82 35.25 Favored Pre-proline 0 C--N 1.32 -0.682 0 C-N-CA 120.602 -0.439 . . . . 1.3400000000000001 109.822 174.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.592 ' O ' HD13 ' A' ' 86' ' ' LEU . 32.9 Cg_exo -60.1 151.95 69.04 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.982 2.454 . . . . 0.62 112.432 176.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -57.67 -33.14 68.02 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.424 -0.353 . . . . 0.93999999999999995 111.244 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.34 -38.68 80.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.437 0.637 . . . . 0.58999999999999997 110.514 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 89' ' ' ILE . 57.3 t -75.83 -39.6 38.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.754 -0.832 . . . . 0.40000000000000002 108.754 -177.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.652 ' HG ' ' CG ' ' A' ' 76' ' ' MET . 3.6 mp -60.76 -44.82 96.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.997 -1.001 . . . . 1.25 111.16 176.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.623 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -61.92 -35.35 91.24 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.888 -0.672 . . . . 0.34000000000000002 111.784 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.715 ' HD3' ' HB2' ' A' ' 122' ' ' LEU . 38.6 ttmt -71.48 -45.39 62.64 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.188 0.518 . . . . 1.1599999999999999 110.063 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.691 HG23 ' HB2' ' A' ' 112' ' ' LEU . 72.0 mt -61.44 -50.77 79.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.539 -0.755 . . . . 0.89000000000000001 110.692 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -60.32 -43.04 96.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.89 -0.595 . . . . 0.34999999999999998 110.67 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.13 -25.2 64.27 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.92 -0.312 . . . . 1.3799999999999999 111.244 -175.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.34 -43.78 55.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.344 0.592 . . . . 1.53 110.026 172.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -66.97 -42.63 84.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.196 -0.911 . . . . 0.42999999999999999 111.411 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.547 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 27.9 t0 -95.89 62.14 2.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.8 0.809 . . . . 0.58999999999999997 109.348 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.0 p -64.66 -28.09 44.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 114.543 -1.208 . . . . 1.49 111.575 -177.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -86.99 -10.94 51.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.997 -0.547 . . . . 1.45 111.795 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HD2' ' O ' ' A' ' 94' ' ' ASP . 1.3 mptm? 56.17 73.64 0.43 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.715 0.406 . . . . 2.6699999999999999 112.062 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -120.32 -20.94 7.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.478 -0.328 . . . . 1.1299999999999999 110.753 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 100.5 -18.99 54.44 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.706 -0.759 . . . . 0.42999999999999999 113.444 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.424 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 86.6 mt -110.21 169.03 9.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.013 0.406 . . . . 0.45000000000000001 109.985 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 106' ' ' PHE . 76.3 mt -124.52 114.93 20.07 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.565 -0.454 . . . . 0.70999999999999996 110.952 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.63 ' N ' ' HE3' ' A' ' 66' ' ' LYS . 1.0 OUTLIER -84.85 -175.78 5.93 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.119 -0.697 . . . . 1.4199999999999999 109.119 171.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -62.27 -32.93 73.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.882 -0.327 . . . . 1.73 110.713 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.88 -52.29 11.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.766 0.317 . . . . 1.53 110.637 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.547 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 31.5 mt-10 -62.18 -47.36 84.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.345 -0.389 . . . . 0.81999999999999995 111.606 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 92.4 t80 -63.78 -37.1 86.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.987 0.422 . . . . 0.37 110.469 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.05 90.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.843 -0.617 . . . . 0.5 110.778 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.59 HD23 HG21 ' A' ' 46' ' ' VAL . 26.1 mt -64.08 -41.52 97.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 1.3200000000000001 110.632 174.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -54.94 -52.4 63.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.257 0.551 . . . . 0.26000000000000001 110.281 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . 0.415 HD22 ' N ' ' A' ' 110' ' ' ASN . 0.9 OUTLIER -69.0 -21.78 64.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.614 . . . . 1.3600000000000001 110.912 -177.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.609 ' O ' HG23 ' A' ' 115' ' ' VAL . 9.5 t60 -60.52 -61.2 2.77 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.18 0.514 . . . . 0.67000000000000004 109.626 174.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.691 ' HB2' HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -60.17 -34.9 74.23 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.73 -1.123 . . . . 0.89000000000000001 110.76 -176.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.716 HD11 ' SD ' ' A' ' 76' ' ' MET . 86.7 mt -60.75 -46.88 95.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.242 -0.436 . . . . 0.46000000000000002 110.484 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.414 ' HA ' HD12 ' A' ' 117' ' ' LEU . 36.6 ttmt -63.06 -36.41 83.49 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.429 -0.351 . . . . 2.0699999999999998 111.162 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 111' ' ' HIS . 14.1 t -62.74 -36.97 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.063 0.459 . . . . 0.5 109.793 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.7 mmtt -72.14 -28.11 63.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 1.25 111.135 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 95.4 mt -68.98 -20.59 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.125 0.488 . . . . 0.93999999999999995 110.326 176.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -87.75 -1.12 57.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.185 0.516 . . . . 1.6499999999999999 110.396 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.74 35.44 54.89 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.783 -0.644 . . . . 0.80000000000000004 112.203 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.482 ' HB2' HG12 ' A' ' 115' ' ' VAL . 20.4 m-70 -99.49 -171.84 2.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.196 0.522 . . . . 1.0600000000000001 111.99 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -118.59 152.06 36.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.376 -0.829 . . . . 3.6000000000000001 110.638 -174.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.715 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 5.1 mt -118.74 122.04 30.19 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.852 -0.425 . . . . 1.51 109.852 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.45 -11.79 12.91 Favored 'Trans proline' 0 C--N 1.334 -0.22 0 C-N-CA 123.458 2.772 . . . . 1.01 112.698 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.584 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . 65.98 19.29 11.22 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.838 -0.619 . . . . 0.87 110.896 -176.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . 0.425 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 10.7 m-20 -107.0 137.34 45.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.849 -0.614 . . . . 1.9399999999999999 110.573 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.4 mt -95.89 109.53 46.96 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.934 -0.575 . . . . 0.67000000000000004 111.21 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.791 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -83.72 160.62 14.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.504 2.803 . . . . 0.75 111.61 176.131 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.84 -25.38 76.31 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.709 2.272 . . . . 0.70999999999999996 113.057 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 12.1 p-80 -89.46 8.6 30.14 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.943 -0.303 . . . . 0.93999999999999995 111.586 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.791 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 30.0 mt -123.45 -19.54 5.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.734 -0.212 . . . . 0.82999999999999996 111.204 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.4 t . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.983 0.42 . . . . 1.4399999999999999 110.198 176.912 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 121.551 0.691 . . . . 0.89000000000000001 109.404 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.623 HD21 ' HA2' ' A' ' 87' ' ' GLY . 51.7 t-20 -102.34 118.9 57.83 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.021 -0.99 . . . . 0.42999999999999999 109.814 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 18.9 Cg_exo -67.45 -7.45 19.19 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.504 2.803 . . . . 0.51000000000000001 112.951 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.559 ' HZ ' ' HA ' ' A' ' 73' ' ' LYS . 40.6 m-85 -107.68 4.21 25.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.295 0.569 . . . . 0.5 110.081 176.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.604 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 32.8 tt0 . . . . . 0 C--N 1.321 -0.652 0 CA-C-N 115.05 -0.977 . . . . 1.4199999999999999 109.393 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.3 t90 . . . . . 0 N--CA 1.452 -0.343 0 N-CA-C 108.83 -0.804 . . . . 0.84999999999999998 108.83 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.7 t -57.5 -40.66 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 113.614 0.968 . . . . 1.24 113.614 -167.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.5 HG12 ' CG ' ' A' ' 111' ' ' HIS . 5.3 m -69.87 -10.76 14.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.893 -0.323 . . . . 1.3 111.723 -171.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.767 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -69.53 -15.94 71.22 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.745 -0.741 . . . . 0.62 111.895 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -78.33 -28.2 47.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 2.9900000000000002 110.628 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -121.16 23.4 10.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.538 0.685 . . . . 1.8200000000000001 109.959 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.767 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 4.4 mmmp? -52.61 -41.98 86.17 Favored Pre-proline 0 C--O 1.218 -0.556 0 CA-C-N 115.342 -0.845 . . . . 0.93000000000000005 112.942 177.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 7.8 Cg_endo -48.8 -43.31 35.14 Favored 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 122.582 2.188 . . . . 0.56999999999999995 112.671 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.583 ' O ' HG13 ' A' ' 56' ' ' ILE . 14.3 m -70.18 -44.58 68.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.035 0.445 . . . . 0.67000000000000004 110.889 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -71.07 -22.74 62.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.352 0.596 . . . . 0.92000000000000004 109.809 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.414 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 9.3 t70 -73.67 -44.3 57.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.031 -0.986 . . . . 1.8600000000000001 108.85 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -55.31 -53.44 56.16 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 114.916 -1.038 . . . . 2.0 110.318 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.583 HG13 ' O ' ' A' ' 52' ' ' THR . 17.3 mt -64.56 -40.0 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 114.962 -1.017 . . . . 0.53000000000000003 110.668 -175.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 62' ' ' PRO . 79.9 t80 -59.03 -38.13 78.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.066 -0.516 . . . . 0.42999999999999999 110.783 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.493 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 17.5 m-85 -82.07 -22.99 36.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.445 -0.343 . . . . 3.0800000000000001 111.892 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.3 p -77.62 -18.71 56.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.14 0.495 . . . . 0.75 111.006 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.0 mp -91.08 4.1 53.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.972 -0.558 . . . . 1.26 110.465 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.7 m 68.01 91.43 0.07 OUTLIER Pre-proline 0 CA--C 1.529 0.165 0 O-C-N 124.047 0.842 . . . . 1.1100000000000001 111.726 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.493 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 1.9 Cg_endo -81.14 96.36 0.96 Allowed 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.599 2.2 . . . . 0.68999999999999995 111.299 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.5 m -86.87 117.44 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.34 0.591 . . . . 1.4299999999999999 110.205 -175.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 64.2 23.87 13.25 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.231 -0.895 . . . . 2.1499999999999999 110.819 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.48 33.42 19.61 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.931 -0.652 . . . . 0.62 113.36 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HG2' ' HB2' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -165.08 145.58 7.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.079 -0.711 . . . . 2.2400000000000002 109.079 175.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.4 pt -102.69 145.92 11.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.492 -0.483 . . . . 0.31 110.13 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.803 ' HA ' HD22 ' A' ' 100' ' ' LEU . 44.3 p -84.91 165.91 17.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.11 0.481 . . . . 0.52000000000000002 111.108 -176.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.2 -17.75 64.13 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.67 -0.695 . . . . 0.38 112.663 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.03 -54.34 22.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.113 0.482 . . . . 0.40000000000000002 110.656 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.547 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 1.0 OUTLIER -69.97 -41.29 74.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.769 -0.651 . . . . 1.73 110.593 -174.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.523 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -68.19 -29.34 68.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.012 -0.54 . . . . 0.35999999999999999 110.831 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.542 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 40.8 ttmt -65.38 -40.22 93.24 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.645 -0.502 . . . . 0.60999999999999999 109.645 174.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.596 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.2 mtpp -60.1 -43.28 95.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.51 -0.768 . . . . 2.2400000000000002 110.669 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.438 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 4.2 tp10 -65.74 -44.94 84.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.344 0.592 . . . . 0.81999999999999995 110.692 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.697 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 25.6 mmt -56.35 -46.48 79.97 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.769 -0.651 . . . . 1.04 111.243 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.7 m -75.3 -17.69 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.393 -0.367 . . . . 1.02 110.944 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 93.4 mttt -70.4 -30.33 67.19 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 120.402 -0.519 . . . . 3.04 109.831 172.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.0 m -76.3 -9.07 58.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.596 -0.729 . . . . 0.85999999999999999 110.999 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm 62.46 26.95 16.04 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.64 0.734 . . . . 2.0499999999999998 110.665 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.482 ' HB3' HD11 ' A' ' 86' ' ' LEU . 7.9 tp -89.75 137.44 28.5 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.039 -0.982 . . . . 1.3400000000000001 109.893 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.522 ' O ' HD13 ' A' ' 86' ' ' LEU . 45.1 Cg_exo -55.52 145.46 68.99 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 123.23 2.62 . . . . 0.62 113.406 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.409 ' HA ' HD22 ' A' ' 86' ' ' LEU . 13.2 m120 -52.75 -39.96 62.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.98 -0.555 . . . . 0.93999999999999995 112.145 -178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.5 m -58.08 -35.09 70.89 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.3 0.572 . . . . 0.58999999999999997 110.93 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.625 ' O ' HG12 ' A' ' 89' ' ' ILE . 57.4 t -76.11 -40.96 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 108.867 -0.79 . . . . 0.40000000000000002 108.867 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.697 ' HG ' ' HB3' ' A' ' 76' ' ' MET . 2.2 mp -57.17 -45.37 83.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.309 -0.859 . . . . 1.25 110.05 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.576 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -56.35 -41.68 87.89 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.746 -0.661 . . . . 0.34000000000000002 112.572 175.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -71.16 -46.41 61.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.979 0.39 . . . . 1.1599999999999999 110.664 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 85' ' ' VAL . 49.0 mm -55.89 -50.86 66.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.76 -0.655 . . . . 0.89000000000000001 110.122 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -65.11 -41.98 94.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 0.34999999999999998 110.658 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -65.2 -32.62 74.39 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.207 -0.451 . . . . 1.3799999999999999 111.45 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.513 HD22 HD12 ' A' ' 122' ' ' LEU . 8.3 mp -86.75 -41.98 13.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.42 -0.354 . . . . 1.53 111.367 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -64.9 -43.22 93.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.464 -0.335 . . . . 0.42999999999999999 111.797 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . 0.508 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 34.4 t70 -84.7 88.59 7.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.536 0.684 . . . . 0.58999999999999997 109.831 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.0 t -83.16 -38.0 14.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.984 -1.007 . . . . 1.49 111.141 -176.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -76.82 -17.25 59.13 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.91 -0.586 . . . . 1.45 110.741 -173.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.505 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 71.8 mmtt 63.16 50.86 2.91 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.571 -0.741 . . . . 2.6699999999999999 111.154 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.401 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 6.8 p-10 -92.91 -16.48 25.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.583 -0.735 . . . . 1.1299999999999999 109.796 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.71 -1.87 66.4 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.745 -0.662 . . . . 0.42999999999999999 112.464 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.803 HD22 ' HA ' ' A' ' 68' ' ' THR . 56.6 mt -128.06 177.75 6.68 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.331 -0.618 . . . . 0.45000000000000001 109.331 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.2 mt -114.56 113.86 24.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.201 0.524 . . . . 0.70999999999999996 110.832 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.478 ' CA ' ' HD3' ' A' ' 66' ' ' LYS . 12.7 t70 -84.81 -177.8 6.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.342 -0.845 . . . . 1.4199999999999999 109.21 173.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -66.62 -35.89 81.28 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.186 0.448 . . . . 1.73 111.719 -170.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -71.92 -42.61 66.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.225 0.536 . . . . 1.53 110.361 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.508 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 19.2 mt-10 -68.05 -45.15 74.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.325 -0.852 . . . . 0.81999999999999995 110.794 -175.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -68.84 -36.51 78.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.032 -0.531 . . . . 0.37 110.908 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.8 -40.81 98.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.903 0.382 . . . . 0.5 110.413 176.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.2 mt -66.99 -36.29 81.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.021 -0.536 . . . . 1.3200000000000001 110.545 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.85 -52.34 65.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.26000000000000001 110.455 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -61.42 -39.65 91.53 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.691 0.281 . . . . 1.3600000000000001 110.661 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' HIS . . . . . 0.609 ' O ' HG23 ' A' ' 115' ' ' VAL . 83.5 t60 -59.74 -47.79 84.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.472 . . . . 0.67000000000000004 110.807 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.756 HD13 HD13 ' A' ' 122' ' ' LEU . 96.3 mt -64.53 -41.81 96.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.367 -0.379 . . . . 0.89000000000000001 111.116 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.4 mt -60.75 -40.68 85.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.133 0.492 . . . . 0.46000000000000002 109.713 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.651 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 59.7 tttp -59.31 -42.11 90.61 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.715 -0.675 . . . . 2.0699999999999998 110.428 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 111' ' ' HIS . 25.5 t -56.79 -40.15 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.816 0.341 . . . . 0.5 110.116 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 2.3 mmmp? -60.68 -45.49 93.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 1.25 109.912 175.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.9 -25.2 65.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.555 -0.748 . . . . 0.93999999999999995 111.07 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 45.0 mm-40 -70.85 -21.71 62.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.348 -0.387 . . . . 1.6499999999999999 110.461 176.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 111.62 12.54 14.57 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.0 -0.619 . . . . 0.80000000000000004 112.38 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.563 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 29.6 m-70 -121.4 -179.35 4.04 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.553 -0.536 . . . . 1.0600000000000001 109.553 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.469 ' HA ' ' HD2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -140.44 160.18 40.56 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 110.048 -0.353 . . . . 3.6000000000000001 110.048 174.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.756 HD13 HD13 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -92.69 123.94 60.26 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.46 -0.336 . . . . 1.51 110.238 -177.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.38 15.42 0.27 Allowed 'Trans proline' 0 N--CA 1.48 0.695 0 C-N-CA 123.934 3.089 . . . . 1.01 114.229 -169.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 67.01 18.34 10.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.386 0.612 . . . . 0.87 110.489 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.57 147.59 43.55 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.375 -0.829 . . . . 1.9399999999999999 109.506 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.676 ' HB3' ' HB ' ' A' ' 131' ' ' VAL . 96.2 mt -101.31 97.81 8.0 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.574 -0.285 . . . . 0.67000000000000004 110.432 172.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.5 147.97 87.26 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.217 1.945 . . . . 0.75 111.416 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.53 -27.45 25.18 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 123.295 2.663 . . . . 0.70999999999999996 114.173 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -85.01 7.58 20.85 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.061 0.458 . . . . 0.93999999999999995 111.247 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.8 mt -132.39 -31.46 1.41 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.215 -0.448 . . . . 0.82999999999999996 111.327 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.676 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 7.7 p . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 121.117 0.484 . . . . 1.4399999999999999 110.923 178.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 . . . . . 0 CA--C 1.52 -0.191 0 CA-C-O 121.208 0.528 . . . . 0.89000000000000001 110.288 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 149' ' ' ASN . . . . . 0.665 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 34.1 t-20 -96.2 114.92 65.19 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.412 -0.813 . . . . 0.42999999999999999 111.101 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 150' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 10.4 Cg_exo -72.08 -2.65 11.9 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.351 2.701 . . . . 0.51000000000000001 113.007 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 151' ' ' PHE . . . . . 0.542 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 68.8 m-85 -107.02 -23.34 12.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.511 0.672 . . . . 0.5 110.333 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 152' ' ' GLU . . . . . 0.665 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 41.7 tt0 . . . . . 0 C--N 1.316 -0.87 0 CA-C-N 114.975 -1.011 . . . . 1.4199999999999999 109.397 -173.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.404 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.48 1.568 0 N-CA-C 112.337 -0.305 . . . . 11.68 112.337 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.404 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 4.9 Cg_exo -74.65 102.13 1.53 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.79 2.327 . . . . 11.24 111.401 177.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 87.0 mt -80.67 145.3 31.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.955 -0.566 . . . . 8.6199999999999992 110.294 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.86 170.49 54.97 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 121.159 -0.544 . . . . 6.6399999999999997 113.044 -176.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.1 p -88.72 125.28 34.79 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.163 -0.31 . . . . 5.8499999999999996 110.163 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -86.71 97.11 10.4 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.081 0.467 . . . . 4.0099999999999998 110.205 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -101.51 97.46 7.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.858 -0.61 . . . . 3.8599999999999999 109.964 -178.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.0 p -89.19 154.06 3.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 115.407 -0.815 . . . . 1.8400000000000001 109.879 -179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.46 ' H ' ' CD ' ' A' ' 43' ' ' GLU . 1.3 pm0 -79.19 87.2 4.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.552 0.691 . . . . 3.02 111.159 -178.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.407 ' HH2' ' HB2' ' A' ' 104' ' ' GLU . 6.2 t90 -82.22 95.32 7.51 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.526 -0.916 . . . . 0.84999999999999998 108.526 174.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 20.2 m -56.79 -26.06 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 115.911 -0.586 . . . . 1.24 112.28 -174.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.637 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 40.8 t -62.77 -19.42 23.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 120.898 0.38 . . . . 1.3 110.829 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.34 -23.38 64.4 Favored Glycine 0 CA--C 1.52 0.381 0 C-N-CA 120.789 -0.72 . . . . 0.62 111.982 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -84.11 -28.13 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.794 0.807 . . . . 2.9900000000000002 109.314 177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.919 ' HB3' ' CE2' ' A' ' 53' ' ' TYR . 1.1 m-20 -84.29 -28.08 27.39 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.288 -1.324 . . . . 1.8200000000000001 111.455 -175.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.637 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 4.2 mmmp? -47.06 -54.73 18.64 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 115.342 1.608 . . . . 0.93000000000000005 115.342 -168.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.5 Cg_endo -50.21 -41.77 49.0 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.279 1.986 . . . . 0.56999999999999995 112.792 -173.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.4 m -70.63 -43.98 68.11 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.759 -0.655 . . . . 0.67000000000000004 111.026 -175.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.919 ' CE2' ' HB3' ' A' ' 49' ' ' ASP . 16.6 m-85 -76.74 -19.79 57.26 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.074 -0.512 . . . . 0.92000000000000004 110.229 -179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -66.96 -44.65 80.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.894 -0.78 . . . . 1.8600000000000001 108.894 175.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -61.91 -45.51 93.42 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 115.382 -0.826 . . . . 2.0 110.536 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 64.3 mt -63.11 -39.48 85.39 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 121.153 0.501 . . . . 0.53000000000000003 110.58 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -58.59 -37.23 75.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.625 -0.716 . . . . 0.42999999999999999 110.619 178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 7.4 m-85 -75.82 -24.69 55.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 3.0800000000000001 112.11 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.1 p -81.63 -14.95 56.07 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.575 -0.45 . . . . 0.75 111.393 -177.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 76.7 mt -90.88 3.92 53.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.444 -0.344 . . . . 1.26 110.75 177.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.1 t 68.76 84.86 0.14 Allowed Pre-proline 0 C--O 1.232 0.151 0 O-C-N 123.949 0.78 . . . . 1.1100000000000001 111.246 -179.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 56.1 Cg_endo -75.67 110.84 3.17 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.368 2.045 . . . . 0.68999999999999995 112.27 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.8 m -88.22 116.07 29.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.623 0 CA-C-O 121.258 0.552 . . . . 1.4299999999999999 110.195 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 60.31 23.18 12.64 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.608 -0.724 . . . . 2.1499999999999999 111.257 -176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.26 18.53 60.53 Favored Glycine 0 N--CA 1.452 -0.281 0 CA-C-N 115.959 -0.564 . . . . 0.62 113.645 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 100' ' ' LEU . 37.3 tttt -153.84 125.19 7.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.301 0.551 . . . . 2.2400000000000002 109.765 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 40.4 pt -85.32 155.46 3.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 CA-C-O 121.159 0.504 . . . . 0.31 110.874 -177.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.49 ' HA ' HD22 ' A' ' 100' ' ' LEU . 73.5 p -87.37 176.19 7.63 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.375 -0.83 . . . . 0.52000000000000002 110.995 -176.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.466 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -66.24 -26.91 72.65 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.847 -0.692 . . . . 0.38 112.468 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.497 ' O ' ' HG2' ' A' ' 74' ' ' LYS . . . -69.84 -43.62 71.6 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 120.922 0.391 . . . . 0.40000000000000002 111.145 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -60.92 -51.89 67.34 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.714 0.769 . . . . 1.73 109.996 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.473 ' HB3' ' HZ3' ' A' ' 90' ' ' TRP . . . -73.54 -24.29 60.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.481 -0.781 . . . . 0.35999999999999999 110.985 -178.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.661 ' HD3' ' HB2' ' B' ' 150' ' ' PRO . 34.0 ttpt -64.1 -46.84 82.47 Favored 'General case' 0 CA--C 1.521 -0.142 0 C-N-CA 120.586 -0.446 . . . . 0.60999999999999999 110.278 177.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.703 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 5.4 ptpp? -71.09 -27.32 63.53 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 120.232 -0.587 . . . . 2.2400000000000002 110.728 178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.452 ' HA ' ' NZ ' ' A' ' 78' ' ' LYS . 17.7 tp10 -67.3 -44.12 80.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.228 0.537 . . . . 0.81999999999999995 109.851 174.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.425 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 0.0 OUTLIER -61.45 -39.57 91.31 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.427 -0.806 . . . . 1.04 111.674 179.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.498 HG22 ' HA ' ' A' ' 74' ' ' LYS . 19.2 m -73.72 -23.03 18.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.366 -0.534 . . . . 1.02 110.71 179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.703 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 32.6 mtmm -73.17 -24.14 60.52 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-O 120.981 0.419 . . . . 3.04 110.147 174.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 24.2 m -68.84 -16.04 63.67 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.768 -0.651 . . . . 0.85999999999999999 111.089 177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? 67.59 31.08 6.31 Favored 'General case' 0 N--CA 1.468 0.469 0 N-CA-C 112.441 0.534 . . . . 2.0499999999999998 112.441 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.434 HD13 ' HA ' ' A' ' 81' ' ' LEU . 3.6 mm? -97.66 152.92 38.41 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.486 -0.325 . . . . 1.3400000000000001 110.16 176.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.527 ' O ' HD13 ' A' ' 86' ' ' LEU . 35.5 Cg_exo -57.64 143.12 95.67 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.552 2.168 . . . . 0.62 111.616 174.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -57.38 -34.77 69.19 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 120.85 0.357 . . . . 0.93999999999999995 111.436 -173.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.0 m -58.6 -38.86 78.85 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.872 -0.604 . . . . 0.58999999999999997 110.948 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.609 ' O ' HG12 ' A' ' 89' ' ' ILE . 98.6 t -70.21 -39.24 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.81 -0.632 . . . . 0.40000000000000002 109.426 -176.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.527 HD13 ' O ' ' A' ' 82' ' ' PRO . 6.5 mp -57.67 -47.02 83.47 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.462 -0.79 . . . . 1.25 110.527 178.01 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.564 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -60.67 -39.92 97.28 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.033 -0.603 . . . . 0.34000000000000002 112.401 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -69.96 -45.34 67.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.664 0.269 . . . . 1.1599999999999999 110.604 -179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.609 HG12 ' O ' ' A' ' 85' ' ' VAL . 46.0 mm -56.64 -47.09 82.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.184 -0.462 . . . . 0.89000000000000001 110.266 178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.473 ' HZ3' ' HB3' ' A' ' 72' ' ' ALA . 22.9 t-105 -64.46 -46.62 82.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.855 -0.611 . . . . 0.34999999999999998 110.906 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 16.4 ttpt -66.32 -24.1 66.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.976 -0.556 . . . . 1.3799999999999999 111.38 -173.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.472 ' O ' HD11 ' A' ' 126' ' ' LEU . 4.3 mm? -86.72 -47.44 9.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.349 -0.387 . . . . 1.53 110.841 173.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.48 -38.16 83.96 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.95 0.722 . . . . 0.42999999999999999 112.95 -173.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.645 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 35.2 t70 -76.59 86.28 3.27 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.274 0.559 . . . . 0.58999999999999997 109.719 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.0 t -76.62 -25.01 15.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.648 -0.706 . . . . 1.49 110.786 -176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.687 ' OD1' ' HE2' ' A' ' 135' ' ' LYS . 67.1 m-20 -70.49 -24.82 62.92 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.606 -0.438 . . . . 1.45 110.871 178.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.474 ' HD3' ' HA ' ' A' ' 97' ' ' LYS . 41.2 mmtm 56.27 35.78 26.36 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.776 0.798 . . . . 2.6699999999999999 108.997 -170.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.633 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 9.0 p-10 -99.6 -18.72 17.2 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.486 -1.234 . . . . 1.1299999999999999 110.692 -173.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 92.72 -6.85 77.34 Favored Glycine 0 CA--C 1.518 0.265 0 C-N-CA 120.613 -0.803 . . . . 0.42999999999999999 112.777 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.529 ' HB3' ' HG2' ' A' ' 66' ' ' LYS . 67.8 mt -117.67 160.15 21.79 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 109.458 -0.571 . . . . 0.45000000000000001 109.458 177.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.498 HD22 ' HB3' ' A' ' 105' ' ' GLU . 65.0 mt -121.54 113.96 20.54 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.977 0.417 . . . . 0.70999999999999996 110.321 177.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.746 ' OD1' ' HG2' ' A' ' 104' ' ' GLU . 3.4 p30 -84.29 -176.28 6.18 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.56 -0.904 . . . . 1.4199999999999999 108.56 171.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -63.7 -28.16 69.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.623 0.601 . . . . 1.73 112.623 -170.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.746 ' HG2' ' OD1' ' A' ' 102' ' ' ASP . 13.3 pt-20 -85.42 -39.07 17.95 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 119.841 -0.744 . . . . 1.53 110.704 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.498 ' HB3' HD22 ' A' ' 101' ' ' LEU . 46.0 mt-10 -63.61 -45.84 88.52 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-O 121.361 0.601 . . . . 0.81999999999999995 110.27 175.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -64.44 -39.33 93.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.197 -0.91 . . . . 0.37 110.657 -178.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.14 -34.79 79.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.143 -0.481 . . . . 0.5 110.734 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 6.2 mt -68.98 -41.42 77.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.623 -0.262 . . . . 1.3200000000000001 110.462 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -54.01 -52.07 61.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.26000000000000001 110.509 174.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -65.6 -39.78 91.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.273 -0.421 . . . . 1.3600000000000001 110.95 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.646 ' O ' HG23 ' A' ' 115' ' ' VAL . 79.1 t60 -57.87 -47.29 83.17 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 116.534 -0.303 . . . . 0.67000000000000004 110.428 178.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.469 HD13 HD13 ' A' ' 122' ' ' LEU . 92.5 mt -65.18 -43.3 92.13 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.526 -0.306 . . . . 0.89000000000000001 111.018 -179.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.421 HG13 ' O ' ' A' ' 109' ' ' ALA . 73.9 mt -56.63 -44.24 80.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-O 120.989 0.423 . . . . 0.46000000000000002 110.304 176.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.655 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 62.9 tttp -61.35 -42.87 99.39 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.898 -0.592 . . . . 2.0699999999999998 110.833 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 111' ' ' HIS . 29.8 t -55.92 -42.02 69.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 120.889 0.376 . . . . 0.5 110.062 178.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.603 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 29.1 mmmt -62.61 -43.77 97.98 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 115.748 -0.66 . . . . 1.25 110.802 175.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 95.6 mt -64.96 -29.59 70.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.36 -0.382 . . . . 0.93999999999999995 111.494 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.655 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 53.9 mm-40 -72.18 -4.77 31.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.24 -0.436 . . . . 1.6499999999999999 110.753 178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 99.34 2.24 56.71 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.851 -0.69 . . . . 0.80000000000000004 112.295 178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.603 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 72.3 m-70 -112.33 -178.36 3.39 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.755 0.312 . . . . 1.0600000000000001 110.177 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -139.43 156.45 46.96 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.967 0.413 . . . . 3.6000000000000001 110.649 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.469 HD13 HD13 ' A' ' 112' ' ' LEU . 0.1 OUTLIER -80.81 140.25 50.59 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.691 -0.686 . . . . 1.51 109.271 177.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -73.53 8.09 2.02 Favored 'Trans proline' 0 N--CA 1.476 0.483 0 C-N-CA 122.997 2.465 . . . . 1.01 113.655 -174.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.7 19.15 11.58 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.242 0.544 . . . . 0.87 111.027 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.498 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 39.6 m-20 -120.48 127.38 52.16 Favored 'General case' 0 CA--C 1.508 -0.671 0 CA-C-N 115.862 -0.608 . . . . 1.9399999999999999 110.088 177.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 92' ' ' LEU . 86.6 mt -94.18 97.34 2.17 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.317 -0.401 . . . . 0.67000000000000004 110.284 167.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.695 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 86.0 Cg_endo -83.02 173.03 10.41 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.666 2.244 . . . . 0.75 111.542 175.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.96 -31.32 52.47 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.811 2.34 . . . . 0.70999999999999996 113.225 179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 29.4 p-80 -90.8 14.16 14.36 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.759 0.314 . . . . 0.93999999999999995 111.627 -176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.695 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 31.2 mt -131.06 -28.91 1.9 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.413 -0.358 . . . . 0.82999999999999996 110.504 173.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 85.8 t -74.61 120.5 81.81 Favored Pre-proline 0 C--N 1.33 -0.274 0 N-CA-C 110.062 -0.347 . . . . 1.4399999999999999 110.062 174.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -61.81 147.05 96.11 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 122.381 2.054 . . . . 1.22 111.704 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.427 ' HA ' ' HG2' ' A' ' 136' ' ' ARG . 41.4 Cg_exo -57.85 -24.7 65.61 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.047 2.498 . . . . 1.8600000000000001 112.417 -178.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 35.8 t -66.91 -20.51 65.92 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.281 -0.418 . . . . 2.0699999999999998 110.912 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.687 ' HE2' ' OD1' ' A' ' 96' ' ' ASP . 3.0 mptt -120.3 26.23 9.34 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.46 -0.336 . . . . 1.27 111.554 -178.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.427 ' HG2' ' HA ' ' A' ' 133' ' ' PRO . 30.7 mmm180 -92.02 110.18 21.54 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.988 0.423 . . . . 3.0699999999999998 110.65 177.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -75.14 119.8 19.78 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.721 -0.672 . . . . 5.46 111.612 -176.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 14.3 p-80 -102.87 126.82 50.17 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.408 -0.59 . . . . 5.7999999999999998 109.408 171.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 . . . . . 0 C--O 1.251 1.169 0 O-C-N 123.8 0.687 . . . . 6.9299999999999997 110.693 -179.352 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 2.6 pt? . . . . . 0 N--CA 1.48 1.056 0 CA-C-O 120.545 0.212 . . . . 10.57 111.284 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -84.97 -31.84 23.33 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.636 -0.426 . . . . 8.0399999999999991 111.432 -177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 14.7 m -72.61 105.41 4.23 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.26 -1.015 . . . . 5.1100000000000003 108.26 172.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 0.462 ' HA ' ' HD3' ' B' ' 147' ' ' PRO . 49.5 mmtm -86.16 107.28 12.57 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.169 0.509 . . . . 6.7000000000000002 111.041 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' B' ' 146' ' ' LYS . 6.2 Cg_endo -85.35 15.68 2.15 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.382 2.721 . . . . 1.96 112.986 -173.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -98.93 2.32 46.39 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.253 0.549 . . . . 0.89000000000000001 109.813 -178.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.576 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 53.7 t-20 -114.97 117.76 41.35 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.202 -0.908 . . . . 0.42999999999999999 109.772 -176.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.661 ' HB2' ' HD3' ' A' ' 73' ' ' LYS . 59.1 Cg_endo -72.11 -2.76 12.09 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.955 2.437 . . . . 0.51000000000000001 112.596 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 29.7 m-85 -107.87 5.96 26.93 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.287 -0.634 . . . . 0.5 109.287 175.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 29.0 tt0 -129.51 17.44 5.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.851 -1.068 . . . . 1.4199999999999999 108.508 -177.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -77.62 86.87 3.92 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.096 -0.956 . . . . 1.71 111.414 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 72.22 148.93 0.09 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 114.823 -1.081 . . . . 4.8099999999999996 111.696 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -105.47 -73.07 0.69 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.242 -0.436 . . . . 5.9800000000000004 111.362 -173.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -117.8 -25.79 6.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.231 0.539 . . . . 7.1900000000000004 110.301 -177.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 C--O 1.246 0.882 0 CA-C-N 114.828 -1.078 . . . . 7.3200000000000003 108.742 179.653 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.645 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 N-CA-C 112.091 -0.404 . . . . 11.68 112.091 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -74.32 127.23 11.0 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.577 2.185 . . . . 11.24 111.669 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 89.9 mt -94.0 120.07 33.75 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.98 0.419 . . . . 8.6199999999999992 111.222 -176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -105.66 136.62 13.31 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 110.997 -0.841 . . . . 6.6399999999999997 110.997 175.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.3 p -79.46 115.48 19.12 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.162 0.506 . . . . 5.8499999999999996 111.717 -174.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -88.15 93.88 9.64 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.866 -0.606 . . . . 4.0099999999999998 109.484 174.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -144.81 107.94 4.55 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.419 -0.809 . . . . 3.8599999999999999 109.582 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.524 HG13 ' HA ' ' A' ' 129' ' ' HIS . 62.5 t -103.06 124.46 57.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.963 -0.562 . . . . 1.8400000000000001 110.776 -176.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -102.76 105.99 16.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.336 0.589 . . . . 3.02 109.835 174.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.9 t90 -87.59 93.72 9.51 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.534 0.683 . . . . 0.84999999999999998 109.212 179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 33.7 m -69.87 5.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.148 -0.933 . . . . 1.24 112.827 -173.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.521 HG13 ' HE2' ' A' ' 53' ' ' TYR . 24.6 t -93.95 -17.04 7.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.935 0.398 . . . . 1.3 110.091 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -68.18 -18.87 71.6 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.506 -0.854 . . . . 0.62 112.67 -179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -87.18 -26.83 23.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.917 0.389 . . . . 2.9900000000000002 111.759 -178.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' HB3' ' CZ ' ' A' ' 53' ' ' TYR . 22.9 m-20 -101.1 -2.71 30.79 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.324 0.583 . . . . 1.8200000000000001 109.878 178.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.569 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 2.8 tmtp? -55.17 -50.06 88.75 Favored Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 114.932 -1.031 . . . . 0.93000000000000005 112.635 -175.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.9 Cg_endo -51.45 -38.63 64.15 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 122.546 2.164 . . . . 0.56999999999999995 112.095 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.0 m -69.24 -40.08 78.13 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.829 -0.623 . . . . 0.67000000000000004 110.716 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.521 ' HE2' HG13 ' A' ' 46' ' ' VAL . 14.5 m-85 -70.33 -24.29 62.97 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 121.127 0.489 . . . . 0.92000000000000004 109.763 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -72.67 -44.74 61.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.478 -0.783 . . . . 1.8600000000000001 109.989 178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.09 -45.77 90.0 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.6 -0.727 . . . . 2.0 110.388 177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 70.9 mt -64.33 -44.58 97.25 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-O 121.207 0.527 . . . . 0.53000000000000003 110.73 178.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -52.06 -45.19 64.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.495 -0.775 . . . . 0.42999999999999999 111.476 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -81.78 -23.71 36.41 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.36 0.504 . . . . 3.0800000000000001 112.36 -176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 30.3 p -75.33 -16.79 60.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.136 0.493 . . . . 0.75 110.627 177.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 72.4 mt -84.46 -10.0 57.88 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.893 -0.594 . . . . 1.26 110.307 176.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.0 m 70.07 93.09 0.05 OUTLIER Pre-proline 0 CA--C 1.533 0.314 0 O-C-N 124.161 0.913 . . . . 1.1100000000000001 111.311 -178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.411 ' HA ' HG22 ' A' ' 67' ' ' ILE . 1.0 OUTLIER -84.23 140.67 8.79 Favored 'Trans proline' 0 N--CA 1.458 -0.602 0 C-N-CA 123.654 2.903 . . . . 0.68999999999999995 111.653 178.641 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.2 m -97.37 107.62 20.3 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 121.443 0.64 . . . . 1.4299999999999999 110.326 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 11.7 m120 63.55 31.22 14.89 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.194 -0.912 . . . . 2.1499999999999999 111.014 -179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.15 -0.01 66.09 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.726 -0.75 . . . . 0.62 114.37 175.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.524 ' HE2' ' HB2' ' A' ' 100' ' ' LEU . 71.8 tttt -137.47 138.21 39.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.755 0.778 . . . . 2.2400000000000002 109.371 178.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.411 HG22 ' HA ' ' A' ' 62' ' ' PRO . 46.2 pt -93.14 156.71 3.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.632 -0.427 . . . . 0.31 111.102 -177.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.409 ' HA ' ' CD2' ' A' ' 100' ' ' LEU . 50.0 p -88.24 -179.65 6.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.512 -0.767 . . . . 0.52000000000000002 110.322 -179.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -74.81 -14.46 81.48 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.554 -0.831 . . . . 0.38 111.808 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.03 -39.88 28.94 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-O 120.947 0.403 . . . . 0.40000000000000002 110.745 -178.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.718 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 5.4 m120 -63.44 -52.22 62.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.981 0.896 . . . . 1.73 109.653 179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.458 ' HB3' ' HZ3' ' A' ' 90' ' ' TRP . . . -67.66 -26.45 66.21 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.267 -0.879 . . . . 0.35999999999999999 110.732 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.45 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 35.7 ttmt -65.42 -47.79 75.02 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.743 -0.383 . . . . 0.60999999999999999 110.739 178.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.718 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 19.8 ptmt -64.74 -31.0 72.02 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-O 120.928 0.394 . . . . 2.2400000000000002 110.477 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HA ' ' HZ2' ' A' ' 78' ' ' LYS . 17.1 tp10 -71.11 -48.38 52.59 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-O 121.251 0.548 . . . . 0.81999999999999995 110.21 175.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.469 ' HB3' HD22 ' A' ' 86' ' ' LEU . 0.1 OUTLIER -58.13 -47.3 83.72 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.532 -0.758 . . . . 1.04 111.604 -178.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 29.8 m -67.47 -34.74 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.307 0 CA-C-O 120.671 0.272 . . . . 1.02 110.804 -179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HZ2' ' HA ' ' A' ' 75' ' ' GLU . 3.2 mtpm? -64.38 -18.7 64.92 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 112.282 0.475 . . . . 3.04 112.282 174.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.4 m -84.18 2.32 40.26 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.744 0.307 . . . . 0.85999999999999999 111.127 176.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? 54.92 50.36 15.74 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 112.76 0.652 . . . . 2.0499999999999998 112.76 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.632 ' HB2' HD21 ' A' ' 86' ' ' LEU . 96.3 mt -120.49 141.44 32.1 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 110.092 -0.336 . . . . 1.3400000000000001 110.092 177.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.525 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 37.1 Cg_exo -59.62 151.41 69.93 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.061 2.507 . . . . 0.62 112.82 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -51.41 -45.27 62.5 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.822 -0.627 . . . . 0.93999999999999995 111.77 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 27.0 m -58.25 -41.39 84.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.01 0.434 . . . . 0.58999999999999997 111.285 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.513 ' O ' HG12 ' A' ' 89' ' ' ILE . 46.2 t -68.88 -42.08 82.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.981 0.42 . . . . 0.40000000000000002 109.881 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' A' ' 81' ' ' LEU . 67.3 mt -62.31 -38.94 91.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.652 -0.704 . . . . 1.25 110.033 177.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.409 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -61.96 -37.22 94.04 Favored Glycine 0 N--CA 1.448 -0.524 0 CA-C-N 115.792 -0.64 . . . . 0.34000000000000002 112.251 177.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.0 mtpt -66.6 -47.06 73.9 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.894 0.378 . . . . 1.1599999999999999 110.034 177.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.513 HG12 ' O ' ' A' ' 85' ' ' VAL . 38.2 mm -55.08 -50.05 66.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.355 -0.839 . . . . 0.89000000000000001 109.962 177.253 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.458 ' HZ3' ' HB3' ' A' ' 72' ' ' ALA . 34.9 t-105 -65.81 -44.5 85.49 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.919 -0.582 . . . . 0.34999999999999998 111.545 -177.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 19.7 ttpt -67.46 -21.37 65.54 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.079 0.466 . . . . 1.3799999999999999 110.738 -174.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.602 HD12 HD12 ' A' ' 122' ' ' LEU . 24.7 mt -91.92 -38.37 12.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.767 -0.651 . . . . 1.53 111.139 175.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.77 -35.36 67.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.42999999999999999 111.781 -176.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.66 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 22.0 t0 -85.09 82.28 8.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.744 0.783 . . . . 0.58999999999999997 109.289 -179.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 18.2 t -74.1 -27.68 22.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.072 -0.967 . . . . 1.49 110.951 -173.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 55.3 p30 -86.81 -10.14 54.2 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.565 -0.289 . . . . 1.45 111.191 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 53.51 51.52 15.1 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 123.493 0.495 . . . . 2.6699999999999999 110.808 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -111.98 -8.68 14.05 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.061 -0.518 . . . . 1.1299999999999999 111.089 -175.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 85.1 4.84 86.42 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.97 -0.633 . . . . 0.42999999999999999 112.529 178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.524 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 52.3 mt -129.68 162.53 28.14 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.828 -0.434 . . . . 0.45000000000000001 109.828 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 88.4 mt -122.66 117.52 25.97 Favored 'General case' 0 C--N 1.322 -0.61 0 C-N-CA 120.801 -0.359 . . . . 0.70999999999999996 110.946 178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -82.05 -178.04 6.85 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.419 -0.956 . . . . 1.4199999999999999 108.419 169.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -60.51 -29.23 68.97 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.892 0.331 . . . . 1.73 111.892 -173.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -82.78 -42.23 18.18 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.811 -0.356 . . . . 1.53 110.464 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -65.72 -40.44 92.22 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.22 0.534 . . . . 0.81999999999999995 110.265 179.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -69.4 -34.48 74.56 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.678 -0.692 . . . . 0.37 109.998 178.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -63.33 -42.25 98.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.329 -0.396 . . . . 0.5 110.284 175.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.451 ' O ' ' HG ' ' A' ' 112' ' ' LEU . 1.8 mm? -59.5 -44.16 93.17 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.713 -0.477 . . . . 1.3200000000000001 109.713 173.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.445 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.58 -54.24 48.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.651 -0.704 . . . . 0.26000000000000001 110.978 179.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -66.33 -34.88 78.99 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.736 0.303 . . . . 1.3600000000000001 110.855 -177.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.601 ' O ' HG23 ' A' ' 115' ' ' VAL . 85.4 t60 -63.7 -43.1 97.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.403 -0.362 . . . . 0.67000000000000004 110.282 179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.451 ' HG ' ' O ' ' A' ' 108' ' ' LEU . 96.1 mt -66.62 -39.83 88.5 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.305 -0.407 . . . . 0.89000000000000001 110.624 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 109' ' ' ALA . 77.9 mt -61.39 -40.35 85.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.149 0.499 . . . . 0.46000000000000002 109.951 174.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 80.7 tttt -59.6 -47.35 85.91 Favored 'General case' 0 C--O 1.22 -0.463 0 CA-C-N 115.74 -0.664 . . . . 2.0699999999999998 110.391 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 111' ' ' HIS . 21.1 t -56.54 -43.93 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-O 121.353 0.597 . . . . 0.5 110.263 177.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.68 -46.97 83.59 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.04 -0.982 . . . . 1.25 111.041 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 86.8 mt -80.65 -17.24 51.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.272 -0.422 . . . . 0.93999999999999995 111.384 -178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.521 ' HB3' ' HD2' ' A' ' 120' ' ' HIS . 11.7 mm-40 -70.01 -8.01 45.61 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.179 -0.464 . . . . 1.6499999999999999 111.183 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.87 23.06 34.01 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.51 -0.853 . . . . 0.80000000000000004 111.402 -177.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.521 ' HD2' ' HB3' ' A' ' 118' ' ' GLU . 85.0 m-70 -129.67 -173.3 2.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.004 0.43 . . . . 1.0600000000000001 110.123 -179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -134.18 160.08 38.92 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.618 -0.719 . . . . 3.6000000000000001 110.441 -171.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.602 HD12 HD12 ' A' ' 92' ' ' LEU . 0.1 OUTLIER -106.8 115.32 60.6 Favored Pre-proline 0 C--N 1.311 -1.08 0 CA-C-N 115.039 -0.982 . . . . 1.51 108.806 173.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.07 24.3 0.3 Allowed 'Trans proline' 0 N--CA 1.476 0.463 0 C-N-CA 123.664 2.909 . . . . 1.01 114.445 -167.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 59.16 25.58 14.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.113 0.482 . . . . 0.87 111.036 178.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -131.28 138.78 49.43 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.03 -0.532 . . . . 1.9399999999999999 110.047 -176.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.47 ' HB3' ' CG1' ' A' ' 131' ' ' VAL . 96.7 mt -106.14 90.22 4.44 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.623 -0.262 . . . . 0.67000000000000004 110.677 172.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -73.59 158.97 46.85 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 122.844 2.363 . . . . 0.75 112.33 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.414 ' HA ' HG22 ' A' ' 131' ' ' VAL . 14.7 Cg_endo -57.55 -28.55 81.49 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.47 2.78 . . . . 0.70999999999999996 114.177 -175.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.524 ' HA ' HG13 ' A' ' 42' ' ' VAL . 36.2 p-80 -85.94 6.68 27.42 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.736 -0.385 . . . . 0.93999999999999995 111.605 -178.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 62.0 mt -122.92 -22.97 5.11 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.519 0.199 . . . . 0.82999999999999996 111.397 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.47 ' CG1' ' HB3' ' A' ' 126' ' ' LEU . 29.3 m -83.68 142.08 42.22 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-O 120.741 0.305 . . . . 1.4399999999999999 111.318 -178.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.729 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 24.6 Cg_exo -63.42 136.05 52.93 Favored 'Trans proline' 0 C--O 1.235 0.325 0 C-N-CA 122.768 2.312 . . . . 1.22 111.627 175.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -59.12 -31.45 95.49 Favored 'Trans proline' 0 C--N 1.344 0.304 0 C-N-CA 122.746 2.297 . . . . 1.8600000000000001 112.406 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.8 p -66.58 -30.25 70.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.915 -0.584 . . . . 2.0699999999999998 111.309 179.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.729 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 13.8 mptt -85.99 9.42 17.1 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.973 -0.558 . . . . 1.27 112.041 -179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.5 mmm180 -85.47 105.22 15.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.042 0.448 . . . . 3.0699999999999998 111.226 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 1.5 ppt_? -108.83 149.05 29.65 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.784 -0.644 . . . . 5.46 109.731 176.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.558 ' O ' ' HB2' ' A' ' 139' ' ' GLU . 28.8 t60 -94.66 98.2 10.63 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.958 0.355 . . . . 5.7999999999999998 111.958 -174.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . 0.558 ' HB2' ' O ' ' A' ' 138' ' ' HIS . 21.7 tt0 . . . . . 0 C--O 1.248 0.997 0 O-C-N 124.396 1.06 . . . . 6.9299999999999997 109.12 170.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 N--CA 1.484 1.243 0 N-CA-C 109.586 -0.524 . . . . 10.57 109.586 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 15.7 mt-10 -143.64 162.95 34.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.504 -0.771 . . . . 8.0399999999999991 109.661 -171.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 47.5 m -66.7 98.58 0.53 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.82 -0.808 . . . . 5.1100000000000003 108.82 171.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 0.405 ' C ' ' H ' ' B' ' 148' ' ' TYR . 10.2 tptm -64.23 115.26 18.18 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 115.629 -0.714 . . . . 6.7000000000000002 111.133 -172.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.29 23.58 0.31 Allowed 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 123.079 2.519 . . . . 1.96 112.851 -176.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . 0.405 ' H ' ' C ' ' B' ' 146' ' ' LYS . 85.5 m-85 -129.53 -16.25 3.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.975 -0.557 . . . . 0.89000000000000001 110.352 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.438 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 53.2 t-20 -115.96 108.62 46.11 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.192 -0.458 . . . . 0.42999999999999999 109.795 -175.149 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 12.9 Cg_exo -70.23 -5.95 17.7 Favored 'Trans proline' 0 C--O 1.232 0.192 0 C-N-CA 123.191 2.594 . . . . 0.51000000000000001 112.65 -177.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 29.6 m-85 -107.01 -4.43 19.01 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.918 0.39 . . . . 0.5 110.221 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.438 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 30.6 tt0 -108.88 22.9 15.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.879 0.847 . . . . 1.4199999999999999 108.926 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -75.22 -72.86 0.28 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 114.891 -1.05 . . . . 1.71 110.402 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 45.82 -100.41 0.05 OUTLIER 'General case' 0 C--O 1.235 0.297 0 O-C-N 124.125 0.891 . . . . 4.8099999999999996 112.579 -177.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -167.29 -171.87 1.84 Allowed 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.058 -0.349 . . . . 5.9800000000000004 110.058 -175.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -79.72 84.82 5.48 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.224 0.535 . . . . 7.1900000000000004 110.228 178.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 27.7 t70 . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.434 -0.793 . . . . 7.3200000000000003 109.975 -179.079 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.66 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.484 1.84 0 N-CA-C 112.349 -0.3 . . . . 11.68 112.349 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.456 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 9.3 Cg_exo -73.8 107.47 2.42 Favored 'Trans proline' 0 C--O 1.234 0.295 0 C-N-CA 122.625 2.217 . . . . 11.24 111.452 177.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 92.9 mt -82.63 149.55 27.34 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.301 -0.409 . . . . 8.6199999999999992 110.91 -177.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.79 71.2 2.76 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.564 -0.827 . . . . 6.6399999999999997 112.099 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 24.9 m -132.95 113.89 13.37 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.831 -0.433 . . . . 5.8499999999999996 109.831 175.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -105.17 102.9 12.37 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.606 0.717 . . . . 4.0099999999999998 111.486 -177.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -87.43 135.5 33.31 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.285 -0.87 . . . . 3.8599999999999999 108.82 171.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 52.6 t -76.54 113.1 15.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 121.025 0.44 . . . . 1.8400000000000001 110.821 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -115.33 136.62 52.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.858 -0.61 . . . . 3.02 109.716 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.2 t90 -81.83 104.58 12.31 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 108.013 -1.106 . . . . 0.84999999999999998 108.013 172.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.537 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 90.6 t -56.51 -29.56 29.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.843 -0.617 . . . . 1.24 112.229 -171.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.561 HG12 ' HB2' ' A' ' 111' ' ' HIS . 18.9 m -77.69 -13.36 14.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 O-C-N 122.179 -0.326 . . . . 1.3 111.109 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.821 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -65.09 -24.46 70.34 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.063 -0.589 . . . . 0.62 112.255 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 45' ' ' VAL . 18.5 ptpt -87.17 0.34 55.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.746 0.307 . . . . 2.9900000000000002 111.234 -177.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -138.71 21.24 2.69 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.694 0.759 . . . . 1.8200000000000001 109.767 175.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.821 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 5.0 mmmp? -57.86 -40.15 81.56 Favored Pre-proline 0 C--O 1.22 -0.484 0 CA-C-N 115.353 -0.84 . . . . 0.93000000000000005 112.491 177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.644 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 8.9 Cg_endo -50.35 -42.26 48.52 Favored 'Trans proline' 0 C--N 1.361 1.216 0 C-N-CA 122.308 2.005 . . . . 0.56999999999999995 112.527 176.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 23.7 m -69.59 -44.05 71.55 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.12 -0.491 . . . . 0.67000000000000004 110.295 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -71.18 -22.65 62.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.953 -0.567 . . . . 0.92000000000000004 110.416 -178.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -76.71 -45.53 29.07 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.893 -0.781 . . . . 1.8600000000000001 108.893 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -53.69 -54.07 43.07 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 115.3 -0.864 . . . . 2.0 110.629 176.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 60.2 mt -64.88 -44.52 96.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.234 -0.439 . . . . 0.53000000000000003 111.435 -176.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.43 ' HE1' HG12 ' A' ' 67' ' ' ILE . 51.2 t80 -58.56 -44.18 89.6 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.763 0.316 . . . . 0.42999999999999999 110.79 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.42 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 13.1 m-85 -76.34 -24.33 54.25 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.122 0.416 . . . . 3.0800000000000001 112.122 -177.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.8 p -76.3 -15.97 59.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.025 0.44 . . . . 0.75 111.035 178.122 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.9 mp -88.29 -4.25 58.72 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.979 -0.555 . . . . 1.26 110.516 176.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.5 m 69.29 89.32 0.09 OUTLIER Pre-proline 0 N--CA 1.465 0.314 0 CA-C-N 115.232 -0.895 . . . . 1.1100000000000001 111.735 178.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 58.7 Cg_endo -86.65 117.01 1.4 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.705 2.27 . . . . 0.68999999999999995 112.747 179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.1 t -91.45 132.79 34.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.258 -0.645 . . . . 1.4299999999999999 109.258 177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 10.8 p30 49.48 23.71 0.96 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.726 0.81 . . . . 2.1499999999999999 112.108 -176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.78 6.75 61.95 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 121.073 -0.584 . . . . 0.62 113.403 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -135.74 155.58 50.15 Favored 'General case' 0 CA--C 1.511 -0.542 0 CA-C-O 121.673 0.749 . . . . 2.2400000000000002 112.316 179.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.43 HG12 ' HE1' ' A' ' 57' ' ' PHE . 41.3 pt -114.13 152.82 15.74 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 CA-C-N 114.749 -1.114 . . . . 0.31 108.775 171.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 72.2 p -88.0 175.65 7.67 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 120.449 -0.501 . . . . 0.52000000000000002 110.23 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.94 -27.25 71.0 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.641 -0.79 . . . . 0.38 112.528 -179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.63 -48.36 82.13 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-O 120.954 0.407 . . . . 0.40000000000000002 111.915 -176.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -71.8 -40.78 68.94 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.282 0.563 . . . . 1.73 110.571 -173.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.55 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -72.07 -28.79 63.55 Favored 'General case' 0 C--N 1.318 -0.761 0 C-N-CA 120.465 -0.494 . . . . 0.35999999999999999 110.095 177.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.416 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 40.7 ttmt -64.79 -50.15 67.9 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 116.725 -0.216 . . . . 0.60999999999999999 110.533 178.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -62.18 -38.22 88.27 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.508 -0.315 . . . . 2.2400000000000002 110.58 179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.93 -50.64 72.96 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.423 0.63 . . . . 0.81999999999999995 110.22 174.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.828 ' HB3' HD22 ' A' ' 86' ' ' LEU . 22.8 mmt -58.52 -45.24 89.23 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.528 -0.76 . . . . 1.04 112.197 -177.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -74.87 -16.6 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.946 0.403 . . . . 1.02 110.796 -177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -91.19 -5.76 54.45 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 116.169 -0.469 . . . . 3.04 111.063 173.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 7.1 t -89.54 -1.18 57.95 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.271 0.558 . . . . 0.85999999999999999 110.135 176.068 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 79' ' ' SER . 9.1 mptt 70.82 16.61 6.61 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.236 0.828 . . . . 2.0499999999999998 113.236 176.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.537 ' HB2' HD21 ' A' ' 86' ' ' LEU . 2.6 mm? -91.29 142.85 27.49 Favored Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.574 -0.45 . . . . 1.3400000000000001 111.124 177.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.588 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 21.3 Cg_exo -65.49 154.87 71.77 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.263 2.642 . . . . 0.62 112.474 178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -56.12 -41.23 74.96 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 116.223 -0.444 . . . . 0.93999999999999995 111.55 -177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.464 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 7.9 m -58.21 -48.25 80.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.218 0.532 . . . . 0.58999999999999997 110.938 178.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.576 ' O ' HG12 ' A' ' 89' ' ' ILE . 96.4 t -63.57 -42.06 94.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.731 -0.668 . . . . 0.40000000000000002 110.479 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.828 HD22 ' HB3' ' A' ' 76' ' ' MET . 79.0 mt -61.92 -44.06 97.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.062 -0.517 . . . . 1.25 110.762 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.413 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -59.7 -31.63 71.85 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 121.027 -0.606 . . . . 0.34000000000000002 112.308 176.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 84' ' ' THR . 55.4 mtpt -72.66 -46.56 53.26 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.747 0.308 . . . . 1.1599999999999999 110.479 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 85' ' ' VAL . 43.5 mm -55.53 -52.08 50.91 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-N 115.66 -0.7 . . . . 0.89000000000000001 109.899 177.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -63.78 -39.49 94.37 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.983 -0.553 . . . . 0.34999999999999998 110.841 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 4.7 tppp? -59.72 -35.62 74.9 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.773 0.32 . . . . 1.3799999999999999 111.194 -177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.444 ' O ' HD11 ' A' ' 126' ' ' LEU . 6.3 mp -88.75 -34.6 17.08 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.146 -0.479 . . . . 1.53 111.343 179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.21 -42.71 65.47 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.967 0.413 . . . . 0.42999999999999999 111.757 -177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.628 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 24.9 t70 -89.33 91.11 8.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.385 0.612 . . . . 0.58999999999999997 109.545 -179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.474 HG21 ' HG2' ' A' ' 135' ' ' LYS . 34.0 m -82.48 -29.78 9.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.118 -0.946 . . . . 1.49 112.204 -171.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 25.5 p30 -86.99 -13.11 45.46 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.665 -0.243 . . . . 1.45 111.151 -175.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.565 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 17.0 mmmt 57.84 45.07 19.1 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.847 -0.615 . . . . 2.6699999999999999 110.718 -177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.54 ' OD2' ' HB2' ' A' ' 100' ' ' LEU . 11.4 p-10 -93.29 -13.22 28.47 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.612 -0.722 . . . . 1.1299999999999999 110.965 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.63 5.47 74.76 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.797 -0.716 . . . . 0.42999999999999999 111.993 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.54 ' HB2' ' OD2' ' A' ' 98' ' ' ASP . 30.9 mt -128.27 166.27 18.91 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 110.241 -0.281 . . . . 0.45000000000000001 110.241 -179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 72.0 mt -122.35 119.85 32.29 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.322 -0.399 . . . . 0.70999999999999996 110.157 173.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -95.79 -175.86 3.55 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.168 -0.678 . . . . 1.4199999999999999 109.168 171.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -57.34 -33.64 67.95 Favored 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 120.835 0.35 . . . . 1.73 111.495 -176.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -73.96 -56.56 4.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.278 -0.419 . . . . 1.53 110.28 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.453 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 25.6 mt-10 -59.27 -37.0 76.56 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.732 -0.667 . . . . 0.81999999999999995 111.096 -178.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -71.23 -35.28 71.42 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.417 -0.356 . . . . 0.37 110.865 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -64.63 -38.32 90.58 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.735 0.302 . . . . 0.5 110.436 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -64.39 -41.03 96.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.169 -0.469 . . . . 1.3200000000000001 110.12 175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.424 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.06 -52.48 64.1 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.765 -0.652 . . . . 0.26000000000000001 110.941 177.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -68.07 -30.1 69.22 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.207 -0.452 . . . . 1.3600000000000001 111.355 -176.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.561 ' HB2' HG12 ' A' ' 46' ' ' VAL . 83.9 t60 -62.02 -45.86 91.75 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.776 0.322 . . . . 0.67000000000000004 110.377 176.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 80.6 mt -68.87 -41.55 78.21 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.872 -0.604 . . . . 0.89000000000000001 110.856 -178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 109' ' ' ALA . 78.1 mt -61.17 -39.97 84.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.951 -0.568 . . . . 0.46000000000000002 110.034 176.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.606 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 32.3 tttm -56.26 -50.4 71.45 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.93 -0.577 . . . . 2.0699999999999998 110.606 175.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 111' ' ' HIS . 46.0 t -51.34 -39.11 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 116.101 -0.5 . . . . 0.5 111.145 175.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -68.58 -30.39 69.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.722 0.296 . . . . 1.25 111.469 176.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 86.1 mt -72.4 -34.55 67.96 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.97 0.414 . . . . 0.93999999999999995 110.07 174.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.606 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 41.7 mm-40 -68.4 -25.96 65.31 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.884 -0.598 . . . . 1.6499999999999999 109.611 177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 100.52 35.08 4.5 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.604 -0.726 . . . . 0.80000000000000004 112.802 179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -132.99 173.55 11.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.066 0.433 . . . . 1.0600000000000001 110.638 -177.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -108.88 156.14 20.01 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.862 -0.608 . . . . 3.6000000000000001 109.985 -177.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.26 135.18 24.65 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.546 -0.538 . . . . 1.51 109.546 176.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.36 4.66 4.22 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 123.013 2.476 . . . . 1.01 113.726 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 65.33 19.65 11.69 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.488 0.492 . . . . 0.87 111.425 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -131.27 148.63 52.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.048 -0.524 . . . . 1.9399999999999999 110.126 177.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.444 HD11 ' O ' ' A' ' 92' ' ' LEU . 79.1 mt -109.05 108.81 60.78 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.867 -0.606 . . . . 0.67000000000000004 110.38 173.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.647 ' HD2' HD12 ' A' ' 130' ' ' LEU . 26.4 Cg_exo -61.03 154.06 59.67 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.592 2.195 . . . . 0.75 111.662 175.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.461 ' HA ' HG22 ' A' ' 131' ' ' VAL . 32.5 Cg_endo -64.49 -4.93 9.04 Favored 'Trans proline' 0 CA--C 1.531 0.328 0 C-N-CA 122.811 2.341 . . . . 0.70999999999999996 113.116 -178.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 10.2 p-80 -100.94 4.03 42.21 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.981 0.419 . . . . 0.93999999999999995 110.38 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.647 HD12 ' HD2' ' A' ' 127' ' ' PRO . 35.5 mt -116.21 -8.3 11.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.329 -0.396 . . . . 0.82999999999999996 111.095 176.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.461 HG22 ' HA ' ' A' ' 128' ' ' PRO . 27.0 m -103.92 123.14 42.03 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 121.433 0.635 . . . . 1.4399999999999999 110.267 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.18 156.85 63.61 Favored 'Trans proline' 0 C--N 1.33 -0.399 0 C-N-CA 122.926 2.417 . . . . 1.22 111.453 178.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.509 ' HA ' ' HB2' ' A' ' 136' ' ' ARG . 32.1 Cg_exo -58.66 -21.38 55.38 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.96 2.44 . . . . 1.8600000000000001 112.112 179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 39.6 t -60.21 -26.95 66.79 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 115.666 -0.697 . . . . 2.0699999999999998 110.799 177.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.474 ' HG2' HG21 ' A' ' 95' ' ' VAL . 10.4 mptt -112.46 14.22 20.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.998 0.427 . . . . 1.27 110.785 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.509 ' HB2' ' HA ' ' A' ' 133' ' ' PRO . 50.9 mtp180 -111.47 151.61 28.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.099 0.476 . . . . 3.0699999999999998 111.772 -178.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.83 130.13 41.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.728 -0.669 . . . . 5.46 110.021 175.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -101.71 131.66 47.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.885 0.374 . . . . 5.7999999999999998 110.79 -179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 . . . . . 0 C--O 1.25 1.085 0 N-CA-C 109.07 -0.715 . . . . 6.9299999999999997 109.07 171.84 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 51.4 tp . . . . . 0 N--CA 1.479 0.996 0 CA-C-O 120.704 0.288 . . . . 10.57 110.759 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 144' ' ' GLU . . . . . 0.428 ' HB3' ' HG3' ' B' ' 146' ' ' LYS . 42.8 mt-10 -99.9 134.89 42.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.666 0.27 . . . . 8.0399999999999991 110.881 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 5.6 p -75.72 -55.75 5.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.969 -0.56 . . . . 5.1100000000000003 109.992 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 0.428 ' HG3' ' HB3' ' B' ' 144' ' ' GLU . 67.3 mttm 58.58 79.54 0.31 Allowed Pre-proline 0 N--CA 1.467 0.412 0 CA-C-N 115.331 -0.85 . . . . 6.7000000000000002 111.627 178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . 0.428 ' CG ' ' HA ' ' B' ' 153' ' ' GLU . 81.1 Cg_endo -77.75 170.89 18.3 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.498 2.132 . . . . 1.96 112.351 179.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -120.7 33.1 5.7 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-N 116.109 -0.496 . . . . 0.89000000000000001 110.27 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.698 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 55.9 t-20 -138.52 116.17 9.17 Favored Pre-proline 0 C--N 1.317 -0.818 0 CA-C-N 115.474 -0.785 . . . . 0.42999999999999999 109.39 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.462 ' HA ' ' OE1' ' B' ' 153' ' ' GLU . 23.1 Cg_exo -66.1 -14.48 44.59 Favored 'Trans proline' 0 CA--C 1.528 0.22 0 C-N-CA 123.442 2.761 . . . . 0.51000000000000001 113.362 -177.026 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.672 ' CZ ' ' HG3' ' A' ' 76' ' ' MET . 17.9 m-85 -107.33 -1.62 21.46 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.498 0.666 . . . . 0.5 110.133 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.698 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 42.4 tt0 -133.92 23.64 3.91 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.673 -1.149 . . . . 1.4199999999999999 108.39 -175.721 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . 0.462 ' OE1' ' HA ' ' B' ' 150' ' ' PRO . 8.5 pt-20 -80.46 -13.51 59.05 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 114.9 -1.045 . . . . 1.71 111.12 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 57.37 -154.3 0.35 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.013 -0.539 . . . . 4.8099999999999996 111.643 175.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -116.07 -68.35 0.93 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.558 -0.292 . . . . 5.9800000000000004 110.598 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -141.16 58.79 1.53 Allowed 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.852 -0.796 . . . . 7.1900000000000004 108.852 176.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 . . . . . 0 C--O 1.246 0.881 0 CA-C-N 115.182 -0.917 . . . . 7.3200000000000003 110.977 -172.718 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.628 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 111.533 -0.627 . . . . 11.68 111.533 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -80.69 141.73 13.86 Favored 'Trans proline' 0 N--CA 1.46 -0.448 0 C-N-CA 122.465 2.11 . . . . 11.24 111.827 178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.8 mp -115.0 147.88 39.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.245 -0.434 . . . . 8.6199999999999992 110.383 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -131.34 136.95 9.11 Favored Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 111.471 -0.652 . . . . 6.6399999999999997 111.471 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 18.7 m -77.91 134.52 37.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.852 0.358 . . . . 5.8499999999999996 110.171 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -77.0 134.48 38.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.096 -0.502 . . . . 4.0099999999999998 111.07 -177.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -119.8 107.6 13.38 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.181 -0.463 . . . . 3.8599999999999999 109.921 179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.0 t -101.34 118.93 48.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.277 -0.419 . . . . 1.8400000000000001 110.676 -179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -89.97 125.77 35.5 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.195 -0.457 . . . . 3.02 109.981 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 8.9 t90 -75.02 104.52 5.63 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.587 -0.894 . . . . 0.84999999999999998 108.587 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 26.1 t -54.82 -32.25 25.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.951 -0.568 . . . . 1.24 111.164 -175.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 50' ' ' LYS . 45.2 t -79.04 -15.21 13.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.93 -0.577 . . . . 1.3 111.321 -177.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.83 -23.88 71.11 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.798 -0.715 . . . . 0.62 111.813 178.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -87.09 -16.02 36.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 122.304 1.049 . . . . 2.9900000000000002 109.881 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.461 ' HB2' ' HA ' ' A' ' 46' ' ' VAL . 0.3 OUTLIER -104.84 -11.74 16.61 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 113.433 -1.712 . . . . 1.8200000000000001 110.893 -163.691 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.521 ' HG2' ' O ' ' A' ' 46' ' ' VAL . 3.6 mmmp? -57.79 -55.81 41.09 Favored Pre-proline 0 C--O 1.224 -0.281 0 N-CA-C 114.521 1.304 . . . . 0.93000000000000005 114.521 -172.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 10.5 Cg_endo -48.8 -37.88 36.62 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.73 2.287 . . . . 0.56999999999999995 113.44 -168.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.547 ' O ' HG13 ' A' ' 56' ' ' ILE . 16.8 m -71.29 -44.39 65.28 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.059 -0.519 . . . . 0.67000000000000004 110.88 -177.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.44 ' HE2' ' HB3' ' A' ' 49' ' ' ASP . 12.2 m-85 -78.26 -22.32 48.49 Favored 'General case' 0 CA--C 1.513 -0.452 0 CA-C-N 116.085 -0.507 . . . . 0.92000000000000004 109.992 -176.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -71.96 -42.07 66.98 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.108 -0.701 . . . . 1.8600000000000001 109.108 176.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -53.41 -52.83 58.08 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.125 -0.943 . . . . 2.0 109.898 174.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.547 HG13 ' O ' ' A' ' 52' ' ' THR . 15.8 mt -67.84 -31.33 51.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.109 -0.95 . . . . 0.53000000000000003 110.637 -178.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 86.7 t80 -59.91 -37.38 79.26 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.765 -0.652 . . . . 0.42999999999999999 110.774 177.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -70.83 -24.94 62.64 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 111.771 0.285 . . . . 3.0800000000000001 111.771 -179.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.1 p -86.23 -5.68 59.14 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.848 0.356 . . . . 0.75 111.399 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.486 HD11 ' OE1' ' A' ' 75' ' ' GLU . 8.8 mp -96.19 5.19 51.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.978 0.418 . . . . 1.26 110.086 175.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 20.3 m 64.71 86.15 0.14 Allowed Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 115.074 -0.966 . . . . 1.1100000000000001 111.567 175.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.28 115.24 4.19 Favored 'Trans proline' 0 N--CA 1.46 -0.483 0 C-N-CA 123.103 2.535 . . . . 0.68999999999999995 112.192 -178.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.5 t -89.28 113.48 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.601 -0.518 . . . . 1.4299999999999999 109.601 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 65.09 22.65 12.35 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.012 -0.54 . . . . 2.1499999999999999 110.296 -176.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.02 19.12 59.81 Favored Glycine 0 N--CA 1.45 -0.415 0 CA-C-N 115.903 -0.59 . . . . 0.62 112.408 -179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.425 ' HE3' ' HB2' ' A' ' 100' ' ' LEU . 32.4 tttp -144.2 131.79 21.13 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.652 -0.499 . . . . 2.2400000000000002 109.652 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 101' ' ' LEU . 38.9 pt -92.71 152.54 3.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.36 -0.536 . . . . 0.31 111.078 -178.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.454 ' HA ' HD22 ' A' ' 100' ' ' LEU . 37.6 p -85.07 160.46 19.98 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.721 -0.672 . . . . 0.52000000000000002 110.982 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.416 ' HA2' ' CH2' ' A' ' 90' ' ' TRP . . . -61.18 -29.71 71.89 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 121.153 -0.546 . . . . 0.38 112.596 178.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.9 -50.57 72.12 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.029 0.442 . . . . 0.40000000000000002 111.634 179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.47 ' HA ' ' HG2' ' A' ' 74' ' ' LYS . 40.1 m-80 -74.69 -37.01 62.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.897 -0.592 . . . . 1.73 110.954 -175.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.39 -27.5 65.35 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.378 -0.374 . . . . 0.35999999999999999 110.458 177.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.561 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 38.8 ttpt -72.6 -49.54 31.43 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-N 116.537 -0.301 . . . . 0.60999999999999999 111.094 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.47 ' HG2' ' HA ' ' A' ' 71' ' ' ASN . 20.2 ptmt -59.82 -36.86 77.65 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 121.132 -0.227 . . . . 2.2400000000000002 110.481 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.486 ' OE1' HD11 ' A' ' 60' ' ' LEU . 17.3 tp10 -61.46 -52.46 64.44 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.492 0.663 . . . . 0.81999999999999995 110.142 175.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.756 ' HG2' ' HG ' ' A' ' 86' ' ' LEU . 17.5 ttm -67.64 -27.47 66.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.426 -0.806 . . . . 1.04 111.376 -174.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -77.55 -40.46 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.039 0 CA-C-N 116.432 -0.349 . . . . 1.02 110.231 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 64.7 mttm -73.36 -8.89 57.78 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 116.226 -0.443 . . . . 3.04 110.742 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.427 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 7.4 t -73.31 -12.63 60.9 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.191 -0.459 . . . . 0.85999999999999999 110.447 175.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 79' ' ' SER . 45.3 mmtm 73.5 26.67 1.94 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.411 0.685 . . . . 2.0499999999999998 112.608 178.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -98.81 144.27 27.86 Favored Pre-proline 0 C--N 1.323 -0.573 0 N-CA-C 109.518 -0.549 . . . . 1.3400000000000001 109.518 172.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.587 ' O ' HD13 ' A' ' 86' ' ' LEU . 12.6 Cg_endo -60.23 139.06 85.15 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.814 2.343 . . . . 0.62 112.563 179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.456 ' HA ' HD22 ' A' ' 86' ' ' LEU . 15.9 m120 -51.83 -35.03 43.05 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.031 0.532 . . . . 0.93999999999999995 112.164 -177.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.497 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 2.7 m -57.64 -40.73 79.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.383 0.611 . . . . 0.58999999999999997 110.634 177.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.588 ' O ' HG12 ' A' ' 89' ' ' ILE . 66.8 t -74.19 -38.71 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 N-CA-C 109.041 -0.726 . . . . 0.40000000000000002 109.041 -176.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.756 ' HG ' ' HG2' ' A' ' 76' ' ' MET . 5.1 mp -58.77 -45.72 89.14 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.992 -1.003 . . . . 1.25 110.321 176.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.54 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -59.46 -39.68 95.21 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.528 -0.76 . . . . 0.34000000000000002 112.001 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.497 ' HG3' ' O ' ' A' ' 84' ' ' THR . 55.4 mtpt -71.09 -43.95 66.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.751 0.31 . . . . 1.1599999999999999 110.349 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 85' ' ' VAL . 45.0 mm -57.3 -47.44 84.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.08 -0.509 . . . . 0.89000000000000001 110.201 178.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.416 ' CH2' ' HA2' ' A' ' 69' ' ' GLY . 15.3 t-105 -66.7 -41.42 88.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.252 -0.431 . . . . 0.34999999999999998 110.398 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.5 tppp? -64.86 -22.49 67.0 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.164 -0.471 . . . . 1.3799999999999999 111.101 -175.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.519 HD12 ' HG ' ' A' ' 126' ' ' LEU . 4.0 mm? -93.29 -41.63 9.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.349 -0.387 . . . . 1.53 111.018 174.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.14 88.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.563 -0.29 . . . . 0.42999999999999999 111.648 -176.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.62 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 41.6 t0 -83.51 75.52 10.01 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.371 -0.603 . . . . 0.58999999999999997 109.371 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.4 t -67.93 -34.72 68.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 CA-C-N 115.369 -0.832 . . . . 1.49 110.987 -176.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.627 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.7 OUTLIER -82.81 -15.37 51.9 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.407 -0.815 . . . . 1.45 111.866 -175.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp 60.66 72.48 0.52 Allowed 'General case' 0 N--CA 1.465 0.277 0 O-C-N 123.515 0.509 . . . . 2.6699999999999999 111.63 176.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 41.1 p30 -129.26 -14.43 4.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.007 -0.542 . . . . 1.1299999999999999 111.328 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.13 4.34 84.22 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.347 -0.93 . . . . 0.42999999999999999 112.234 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.454 HD22 ' HA ' ' A' ' 68' ' ' THR . 67.7 mt -127.88 160.48 31.68 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.447 -0.575 . . . . 0.45000000000000001 109.447 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 105' ' ' GLU . 51.6 mt -124.28 118.32 26.52 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.804 0.335 . . . . 0.70999999999999996 110.565 177.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -82.84 -175.25 5.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.062 -0.718 . . . . 1.4199999999999999 109.062 167.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -61.67 -31.23 71.35 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.643 0.259 . . . . 1.73 111.115 -176.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.435 ' CD ' ' HG2' ' A' ' 132' ' ' PRO . 11.1 tt0 -72.11 -57.43 4.27 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.446 -0.343 . . . . 1.53 110.183 178.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.67 ' OE1' 'CA ' ' A' ' 141' ' ' ' CA' . 32.0 mt-10 -56.06 -44.63 79.07 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.075 -0.512 . . . . 0.81999999999999995 111.04 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -66.9 -38.24 85.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.898 -0.592 . . . . 0.37 110.954 -177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -67.51 -39.28 85.14 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.943 -0.303 . . . . 0.5 110.632 177.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -60.12 -43.83 95.33 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.99 -0.374 . . . . 1.3200000000000001 109.99 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -53.33 -58.03 8.51 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.041 -0.527 . . . . 0.26000000000000001 111.069 176.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -67.29 -33.23 74.86 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.242 -0.436 . . . . 1.3600000000000001 111.319 -174.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.657 ' O ' HG23 ' A' ' 115' ' ' VAL . 77.3 t60 -64.17 -45.89 86.42 Favored 'General case' 0 C--O 1.224 -0.281 0 C-N-CA 120.699 -0.4 . . . . 0.67000000000000004 109.991 176.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.428 ' HB3' HD12 ' A' ' 89' ' ' ILE . 75.0 mt -60.95 -41.46 96.35 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-O 120.59 0.233 . . . . 0.89000000000000001 111.063 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 78.8 mt -59.96 -45.28 95.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.339 -0.391 . . . . 0.46000000000000002 110.196 176.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.475 ' HE2' ' OE2' ' A' ' 118' ' ' GLU . 86.8 tttt -64.86 -35.85 82.47 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.897 -0.321 . . . . 2.0699999999999998 110.795 178.56 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 111' ' ' HIS . 95.9 t -53.77 -44.27 58.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 109.359 -0.608 . . . . 0.5 109.359 173.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.8 mmmp? -66.83 -42.85 85.11 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.403 -0.817 . . . . 1.25 111.405 178.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.44 -27.27 64.13 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.334 -0.394 . . . . 0.93999999999999995 111.605 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.475 ' OE2' ' HE2' ' A' ' 114' ' ' LYS . 34.1 mt-10 -75.84 -6.98 53.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.306 -0.406 . . . . 1.6499999999999999 111.469 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 95.39 17.8 35.44 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.407 -0.901 . . . . 0.80000000000000004 112.327 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.462 ' HB2' ' CG1' ' A' ' 115' ' ' VAL . 11.5 m-70 -109.86 176.32 5.11 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.459 -0.571 . . . . 1.0600000000000001 109.459 177.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -139.63 130.77 26.51 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.876 0.369 . . . . 3.6000000000000001 111.275 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.72 126.32 88.63 Favored Pre-proline 0 C--N 1.327 -0.405 0 N-CA-C 109.296 -0.631 . . . . 1.51 109.296 173.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -77.67 13.87 1.57 Allowed 'Trans proline' 0 N--CA 1.474 0.343 0 C-N-CA 123.202 2.601 . . . . 1.01 113.748 -172.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 66.38 19.52 10.96 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.403 0.62 . . . . 0.87 110.719 -175.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -111.7 137.2 49.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.566 -0.743 . . . . 1.9399999999999999 109.433 176.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.519 ' HG ' HD12 ' A' ' 92' ' ' LEU . 92.3 mt -100.94 90.07 1.44 Allowed Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 110.193 -0.299 . . . . 0.67000000000000004 110.193 168.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 130' ' ' LEU . 43.9 Cg_endo -71.17 155.02 61.74 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.298 1.999 . . . . 0.75 111.713 177.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -63.25 -10.15 20.08 Favored 'Trans proline' 0 N--CA 1.474 0.358 0 C-N-CA 123.275 2.65 . . . . 0.70999999999999996 113.583 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 11.9 p-80 -92.8 1.06 57.48 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-O 121.134 0.492 . . . . 0.93999999999999995 110.386 179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.475 HD12 ' HD2' ' A' ' 127' ' ' PRO . 66.2 mt -117.34 -35.31 4.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.82999999999999996 110.571 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.431 ' HA ' ' HD3' ' A' ' 132' ' ' PRO . 92.6 t -88.75 124.03 66.46 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.088 -0.505 . . . . 1.4399999999999999 111.478 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.435 ' HG2' ' CD ' ' A' ' 104' ' ' GLU . 18.5 Cg_exo -67.86 153.85 74.48 Favored 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 122.885 2.39 . . . . 1.22 111.43 172.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.683 ' HA ' ' HB2' ' A' ' 136' ' ' ARG . 61.3 Cg_endo -67.85 11.28 0.25 Allowed 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 123.594 2.862 . . . . 1.8600000000000001 113.51 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.7 p -75.85 -33.94 60.04 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.96 0.409 . . . . 2.0699999999999998 110.709 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.91 20.89 12.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.251 0.548 . . . . 1.27 110.706 177.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.683 ' HB2' ' HA ' ' A' ' 133' ' ' PRO . 78.8 mtp180 -104.07 149.99 24.7 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.581 -0.736 . . . . 3.0699999999999998 109.612 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -87.74 160.98 17.86 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.934 0.397 . . . . 5.46 110.608 -179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -109.01 114.87 28.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.961 -0.563 . . . . 5.7999999999999998 110.635 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 24.1 mm-40 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.274 -0.87 . . . . 6.9299999999999997 109.805 175.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . 0.435 ' N ' HD22 ' B' ' 143' ' ' LEU . 1.3 mm? . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.24 -0.652 . . . . 10.57 109.24 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 19.9 mp0 -119.84 156.58 30.4 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-N 115.517 -0.765 . . . . 8.0399999999999991 110.331 -168.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 13.6 p -108.81 127.28 53.88 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.103 -0.499 . . . . 5.1100000000000003 110.88 178.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' B' ' 147' ' ' PRO . 16.5 ttmm -108.25 111.46 61.72 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 109.459 -0.571 . . . . 6.7000000000000002 109.459 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' B' ' 146' ' ' LYS . 4.0 Cg_exo -78.11 -167.21 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.248 2.632 . . . . 1.96 113.454 -176.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -83.74 -3.99 58.26 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.216 -0.902 . . . . 0.89000000000000001 110.571 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.591 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 47.5 t-20 -96.86 112.88 61.79 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.591 -0.731 . . . . 0.42999999999999999 110.055 -174.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.479 ' HB2' ' HD3' ' A' ' 73' ' ' LYS . 56.7 Cg_endo -70.47 -9.17 25.3 Favored 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.008 2.472 . . . . 0.51000000000000001 112.616 -178.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 31.4 m-85 -96.84 -7.99 32.12 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.129 -0.693 . . . . 0.5 109.129 176.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.591 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 28.3 tt0 -115.2 28.06 8.95 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.002 -0.999 . . . . 1.4199999999999999 109.508 -175.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -72.49 82.56 1.09 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.426 -0.806 . . . . 1.71 110.674 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . 0.418 ' O ' ' HB2' ' B' ' 155' ' ' GLU . 15.8 mt-10 73.17 174.46 0.28 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.608 -0.724 . . . . 4.8099999999999996 111.959 175.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 155' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' B' ' 154' ' ' GLU . 47.9 mm-40 72.2 151.18 0.11 Allowed 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 115.14 -0.936 . . . . 5.9800000000000004 113.189 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 69.3 107.14 0.06 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 114.328 -1.305 . . . . 7.1900000000000004 112.158 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 2.9 t70 . . . . . 0 C--O 1.249 1.04 0 CA-C-N 114.933 -1.03 . . . . 7.3200000000000003 109.169 175.942 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.67 'CA ' ' OE1' ' A' ' 105' ' ' GLU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.595 0 N-CA-C 112.054 -0.418 . . . . 11.68 112.054 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -74.36 142.92 30.69 Favored 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.865 2.377 . . . . 11.24 112.29 178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.2 mp -96.69 121.51 38.61 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.044 -0.526 . . . . 8.6199999999999992 109.999 177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.57 159.58 27.18 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.756 -0.735 . . . . 6.6399999999999997 112.187 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 20.4 m -106.77 143.31 35.05 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.245 -0.28 . . . . 5.8499999999999996 110.245 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -76.86 118.7 19.73 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.209 -0.451 . . . . 4.0099999999999998 109.982 179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -88.06 117.99 27.32 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.519 0.676 . . . . 3.8599999999999999 111.324 -175.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 58.3 t -123.03 114.93 44.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.499 -0.773 . . . . 1.8400000000000001 110.23 178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -85.42 137.92 32.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.86 0.362 . . . . 3.02 110.603 178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -75.19 104.88 5.94 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.969 -0.752 . . . . 0.84999999999999998 108.969 175.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.6 t -55.63 -47.25 79.18 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 CA-C-N 116.023 -0.535 . . . . 1.24 112.434 -172.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.582 HG23 ' HE2' ' A' ' 53' ' ' TYR . 2.7 p -69.31 -22.04 25.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.392 0.615 . . . . 1.3 110.77 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.822 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -67.65 -11.96 60.95 Favored Glycine 0 N--CA 1.439 -1.101 0 CA-C-N 115.422 -0.808 . . . . 0.62 112.082 178.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.3 tppp? -80.59 -27.7 37.31 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.943 -0.391 . . . . 2.9900000000000002 109.943 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.412 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 63.2 m-20 -100.4 10.55 41.05 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.839 -0.619 . . . . 1.8200000000000001 110.0 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.822 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 15.8 mmmt -52.58 -55.46 32.21 Favored Pre-proline 0 C--N 1.328 -0.369 0 N-CA-C 114.371 1.248 . . . . 0.93000000000000005 114.371 -171.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 10.6 Cg_endo -51.3 -37.36 59.95 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 122.532 2.155 . . . . 0.56999999999999995 112.808 -174.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.447 ' O ' HG13 ' A' ' 56' ' ' ILE . 8.6 m -69.99 -43.1 72.15 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.82 -0.627 . . . . 0.67000000000000004 110.34 -179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.582 ' HE2' HG23 ' A' ' 46' ' ' VAL . 13.9 m-30 -73.92 -23.21 59.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.365 -0.38 . . . . 0.92000000000000004 110.436 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.482 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 22.4 m-20 -69.29 -45.48 69.5 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-O 121.237 0.541 . . . . 1.8600000000000001 109.586 176.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -60.82 -38.91 87.06 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.121 -0.945 . . . . 2.0 110.892 178.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 52' ' ' THR . 62.7 mt -68.95 -40.96 81.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.53000000000000003 110.568 176.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -55.82 -39.68 71.7 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.997 -0.547 . . . . 0.42999999999999999 111.243 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.482 ' HD1' ' O ' ' A' ' 54' ' ' ASP . 48.9 m-85 -75.92 -13.58 60.25 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.763 0.653 . . . . 3.0800000000000001 112.763 -177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 64.1 p -73.93 -18.55 60.88 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 120.179 -0.608 . . . . 0.75 110.824 -178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 2.0 mm? -87.12 -9.34 55.55 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.418 -0.356 . . . . 1.26 110.895 175.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 37.6 t 67.91 94.05 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.25 0 O-C-N 123.905 0.753 . . . . 1.1100000000000001 110.758 -176.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.37 134.51 42.18 Favored 'Trans proline' 0 N--CA 1.465 -0.153 0 C-N-CA 123.009 2.473 . . . . 0.68999999999999995 112.992 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.403 HG12 HD22 ' A' ' 64' ' ' ASN . 36.2 t -107.96 123.54 63.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 108.881 -0.785 . . . . 1.4299999999999999 108.881 177.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.403 HD22 HG12 ' A' ' 63' ' ' VAL . 9.8 p30 45.33 33.72 1.31 Allowed 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.452 0.701 . . . . 2.1499999999999999 112.499 -175.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.98 -3.4 67.09 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 121.053 -0.594 . . . . 0.62 114.448 172.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -137.87 170.25 16.38 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.812 0.806 . . . . 2.2400000000000002 110.692 176.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 45.7 pt -114.7 155.24 15.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 C-N-CA 120.79 -0.364 . . . . 0.31 110.177 175.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.598 ' HA ' HD22 ' A' ' 100' ' ' LEU . 76.0 p -87.25 167.58 13.97 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.239 -0.437 . . . . 0.52000000000000002 110.897 -176.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.47 -24.44 63.83 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.768 -0.73 . . . . 0.38 112.315 176.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.4 -35.92 76.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.204 0.526 . . . . 0.40000000000000002 110.76 178.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 13.5 m120 -70.58 -49.05 51.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.575 -0.739 . . . . 1.73 110.529 -177.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.471 ' HB3' ' HZ3' ' A' ' 90' ' ' TRP . . . -73.49 -20.1 60.76 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 120.47 -0.492 . . . . 0.35999999999999999 110.411 178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.596 ' HA ' ' CE1' ' B' ' 151' ' ' PHE . 39.5 ttmt -67.3 -50.35 60.63 Favored 'General case' 0 CA--C 1.521 -0.153 0 N-CA-C 109.558 -0.534 . . . . 0.60999999999999999 109.558 176.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 22.2 ptmt -64.79 -35.68 81.87 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.237 -0.438 . . . . 2.2400000000000002 110.793 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.83 -51.97 62.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.362 0.601 . . . . 0.81999999999999995 110.279 177.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.855 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -65.12 -36.51 84.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.464 -0.789 . . . . 1.04 112.384 -174.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 34.7 m -75.37 -26.07 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.294 -0.562 . . . . 1.02 110.339 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -85.43 -1.77 57.39 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 116.06 -0.518 . . . . 3.04 110.413 175.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 33.5 m -79.66 -7.76 58.77 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.85999999999999999 109.992 171.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 79' ' ' SER . 0.1 OUTLIER 69.97 27.36 4.43 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.631 -0.713 . . . . 2.0499999999999998 111.603 178.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.547 ' HB2' HD11 ' A' ' 86' ' ' LEU . 95.3 mt -110.31 157.93 36.72 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.268 -0.424 . . . . 1.3400000000000001 110.368 178.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.667 ' O ' HD13 ' A' ' 86' ' ' LEU . 60.6 Cg_endo -74.16 147.43 37.86 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 122.704 2.269 . . . . 0.62 113.323 -178.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.404 ' HA ' HD22 ' A' ' 86' ' ' LEU . 4.5 m-20 -51.46 -38.5 54.07 Favored 'General case' 0 N--CA 1.468 0.444 0 CA-C-N 115.979 -0.555 . . . . 0.93999999999999995 112.029 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.503 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 35.0 m -56.69 -43.23 80.29 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.107 0.48 . . . . 0.58999999999999997 111.092 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.58 ' O ' HG12 ' A' ' 89' ' ' ILE . 53.5 t -73.93 -36.59 45.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.135 -0.691 . . . . 0.40000000000000002 109.135 -177.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.855 ' HG ' ' HB3' ' A' ' 76' ' ' MET . 1.7 mp -62.62 -45.3 93.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.076 -0.966 . . . . 1.25 110.546 176.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.521 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -58.72 -37.22 89.37 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-N 115.892 -0.595 . . . . 0.34000000000000002 112.308 176.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 84' ' ' THR . 52.4 mtpt -71.76 -42.3 67.38 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.208 -0.293 . . . . 1.1599999999999999 110.208 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.58 HG12 ' O ' ' A' ' 85' ' ' VAL . 32.7 mm -53.15 -52.54 29.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.942 -0.572 . . . . 0.89000000000000001 110.132 173.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.471 ' HZ3' ' HB3' ' A' ' 72' ' ' ALA . 27.3 t-105 -64.38 -43.03 95.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.78 -0.645 . . . . 0.34999999999999998 111.159 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -63.83 -25.05 68.0 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.081 0.467 . . . . 1.3799999999999999 111.318 -175.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.424 ' HA ' HD13 ' A' ' 92' ' ' LEU . 3.7 mm? -89.36 -31.23 17.88 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.132 -0.486 . . . . 1.53 111.158 175.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.59 -36.45 28.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.361 -0.381 . . . . 0.42999999999999999 111.883 -175.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.62 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 24.7 t0 -84.93 57.2 4.29 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.824 0.821 . . . . 0.58999999999999997 109.942 -176.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.476 HG13 ' HG2' ' A' ' 135' ' ' LYS . 13.6 p -68.37 -16.12 20.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 114.849 -1.069 . . . . 1.49 111.483 -177.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -89.71 -18.46 26.35 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.119 -0.492 . . . . 1.45 110.824 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.539 ' NZ ' ' HB2' ' A' ' 97' ' ' LYS . 0.1 OUTLIER 61.01 73.46 0.48 Allowed 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.14 0.576 . . . . 2.6699999999999999 111.55 179.229 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.647 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 15.4 p-10 -132.96 -18.93 2.3 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.463 -0.335 . . . . 1.1299999999999999 111.759 179.44 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 89.68 4.47 72.91 Favored Glycine 0 N--CA 1.454 -0.161 0 C-N-CA 120.437 -0.887 . . . . 0.42999999999999999 112.064 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.598 HD22 ' HA ' ' A' ' 68' ' ' THR . 41.4 mt -130.35 171.6 12.76 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.361 -0.607 . . . . 0.45000000000000001 109.361 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' A' ' 105' ' ' GLU . 79.9 mt -127.06 118.45 24.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.46 -0.336 . . . . 0.70999999999999996 110.702 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -83.31 -176.48 6.34 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.842 -0.799 . . . . 1.4199999999999999 108.842 167.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -65.96 -29.44 69.84 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.616 -0.434 . . . . 1.73 111.798 -173.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -69.49 -50.12 48.22 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 109.316 -0.624 . . . . 1.53 109.316 177.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.484 ' HB3' HD22 ' A' ' 101' ' ' LEU . 36.5 mt-10 -59.96 -52.77 63.98 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.352 -0.84 . . . . 0.81999999999999995 111.431 -178.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -63.09 -35.86 81.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.941 -0.572 . . . . 0.37 110.703 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -65.84 -47.32 75.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.259 -0.428 . . . . 0.5 110.682 177.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.84 -37.85 88.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.355 -0.384 . . . . 1.3200000000000001 109.974 -179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.506 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.0 -49.73 72.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.86 -0.609 . . . . 0.26000000000000001 110.426 173.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -69.19 -28.46 66.42 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.838 -0.619 . . . . 1.3600000000000001 111.846 -176.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.597 ' O ' HG23 ' A' ' 115' ' ' VAL . 82.3 t60 -67.06 -41.97 85.54 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.395 -0.522 . . . . 0.67000000000000004 109.932 175.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 87.7 mt -64.75 -38.58 91.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.994 0.426 . . . . 0.89000000000000001 110.111 177.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 109' ' ' ALA . 72.0 mt -63.23 -41.23 92.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.712 -0.676 . . . . 0.46000000000000002 110.505 176.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.2 ttmt -54.77 -49.88 69.81 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.836 0.35 . . . . 2.0699999999999998 110.585 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 111' ' ' HIS . 29.9 t -59.68 -40.49 82.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.99 -0.55 . . . . 0.5 109.926 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.591 ' NZ ' ' HA ' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -61.51 -42.63 99.1 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.492 -0.776 . . . . 1.25 111.181 175.416 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 86.4 mt -72.37 -32.11 66.17 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.613 0.244 . . . . 0.93999999999999995 111.569 -176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -75.36 3.41 9.13 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.478 -0.328 . . . . 1.6499999999999999 111.543 178.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 89.69 2.5 75.64 Favored Glycine 0 CA--C 1.504 -0.604 0 C-N-CA 120.642 -0.789 . . . . 0.80000000000000004 112.478 175.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.46 ' HB2' HG12 ' A' ' 115' ' ' VAL . 28.3 m-70 -92.92 173.93 7.5 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.097 0.475 . . . . 1.0600000000000001 109.887 -175.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -112.33 145.39 40.12 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.0 -0.545 . . . . 3.6000000000000001 110.675 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.76 125.21 56.31 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 115.827 -0.624 . . . . 1.51 109.634 175.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.79 -2.14 11.45 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.898 2.399 . . . . 1.01 113.165 -172.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.3 21.02 12.22 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.421 0.629 . . . . 0.87 110.25 -175.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.463 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -115.37 131.86 56.8 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.048 -0.978 . . . . 1.9399999999999999 109.872 -178.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.612 ' HB3' ' HB ' ' A' ' 131' ' ' VAL . 92.5 mt -96.85 96.57 2.85 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 123.139 0.274 . . . . 0.67000000000000004 110.624 170.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.499 ' O ' HG12 ' A' ' 131' ' ' VAL . 57.8 Cg_endo -76.48 159.76 35.73 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.406 2.07 . . . . 0.75 111.265 177.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -52.98 -25.57 28.63 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.998 2.466 . . . . 0.70999999999999996 114.023 -176.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -86.92 9.26 19.9 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 120.823 0.344 . . . . 0.93999999999999995 111.42 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.447 ' O ' ' HD3' ' A' ' 132' ' ' PRO . 63.1 mt -131.71 -35.37 1.28 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 0.82999999999999996 110.65 174.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.612 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 7.1 p -91.14 108.45 28.5 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-O 121.497 0.665 . . . . 1.4399999999999999 110.693 177.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.462 ' O ' ' HG3' ' A' ' 136' ' ' ARG . 16.8 Cg_exo -67.86 151.29 78.49 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.661 2.24 . . . . 1.22 111.48 -179.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 41.6 Cg_exo -56.38 -27.3 66.95 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.969 2.446 . . . . 1.8600000000000001 112.837 -178.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.8 t -69.4 -17.7 63.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.886 -0.597 . . . . 2.0699999999999998 111.041 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.476 ' HG2' HG13 ' A' ' 95' ' ' VAL . 1.0 OUTLIER -114.09 12.72 17.95 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 120.845 0.355 . . . . 1.27 110.926 179.547 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 132' ' ' PRO . 98.8 mtt180 -95.77 116.35 28.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.629 0.252 . . . . 3.0699999999999998 110.815 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -109.4 133.52 52.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.996 0.427 . . . . 5.46 110.575 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 13.8 t-80 -94.8 115.93 28.1 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.053 -0.721 . . . . 5.7999999999999998 109.053 174.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 C--O 1.247 0.969 0 O-C-N 123.949 0.78 . . . . 6.9299999999999997 109.842 -175.256 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 4.1 pp . . . . . 0 N--CA 1.477 0.908 0 N-CA-C 110.29 -0.263 . . . . 10.57 110.29 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -90.44 -75.88 0.45 Allowed 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.493 -0.558 . . . . 8.0399999999999991 109.493 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 45.7 m -118.6 -97.66 0.46 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.961 -0.563 . . . . 5.1100000000000003 110.088 174.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 68.1 mttm 52.16 72.4 1.2 Allowed Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 122.756 0.422 . . . . 6.7000000000000002 111.13 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.02 171.55 13.99 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.458 2.105 . . . . 1.96 113.032 -176.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -99.75 21.34 12.6 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.625 -0.88 . . . . 0.89000000000000001 108.625 -179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.521 HD21 ' HA2' ' A' ' 87' ' ' GLY . 45.9 t-20 -97.36 119.39 63.07 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 114.451 -1.249 . . . . 0.42999999999999999 109.882 -173.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.56 ' O ' ' HE2' ' A' ' 73' ' ' LYS . 9.2 Cg_exo -71.99 -10.36 25.99 Favored 'Trans proline' 0 CA--C 1.528 0.184 0 C-N-CA 123.259 2.639 . . . . 0.51000000000000001 112.948 -175.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.596 ' CE1' ' HA ' ' A' ' 73' ' ' LYS . 15.0 m-85 -106.41 -16.08 14.65 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.626 0.726 . . . . 0.5 109.475 178.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.401 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 41.5 tt0 -123.33 54.6 1.26 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.557 -1.202 . . . . 1.4199999999999999 108.595 177.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -74.61 -15.43 60.83 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 114.756 -1.111 . . . . 1.71 110.651 -177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 68.85 151.43 0.09 Allowed 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.191 -0.913 . . . . 4.8099999999999996 110.996 -175.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -99.34 -68.21 0.81 Allowed 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 112.623 0.601 . . . . 5.9800000000000004 112.623 -170.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -110.2 109.36 19.83 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.974 0.416 . . . . 7.1900000000000004 111.608 -172.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.802 -0.618 . . . . 7.3200000000000003 109.615 172.912 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.647 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.796 0 N-CA-C 112.06 -0.416 . . . . 11.68 112.06 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.69 113.42 3.79 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.625 2.217 . . . . 11.24 111.619 177.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.416 ' HG ' ' H ' ' A' ' 37' ' ' LEU . 3.6 pp -85.9 159.09 19.76 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.859 -0.609 . . . . 8.6199999999999992 110.882 -178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -106.83 133.62 11.74 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.645 -0.788 . . . . 6.6399999999999997 111.488 178.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 65.9 p -91.19 136.73 32.89 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.019 0.438 . . . . 5.8499999999999996 110.896 -178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -80.91 92.69 6.18 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.168 0.509 . . . . 4.0099999999999998 110.013 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -123.45 69.37 1.02 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.741 -0.663 . . . . 3.8599999999999999 109.461 176.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.735 HG23 ' HA ' ' A' ' 129' ' ' HIS . 4.3 p -124.15 126.04 71.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 116.042 -0.527 . . . . 1.8400000000000001 112.178 -177.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -122.53 124.88 44.57 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.614 -0.721 . . . . 3.02 109.094 169.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -78.56 90.36 4.52 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.221 -0.659 . . . . 0.84999999999999998 109.221 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.9 m -57.77 -33.66 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 115.667 -0.697 . . . . 1.24 112.315 -174.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.421 HG23 ' HB2' ' A' ' 111' ' ' HIS . 7.4 p -69.87 -16.07 19.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.589 0.709 . . . . 1.3 110.745 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.522 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -72.81 -6.38 67.1 Favored Glycine 0 N--CA 1.44 -1.083 0 CA-C-N 115.397 -0.819 . . . . 0.62 111.941 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -91.94 -25.44 18.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.185 0.517 . . . . 2.9900000000000002 110.221 177.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.453 ' HB2' ' CE2' ' A' ' 53' ' ' TYR . 20.7 m-20 -91.94 1.88 56.9 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.708 -0.678 . . . . 1.8200000000000001 110.701 -176.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.553 ' HZ1' ' CG ' ' A' ' 103' ' ' ASP . 3.5 mmmp? -53.96 -49.66 88.42 Favored Pre-proline 0 N--CA 1.467 0.394 0 N-CA-C 114.062 1.134 . . . . 0.93000000000000005 114.062 -172.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 11.7 Cg_endo -52.69 -39.72 75.58 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.107 1.871 . . . . 0.56999999999999995 112.891 -176.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.506 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . 58.5 m -82.62 -31.92 28.6 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.902 0.382 . . . . 0.67000000000000004 111.414 -177.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.453 ' CE2' ' HB2' ' A' ' 49' ' ' ASP . 16.4 m-30 -71.11 -22.38 62.09 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.09 -0.708 . . . . 0.92000000000000004 109.09 175.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.432 ' HB3' ' O ' ' A' ' 51' ' ' PRO . 16.5 t70 -71.22 -42.5 68.85 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.15 -0.932 . . . . 1.8600000000000001 109.365 172.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.506 ' OE2' ' HA ' ' A' ' 52' ' ' THR . 40.3 mt-10 -58.53 -34.35 70.89 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.33 -0.85 . . . . 2.0 110.837 177.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 63.7 mt -78.59 -52.44 15.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 121.075 0.464 . . . . 0.53000000000000003 110.512 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.421 ' HZ ' ' HA ' ' A' ' 66' ' ' LYS . 74.2 t80 -50.01 -41.37 47.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.393 -0.821 . . . . 0.42999999999999999 111.855 -178.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -74.75 -22.58 58.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.742 0.645 . . . . 3.0800000000000001 112.742 -177.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 71.5 p -79.47 -20.82 46.44 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 120.018 -0.673 . . . . 0.75 110.944 -179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.5 mt -85.06 -5.05 59.36 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 1.26 110.647 178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 14.0 t 68.0 92.03 0.07 OUTLIER Pre-proline 0 C--O 1.233 0.232 0 CA-C-N 115.588 -0.733 . . . . 1.1100000000000001 111.0 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -66.67 134.08 34.03 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.988 2.459 . . . . 0.68999999999999995 111.941 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 59.2 t -110.8 107.52 23.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.09 -0.505 . . . . 1.4299999999999999 110.124 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 13.9 m120 64.1 41.47 6.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.547 -0.751 . . . . 2.1499999999999999 111.607 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.32 -3.38 72.36 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 120.984 -0.627 . . . . 0.62 113.94 172.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -160.3 170.53 20.91 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 117.412 0.606 . . . . 2.2400000000000002 110.476 178.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.48 HD11 ' CD1' ' A' ' 106' ' ' PHE . 25.6 pt -104.94 159.4 5.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.828 0.346 . . . . 0.31 111.227 -177.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.479 ' HA ' HD22 ' A' ' 100' ' ' LEU . 73.5 p -89.27 170.66 10.39 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.856 -0.611 . . . . 0.52000000000000002 110.972 -177.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.93 -27.98 72.06 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.688 -0.687 . . . . 0.38 112.546 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -69.96 -45.15 68.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.076 0.465 . . . . 0.40000000000000002 111.295 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.465 ' O ' ' HG2' ' A' ' 74' ' ' LYS . 8.9 m120 -63.73 -46.24 86.29 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.509 0.671 . . . . 1.73 110.127 -177.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.533 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -75.77 -23.89 55.98 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.729 -0.669 . . . . 0.35999999999999999 110.489 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.799 ' HA ' ' HZ ' ' B' ' 151' ' ' PHE . 35.1 ttmt -61.32 -50.62 72.21 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.893 0.377 . . . . 0.60999999999999999 110.033 174.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 71' ' ' ASN . 19.4 ptmt -70.13 -27.71 64.78 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 116.312 -0.404 . . . . 2.2400000000000002 110.395 -177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 13.2 tp10 -68.36 -40.39 81.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.612 0.72 . . . . 0.81999999999999995 109.98 174.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.647 ' HB3' HD22 ' A' ' 86' ' ' LEU . 22.3 mmt -59.8 -42.81 94.25 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.67 -0.695 . . . . 1.04 111.24 177.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 74' ' ' LYS . 15.0 m -72.0 -24.07 22.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 C-N-CA 120.459 -0.496 . . . . 1.02 110.441 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 75' ' ' GLU . 10.1 mtpm? -71.67 -20.87 61.88 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 3.04 110.644 175.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.9 m -84.88 1.35 47.51 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 116.08 -0.509 . . . . 0.85999999999999999 111.263 177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.1 mptt 62.01 25.19 15.09 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.862 0.69 . . . . 2.0499999999999998 112.862 176.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.603 ' HB2' HD21 ' A' ' 86' ' ' LEU . 98.8 mt -98.79 140.61 21.89 Favored Pre-proline 0 C--N 1.326 -0.45 0 C-N-CA 121.06 -0.256 . . . . 1.3400000000000001 110.908 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.607 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 19.3 Cg_exo -64.92 159.49 45.88 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.189 2.592 . . . . 0.62 112.614 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -56.74 -43.71 80.96 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 115.823 -0.626 . . . . 0.93999999999999995 111.611 -177.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 5.2 m -56.34 -45.92 80.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.16 0.505 . . . . 0.58999999999999997 110.905 178.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 89' ' ' ILE . 96.3 t -64.27 -45.24 96.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.763 -0.653 . . . . 0.40000000000000002 110.618 -179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.647 HD22 ' HB3' ' A' ' 76' ' ' MET . 31.3 mt -62.62 -38.48 90.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.088 -0.506 . . . . 1.25 110.271 177.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.729 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -56.56 -37.42 75.54 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.289 -0.869 . . . . 0.34000000000000002 111.783 176.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -77.63 -47.69 18.68 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.927 0.394 . . . . 1.1599999999999999 110.561 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.648 HD13 HG12 ' A' ' 113' ' ' ILE . 67.8 mt -57.84 -49.57 80.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.01 -0.541 . . . . 0.89000000000000001 111.105 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.588 ' HB3' ' ND2' ' B' ' 149' ' ' ASN . 13.4 t-105 -66.04 -38.48 88.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.215 0.531 . . . . 0.34999999999999998 110.197 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 87' ' ' GLY . 24.4 ttmm -56.91 -33.33 66.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.521 -0.763 . . . . 1.3799999999999999 111.05 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.416 ' HA ' HD13 ' A' ' 92' ' ' LEU . 3.8 mm? -90.72 -43.1 10.33 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.587 0.588 . . . . 1.53 112.587 179.015 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.63 -42.45 98.15 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 112.5 0.556 . . . . 0.42999999999999999 112.5 -171.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.635 ' OD2' ' HA ' ' A' ' 97' ' ' LYS . 36.0 t0 -90.22 99.72 12.69 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.327 -0.62 . . . . 0.58999999999999997 109.327 177.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 13.8 m -82.83 -30.31 8.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.767 -0.651 . . . . 1.49 111.839 -170.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.646 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 1.2 p30 -102.28 -9.29 20.53 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.131 0.419 . . . . 1.45 112.131 -176.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.635 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 67.9 mmtt 66.15 74.48 0.35 Allowed 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.187 0.517 . . . . 2.6699999999999999 112.326 175.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.652 ' OD2' 'CA ' ' A' ' 141' ' ' ' CA' . 5.5 m-20 -91.82 -29.08 16.94 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.748 -0.66 . . . . 1.1299999999999999 109.525 178.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 88.49 2.39 79.56 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 109.58 -1.408 . . . . 0.42999999999999999 109.58 -167.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.479 HD22 ' HA ' ' A' ' 68' ' ' THR . 23.1 mt -133.93 175.8 9.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 114.195 -1.003 . . . . 0.45000000000000001 108.435 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.565 ' O ' ' HB2' ' A' ' 66' ' ' LYS . 96.6 mt -131.88 118.12 19.41 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.972 -0.291 . . . . 0.70999999999999996 110.413 174.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.536 ' HA ' ' CB ' ' A' ' 66' ' ' LYS . 1.3 p-10 -81.08 -175.82 5.62 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.047 -0.723 . . . . 1.4199999999999999 109.047 175.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.553 ' CG ' ' HZ1' ' A' ' 50' ' ' LYS . 17.9 t70 -61.4 -35.48 77.63 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 111.865 0.32 . . . . 1.73 111.865 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.431 ' OE2' ' HB3' ' A' ' 132' ' ' PRO . 48.4 mt-10 -68.36 -55.45 11.94 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.986 0.422 . . . . 1.53 110.542 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.491 ' HG3' ' OD1' ' A' ' 102' ' ' ASP . 36.0 mt-10 -72.22 -32.25 66.57 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.885 -0.598 . . . . 0.81999999999999995 112.383 -173.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.48 ' CD1' HD11 ' A' ' 67' ' ' ILE . 49.5 t80 -69.29 -39.0 78.6 Favored 'General case' 0 CA--C 1.515 -0.391 0 C-N-CA 120.091 -0.644 . . . . 0.37 109.625 177.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.64 -40.28 96.51 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 120.41 -0.516 . . . . 0.5 110.074 176.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.5 mt -65.55 -36.52 84.02 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.492 -0.322 . . . . 1.3200000000000001 111.057 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.48 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -58.51 -52.16 66.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.801 0.334 . . . . 0.26000000000000001 110.305 174.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -63.64 -36.47 83.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.043 -0.526 . . . . 1.3600000000000001 110.627 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.622 ' O ' HG23 ' A' ' 115' ' ' VAL . 77.1 t60 -63.72 -46.19 86.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.28 -0.418 . . . . 0.67000000000000004 111.008 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.581 ' HB3' HD23 ' A' ' 122' ' ' LEU . 96.1 mt -63.66 -41.02 98.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 120.887 0.375 . . . . 0.89000000000000001 110.731 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.648 HG12 HD13 ' A' ' 89' ' ' ILE . 73.9 mt -59.72 -44.15 93.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.929 -0.578 . . . . 0.46000000000000002 109.986 175.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.407 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 22.5 ttmm -60.51 -42.15 95.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.814 -0.63 . . . . 2.0699999999999998 111.203 177.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 111' ' ' HIS . 59.5 t -58.11 -46.35 88.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 120.816 0.341 . . . . 0.5 110.351 178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 16.5 mtpp -62.13 -42.24 99.05 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 112.033 0.383 . . . . 1.25 112.033 175.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 97.2 mt -64.51 -28.47 69.67 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.185 0.516 . . . . 0.93999999999999995 110.723 178.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.407 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 58.2 mm-40 -73.04 -2.74 22.39 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.651 -0.704 . . . . 1.6499999999999999 111.471 176.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 90.48 32.43 9.44 Favored Glycine 0 CA--C 1.505 -0.588 0 C-N-CA 120.647 -0.787 . . . . 0.80000000000000004 112.099 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 95.4 m-70 -131.14 179.72 5.84 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.389 0.614 . . . . 1.0600000000000001 111.406 -176.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.85 149.79 49.56 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.11 -0.95 . . . . 3.6000000000000001 109.404 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.581 HD23 ' HB3' ' A' ' 112' ' ' LEU . 0.2 OUTLIER -79.9 144.51 59.82 Favored Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 109.505 -0.554 . . . . 1.51 109.505 175.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.33 -5.91 15.06 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 122.998 2.465 . . . . 1.01 113.315 -173.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 62.42 17.83 9.81 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.329 0.585 . . . . 0.87 110.599 -175.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -134.78 156.58 48.61 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.222 -0.899 . . . . 1.9399999999999999 109.496 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 90.1 mt -106.83 93.87 9.56 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.399 -0.364 . . . . 0.67000000000000004 110.721 173.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -78.2 160.19 29.7 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.39 2.06 . . . . 0.75 112.084 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.465 ' HA ' HG22 ' A' ' 131' ' ' VAL . 78.4 Cg_exo -51.63 -27.42 25.77 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 123.422 2.748 . . . . 0.70999999999999996 113.805 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.735 ' HA ' HG23 ' A' ' 42' ' ' VAL . 28.0 p-80 -88.37 9.07 24.67 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.649 -0.42 . . . . 0.93999999999999995 111.776 -177.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 53.8 mt -128.25 -32.87 2.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.508 0.194 . . . . 0.82999999999999996 111.028 177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 128' ' ' PRO . 28.1 m -61.93 133.07 93.75 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 120.887 0.375 . . . . 1.4399999999999999 110.56 176.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.431 ' HB3' ' OE2' ' A' ' 104' ' ' GLU . 37.9 Cg_exo -58.2 142.73 97.44 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.281 1.987 . . . . 1.22 110.829 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 136' ' ' ARG . 31.3 Cg_exo -56.99 -22.53 47.11 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.643 2.229 . . . . 1.8600000000000001 112.15 -177.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.7 t -77.84 -16.9 57.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.742 -0.663 . . . . 2.0699999999999998 111.279 -177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.464 ' HE2' ' OD2' ' A' ' 96' ' ' ASP . 6.1 mptt -120.29 23.5 10.88 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.318 0.488 . . . . 1.27 112.318 -174.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 133' ' ' PRO . 31.3 ptt180 -110.32 151.85 26.91 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.638 -0.425 . . . . 3.0699999999999998 111.664 -177.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 84.4 mtt180 -64.17 174.02 1.74 Allowed 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.415 0.626 . . . . 5.46 112.238 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 -133.79 128.62 35.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.385 -0.825 . . . . 5.7999999999999998 109.091 167.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 . . . . . 0 C--O 1.253 1.286 0 O-C-N 123.801 0.688 . . . . 6.9299999999999997 111.808 -179.381 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 78.8 mt . . . . . 0 N--CA 1.48 1.066 0 N-CA-C 109.006 -0.738 . . . . 10.57 109.006 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -154.84 111.82 3.32 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.233 -0.44 . . . . 8.0399999999999991 110.456 -170.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 8.1 t -162.27 158.48 24.36 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.55 -0.537 . . . . 5.1100000000000003 109.55 -178.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -105.6 154.19 39.35 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.559 -0.291 . . . . 6.7000000000000002 110.811 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -82.88 -176.67 2.98 Favored 'Trans proline' 0 N--CA 1.459 -0.529 0 C-N-CA 123.137 2.558 . . . . 1.96 112.386 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -130.46 1.45 4.55 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.057 -0.52 . . . . 0.89000000000000001 110.705 -175.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.729 HD21 ' HA2' ' A' ' 87' ' ' GLY . 54.9 t-20 -93.16 122.11 64.05 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 115.904 -0.589 . . . . 0.42999999999999999 109.741 -176.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 23.7 Cg_exo -64.92 -5.68 11.17 Favored 'Trans proline' 0 CA--C 1.535 0.528 0 C-N-CA 123.171 2.581 . . . . 0.51000000000000001 113.394 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.799 ' HZ ' ' HA ' ' A' ' 73' ' ' LYS . 43.4 m-85 -108.09 -3.52 18.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.368 0.604 . . . . 0.5 110.108 176.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.601 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 46.9 tt0 -123.19 29.36 6.74 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.329 -0.989 . . . . 1.4199999999999999 108.329 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -62.03 -40.3 95.24 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.185 -0.916 . . . . 1.71 111.352 -176.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 65.05 -79.69 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 122.987 0.515 . . . . 4.8099999999999996 112.168 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -94.94 106.84 18.85 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.068 -0.345 . . . . 5.9800000000000004 110.068 -175.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -95.54 -55.93 2.86 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.917 -0.583 . . . . 7.1900000000000004 109.803 -178.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 3.0 p30 . . . . . 0 C--O 1.251 1.152 0 CA-C-N 115.024 -0.989 . . . . 7.3200000000000003 108.91 175.959 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.652 'CA ' ' OD2' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.627 0 N-CA-C 111.694 -0.562 . . . . 11.68 111.694 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.89 136.4 25.07 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.82 2.347 . . . . 11.24 111.75 -176.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.758 HD23 ' H ' ' A' ' 37' ' ' LEU . 2.2 pt? -84.44 134.14 34.47 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.935 -0.575 . . . . 8.6199999999999992 110.812 -177.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -120.08 143.06 16.54 Favored Glycine 0 N--CA 1.448 -0.554 0 N-CA-C 111.376 -0.69 . . . . 6.6399999999999997 111.376 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 33.9 m -131.22 124.13 29.92 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.889 0.344 . . . . 5.8499999999999996 111.226 -179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -83.33 93.11 7.66 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.672 -0.492 . . . . 4.0099999999999998 109.672 173.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -125.2 78.76 1.74 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.548 0.69 . . . . 3.8599999999999999 110.873 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 7.5 p -124.61 138.28 54.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.204 -0.907 . . . . 1.8400000000000001 110.402 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -105.71 136.25 45.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.468 -0.333 . . . . 3.02 110.392 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 5.2 t90 -76.13 96.7 3.92 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.374 -0.972 . . . . 0.84999999999999998 108.374 173.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 21.1 m -58.56 -15.01 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 N-CA-C 112.876 0.695 . . . . 1.24 112.876 -172.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.486 HG21 HD23 ' A' ' 108' ' ' LEU . 61.2 t -80.6 -26.96 11.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.996 0.427 . . . . 1.3 110.714 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.471 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -73.85 -1.64 59.45 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.694 -0.765 . . . . 0.62 111.712 177.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.2 ttmt -97.35 -17.13 19.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.166 0.508 . . . . 2.9900000000000002 110.307 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -129.08 20.62 5.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.773 -0.649 . . . . 1.8200000000000001 110.244 -171.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.642 ' N ' ' HD2' ' A' ' 51' ' ' PRO . 8.3 mmmm -58.25 -43.74 98.55 Favored Pre-proline 0 N--CA 1.469 0.5 0 N-CA-C 114.751 1.389 . . . . 0.93000000000000005 114.751 -176.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.9 Cg_endo -46.47 -41.98 23.15 Favored 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 122.906 2.404 . . . . 0.56999999999999995 113.654 -172.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.3 m -70.54 -40.34 73.47 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.101 0.477 . . . . 0.67000000000000004 110.679 -178.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.441 ' CD1' ' HB2' ' A' ' 110' ' ' ASN . 7.4 m-85 -71.11 -23.41 62.09 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.112 -0.495 . . . . 0.92000000000000004 109.67 -178.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -75.22 -45.69 38.72 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.329 -0.85 . . . . 1.8600000000000001 110.102 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -58.99 -50.44 74.1 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 115.449 -0.796 . . . . 2.0 110.39 177.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 67.1 mt -63.68 -41.79 93.81 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 CA-C-N 116.164 -0.471 . . . . 0.53000000000000003 111.259 -177.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.417 ' HB2' ' CD2' ' A' ' 106' ' ' PHE . 90.5 t80 -58.55 -47.83 82.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.287 -0.415 . . . . 0.42999999999999999 110.927 -178.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -76.37 -20.86 56.77 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.225 0.454 . . . . 3.0800000000000001 112.225 -176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 23.7 p -78.43 -13.0 60.04 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.214 -0.594 . . . . 0.75 111.463 176.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.3 mt -92.24 2.76 56.42 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.496 -0.32 . . . . 1.26 111.003 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.0 m 66.51 90.1 0.09 OUTLIER Pre-proline 0 CA--C 1.533 0.307 0 O-C-N 123.785 0.678 . . . . 1.1100000000000001 111.468 177.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -78.9 137.16 13.75 Favored 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 123.064 2.51 . . . . 0.68999999999999995 112.436 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.507 HG12 ' OD1' ' A' ' 64' ' ' ASN . 22.4 t -108.81 115.36 49.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.191 -0.458 . . . . 1.4299999999999999 110.195 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.507 ' OD1' HG12 ' A' ' 63' ' ' VAL . 3.0 p-10 40.94 51.61 3.22 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 123.621 0.768 . . . . 2.1499999999999999 112.859 -177.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 93.59 -3.77 71.97 Favored Glycine 0 CA--C 1.518 0.233 0 N-CA-C 114.754 0.662 . . . . 0.62 114.754 170.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.464 ' HG2' ' CA ' ' A' ' 102' ' ' ASP . 14.0 mtmm -147.95 149.79 32.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.951 0.875 . . . . 2.2400000000000002 111.173 177.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.9 pt -92.09 147.57 5.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.807 -0.442 . . . . 0.31 109.807 176.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 41.2 p -77.77 155.11 31.36 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.363 -0.38 . . . . 0.52000000000000002 110.688 -179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.38 -15.37 45.36 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 121.285 -0.483 . . . . 0.38 113.387 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.436 ' O ' ' HG3' ' A' ' 74' ' ' LYS . . . -63.77 -56.96 11.57 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.254 0.55 . . . . 0.40000000000000002 111.081 178.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.65 -37.93 83.11 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.644 -0.707 . . . . 1.73 110.25 -174.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.46 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -69.64 -32.55 71.3 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.809 -0.632 . . . . 0.35999999999999999 110.551 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.577 ' HA ' ' CZ ' ' B' ' 151' ' ' PHE . 39.9 ttmt -64.05 -42.71 96.93 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 121.4 0.619 . . . . 0.60999999999999999 109.561 177.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.8 mtpp -67.76 -38.27 83.23 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.281 -0.872 . . . . 2.2400000000000002 110.982 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -61.92 -45.39 93.91 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-O 121.481 0.658 . . . . 0.81999999999999995 110.263 176.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.938 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 25.0 mmt -57.48 -48.11 80.1 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.354 -0.839 . . . . 1.04 111.274 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.1 m -73.12 -21.57 19.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.849 -0.34 . . . . 1.02 111.074 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 92.5 mttt -70.31 -25.12 63.17 Favored 'General case' 0 CA--C 1.519 -0.215 0 CA-C-N 116.545 -0.298 . . . . 3.04 110.82 174.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.406 ' O ' ' HB2' ' A' ' 80' ' ' LYS . 42.5 m -81.99 -1.69 49.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.255 -0.43 . . . . 0.85999999999999999 111.124 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 79' ' ' SER . 10.1 mptt 70.15 14.95 7.65 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.984 0.735 . . . . 2.0499999999999998 112.984 177.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -83.99 143.62 43.24 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.57 -0.452 . . . . 1.3400000000000001 110.672 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.544 ' O ' HD13 ' A' ' 86' ' ' LEU . 39.7 Cg_exo -62.27 152.07 78.59 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.292 2.661 . . . . 0.62 112.803 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.534 ' HA ' HD22 ' A' ' 86' ' ' LEU . 16.5 m120 -57.79 -38.45 75.52 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.226 -0.443 . . . . 0.93999999999999995 111.33 -177.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 28.3 m -57.8 -37.42 73.71 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 121.197 0.522 . . . . 0.58999999999999997 111.161 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.546 ' O ' HG12 ' A' ' 89' ' ' ILE . 70.7 t -77.08 -37.25 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 109.029 -0.73 . . . . 0.40000000000000002 109.029 -176.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.938 ' HG ' ' HB3' ' A' ' 76' ' ' MET . 0.4 OUTLIER -61.42 -44.85 96.41 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.143 -0.935 . . . . 1.25 110.715 176.023 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.608 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -61.31 -37.2 93.65 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.87 -0.681 . . . . 0.34000000000000002 111.634 176.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 35.5 ttmt -68.03 -48.31 66.02 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.819 0.342 . . . . 1.1599999999999999 110.754 178.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 85' ' ' VAL . 39.8 mm -56.89 -48.82 80.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.916 -0.584 . . . . 0.89000000000000001 110.253 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . 0.504 ' CH2' HD23 ' A' ' 101' ' ' LEU . 16.6 t-105 -61.94 -51.31 68.62 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.055 -0.521 . . . . 0.34999999999999998 111.161 -179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 32.4 ttmt -60.65 -27.64 67.96 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.122 -0.49 . . . . 1.3799999999999999 111.823 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.487 HD12 HD22 ' A' ' 122' ' ' LEU . 66.3 mt -85.51 -49.97 7.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.502 -0.317 . . . . 1.53 111.214 175.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -67.2 -36.89 82.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.504 -0.316 . . . . 0.42999999999999999 111.834 -175.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.731 ' HA ' ' OE2' ' A' ' 105' ' ' GLU . 18.7 t70 -78.66 83.94 4.8 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.831 -0.803 . . . . 0.58999999999999997 108.831 176.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.62 -25.99 13.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 114.91 -1.041 . . . . 1.49 110.887 -173.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.611 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 0.7 OUTLIER -90.53 -15.55 30.48 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.901 -0.59 . . . . 1.45 111.949 -176.176 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.698 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 4.2 mptp? 54.74 72.07 0.49 Allowed 'General case' 0 C--O 1.235 0.306 0 CA-C-O 121.31 0.576 . . . . 2.6699999999999999 110.983 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.62 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 7.3 p-10 -117.25 -33.16 4.75 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.767 -0.652 . . . . 1.1299999999999999 111.932 -173.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 113.12 -23.09 14.65 Favored Glycine 0 N--CA 1.454 -0.146 0 C-N-CA 120.476 -0.869 . . . . 0.42999999999999999 112.357 178.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 97.5 mt -102.01 -171.74 2.02 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.881 -0.785 . . . . 0.45000000000000001 108.881 174.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.552 HD13 ' HG2' ' A' ' 105' ' ' GLU . 0.1 OUTLIER -132.66 111.69 11.39 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.754 -0.462 . . . . 0.70999999999999996 109.754 178.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.464 ' CA ' ' HG2' ' A' ' 66' ' ' LYS . 7.0 t70 -87.55 -177.13 5.81 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.701 -0.681 . . . . 1.4199999999999999 110.843 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -76.34 -37.02 57.91 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.246 0.461 . . . . 1.73 112.246 -173.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -69.56 -41.92 75.24 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-O 122.782 1.277 . . . . 1.53 107.91 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.731 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 5.9 tt0 -65.4 -40.88 93.98 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 112.375 -2.193 . . . . 0.81999999999999995 110.899 -178.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.536 ' HB2' HD12 ' A' ' 101' ' ' LEU . 52.9 t80 -72.75 -35.41 67.48 Favored 'General case' 0 CA--C 1.511 -0.541 0 CA-C-O 121.608 0.718 . . . . 0.37 109.77 -177.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . 0.412 ' HB1' ' CD2' ' A' ' 53' ' ' TYR . . . -66.28 -39.82 89.67 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.733 -1.121 . . . . 0.5 110.629 178.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.486 HD23 HG21 ' A' ' 46' ' ' VAL . 15.7 mt -70.05 -35.42 74.25 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.165 -0.47 . . . . 1.3200000000000001 110.47 175.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.44 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -56.74 -55.47 33.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 0.26000000000000001 110.561 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 53' ' ' TYR . 94.8 m-20 -70.63 -25.72 63.16 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-N 116.32 -0.4 . . . . 1.3600000000000001 110.932 -177.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.593 ' O ' HG23 ' A' ' 115' ' ' VAL . 72.6 t60 -69.83 -43.82 71.19 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 116.408 -0.36 . . . . 0.67000000000000004 110.051 179.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 96.4 mt -63.83 -41.1 97.92 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.95 0.405 . . . . 0.89000000000000001 110.077 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.492 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 80.3 mt -59.81 -43.73 92.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-N 115.437 -0.801 . . . . 0.46000000000000002 110.437 174.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -59.72 -46.64 88.5 Favored 'General case' 0 C--O 1.225 -0.197 0 CA-C-N 116.187 -0.461 . . . . 2.0699999999999998 111.196 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 111' ' ' HIS . 38.4 t -60.38 -42.83 92.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.114 0.483 . . . . 0.5 110.325 178.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.0 tptp -56.16 -43.86 78.74 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.847 -0.615 . . . . 1.25 110.998 173.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 91.5 mt -74.04 -16.97 61.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.398 -0.365 . . . . 0.93999999999999995 111.316 -179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -78.3 0.41 25.49 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.735 0.302 . . . . 1.6499999999999999 110.421 174.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 88.52 -1.48 84.03 Favored Glycine 0 CA--C 1.503 -0.705 0 N-CA-C 111.42 -0.672 . . . . 0.80000000000000004 111.42 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -97.05 -179.14 4.44 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.115 0.483 . . . . 1.0600000000000001 111.11 -174.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -126.15 144.45 50.75 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.465 -0.789 . . . . 3.6000000000000001 110.179 -176.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.487 HD22 HD12 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -77.96 138.97 61.21 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 109.711 -0.477 . . . . 1.51 109.711 173.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -70.45 -3.43 12.45 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.537 2.158 . . . . 1.01 113.699 -170.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 63.22 21.55 12.9 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.309 0.576 . . . . 0.87 110.739 -177.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.702 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 0.8 OUTLIER -127.93 142.23 51.32 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.099 -0.955 . . . . 1.9399999999999999 108.999 178.287 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 92.2 mt -97.32 92.49 1.25 Allowed Pre-proline 0 C--N 1.322 -0.606 0 CA-C-O 121.166 0.508 . . . . 0.67000000000000004 110.551 169.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.758 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 17.8 Cg_endo -94.35 165.95 1.93 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 123.749 2.966 . . . . 0.75 112.254 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.6 -25.04 24.52 Favored 'Trans proline' 0 CA--C 1.531 0.353 0 C-N-CA 123.523 2.815 . . . . 0.70999999999999996 113.948 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.408 ' CD2' ' HG ' ' A' ' 130' ' ' LEU . 20.2 p-80 -86.79 5.54 35.99 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.458 -0.497 . . . . 0.93999999999999995 111.476 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.758 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 72.9 mt -129.23 -35.56 1.78 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.585 -0.28 . . . . 0.82999999999999996 111.182 178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 31.0 m -75.99 122.01 86.11 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 121.342 0.591 . . . . 1.4399999999999999 111.352 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.472 ' HG2' ' HE2' ' A' ' 135' ' ' LYS . 24.5 Cg_exo -63.25 140.97 80.25 Favored 'Trans proline' 0 N--CA 1.462 -0.351 0 C-N-CA 122.581 2.187 . . . . 1.22 111.88 178.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 37.9 Cg_exo -59.04 -19.82 50.54 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.936 2.424 . . . . 1.8600000000000001 112.663 -178.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 5.3 p -67.45 -22.12 65.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.045 -0.525 . . . . 2.0699999999999998 111.601 -179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.472 ' HE2' ' HG2' ' A' ' 132' ' ' PRO . 0.7 OUTLIER -99.37 -6.91 26.97 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.789 0.328 . . . . 1.27 110.744 179.56 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -77.88 132.78 38.1 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.109 0.48 . . . . 3.0699999999999998 111.181 -177.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -117.68 132.73 56.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.875 -0.602 . . . . 5.46 110.626 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 37.1 p-80 -103.61 141.79 35.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.297 -0.411 . . . . 5.7999999999999998 110.784 -175.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.428 -0.796 . . . . 6.9299999999999997 109.601 175.793 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 57.0 tp . . . . . 0 N--CA 1.485 1.28 0 CA-C-O 120.642 0.258 . . . . 10.57 110.808 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -136.43 -8.88 1.95 Allowed 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.22 0.533 . . . . 8.0399999999999991 110.611 177.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 4.0 p -102.18 156.76 17.35 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.438 -0.801 . . . . 5.1100000000000003 110.264 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' B' ' 147' ' ' PRO . 23.9 pttm -145.89 128.79 8.13 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-O 120.779 0.324 . . . . 6.7000000000000002 110.409 178.103 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' B' ' 146' ' ' LYS . 1.7 Cg_endo -84.34 -79.44 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.742 0 C-N-CA 122.687 2.258 . . . . 1.96 111.191 175.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -139.13 -36.83 0.52 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.851 -0.796 . . . . 0.89000000000000001 108.851 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.608 HD21 ' HA2' ' A' ' 87' ' ' GLY . 45.2 t-20 -87.91 114.51 59.51 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 114.822 -1.081 . . . . 0.42999999999999999 109.641 178.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 11.0 Cg_exo -72.22 -6.55 19.31 Favored 'Trans proline' 0 CA--C 1.528 0.179 0 C-N-CA 123.09 2.526 . . . . 0.51000000000000001 112.8 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.577 ' CZ ' ' HA ' ' A' ' 73' ' ' LYS . 40.7 m-85 -105.55 0.19 26.36 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.452 0.644 . . . . 0.5 109.676 179.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.419 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 23.2 tt0 -117.68 35.25 4.77 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.018 -0.992 . . . . 1.4199999999999999 109.255 -174.387 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -82.79 -7.36 59.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.05 -0.977 . . . . 1.71 111.775 -176.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 68.92 149.66 0.07 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.705 0.764 . . . . 4.8099999999999996 112.873 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -113.73 -165.04 0.97 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.299 -0.864 . . . . 5.9800000000000004 110.29 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -75.75 143.24 42.12 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.328 0.585 . . . . 7.1900000000000004 111.314 178.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 21.9 t70 . . . . . 0 C--O 1.247 0.974 0 CA-C-N 115.258 -0.883 . . . . 7.3200000000000003 108.992 174.884 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.62 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.47 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.647 0 N-CA-C 111.67 -0.572 . . . . 11.68 111.67 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.47 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 7.0 Cg_exo -73.87 109.41 2.86 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.623 2.215 . . . . 11.24 111.932 179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.431 HD22 ' HA ' ' A' ' 37' ' ' LEU . 1.9 tm? -102.2 120.02 39.76 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.015 -0.539 . . . . 8.6199999999999992 109.592 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.28 137.52 13.66 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.713 -0.756 . . . . 6.6399999999999997 112.102 -179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.5 m -131.67 134.07 45.56 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.687 0.28 . . . . 5.8499999999999996 110.919 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -85.65 93.21 8.78 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 108.866 -0.79 . . . . 4.0099999999999998 108.866 176.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -107.85 130.64 54.98 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.085 -0.507 . . . . 3.8599999999999999 110.608 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.458 ' CG1' ' HA ' ' A' ' 129' ' ' HIS . 90.3 t -123.19 121.12 62.19 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.463 -0.79 . . . . 1.8400000000000001 110.087 178.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -80.22 120.33 24.17 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-O 121.534 0.683 . . . . 3.02 109.576 174.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.419 ' HH2' ' HA ' ' A' ' 104' ' ' GLU . 0.6 OUTLIER -79.81 98.75 7.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.82 -0.627 . . . . 0.84999999999999998 109.355 -178.647 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 15.5 m -56.65 -31.5 34.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 112.761 0.652 . . . . 1.24 112.761 -173.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.658 ' HB ' ' HE2' ' A' ' 53' ' ' TYR . 22.7 m -77.1 -6.42 8.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 C-N-CA 120.623 -0.431 . . . . 1.3 110.795 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.89 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -72.97 -20.25 79.88 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.86 -0.896 . . . . 0.62 110.86 173.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -84.51 -10.86 57.07 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.021 -0.59 . . . . 2.9900000000000002 110.011 178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 47.4 m-20 -118.89 9.26 11.91 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.447 -0.797 . . . . 1.8200000000000001 110.882 179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.89 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 28.8 mmmt -53.11 -49.75 85.88 Favored Pre-proline 0 N--CA 1.471 0.582 0 N-CA-C 113.252 0.834 . . . . 0.93000000000000005 113.252 -175.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 10.1 Cg_endo -51.74 -38.67 67.2 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.585 2.19 . . . . 0.56999999999999995 112.432 179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 19.4 m -70.82 -42.73 69.85 Favored 'General case' 0 C--O 1.242 0.66 0 CA-C-O 121.625 0.726 . . . . 0.67000000000000004 110.102 -179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.658 ' HE2' ' HB ' ' A' ' 46' ' ' VAL . 15.9 m-30 -70.36 -22.63 62.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.39 -0.823 . . . . 0.92000000000000004 109.86 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -73.84 -43.94 57.14 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-N 115.687 -0.688 . . . . 1.8600000000000001 110.1 175.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.609 ' HA ' ' CE2' ' A' ' 58' ' ' TYR . 39.8 mt-10 -58.14 -33.38 69.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.728 -0.669 . . . . 2.0 111.259 178.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 30.0 mt -85.19 -22.44 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-O 121.241 0.544 . . . . 0.53000000000000003 110.569 177.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -77.83 -55.53 5.25 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.315 -0.402 . . . . 0.42999999999999999 112.009 -175.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.609 ' CE2' ' HA ' ' A' ' 55' ' ' GLU . 23.1 p90 -70.43 -17.14 63.0 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 120.679 -0.408 . . . . 3.0800000000000001 111.509 -172.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.0 p -71.54 -12.61 61.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.106 0.479 . . . . 0.75 111.074 178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 71' ' ' ASN . 87.7 mt -99.92 14.62 29.82 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.75 -0.659 . . . . 1.26 110.648 178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 40.9 m 65.06 88.69 0.11 Allowed Pre-proline 0 C--N 1.333 -0.122 0 CA-C-N 115.509 -0.769 . . . . 1.1100000000000001 111.136 177.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 58' ' ' TYR . 38.2 Cg_endo -74.54 98.74 1.15 Allowed 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.478 2.119 . . . . 0.68999999999999995 112.385 178.513 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 50.3 t -89.9 117.28 32.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.725 -0.472 . . . . 1.4299999999999999 109.725 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 60.6 22.82 12.6 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.223 0.535 . . . . 2.1499999999999999 110.856 -178.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.95 14.35 69.83 Favored Glycine 0 CA--C 1.521 0.462 0 C-N-CA 120.706 -0.759 . . . . 0.62 113.259 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.735 ' HE3' ' HB2' ' A' ' 100' ' ' LEU . 39.5 tttp -147.26 126.36 12.91 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.385 0.593 . . . . 2.2400000000000002 109.459 178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.422 HG12 ' O ' ' A' ' 101' ' ' LEU . 35.3 pt -83.87 146.11 7.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 120.94 0.4 . . . . 0.31 110.552 -177.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.639 ' HA ' HD22 ' A' ' 100' ' ' LEU . 68.6 p -80.48 159.53 25.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.795 -0.639 . . . . 0.52000000000000002 111.314 -177.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.41 -22.3 67.41 Favored Glycine 0 N--CA 1.45 -0.404 0 CA-C-N 115.957 -0.565 . . . . 0.38 112.845 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.04 -49.75 74.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.372 0.606 . . . . 0.40000000000000002 111.332 177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.459 ' HB3' ' HB3' ' A' ' 60' ' ' LEU . 39.5 m-80 -73.36 -38.05 65.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.515 -0.766 . . . . 1.73 111.18 -175.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.51 -30.93 69.85 Favored 'General case' 0 C--N 1.318 -0.78 0 C-N-CA 120.496 -0.482 . . . . 0.35999999999999999 109.862 176.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -62.64 -48.96 77.05 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 116.537 -0.301 . . . . 0.60999999999999999 110.704 176.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.658 ' HD3' ' N ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -64.91 -31.96 73.44 Favored 'General case' 0 C--O 1.227 -0.119 0 C-N-CA 120.482 -0.487 . . . . 2.2400000000000002 111.123 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.658 ' N ' ' HD3' ' A' ' 74' ' ' LYS . 7.5 tp10 -67.57 -45.12 76.5 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-O 121.32 0.581 . . . . 0.81999999999999995 109.914 -179.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.469 ' HB3' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -64.99 -46.55 80.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.381 -0.827 . . . . 1.04 111.547 -178.17 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.3 m -71.04 -30.38 40.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.946 -0.302 . . . . 1.02 111.558 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.9 mtpp -80.48 -11.31 59.69 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 122.101 -0.374 . . . . 3.04 110.602 177.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 7.9 t -74.22 -11.44 60.29 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.893 -0.78 . . . . 0.85999999999999999 108.893 171.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 80' ' ' LYS . 72.4 mmtt 66.4 35.11 5.87 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 115.249 -0.887 . . . . 2.0499999999999998 112.208 175.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.597 ' HB2' HD21 ' A' ' 86' ' ' LEU . 89.7 mt -100.7 144.85 29.31 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.867 -0.79 . . . . 1.3400000000000001 108.867 171.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.402 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 52.1 Cg_exo -55.35 142.65 79.21 Favored 'Trans proline' 0 C--O 1.234 0.291 0 C-N-CA 122.587 2.191 . . . . 0.62 112.241 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -56.23 -34.14 66.05 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.149 -0.478 . . . . 0.93999999999999995 111.28 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . 0.502 ' O ' ' HG3' ' A' ' 88' ' ' LYS . 6.2 m -59.62 -48.52 81.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.198 0.523 . . . . 0.58999999999999997 110.496 177.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.632 ' O ' HG12 ' A' ' 89' ' ' ILE . 58.7 t -63.05 -43.29 98.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 115.716 -0.674 . . . . 0.40000000000000002 109.968 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.597 HD21 ' HB2' ' A' ' 81' ' ' LEU . 78.9 mt -59.36 -43.94 92.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.746 -0.661 . . . . 1.25 110.685 178.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -60.04 -34.38 83.33 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.982 -0.627 . . . . 0.34000000000000002 112.069 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 84' ' ' THR . 27.9 mtpp -72.62 -45.32 59.64 Favored 'General case' 0 C--O 1.238 0.498 0 CA-C-O 120.83 0.348 . . . . 1.1599999999999999 110.23 179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.632 HG12 ' O ' ' A' ' 85' ' ' VAL . 42.7 mm -56.37 -49.39 77.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.725 -0.671 . . . . 0.89000000000000001 110.107 178.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 19.1 t-105 -66.79 -41.16 88.1 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.086 -0.506 . . . . 0.34999999999999998 110.524 -178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -55.81 -29.23 59.42 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.696 -0.683 . . . . 1.3799999999999999 110.695 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.488 HD12 HD22 ' A' ' 122' ' ' LEU . 82.8 mt -91.86 -42.95 9.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.788 -0.642 . . . . 1.53 112.056 178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.09 -40.29 95.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.42999999999999999 111.779 -171.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 51.1 t0 -92.05 94.23 9.14 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.983 -0.747 . . . . 0.58999999999999997 108.983 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 22.0 t -75.5 -48.94 28.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.267 -0.879 . . . . 1.49 111.24 -172.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.624 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 4.4 p30 -83.93 -9.97 58.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.599 -0.728 . . . . 1.45 112.051 -174.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt 73.45 76.4 0.13 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.641 0.608 . . . . 2.6699999999999999 112.641 171.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.652 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 3.8 m-20 -104.31 -44.85 4.84 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.456 0.646 . . . . 1.1299999999999999 110.226 178.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 98.69 2.35 57.43 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.34 -1.104 . . . . 0.42999999999999999 110.34 -167.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.735 ' HB2' ' HE3' ' A' ' 66' ' ' LYS . 36.7 mt -131.22 165.02 24.28 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 108.549 -0.908 . . . . 0.45000000000000001 108.549 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.422 ' O ' HG12 ' A' ' 67' ' ' ILE . 96.2 mt -125.56 122.68 37.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.267 0.555 . . . . 0.70999999999999996 111.573 178.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.419 ' OD1' ' HB2' ' A' ' 104' ' ' GLU . 2.1 p30 -87.16 -176.29 5.63 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.74 -0.837 . . . . 1.4199999999999999 108.74 167.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -70.02 -22.79 63.07 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 120.712 -0.395 . . . . 1.73 111.444 -175.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.419 ' HA ' ' HH2' ' A' ' 44' ' ' TRP . 52.2 mt-10 -72.01 -56.77 5.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.14 0.495 . . . . 1.53 109.818 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -68.28 -32.13 72.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.384 -0.826 . . . . 0.81999999999999995 111.086 -176.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -71.49 -29.79 65.21 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.751 -0.463 . . . . 0.37 109.751 176.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -66.52 -39.11 88.47 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-N 116.285 -0.416 . . . . 0.5 110.152 174.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -62.47 -42.57 99.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.035 -0.529 . . . . 1.3200000000000001 110.347 172.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.12 -55.46 30.85 Favored 'General case' 0 N--CA 1.462 0.148 0 O-C-N 123.553 0.533 . . . . 0.26000000000000001 110.672 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -63.01 -41.49 99.57 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.78 -0.646 . . . . 1.3600000000000001 111.046 -177.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.618 ' O ' HG23 ' A' ' 115' ' ' VAL . 81.5 t60 -61.52 -45.84 92.48 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.908 -0.317 . . . . 0.67000000000000004 111.187 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 95.5 mt -67.0 -40.66 87.37 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 120.752 0.311 . . . . 0.89000000000000001 111.233 -178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.437 ' O ' ' HG ' ' A' ' 117' ' ' LEU . 80.7 mt -61.41 -42.69 94.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.46000000000000002 109.837 175.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.452 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 52.9 tttp -55.45 -46.2 76.78 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-N 115.754 -0.657 . . . . 2.0699999999999998 110.683 174.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 111' ' ' HIS . 60.4 t -58.2 -44.71 88.37 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 CA-C-O 120.716 0.293 . . . . 0.5 110.702 -179.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.6 mmpt? -65.58 -39.85 92.09 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.153 -0.476 . . . . 1.25 111.465 177.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 93.6 mt -70.68 -26.03 63.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.938 0.399 . . . . 0.93999999999999995 110.8 179.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 68.8 mm-40 -71.02 -18.2 62.59 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.201 -0.454 . . . . 1.6499999999999999 110.559 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 105.23 -13.16 48.44 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.859 -0.686 . . . . 0.80000000000000004 112.007 -178.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -85.17 172.8 10.91 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.885 -0.413 . . . . 1.0600000000000001 109.885 -175.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -121.41 134.39 55.1 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.899 0.38 . . . . 3.6000000000000001 110.906 -176.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.537 HD21 HD13 ' A' ' 89' ' ' ILE . 0.4 OUTLIER -74.97 139.9 73.5 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.96 -0.564 . . . . 1.51 109.747 175.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 122' ' ' LEU . 3.7 Cg_exo -76.85 1.32 8.72 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.911 2.407 . . . . 1.01 113.236 -173.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 61.75 20.38 11.34 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-O 121.549 0.69 . . . . 0.87 110.36 -174.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.512 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 12.2 t70 -130.53 131.91 45.31 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.08 -0.964 . . . . 1.9399999999999999 109.399 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 89.4 mt -91.99 103.22 7.63 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.244 -0.435 . . . . 0.67000000000000004 110.439 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 125' ' ' ASP . 2.5 Cg_endo -81.45 158.56 19.57 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 122.937 2.425 . . . . 0.75 111.897 -178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -56.44 -20.62 33.88 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.992 2.461 . . . . 0.70999999999999996 113.426 -178.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.458 ' HA ' ' CG1' ' A' ' 42' ' ' VAL . 10.5 p-80 -91.27 11.93 21.93 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.923 -0.311 . . . . 0.93999999999999995 111.29 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.43 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 37.8 mt -128.43 -21.41 3.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.555 -0.293 . . . . 0.82999999999999996 110.878 174.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 30.4 m -100.48 128.49 30.1 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-O 120.825 0.345 . . . . 1.4399999999999999 110.762 178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 32.6 Cg_exo -62.16 154.09 65.13 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 122.624 2.216 . . . . 1.22 111.349 176.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 52.5 Cg_exo -55.02 -29.53 65.4 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.819 2.346 . . . . 1.8600000000000001 112.37 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.4 m -58.83 -32.47 69.43 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.017 -0.538 . . . . 2.0699999999999998 111.029 178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 12.6 mptt -97.46 7.08 47.19 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.438 -0.346 . . . . 1.27 111.218 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -100.1 151.69 21.1 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 3.0699999999999998 111.301 -177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -100.63 158.98 15.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.941 -0.572 . . . . 5.46 110.221 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 74.6 t60 -133.76 129.16 36.24 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.397 -0.365 . . . . 5.7999999999999998 110.231 175.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 . . . . . 0 C--O 1.251 1.16 0 CA-C-O 118.823 -0.608 . . . . 6.9299999999999997 109.876 174.499 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 N--CA 1.484 1.249 0 CA-C-O 121.26 0.552 . . . . 10.57 110.479 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -111.05 162.72 14.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.589 -0.732 . . . . 8.0399999999999991 110.396 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 96.9 p 54.19 -166.04 0.09 Allowed 'General case' 0 N--CA 1.474 0.744 0 O-C-N 124.029 0.831 . . . . 5.1100000000000003 111.547 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . . . . . . . . . 43.9 mttp 63.27 92.79 0.06 OUTLIER Pre-proline 0 N--CA 1.465 0.303 0 CA-C-N 116.017 -0.538 . . . . 6.7000000000000002 111.373 175.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -73.85 -173.66 1.46 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.925 2.417 . . . . 1.96 112.543 -177.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -87.54 -11.25 49.35 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.908 -0.587 . . . . 0.89000000000000001 110.365 -177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.595 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 52.2 t-20 -97.62 113.7 63.87 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.588 -0.733 . . . . 0.42999999999999999 110.081 -178.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 10.0 Cg_exo -72.66 -7.34 20.65 Favored 'Trans proline' 0 C--N 1.343 0.261 0 C-N-CA 123.421 2.747 . . . . 0.51000000000000001 112.862 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -107.15 5.65 28.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.317 0.579 . . . . 0.5 109.861 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.595 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 23.0 tt0 -130.36 26.65 5.1 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.188 -0.915 . . . . 1.4199999999999999 108.643 -175.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -91.46 138.81 31.28 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.002 -0.999 . . . . 1.71 111.274 -177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 67.25 -175.56 0.2 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.371 -0.831 . . . . 4.8099999999999996 112.32 177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 62.2 mm-40 -119.58 -62.21 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.741 -0.663 . . . . 5.9800000000000004 111.259 -178.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 55.64 41.48 30.47 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.57 0.7 . . . . 7.1900000000000004 111.051 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.25 1.103 0 CA-C-N 115.002 -0.999 . . . . 7.3200000000000003 110.169 178.827 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.652 'CA ' ' OD1' ' A' ' 98' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.827 0 N-CA-C 112.162 -0.375 . . . . 11.68 112.162 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -74.39 102.31 1.53 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.619 2.212 . . . . 11.24 111.726 176.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 91.5 mt -66.41 121.46 15.34 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.896 -0.593 . . . . 8.6199999999999992 111.642 -176.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -98.32 117.98 6.0 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.759 -0.734 . . . . 6.6399999999999997 111.785 177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.7 t -129.48 115.85 18.09 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.801 0.334 . . . . 5.8499999999999996 110.392 -178.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -92.07 95.04 9.55 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.256 -0.646 . . . . 4.0099999999999998 109.256 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -77.31 121.8 24.23 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.451 0.643 . . . . 3.8599999999999999 109.815 179.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.464 HG11 ' HB3' ' A' ' 129' ' ' HIS . 24.7 t -98.17 133.59 39.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.673 -0.694 . . . . 1.8400000000000001 110.66 -176.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -72.56 139.65 47.63 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.06 -0.518 . . . . 3.02 110.427 178.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . 0.468 ' HZ2' ' HG ' ' A' ' 108' ' ' LEU . 13.9 t90 -70.32 101.95 2.03 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.512 -0.921 . . . . 0.84999999999999998 108.512 175.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 96.4 t -48.56 -33.35 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 CA-C-N 115.497 -0.774 . . . . 1.24 112.848 -171.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.59 HG21 HD23 ' A' ' 108' ' ' LEU . 58.8 t -67.6 -22.71 28.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.252 -0.431 . . . . 1.3 111.722 -175.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.61 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -66.28 -22.37 70.95 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.455 -0.878 . . . . 0.62 111.503 176.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -78.54 -21.32 48.94 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.235 0.54 . . . . 2.9900000000000002 110.889 -176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -119.72 15.13 12.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.73 0.776 . . . . 1.8200000000000001 109.761 -177.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.61 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 2.4 mmmm -54.04 -45.03 99.17 Favored Pre-proline 0 CA--C 1.537 0.462 0 CA-C-N 115.1 -0.955 . . . . 0.93000000000000005 113.343 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 9.6 Cg_endo -48.42 -40.72 36.53 Favored 'Trans proline' 0 C--N 1.361 1.186 0 C-N-CA 122.739 2.292 . . . . 0.56999999999999995 113.15 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.8 m -69.66 -43.99 71.43 Favored 'General case' 0 C--O 1.243 0.728 0 CA-C-O 121.611 0.72 . . . . 0.67000000000000004 110.276 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.481 ' CE2' HG13 ' A' ' 46' ' ' VAL . 12.0 m-85 -71.01 -22.51 62.15 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.342 -0.844 . . . . 0.92000000000000004 109.878 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.25 -45.17 66.99 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 109.189 -0.671 . . . . 1.8600000000000001 109.189 178.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -56.3 -47.5 78.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 114.758 -1.11 . . . . 2.0 111.379 177.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 46.3 mt -75.31 -37.86 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.728 0.299 . . . . 0.53000000000000003 111.282 -176.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -59.65 -52.28 66.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.327 -0.397 . . . . 0.42999999999999999 111.431 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 52.7 m-85 -71.15 -21.03 62.24 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.299 0.481 . . . . 3.0800000000000001 112.299 -175.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 21.4 p -78.92 -3.32 44.25 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.425 -0.51 . . . . 0.75 111.679 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.0 mt -100.96 7.58 43.5 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.941 0.401 . . . . 1.26 110.469 176.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.0 m 59.18 84.7 0.2 Allowed Pre-proline 0 N--CA 1.465 0.285 0 CA-C-N 115.475 -0.784 . . . . 1.1100000000000001 112.12 176.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -77.91 142.69 20.08 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.09 2.527 . . . . 0.68999999999999995 112.309 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 47.3 t -114.07 118.98 60.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.609 -0.515 . . . . 1.4299999999999999 109.609 178.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 59.98 27.21 16.58 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.088 -0.505 . . . . 2.1499999999999999 111.49 -178.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 94.17 -3.42 69.69 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 121.001 -0.619 . . . . 0.62 114.003 175.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.63 ' HE3' ' N ' ' A' ' 102' ' ' ASP . 30.5 mtpt -131.1 149.21 52.7 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-N 117.901 0.85 . . . . 2.2400000000000002 110.776 177.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.421 HD11 ' CD1' ' A' ' 106' ' ' PHE . 43.2 pt -101.95 157.89 4.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 116.002 -0.545 . . . . 0.31 110.079 178.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.9 p -86.78 161.96 18.09 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.526 -0.761 . . . . 0.52000000000000002 110.915 -178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -64.88 -27.39 72.07 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.645 -0.707 . . . . 0.38 112.883 -178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.34 -53.59 55.53 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.097 0.475 . . . . 0.40000000000000002 111.866 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.466 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 45.0 m-80 -73.6 -34.32 65.01 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.021 -0.536 . . . . 1.73 111.094 -173.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 76' ' ' MET . . . -73.44 -29.17 62.38 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.346 -0.388 . . . . 0.35999999999999999 110.275 177.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.559 ' HA ' ' HZ ' ' B' ' 151' ' ' PHE . 39.3 ttmt -66.4 -51.16 59.95 Favored 'General case' 0 C--N 1.334 -0.068 0 CA-C-O 120.702 0.287 . . . . 0.60999999999999999 110.263 176.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.466 ' HD3' ' HA ' ' A' ' 71' ' ' ASN . 17.3 ptmt -63.26 -35.75 81.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.365 -0.379 . . . . 2.2400000000000002 111.731 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -67.4 -45.9 74.81 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-O 121.521 0.677 . . . . 0.81999999999999995 109.815 175.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.716 ' SD ' HD11 ' A' ' 113' ' ' ILE . 7.7 tpp -59.62 -42.4 92.61 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.392 -0.822 . . . . 1.04 111.077 -177.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.3 m -74.2 -30.39 26.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 CA-C-O 120.819 0.342 . . . . 1.02 110.663 -178.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -69.47 -17.9 63.66 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.913 -0.315 . . . . 3.04 110.983 176.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.4 m -73.83 -8.56 56.53 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.429 -0.35 . . . . 0.85999999999999999 111.053 176.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 31.4 mmtm 73.17 21.36 3.13 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 113.658 0.985 . . . . 2.0499999999999998 113.658 172.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.413 ' HB2' HD11 ' A' ' 86' ' ' LEU . 2.7 mm? -95.3 148.82 35.25 Favored Pre-proline 0 C--N 1.32 -0.682 0 C-N-CA 120.602 -0.439 . . . . 1.3400000000000001 109.822 174.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.592 ' O ' HD13 ' A' ' 86' ' ' LEU . 32.9 Cg_exo -60.1 151.95 69.04 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.982 2.454 . . . . 0.62 112.432 176.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -57.67 -33.14 68.02 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.424 -0.353 . . . . 0.93999999999999995 111.244 -177.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.34 -38.68 80.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.437 0.637 . . . . 0.58999999999999997 110.514 176.689 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.531 ' O ' HG13 ' A' ' 89' ' ' ILE . 57.3 t -75.83 -39.6 38.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.754 -0.832 . . . . 0.40000000000000002 108.754 -177.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.652 ' HG ' ' CG ' ' A' ' 76' ' ' MET . 3.6 mp -60.76 -44.82 96.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.997 -1.001 . . . . 1.25 111.16 176.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.623 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -61.92 -35.35 91.24 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.888 -0.672 . . . . 0.34000000000000002 111.784 176.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.715 ' HD3' ' HB2' ' A' ' 122' ' ' LEU . 38.6 ttmt -71.48 -45.39 62.64 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.188 0.518 . . . . 1.1599999999999999 110.063 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.691 HG23 ' HB2' ' A' ' 112' ' ' LEU . 72.0 mt -61.44 -50.77 79.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.539 -0.755 . . . . 0.89000000000000001 110.692 178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 20.2 t-105 -60.32 -43.04 96.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.89 -0.595 . . . . 0.34999999999999998 110.67 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -69.13 -25.2 64.27 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.92 -0.312 . . . . 1.3799999999999999 111.244 -175.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.34 -43.78 55.15 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.344 0.592 . . . . 1.53 110.026 172.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.505 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -66.97 -42.63 84.82 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.196 -0.911 . . . . 0.42999999999999999 111.411 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.647 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 27.9 t0 -95.89 62.14 2.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.8 0.809 . . . . 0.58999999999999997 109.348 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.569 HG13 ' HG2' ' A' ' 135' ' ' LYS . 3.0 p -64.66 -28.09 44.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 114.543 -1.208 . . . . 1.49 111.575 -177.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.618 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 3.9 p30 -86.99 -10.94 51.95 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.997 -0.547 . . . . 1.45 111.795 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.439 ' HD2' ' O ' ' A' ' 94' ' ' ASP . 1.3 mptm? 56.17 73.64 0.43 Allowed 'General case' 0 C--O 1.235 0.306 0 C-N-CA 122.715 0.406 . . . . 2.6699999999999999 112.062 178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.634 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 5.4 p-10 -120.32 -20.94 7.09 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.478 -0.328 . . . . 1.1299999999999999 110.753 178.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 100.5 -18.99 54.44 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.706 -0.759 . . . . 0.42999999999999999 113.444 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.424 ' HB2' ' HE2' ' A' ' 66' ' ' LYS . 86.6 mt -110.21 169.03 9.0 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.013 0.406 . . . . 0.45000000000000001 109.985 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.471 ' HB3' ' HB2' ' A' ' 106' ' ' PHE . 76.3 mt -124.52 114.93 20.07 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.565 -0.454 . . . . 0.70999999999999996 110.952 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.63 ' N ' ' HE3' ' A' ' 66' ' ' LYS . 1.0 OUTLIER -84.85 -175.78 5.93 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.119 -0.697 . . . . 1.4199999999999999 109.119 171.473 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 p-10 -62.27 -32.93 73.71 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.882 -0.327 . . . . 1.73 110.713 -175.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -74.88 -52.29 11.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.766 0.317 . . . . 1.53 110.637 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.547 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 31.5 mt-10 -62.18 -47.36 84.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.345 -0.389 . . . . 0.81999999999999995 111.606 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.471 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 92.4 t80 -63.78 -37.1 86.11 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.987 0.422 . . . . 0.37 110.469 -179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -61.79 -39.05 90.36 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.843 -0.617 . . . . 0.5 110.778 177.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.59 HD23 HG21 ' A' ' 46' ' ' VAL . 26.1 mt -64.08 -41.52 97.3 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 1.3200000000000001 110.632 174.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 113' ' ' ILE . . . -54.94 -52.4 63.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.257 0.551 . . . . 0.26000000000000001 110.281 176.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . 0.415 HD22 ' N ' ' A' ' 110' ' ' ASN . 0.9 OUTLIER -69.0 -21.78 64.12 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.848 -0.614 . . . . 1.3600000000000001 110.912 -177.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.609 ' O ' HG23 ' A' ' 115' ' ' VAL . 9.5 t60 -60.52 -61.2 2.77 Favored 'General case' 0 CA--C 1.509 -0.615 0 CA-C-O 121.18 0.514 . . . . 0.67000000000000004 109.626 174.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.691 ' HB2' HG23 ' A' ' 89' ' ' ILE . 3.7 mm? -60.17 -34.9 74.23 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.73 -1.123 . . . . 0.89000000000000001 110.76 -176.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.716 HD11 ' SD ' ' A' ' 76' ' ' MET . 86.7 mt -60.75 -46.88 95.27 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.242 -0.436 . . . . 0.46000000000000002 110.484 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.414 ' HA ' HD12 ' A' ' 117' ' ' LEU . 36.6 ttmt -63.06 -36.41 83.49 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.429 -0.351 . . . . 2.0699999999999998 111.162 179.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 111' ' ' HIS . 14.1 t -62.74 -36.97 77.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.063 0.459 . . . . 0.5 109.793 177.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 46.7 mmtt -72.14 -28.11 63.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 1.25 111.135 175.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 113' ' ' ILE . 95.4 mt -68.98 -20.59 64.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.125 0.488 . . . . 0.93999999999999995 110.326 176.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -87.75 -1.12 57.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.185 0.516 . . . . 1.6499999999999999 110.396 172.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 73.74 35.44 54.89 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.783 -0.644 . . . . 0.80000000000000004 112.203 -178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.482 ' HB2' HG12 ' A' ' 115' ' ' VAL . 20.4 m-70 -99.49 -171.84 2.14 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.196 0.522 . . . . 1.0600000000000001 111.99 -179.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -118.59 152.06 36.72 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.376 -0.829 . . . . 3.6000000000000001 110.638 -174.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.715 ' HB2' ' HD3' ' A' ' 88' ' ' LYS . 5.1 mt -118.74 122.04 30.19 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.852 -0.425 . . . . 1.51 109.852 177.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -80.45 -11.79 12.91 Favored 'Trans proline' 0 C--N 1.334 -0.22 0 C-N-CA 123.458 2.772 . . . . 1.01 112.698 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.584 ' HB2' ' HE2' ' A' ' 88' ' ' LYS . . . 65.98 19.29 11.22 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.838 -0.619 . . . . 0.87 110.896 -176.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . 0.425 ' O ' ' HD3' ' A' ' 127' ' ' PRO . 10.7 m-20 -107.0 137.34 45.25 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.849 -0.614 . . . . 1.9399999999999999 110.573 177.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . . . . . . . . . 80.4 mt -95.89 109.53 46.96 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-N 115.934 -0.575 . . . . 0.67000000000000004 111.21 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.791 ' HD2' ' HB2' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -83.72 160.62 14.3 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.504 2.803 . . . . 0.75 111.61 176.131 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.84 -25.38 76.31 Favored 'Trans proline' 0 CA--C 1.531 0.371 0 C-N-CA 122.709 2.272 . . . . 0.70999999999999996 113.057 -177.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . 0.464 ' HB3' HG11 ' A' ' 42' ' ' VAL . 12.1 p-80 -89.46 8.6 30.14 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.943 -0.303 . . . . 0.93999999999999995 111.586 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.791 ' HB2' ' HD2' ' A' ' 127' ' ' PRO . 30.0 mt -123.45 -19.54 5.86 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.734 -0.212 . . . . 0.82999999999999996 111.204 176.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 53.4 t -87.5 108.96 22.52 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 120.983 0.42 . . . . 1.4399999999999999 110.198 176.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.452 ' HA ' ' HD3' ' A' ' 133' ' ' PRO . 10.2 Cg_exo -69.81 146.75 60.84 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 122.789 2.326 . . . . 1.22 111.933 -177.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 36.2 Cg_exo -59.85 -22.45 68.38 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.016 2.477 . . . . 1.8600000000000001 111.965 178.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 23.2 t -64.93 -19.91 66.18 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.856 -0.611 . . . . 2.0699999999999998 110.801 178.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.569 ' HG2' HG13 ' A' ' 95' ' ' VAL . 2.5 mptp? -110.35 18.74 19.54 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.904 0.383 . . . . 1.27 110.621 179.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 14.0 mmm180 -95.33 123.63 38.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.855 0.36 . . . . 3.0699999999999998 111.148 179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -82.18 106.05 13.76 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.078 0.465 . . . . 5.46 111.453 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 18.7 t60 -110.67 107.26 16.77 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.648 -0.871 . . . . 5.7999999999999998 108.648 172.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 C--O 1.251 1.148 0 CA-C-O 118.332 -0.842 . . . . 6.9299999999999997 110.208 -177.061 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 N--CA 1.481 1.103 0 CA-C-O 120.974 0.416 . . . . 10.57 109.908 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -91.52 143.26 26.77 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-O 121.159 0.504 . . . . 8.0399999999999991 111.101 -171.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 19.6 t -145.74 80.61 1.59 Allowed 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.357 -0.979 . . . . 5.1100000000000003 108.357 171.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 0.473 ' HA ' ' HD3' ' B' ' 147' ' ' PRO . 21.4 pttp -91.38 146.64 33.75 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.614 -0.721 . . . . 6.7000000000000002 109.777 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' B' ' 146' ' ' LYS . 12.1 Cg_exo -69.56 -179.74 3.03 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.793 2.328 . . . . 1.96 112.824 -175.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -107.08 2.72 25.17 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.499 -0.773 . . . . 0.89000000000000001 109.404 -175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.623 HD21 ' HA2' ' A' ' 87' ' ' GLY . 51.7 t-20 -102.34 118.9 57.83 Favored Pre-proline 0 C--N 1.32 -0.713 0 CA-C-N 115.021 -0.99 . . . . 0.42999999999999999 109.814 -179.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 18.9 Cg_exo -67.45 -7.45 19.19 Favored 'Trans proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.504 2.803 . . . . 0.51000000000000001 112.951 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.559 ' HZ ' ' HA ' ' A' ' 73' ' ' LYS . 40.6 m-85 -107.68 4.21 25.52 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.295 0.569 . . . . 0.5 110.081 176.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.604 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 32.8 tt0 -118.5 13.77 13.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.05 -0.977 . . . . 1.4199999999999999 109.393 -174.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -82.97 105.55 14.06 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.584 -0.735 . . . . 1.71 111.846 -176.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 75.3 111.4 0.07 Allowed 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 114.906 -1.043 . . . . 4.8099999999999996 112.023 173.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -147.45 -72.56 0.21 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.391 -0.822 . . . . 5.9800000000000004 109.987 173.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . 0.807 ' HG3' ' H ' ' B' ' 157' ' ' ASP . 4.5 pt-20 -112.84 -74.69 0.62 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.713 -0.676 . . . . 7.1900000000000004 110.509 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 157' ' ' ASP . . . . . 0.807 ' H ' ' HG3' ' B' ' 156' ' ' GLU . 28.2 t70 . . . . . 0 C--O 1.244 0.811 0 CA-C-O 118.155 -0.926 . . . . 7.3200000000000003 109.193 178.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.647 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.422 ' HA2' ' HD3' ' A' ' 36' ' ' PRO . . . . . . . . 0 N--CA 1.48 1.573 0 N-CA-C 111.781 -0.528 . . . . 11.68 111.781 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.422 ' HD3' ' HA2' ' A' ' 35' ' ' GLY . 4.4 Cg_exo -74.85 126.49 10.09 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 123.008 2.472 . . . . 11.24 112.208 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 7.2 mp -96.2 148.74 22.4 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.9 0.381 . . . . 8.6199999999999992 110.577 178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.63 130.91 10.42 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.97 -0.852 . . . . 6.6399999999999997 110.97 175.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 6.8 m -71.29 111.78 6.9 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.872 0.367 . . . . 5.8499999999999996 110.538 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -94.61 92.24 6.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.864 0.364 . . . . 4.0099999999999998 110.765 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -144.56 120.62 10.74 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.287 0.565 . . . . 3.8599999999999999 109.69 172.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 12.2 p -124.08 156.63 31.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.472 -0.785 . . . . 1.8400000000000001 110.046 -173.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.422 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 1.3 pm0 -74.58 105.25 5.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.252 0.549 . . . . 3.02 110.954 178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TRP . . . . . . . . . . . . . 1.3 t90 -82.35 99.31 9.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.83 -0.804 . . . . 0.84999999999999998 108.83 176.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.7 t -57.5 -40.66 76.01 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 N-CA-C 113.614 0.968 . . . . 1.24 113.614 -167.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.5 HG12 ' CG ' ' A' ' 111' ' ' HIS . 5.3 m -69.87 -10.76 14.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 C-N-CA 120.893 -0.323 . . . . 1.3 111.723 -171.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.767 ' HA2' ' HG2' ' A' ' 50' ' ' LYS . . . -69.53 -15.94 71.22 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.745 -0.741 . . . . 0.62 111.895 177.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.9 tppt? -78.33 -28.2 47.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.831 0.348 . . . . 2.9900000000000002 110.628 -178.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 23.1 t0 -121.16 23.4 10.56 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.538 0.685 . . . . 1.8200000000000001 109.959 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.767 ' HG2' ' HA2' ' A' ' 47' ' ' GLY . 4.4 mmmp? -52.61 -41.98 86.17 Favored Pre-proline 0 C--O 1.218 -0.556 0 CA-C-N 115.342 -0.845 . . . . 0.93000000000000005 112.942 177.032 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 50' ' ' LYS . 7.8 Cg_endo -48.8 -43.31 35.14 Favored 'Trans proline' 0 C--N 1.362 1.252 0 C-N-CA 122.582 2.188 . . . . 0.56999999999999995 112.671 178.218 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.583 ' O ' HG13 ' A' ' 56' ' ' ILE . 14.3 m -70.18 -44.58 68.46 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.035 0.445 . . . . 0.67000000000000004 110.889 -178.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.5 m-85 -71.07 -22.74 62.08 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.352 0.596 . . . . 0.92000000000000004 109.809 -178.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.414 ' O ' ' HD1' ' A' ' 58' ' ' TYR . 9.3 t70 -73.67 -44.3 57.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.031 -0.986 . . . . 1.8600000000000001 108.85 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -55.31 -53.44 56.16 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 114.916 -1.038 . . . . 2.0 110.318 176.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.583 HG13 ' O ' ' A' ' 52' ' ' THR . 17.3 mt -64.56 -40.0 87.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 114.962 -1.017 . . . . 0.53000000000000003 110.668 -175.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.455 ' CE2' ' HB3' ' A' ' 62' ' ' PRO . 79.9 t80 -59.03 -38.13 78.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.066 -0.516 . . . . 0.42999999999999999 110.783 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.493 ' HA ' ' HG3' ' A' ' 62' ' ' PRO . 17.5 m-85 -82.07 -22.99 36.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.445 -0.343 . . . . 3.0800000000000001 111.892 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.3 p -77.62 -18.71 56.53 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.14 0.495 . . . . 0.75 111.006 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 9.0 mp -91.08 4.1 53.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.972 -0.558 . . . . 1.26 110.465 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 48.7 m 68.01 91.43 0.07 OUTLIER Pre-proline 0 CA--C 1.529 0.165 0 O-C-N 124.047 0.842 . . . . 1.1100000000000001 111.726 178.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.493 ' HG3' ' HA ' ' A' ' 58' ' ' TYR . 1.9 Cg_endo -81.14 96.36 0.96 Allowed 'Trans proline' 0 N--CA 1.449 -1.132 0 C-N-CA 122.599 2.2 . . . . 0.68999999999999995 111.299 177.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.5 m -86.87 117.44 31.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.34 0.591 . . . . 1.4299999999999999 110.205 -175.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 64.2 23.87 13.25 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 115.231 -0.895 . . . . 2.1499999999999999 110.819 -179.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.48 33.42 19.61 Favored Glycine 0 C--O 1.227 -0.33 0 C-N-CA 120.931 -0.652 . . . . 0.62 113.36 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.521 ' HG2' ' HB2' ' A' ' 100' ' ' LEU . 0.0 OUTLIER -165.08 145.58 7.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.079 -0.711 . . . . 2.2400000000000002 109.079 175.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 43.4 pt -102.69 145.92 11.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 C-N-CA 120.492 -0.483 . . . . 0.31 110.13 175.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.803 ' HA ' HD22 ' A' ' 100' ' ' LEU . 44.3 p -84.91 165.91 17.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.11 0.481 . . . . 0.52000000000000002 111.108 -176.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.2 -17.75 64.13 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.67 -0.695 . . . . 0.38 112.663 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.03 -54.34 22.54 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.113 0.482 . . . . 0.40000000000000002 110.656 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.547 ' HA ' ' HD3' ' A' ' 74' ' ' LYS . 1.0 OUTLIER -69.97 -41.29 74.68 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.769 -0.651 . . . . 1.73 110.593 -174.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.523 ' O ' ' HG2' ' A' ' 76' ' ' MET . . . -68.19 -29.34 68.17 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.012 -0.54 . . . . 0.35999999999999999 110.831 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.542 ' HG3' ' CE1' ' B' ' 151' ' ' PHE . 40.8 ttmt -65.38 -40.22 93.24 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 109.645 -0.502 . . . . 0.60999999999999999 109.645 174.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.596 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 27.2 mtpp -60.1 -43.28 95.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.51 -0.768 . . . . 2.2400000000000002 110.669 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.438 ' HA ' ' OE1' ' A' ' 75' ' ' GLU . 4.2 tp10 -65.74 -44.94 84.45 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 121.344 0.592 . . . . 0.81999999999999995 110.692 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.697 ' HB3' ' HG ' ' A' ' 86' ' ' LEU . 25.6 mmt -56.35 -46.48 79.97 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 115.769 -0.651 . . . . 1.04 111.243 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.7 m -75.3 -17.69 15.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.393 -0.367 . . . . 1.02 110.944 -177.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.596 ' HG3' ' O ' ' A' ' 74' ' ' LYS . 93.4 mttt -70.4 -30.33 67.19 Favored 'General case' 0 CA--C 1.518 -0.278 0 C-N-CA 120.402 -0.519 . . . . 3.04 109.831 172.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 49.0 m -76.3 -9.07 58.36 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.596 -0.729 . . . . 0.85999999999999999 110.999 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.8 mmtm 62.46 26.95 16.04 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.64 0.734 . . . . 2.0499999999999998 110.665 179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.482 ' HB3' HD11 ' A' ' 86' ' ' LEU . 7.9 tp -89.75 137.44 28.5 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-N 115.039 -0.982 . . . . 1.3400000000000001 109.893 -175.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.522 ' O ' HD13 ' A' ' 86' ' ' LEU . 45.1 Cg_exo -55.52 145.46 68.99 Favored 'Trans proline' 0 CA--C 1.531 0.348 0 C-N-CA 123.23 2.62 . . . . 0.62 113.406 -178.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.409 ' HA ' HD22 ' A' ' 86' ' ' LEU . 13.2 m120 -52.75 -39.96 62.67 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-N 115.98 -0.555 . . . . 0.93999999999999995 112.145 -178.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' THR . . . . . . . . . . . . . 8.5 m -58.08 -35.09 70.89 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.3 0.572 . . . . 0.58999999999999997 110.93 179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.625 ' O ' HG12 ' A' ' 89' ' ' ILE . 57.4 t -76.11 -40.96 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 N-CA-C 108.867 -0.79 . . . . 0.40000000000000002 108.867 -176.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.697 ' HG ' ' HB3' ' A' ' 76' ' ' MET . 2.2 mp -57.17 -45.37 83.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.309 -0.859 . . . . 1.25 110.05 175.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.576 ' HA2' HD21 ' B' ' 149' ' ' ASN . . . -56.35 -41.68 87.89 Favored Glycine 0 N--CA 1.446 -0.659 0 CA-C-N 115.746 -0.661 . . . . 0.34000000000000002 112.572 175.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -71.16 -46.41 61.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.979 0.39 . . . . 1.1599999999999999 110.664 -178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ILE . . . . . 0.625 HG12 ' O ' ' A' ' 85' ' ' VAL . 49.0 mm -55.89 -50.86 66.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.76 -0.655 . . . . 0.89000000000000001 110.122 178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TRP . . . . . . . . . . . . . 27.5 t-105 -65.11 -41.98 94.42 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.953 -0.567 . . . . 0.34999999999999998 110.658 -177.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -65.2 -32.62 74.39 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.207 -0.451 . . . . 1.3799999999999999 111.45 -175.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.513 HD22 HD12 ' A' ' 122' ' ' LEU . 8.3 mp -86.75 -41.98 13.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.42 -0.354 . . . . 1.53 111.367 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' A' ' 105' ' ' GLU . . . -64.9 -43.22 93.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.464 -0.335 . . . . 0.42999999999999999 111.797 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . 0.634 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 34.4 t70 -84.7 88.59 7.37 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.536 0.684 . . . . 0.58999999999999997 109.831 178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.0 t -83.16 -38.0 14.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.984 -1.007 . . . . 1.49 111.141 -176.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.581 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 18.5 p-10 -76.82 -17.25 59.13 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.91 -0.586 . . . . 1.45 110.741 -173.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.505 ' HA ' ' OD2' ' A' ' 94' ' ' ASP . 71.8 mmtt 63.16 50.86 2.91 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 115.571 -0.741 . . . . 2.6699999999999999 111.154 178.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.623 ' OD1' 'CA ' ' A' ' 141' ' ' ' CA' . 6.8 p-10 -92.91 -16.48 25.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.583 -0.735 . . . . 1.1299999999999999 109.796 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 94.71 -1.87 66.4 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.745 -0.662 . . . . 0.42999999999999999 112.464 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.803 HD22 ' HA ' ' A' ' 68' ' ' THR . 56.6 mt -128.06 177.75 6.68 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.331 -0.618 . . . . 0.45000000000000001 109.331 179.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 73.2 mt -114.56 113.86 24.97 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.201 0.524 . . . . 0.70999999999999996 110.832 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.478 ' CA ' ' HD3' ' A' ' 66' ' ' LYS . 12.7 t70 -84.81 -177.8 6.68 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.342 -0.845 . . . . 1.4199999999999999 109.21 173.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -66.62 -35.89 81.28 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 118.186 0.448 . . . . 1.73 111.719 -170.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -71.92 -42.61 66.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.225 0.536 . . . . 1.53 110.361 177.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.508 ' OE2' ' HA ' ' A' ' 94' ' ' ASP . 19.2 mt-10 -68.05 -45.15 74.71 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.325 -0.852 . . . . 0.81999999999999995 110.794 -175.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -68.84 -36.51 78.25 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.032 -0.531 . . . . 0.37 110.908 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -62.8 -40.81 98.48 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.903 0.382 . . . . 0.5 110.413 176.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 10.2 mt -66.99 -36.29 81.84 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.021 -0.536 . . . . 1.3200000000000001 110.545 175.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.85 -52.34 65.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.24 -0.436 . . . . 0.26000000000000001 110.455 175.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -61.42 -39.65 91.53 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 120.691 0.281 . . . . 1.3600000000000001 110.661 178.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.609 ' O ' HG23 ' A' ' 115' ' ' VAL . 83.5 t60 -59.74 -47.79 84.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.163 -0.472 . . . . 0.67000000000000004 110.807 179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.756 HD13 HD13 ' A' ' 122' ' ' LEU . 96.3 mt -64.53 -41.81 96.15 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.367 -0.379 . . . . 0.89000000000000001 111.116 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.4 mt -60.75 -40.68 85.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.133 0.492 . . . . 0.46000000000000002 109.713 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.651 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 59.7 tttp -59.31 -42.11 90.61 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.715 -0.675 . . . . 2.0699999999999998 110.428 174.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 111' ' ' HIS . 25.5 t -56.79 -40.15 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.32 0 CA-C-O 120.816 0.341 . . . . 0.5 110.116 178.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.563 ' HA ' ' O ' ' A' ' 120' ' ' HIS . 2.3 mmmp? -60.68 -45.49 93.96 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.143 -0.48 . . . . 1.25 109.912 175.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 80.6 mt -67.9 -25.2 65.37 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.555 -0.748 . . . . 0.93999999999999995 111.07 -179.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 114' ' ' LYS . 45.0 mm-40 -70.85 -21.71 62.4 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.348 -0.387 . . . . 1.6499999999999999 110.461 176.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 111.62 12.54 14.57 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.0 -0.619 . . . . 0.80000000000000004 112.38 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.563 ' O ' ' HA ' ' A' ' 116' ' ' LYS . 29.6 m-70 -121.4 -179.35 4.04 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.553 -0.536 . . . . 1.0600000000000001 109.553 -177.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.469 ' HA ' ' HD2' ' A' ' 116' ' ' LYS . 0.3 OUTLIER -140.44 160.18 40.56 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 110.048 -0.353 . . . . 3.6000000000000001 110.048 174.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.756 HD13 HD13 ' A' ' 112' ' ' LEU . 0.2 OUTLIER -92.69 123.94 60.26 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.46 -0.336 . . . . 1.51 110.238 -177.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.38 15.42 0.27 Allowed 'Trans proline' 0 N--CA 1.48 0.695 0 C-N-CA 123.934 3.089 . . . . 1.01 114.229 -169.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . 67.01 18.34 10.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.386 0.612 . . . . 0.87 110.489 -177.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -118.57 147.59 43.55 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 115.375 -0.829 . . . . 1.9399999999999999 109.506 176.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.676 ' HB3' ' HB ' ' A' ' 131' ' ' VAL . 96.2 mt -101.31 97.81 8.0 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 116.574 -0.285 . . . . 0.67000000000000004 110.432 172.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.5 147.97 87.26 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.217 1.945 . . . . 0.75 111.416 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -51.53 -27.45 25.18 Favored 'Trans proline' 0 CA--C 1.53 0.308 0 C-N-CA 123.295 2.663 . . . . 0.70999999999999996 114.173 -176.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' HIS . . . . . . . . . . . . . 42.9 p-80 -85.01 7.58 20.85 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.061 0.458 . . . . 0.93999999999999995 111.247 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 77.8 mt -132.39 -31.46 1.41 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.215 -0.448 . . . . 0.82999999999999996 111.327 178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.676 ' HB ' ' HB3' ' A' ' 126' ' ' LEU . 7.7 p -82.95 123.42 77.77 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 121.117 0.484 . . . . 1.4399999999999999 110.923 178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' PRO . . . . . 0.728 ' HB2' ' HD3' ' A' ' 135' ' ' LYS . 44.4 Cg_exo -57.02 130.0 37.47 Favored 'Trans proline' 0 CA--C 1.531 0.375 0 C-N-CA 122.934 2.423 . . . . 1.22 112.123 177.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 132' ' ' PRO . 33.3 Cg_exo -58.61 -27.53 83.08 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 123.613 2.875 . . . . 1.8600000000000001 112.933 -175.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 46.7 t -67.11 -27.14 67.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.172 -0.467 . . . . 2.0699999999999998 111.137 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.728 ' HD3' ' HB2' ' A' ' 132' ' ' PRO . 12.8 mptt -96.29 29.69 2.76 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.089 -0.505 . . . . 1.27 111.021 -175.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -101.6 112.0 24.43 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.161 0.505 . . . . 3.0699999999999998 111.409 -179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -112.02 158.56 19.4 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.651 -0.704 . . . . 5.46 109.87 176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -99.97 114.64 28.06 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.85 0.357 . . . . 5.7999999999999998 111.672 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 . . . . . 0 C--O 1.25 1.082 0 CA-C-N 115.284 -0.871 . . . . 6.9299999999999997 109.683 174.461 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 143' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.734 -0.469 . . . . 10.57 109.734 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 144' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -119.46 166.51 13.01 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.016 -0.538 . . . . 8.0399999999999991 110.592 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 145' ' ' SER . . . . . . . . . . . . . 16.3 m -106.88 -165.27 1.06 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.133 -0.485 . . . . 5.1100000000000003 110.936 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 146' ' ' LYS . . . . . 0.418 ' HB3' ' HE2' ' B' ' 146' ' ' LYS . 49.8 mtpt -117.73 157.98 46.65 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.115 -0.493 . . . . 6.7000000000000002 110.426 176.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 147' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.62 169.67 18.19 Favored 'Trans proline' 0 CA--C 1.53 0.297 0 C-N-CA 122.518 2.145 . . . . 1.96 112.374 175.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 148' ' ' TYR . . . . . . . . . . . . . 13.2 m-85 -89.13 -13.66 37.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.018 -0.537 . . . . 0.89000000000000001 110.288 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 149' ' ' ASN . . . . . 0.665 ' HB3' ' HB3' ' B' ' 152' ' ' GLU . 34.1 t-20 -96.2 114.92 65.19 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 115.412 -0.813 . . . . 0.42999999999999999 111.101 -171.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 150' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' B' ' 149' ' ' ASN . 10.4 Cg_exo -72.08 -2.65 11.9 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.351 2.701 . . . . 0.51000000000000001 113.007 -176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 151' ' ' PHE . . . . . 0.542 ' CE1' ' HG3' ' A' ' 73' ' ' LYS . 68.8 m-85 -107.02 -23.34 12.36 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.511 0.672 . . . . 0.5 110.333 175.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . 0.665 ' HB3' ' HB3' ' B' ' 149' ' ' ASN . 41.7 tt0 -109.46 22.38 15.85 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 114.975 -1.011 . . . . 1.4199999999999999 109.397 -173.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 153' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.0 142.96 56.2 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.401 -0.818 . . . . 1.71 110.731 176.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 154' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 74.3 79.28 0.12 Allowed 'General case' 0 C--O 1.234 0.287 0 O-C-N 124.046 0.841 . . . . 4.8099999999999996 110.654 175.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 155' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -106.57 161.32 14.73 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.439 -0.8 . . . . 5.9800000000000004 110.284 177.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 156' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -119.3 -66.87 1.03 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.393 -0.595 . . . . 7.1900000000000004 109.393 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 157' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 . . . . . 0 C--O 1.248 1.016 0 CA-C-N 115.359 -0.837 . . . . 7.3200000000000003 109.477 173.33 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ' CA' . . . . . 0.634 'CA ' ' OD1' ' A' ' 94' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_